<SEC-DOCUMENT>0001178913-17-002404.txt : 20170814
<SEC-HEADER>0001178913-17-002404.hdr.sgml : 20170814
<ACCEPTANCE-DATETIME>20170814091625
ACCESSION NUMBER:		0001178913-17-002404
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		50
CONFORMED PERIOD OF REPORT:	20170630
FILED AS OF DATE:		20170814
DATE AS OF CHANGE:		20170814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Integrity Applications, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54785
		FILM NUMBER:		171027595

	BUSINESS ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zk1720396.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">UNITED STATES</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Washington, D.C. 20549</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Form 10-Q</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Mark One)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-WEIGHT: bold">Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">For the Quarterly Period Ended June 30, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">OR</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-WEIGHT: bold">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">For the Transition Period from ________ to________.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Commission file number:&#160; 000-54785</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>

<div style="FONT-SIZE: 16pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Exact name of Registrant as Specified in Its Charter)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z65c97ec896bb421cbff3a03051a57643" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.01%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Delaware</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(State or Other Jurisdiction of Incorporation or Organization)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.99%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">98-0668934</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(I.R.S. Employer Identification No.)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">19 Ha&#8217;Yahalomim Street P.O. Box 12163 Ashdod, Israel L3 7760049</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Address of Principal Executive Offices) (Zip Code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Telephone:&#160; 972 (8) 675-7878</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Registrant&#8217;s Telephone Number, Including Area Code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">N/A</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Yes&#160;&#9746;&#160; No&#160; &#9744;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes&#160;&#9746;&#160; No&#160; &#9744;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.&#160; See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zd2a74f8885c94cd69fb9a6dfa92d59ce" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Large accelerated filer &#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.34%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accelerated filer &#9744;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Non-accelerated filer &#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.34%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Smaller reporting company &#9746;</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Emerging growth company &#9744;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes&#160;&#9744;&#160; No&#160;&#9746; </div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">As of August&#160;15, 2017, 6,381,149 shares of the Company&#8217;s common stock, par value $0.001 per share, were outstanding.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">TABLE OF CONTENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Page</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="zad1bf090133f4d84b776b5accb53539d" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%" cellspacing="0" cellpadding="1" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 64.43%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#PARTI-FINANCIALINFORMATIO">PART I - FINANCIAL INFORMATION</a></div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 5.53%">3</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 10.6%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160; <a href="#Item1.FinancialStatements">Item 1.</a></div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 84.4%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#Item1.FinancialStatements">Financial Statements.</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">3</div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 64.43%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a href="#BALANCESHEETS">CONDENSED CONSOLIDATED BALANCE SHEETS</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">3</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 64.43%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a href="#COMPREHENSIVELOSS">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">4</div>
</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 64.43%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a href="#STOCKHOLDERSDEFICIT">CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">5</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 64.43%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a href="#CASHFLOWS">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">6</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 64.43%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a href="#NOTES">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">8</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 10.6%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160; <a href="#Item2.">Item 2.</a></div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 84.4%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#Item2.">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">22</div>
</td>
</tr>

<tr style="HEIGHT: 17px">
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 10.6%">
<div>&#160;&#160;&#160;&#160; <a href="#Item3">Item 3.</a></div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 84.4%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#Item3">Quantitative and Qualitative Disclosures About Market Risk.</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">36</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 10.6%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160; <a href="#Item4">Item 4.</a></div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 84.4%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#Item4">Controls and Procedures.</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">37</div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 10.08%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#PARTII-OTHERINFORMATION">PART II - OTHER INFORMATION</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 5.53%">38</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 10.6%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt">&#160;&#160;&#160;&#160; <a href="#Item6.">Item 6.</a></div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 84.4%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt"><a href="#Item6.">Exhibits.</a></div>
</td>
<td style="BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 5.53%">
<div style="TEXT-ALIGN: right">40</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%3%%%-->
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a id="PARTI-FINANCIALINFORMATIO" name="PARTI-FINANCIALINFORMATIO"><!--Anchor--></a>PART I - FINANCIAL INFORMATION</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item1.FinancialStatements" name="Item1.FinancialStatements"><!--Anchor--></a>Item 1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Financial Statements.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONDENSED CONSOLIDATED <a id="BALANCESHEETS" name="BALANCESHEETS"><!--Anchor--></a>BALANCE SHEETS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z0f3e84aecdee41e7b81054057a87a89d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars (except share data)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">A S S E T S</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Current Assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,132,622</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">148,836</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Accounts receivable, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">130,296</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">92,061</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Inventories</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,508,312</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,419,604</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Other current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">157,868</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">356,994</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,929,098</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,017,495</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Property and Equipment, Net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">235,230</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">240,452</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Long-Term Restricted Cash</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,234</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35,673</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Funds in Respect of Employee Rights Upon Retirement</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">184,031</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">167,326</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,387,593</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,460,946</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; DEFICIT</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Current Liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Accounts payable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,789,026</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,634,642</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Other current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">957,436</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">713,549</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,746,462</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,348,191</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Long-Term Liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Long-Term Loans from Stockholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">178,186</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">162,034</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Liability for Employee Rights Upon Retirement</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">184,030</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">176,719</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Warrants with down-round protection</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">764,545</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">681,970</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total long-term liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,126,761</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,020,723</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,873,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,368,914</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Temporary Equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Convertible Preferred Stock of $ 0.001 par value (&#8220;Preferred Stock&#8221;):</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">10,000,000 shares of Preferred Stock authorized as of June 30, 2017 and December 31, 2016; 376 shares of Series A Preferred Stock issued and outstanding as of June 30, 2017 and December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">221,152</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">221,152</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">15,031 shares of Series B Preferred Stock issued and outstanding as of June 30, 2017 and December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,715,844</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,715,844</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">11,004 and 5,829 shares of Series C Preferred Stock issued and outstanding as of June 30, 2017 and December 31, 2016, respectively</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,943,451</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,104,466</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total temporary equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,880,447</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,041,462</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stockholders&#8217; Deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Common Stock of $ 0.001 par value (&#8220;Common Stock&#8221;):</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">40,000,000 shares authorized as of June 30, 2017 and December 31, 2016; 6,381,149 and 6,026,527 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,384</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,028</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Additional paid in capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27,967,185</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,586,142</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Accumulated other comprehensive income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">127,012</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62,576</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Accumulated deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(41,466,658</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(35,604,176</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total stockholders&#8217; deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(13,366,077</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(10,949,430</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total liabilities, temporary equity and stockholders&#8217; deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,387,593</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,460,946</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of these condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: ; LINE-HEIGHT: 1.25">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND <a id="COMPREHENSIVELOSS" name="COMPREHENSIVELOSS"><!--Anchor--></a>COMPREHENSIVE LOSS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z689bbe75dc9a456f8896d5a80aeafa81" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="14">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars (except share data)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Six-month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three-month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">104,981</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">470,878</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,744</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">381,731</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Research and development expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,198,363</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,531,396</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">616,824</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">880,696</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Selling and marketing expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">598,234</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">614,121</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">361,295</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">349,804</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">General and administrative expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,556,078</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,173,188</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,678,719</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">734,661</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total operating expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,352,675</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,318,705</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,656,838</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,965,161</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Operating loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,247,694</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,847,827</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,648,094</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,583,430</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Financing income (expenses), net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">160,168</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32,065</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">90,893</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,568</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Loss for the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,087,526</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,815,762</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,557,201</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,588,998</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Other comprehensive (income) loss:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Foreign currency translation loss (income)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64,436</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,039</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(31,697</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,063</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Comprehensive loss for the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,023,090</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,845,801</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,525,504</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,597,061</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Loss per share (Basic and Diluted)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.96</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.54</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.48</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Common shares used in computing loss per share (Basic and Diluted)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,116,366</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,716,566</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,205,104</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,742,468</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of these condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN <a id="STOCKHOLDERSDEFICIT" name="STOCKHOLDERSDEFICIT"><!--Anchor--></a>STOCKHOLDERS&#8217; DEFICIT</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z99f6d3e0f87b4d4597c7bbcdc5425681" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="22">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars (except share data)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="22">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number of shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Common Stock Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Additional paid in capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated other comprehensive income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total Stockholders&#8217; deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Balance as of January 1, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,026,527</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,028</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,586,142</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62,576</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(35,604,176</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(10,949,430</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Loss for the period of six months</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,087,526</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,087,526</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Other comprehensive income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64,436</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64,436</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Amounts allocated to Series C-1 and Series C-2 Warrants, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,404,911</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,404,911</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">116,354</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">117</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">276,457</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(276,574</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">206,844</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">207</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">491,461</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(491,668</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,714</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,714</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stock-based compensation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,424</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,208,214</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,208,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Balance as of June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,381,149</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,384</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27,967,185</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">127,012</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(41,466,658</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(13,366,077</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of these condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONDENSED CONSOLIDATED STATEMENTS OF <a id="CASHFLOWS" name="CASHFLOWS"><!--Anchor--></a>CASH FLOWS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z80fb81d7d0ed443ea211e6746a8c4361" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Six-month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash flows from operating activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Loss for the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,087,526</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,815,762</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Adjustments to reconcile loss for the period to net cash used in operating activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Depreciation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">33,024</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27,980</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stock-based compensation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,208,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">34,297</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Remeasurement adjustment of warrants issued to placement agent</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">211,077</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Change in the fair value of Warrants with down-round protection</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(191,075</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64,212</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Linkage difference on principal of loans from stockholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(639</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Changes in assets and liabilities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">(Increase) in accounts receivable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(28,615</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(51,053</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Decrease in inventory</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49,255</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">130,203</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Decrease in other current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">222,952</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">147,697</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">(Decrease) increase in accounts payable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,829</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(638,908</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Increase in other current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">171,018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">132,153</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Decrease in liability for employee rights upon retirement</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(10,148</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Net cash used in operating activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,606,014</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,887,167</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash flows from investing activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Purchase of property and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,849</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(46,397</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Net cash used in investing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,849</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(46,397</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash flows from financing activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,686</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,753</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,022,002</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,508,321</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Proceeds allocated to Series C Warrants, net of cash issuance expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,495,541</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,242,158</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Net cash provided by financing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,520,229</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,745,726</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Effect of exchange rate changes on cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">74,420</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,329</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Increase in cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">983,786</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">796,833</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash and cash equivalents at beginning of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">148,836</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">608,701</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 46.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash and cash equivalents at end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,132,622</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,405,534</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of these condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Supplementary information on financing activities not involving cash flows (unaudited):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the six-month period ended June 30, 2017, $491,668 and $276,574, representing the fair value of the shares of Common Stock issued to owners of Series B Preferred Stock and owners of Series C Preferred Stock, respectively, were accounted for as stock dividends in the statement of changes in stockholders&#8217; deficit and was charged to accumulated deficit against additional paid in capital and Common Stock therein.</div>

<div style="FONT-WEIGHT: normal; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the three months ended June 30, 2017, the Company accrued a cash dividend in the amount of $4,700, in the aggregate, to be paid to holders of its Series A Preferred Stock and a stock dividend in the amount of $406,225, in the aggregate, representing the fair value of the shares of Common Stock to be issued to owners of Series B Preferred Stock and of Series C Preferred Stock, in lieu of cash dividends.&#160; The Company paid such dividends, plus interest at a rate of 9% per annum, on August 4, 2017.</div>

<div style="FONT-WEIGHT: normal; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the six-month period ended June 30, 2017, $273,650, representing the fair value of warrants issued as consideration for placement agent services, was accounted for as Warrants with down-round protection within long-term liabilities.&#160; Of these direct issuance expenses, $90,633 was allocated to the Series C-1 and Series C-2 Warrants and was recorded as a reduction of additional paid in capital, and $183,017 was allocated to the Series C Preferred Stock and recorded as a reduction of temporary equity.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">The accompanying notes are an integral part of these condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
<br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a id="NOTES" name="NOTES"><!--Anchor--></a>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(UNAUDITED)</font></div>

<div id="DSPFPageHeader" style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 1</font>&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;GENERAL</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z0eaaec54c48a4597b73f5b0db7d79687" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">A.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Integrity Applications, Inc. (the &#8220;Company&#8221;) was incorporated on May 18, 2010 under the laws of the State of Delaware.&#160; On July 15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter:&#160; &#8220;Integrity Acquisition&#8221;), a wholly owned Israeli subsidiary of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter:&#160; &#8220;Integrity Israel&#8221;), an Israeli corporation that was previously held by the stockholders of the Company.&#160; Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger.&#160; Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.&#160; As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.&#160; Integrity Israel was incorporated in 2001 and commenced its operations in 2002.&#160; Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetes.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z9d7cdae391124ace8c337b23dddd54d2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">B.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Going concern uncertainty</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.&#160; The development and commercialization of Integrity Israel&#8217;s product is expected to require substantial expenditures.&#160; Integrity Israel and the Company (collectively, the &#8220;Group&#8221;) have not yet generated significant revenues from operations, and therefore they are dependent upon external sources for financing their operations.&#160; As of June 30, 2017, the Group has incurred an accumulated deficit of $41,466,658, a stockholder&#8217;s deficit of $13,366,077 and negative operating cash flows.&#160; Management considered the significance of such conditions in relation to the Group&#8217;s ability to meet its current and future obligations and determined that these conditions raise substantial doubt about the Group&#8217;s ability to continue as a going concern.&#160; The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&#160; To fund its operations the Company has raised funds through the issuance of (a) Series A units (the &#8220;Series A Units&#8221;) consisting of shares of the Company&#8217;s Series A Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) and detachable warrants to purchase shares of the Company&#8217;s Common Stock (the &#8220;Series A Warrants&#8221; or &#8220;Warrants with down-round protection&#8221;) and (b)&#160;Series B units (the &#8220;Series B Units&#8221;), each consisting of (i) one share of the Company&#8217;s designated Series B 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series B Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $5.80 per share, (ii) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-1 Warrant&#8221;) and (iii) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-2 Warrant&#8221; and, together with the Series B-1 Warrants, collectively, the &#8220;Series B Warrants&#8221;).&#160; Additionally, during the period between April 2016 and June 2017, the Company raised funds in an aggregate amount of approximately $9.47 million (of which amount of approximately $4.52 million was raised during the six-month period ended June 30, 2017) (net of related cash expenses) through the issuance of 11,003.80 units (the &#8220;Series C Units&#8221;).&#160; Each of the Series&#160;C Units consists of (a) one share of the Company&#8217;s designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series C Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $4.50 per share, (b) a five&#8209;year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-1 Warrant&#8221;) and (c) a five-year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-2 Warrant&#8221; and, together with the Series C-1 Warrants, collectively, the &#8220;Series C Warrants&#8221;), as described in further detail in Note 3.&#160; See also Note 8 regarding issuance of additional Series C Units subsequent to the balance sheet date.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long-term loans.&#160; There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations as a going concern.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><strong>NOTE 1</strong>&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;GENERAL (cont.)</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z8ce5980da1ac491eab6681a9e83fed99" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">C.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Risk factors</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">As described in Note 1A and Note 1B above, the Group has a limited operating history and faces a number of risks and uncertainties, including risks and uncertainties regarding continuation of the development process, demand and market acceptance of the Group&#8217;s products, the effects of technological changes, competition and the development of products by competitors.&#160; Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group&#8217;s future results and the availability of necessary financing.&#160; In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts.&#160; The Group has not yet generated material revenues from its operations to fund its activities and therefore is dependent on the receipt of additional funding from its stockholders and/ or new investors in order to continue its operations.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z61039d533ff5421587bb93882f4a5489" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">D.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Use of estimates in the preparation of financial statements</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods.&#160; Actual results could differ from those estimates.&#160; As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series C Units, and (iii) the going concern assumptions.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 2</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="ze3bed8565cbd4af196e0f9930c9f7510" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">A.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Basis of presentation</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">Accounting Principles</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.&#160; The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) related to interim financial statements.&#160; As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.&#160; The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&#8217;s financial position and operating results for the interim periods.&#160; All such adjustments are of a normal recurring nature.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The results for the three and six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any other interim period or for any future period.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong>NOTE 2</strong>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">Principles of Consolidation</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The consolidated financial statements include the accounts of the Company and its subsidiary.&#160; Significant intercompany balances and transactions have been eliminated in consolidation.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z2989f80eb6924fd0be110b6a761018c3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">B.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Warrants with down-round protection</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The Company has determined its derivative warrant liability with respect to the remaining Series A Warrants and warrants issued to Andrew Garrett, Inc., (&#8220;AGI&#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value.&#160; Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1132eec3ceab41aaa949f8987297b2a5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Warrants with down-round Protection<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Balance, Beginning of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">681,970</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">321,695</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Warrants issued as consideration for placement services</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">273,650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">234,008</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Amount classified out of stockholders&#8217; deficit and presented as Warrants with down-round protection</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">341,662</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Change in fair value Warrants with down-round protection</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(191,075</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64,212</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Balance, End of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">764,545</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">833,153</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">The key inputs used in the fair value calculations were as follows:</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2b2a3288de9344079dc77d44b79841c1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Dividend yield (%)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Expected volatility (%) (*)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56.59</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62.16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Risk free interest rate (%)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.92</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.72-1.11</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Expected term of options (years)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.70-4.98</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.70-5.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Exercise price (US dollars)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.50, 7.75</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.50, 7.75</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Share price (US dollars) (**)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Fair value (US dollars)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.06-0.76</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.61</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 138px"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 62px; align: right">(*)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 137px"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 63px; align: right">(**)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-WEIGHT: bold">NOTE 2</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z8bbffd1de76d495fa0364f370875f35d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">C.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Recently issued accounting pronouncements</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zec85f35dae2544c0b0224644e914d57d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 90pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting Standards Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606) (&#8220;ASU 2014-09&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance.&#160; ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">An entity should apply the amendments in ASU 2014-09 using one of the following two methods:&#160; 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application.&#160; If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">During 2016, the FASB issued several Accounting Standards Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, &#8220;Revenue from contracts with Customers &#8211; Deferral of the Effective Date&#8221;, for a public entity, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).&#160; Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">The Company intends to adopt ASU 2014-09 as of January 1, 2018.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">The Company is in the process of evaluating the impact of ASU 2014-09 on its revenue streams and selling contracts, if any, and on its financial reporting and disclosures.&#160; Management is expecting to complete the evaluation of the impact of the accounting and disclosure changes on the business processes, controls and systems during 2017.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">Since the company did not report significant revenues, management believes that the adoption of ASU 2014-09 will not have a significant impact on its consolidated financial statements.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z758d56036bd141459bf82772df83228d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 90pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting Standards Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">Effective January 1, 2017, the Group adopted ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) (&#8220;ASU 2015- 11&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value.&#160; Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance.&#160; Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">The adoption of ASU 2015-11 did not have a significant effect on the consolidated financial statements.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-WEIGHT: bold">NOTE 2</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z8dd941e9a76d4c9093332bde8c50d2fe" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 90pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting Standard Update (ASU) No. 2017-11, &#8220;Earnings Per Share&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815):&#160; (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings.&#160; Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification.&#160; Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company).&#160; Early adoption is permitted for all entities.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">The Company is evaluating the impact of ASU 2017-11 on its financial statements.&#160; Although this process has not been completed, managements believes that its provisions might impact the accounting of the financial instruments issued by the Company that include down-round protection.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z7598ba7b9ca1490684b1de837f2bc02f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 18pt; align: right">D.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Reclassified Amounts</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25">Certain prior year amounts have been reclassified for consistency with the current year presentation.&#160; These reclassifications did not have material effect on the reported results of operations, shareholder&#8217;s deficit or cash flows.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 3</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z619088227ed94ab3bb44f84c79fc5a96" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On April 7, 2017, the Board of Directors of the Company (the &#8220;Board&#8221;) approved an amendment to the 2010 Incentive Compensation Plan of the Company (the &#8220;Plan&#8221;) to increase the number of shares of the Company&#8217;s Common Stock reserved for issuance under the Plan from 1,000,000 shares to 5,625,000 shares.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zdad3c9f82a474bd6b4faf6b20bf4ac65" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Effective April 7, 2017 (the &#8220;Gal Effective Date&#8221;), the Company and Integrity Israel entered into a letter agreement with Avner Gal whereby Mr.&#160;Gal separated from his employment and directorship at the Company to act as a part time consultant to the Company (the &#8220;Gal Agreement&#8221;).&#160; Pursuant to the terms of the Gal Agreement, and as consideration for Mr.&#160;Gal&#8217;s separation from employment and services as a consultant, the Company agreed, among other things, to (a) pay Mr.&#160;Gal an amount equal to his Salary (as defined in the Gal Employment Agreement) and other financial benefits Mr.&#160;Gal was entitled to receive under the Employment Agreement entered into by and between Integrity Israel and Mr.&#160;Gal in October 2010 (the &#8220;Gal Employment Agreement&#8221;), that would have been paid to Mr.&#160;Gal during the Notice Period (as defined in the Gal Employment Agreement), in lieu of such prior notice; (b) modify the Adjustment Period, pursuant to section 19 of the Gal Employment Agreement, to 24 Salaries (as defined in the Gal Employment Agreement), including all the benefits mentioned in the Gal Employment Agreement, provided Mr.&#160;Gal does not work or provide services to a company in direct competition with the Company; (c) accelerate the vesting of 88,259 outstanding unvested options to purchase Common Stock, at an exercise price per share equal to $6.25, held by Mr.&#160;Gal as of the Gal Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">; s</font>uch amount was measured as approximately $51,000);&#160; (d) extend the term of all outstanding options (vested and unvested) held by Mr.&#160;Gal to be exercisable for five years from the Gal Effective Date (with respect to all vested options, at the modification date the company recognized compensation cost in an amount equal to the excess amount of the fair value of the modified award as of the modification date over the fair value of the original award immediately); and (e) grant Mr.&#160;Gal an option to purchase up to 300,000 shares of Common Stock of the Company having an exercise price per share equal to $4.50 and an option to purchase up to an additional 50,000 shares of common stock of the Company having an exercise price per share equal to $7.75.&#160; These options vest monthly over a 24 months period following the date of grant.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z31c31810474845138f161eaa694e3bff" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Effective April 7, 2017, the Company entered into an amendment to the employment agreement (the &#8220;Graham Employment Amendment&#8221;) with John Graham, whom the Company appointed as Chief Executive Officer on March 20, 2017, to modify the base compensation provision and the equity compensation provision under that certain Employment Agreement, dated March 20, 2017 (the &#8220;Graham Effective Date&#8221;), by and between the Company and Mr.&#160;Graham.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z84a49bf20de1467f9d45d964c0caa136" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Pursuant to the terms of the Graham Employment Amendment, (a) Mr.&#160;Graham&#8217;s base compensation was modified such that he receives a base salary of $500,000 per year, as well as a one-time payment of $375,000 paid to Mr.&#160;Graham upon commencement of Mr.&#160;Graham&#8217;s employment with the Company which amount was recognized as an expense as of the employment commencement date, and (b) the vesting periods of Mr.&#160;Graham&#8217;s options to purchase Common Stock were modified whereby (1) 307,754 shares of Common Stock underlying Mr.&#160;Graham&#8217;s option to purchase Common Stock at an exercise price of $4.50 per share (the &#8220;$4.50 Options&#8221;) vested immediately, (2) 923,262 of the $4.50 Options vest on the six month anniversary of the Graham Effective Date, and (3) the remaining 442,980 of the $4.50 Options as well as Mr.&#160;Graham&#8217;s remaining unvested options granted pursuant to the Graham Employment Amendment vest on the two (2) year anniversary of the Graham Effective Date.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z87b18fe9f20b4aee869df74827371a13" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Effective April 7, 2017, Integrity Israel entered into an amended and restated personal employment agreement (the &#8220;Malka Employment Agreement&#8221;) with David Malka for his continued service as Vice President of Operations of the Company and Integrity Israel, effective as of March 20, 2017 (the &#8220;Malka Effective Date&#8221;).&#160; Pursuant to the terms of the Malka Employment Agreement, Mr.&#160;Malka (a) receives a base monthly salary of NIS 20,000 (approximately $5,508 based on an exchange rate of 3.63 NIS / 1 USD in effect on August 8, 2017), which may increase to NIS 35,000 per month (approximately $9.639 using the same exchange rate) in the event certain performance milestones are met (the &#8220;Malka Base Salary&#8221;); (b)&#160;is eligible to earn an annual performance bonus between 420-864% of the Malka Base Salary, subject to certain performance criteria to be established by the Board within the first ninety (90) days of each fiscal year; (c) is eligible to earn a retention bonus equal to 60% of the aggregate Malka Base Salary earned through the one-year anniversary of the Malka Effective Date, payable thirty days following the one-year anniversary of the Malka Effective Date and provided that Mr.&#160;Malka remains employed with Integrity Israel through and on the one-year anniversary of the Malka Effective Date; (d)&#160;received a modification to the terms of his option to purchase Common Stock at an exercise price per share equal to $6.25 whereby the unvested portion of such options will accelerate and will be immediately exercisable, effective as of the Malka Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date);&#160; and (e) received certain additional equity awards (pursuant to the Plan) under the terms and conditions as set forth in the Malka Employment Agreement.&#160; In addition, the Malka Employment Agreement provides for the payment of certain social benefits and the use of a company car.&#160; The Malka Employment Agreement is terminable by Integrity Israel and Mr.&#160;Malka on 90 days&#8217; prior written notice (the &#8220;Malka Notice Period&#8221;), without Cause, or immediately by Integrity Israel for Cause (as defined in the Malka Employment Agreement).&#160; Integrity Israel may terminate Mr.&#160;Malka&#8217;s employment without Cause prior to the expiration of the Malka Notice Period, but will be required to pay Mr.&#160;Malka a severance fee equal to the Malka Base Salary plus the financial value of all other benefits Mr.&#160;Malka would have been entitled to receive in respect of the portion of the Malka Notice Period which was forfeited.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-WEIGHT: bold">NOTE 3</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS&#160;(cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">On May 23, 2017, the Board approved the salary increase to NIS 35,000 per month pursuant to the Malka Employment Agreement, notwithstanding the foregoing performance goal requirement, as consideration for Mr.&#160;Malka&#8217;s continued service as Vice President of Operations of the Company and Integrity Israel.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5f7b68a68bcf46f9bcff4face6b7ebcb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">6.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On May 4, 2017, the Board unanimously voted to appoint Angela Strand, a member of the Board, as the interim Chief Strategy Officer of the Company, effective as of May 1, 2017 through September 30, 2017. On May 5, 2017, the Company entered into a letter agreement (the &#8220;Strand Employment Agreement&#8221;) with Ms.&#160;Angela Strand confirming her appointment as interim Chief Strategy Officer of the Company.&#160; Pursuant to the terms of the Strand Employment Agreement, Ms.&#160;Strand receives aggregate compensation of $150,000 for her service during the term of employment, paid monthly on the schedule mutually agreed upon by the parties.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z9156810b192944449d02317c2f91730a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">7.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On May 23, 2017, the Board approved the following compensation for all non-employee directors and interim officers serving on the Board:</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z482b475b085d45fdb8d988adf113e7fc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an annual cash payment to each non-employee director and interim officer of the Company in the amount of $35,000, payable in four equal quarterly installments of $8,750 each on the last day of each calendar quarter commencing with the fourth quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zcb358595b2994e52812eab1b474b580b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an additional annual cash payment to each member of a Board committee who is not the Chairperson of that particular committee in the amount of $5,000, payable in four equal quarterly installments of $1,250 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zc176fe69347b41a3a81634526d119f27" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">an additional annual cash payment to the chairperson of a Board committee in the amount of $12,500, payable in four equal quarterly installments of $3,125 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong>NOTE 3</strong>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS&#160;(cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z81a45bf2aa3049ecb6a3e5db605cd75b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">d.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the grant to each non-employee director and each interim officer of the Company of a one-time award of options to purchase up to an aggregate of 14,894 shares of Common Stock, at an exercise price of $4.50, under and pursuant to the Plan, which options vest in 12 equal monthly increments commencing as of June 1, 2017 (subject to their continued service as of each such date) and have a term of 10 years;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zfcd1c1296795424e95305a241828a6d2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">e.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the grant to each non-employee director and each interim officer of the Company of an award of Restricted Stock Units (&#8220;RSUs&#8221;), to be granted on June 1, 2017 and vesting on June 1, 2018, with a fair value of $45,000 based on the 30-day volume weighted average price of the Company&#8217;s Common Stock on June 1, 2017, subject to their continued service on and through such date; and</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5a37ef11c08e4b82b9d034ab9f8c3cff" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">f.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">an additional annual fair value payment to the vice chairperson of the Board in the amount of $20,000, payable in RSUs under the same vesting terms.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb9f1fe0447824a18a10218d586431d39" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">8.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On May 23, 2017, the Board appointed Michael Hauck to serve as a director of the Company, effective on that date.&#160; The Board further appointed Mr.&#160;Hauck to serve as a member of the Nominating and Corporate Governance Committee of the Board as well as on the Compensation Committee of the Board.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">There are no arrangements or understandings between Mr.&#160;Hauck and any other person pursuant to which Mr.&#160;Hauck was selected as a director.&#160; There are no relationships between Mr.&#160;Hauck and the Company that would require disclosure under Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z98fa32447c9a4f2a8f6ecf47de59785c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">9.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On May 23, 2017, the Board established an Audit Committee of the Board and appointed each of Leslie Seff and Revan Schwartz to serve as members of the committee.&#160; Mr. Schwartz will serve as chairperson of the committee. The Board determined that each of the members of the Audit Committee designated above is independent pursuant to the required standards set forth in Rule 10A-3(b) of the Securities Exchange Act of 1934, as amended, based on an evaluation of the relationships between the Company and each of the members.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1b32e95ea1774520bf8316873c9c6e85" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">10.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On June 7, 2017, the Board appointed David Podwalski as the Chief Commercial Officer of the Company, effective as of June 26, 2017 (the &#8220;Podwalski Effective Date&#8221;).</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">On June 7, 2017, the Company entered into an employment agreement (the &#8220;CCO Employment Agreement&#8221;) with Mr.&#160;Podwalski to serve as Chief Commercial Officer of the Company.&#160; Under the CCO Employment Agreement, Mr.&#160;Podwalski (1) receives a base salary of $240,000 per year (&#8220;Base Salary&#8221;); (2) receives a sign-on bonus of $25,000, payable on the six month anniversary of the Podwalski Effective Date, subject to his continued employment through and on such payment date; (3) is eligible to receive an annual performance bonus, having a minimum bonus opportunity equal to 20% of his current Base Salary based upon 80% achievement of performance criteria (the &#8220;Minimum Performance Goal&#8221;), a target bonus opportunity equal to 25% of his current Base Salary based upon 100% achievement of performance criteria, and a maximum bonus opportunity equal to 37.5% of his current Base Salary based upon 150% achievement of performance criteria (the &#8220;Maximum Performance Goal&#8221;), provided, however, that such performance bonus will be determined using straight-line interpolation of the level of achievement between the Minimum Performance Goal and the Maximum Performance Goal; and (4) <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">receive an initial stock option grant to purchase shares of Common Stock equal to 1% of the total fully diluted shares of Common Stock as of the </font>Podwalski <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">Effective Date, with an exercise price of $4.50 per share or the fair market value of a share of Common Stock on the grant date, whichever is greater, vesting monthly over a three year period commencing on the </font>Podwalski <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">Effective Date, subject to his continued employment through and on each such vesting date (the total fair value of the grant as of the </font>Podwalski <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">Effective Date is approximately $270,000).</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The CCO Employment Agreement is terminable by the Company on 90 days written notice and by Mr.&#160;Podwalski on 30 days written notice.&#160; The CCO Employment Agreement is immediately terminable by the Company for Cause (as defined in the CCO Employment Agreement) without the payment of severance.&#160; The CCO Employment Agreement contains non-compete obligations applicable during the term of the agreement and for one year thereafter and confidentiality obligations that survive the termination of the agreement indefinitely.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong>NOTE 3</strong>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS&#160;(cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Between April 2016 and December 31, 2016, and during the first six months of 2017, the Company received aggregate net proceeds of approximately $4.9 million and $4.5 million, respectively (net of related cash expenses), from the issuance and sale in a private placement transaction, at a price of $1,000 per unit, of 11,003.80 Series C Units.&#160; As of June 30, 2017, the shares of Series C Preferred Stock comprising the Series C Units are convertible into an aggregate of 2,445,317 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 4,890,634 shares of Common Stock, in each case subject to adjustment in certain circumstances.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Pursuant to a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with AGI, at the initial closing of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units.&#160; At the end of the second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth and eleventh closings of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing.&#160; In addition, pursuant to the Placement Agent Agreement, the Company is required to issue to AGI: (a) 5-year warrants to purchase up to 489,064 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 244,531 shares of Common Stock at an exercise price of $7.75 per share.&#160; The terms of such warrants are substantially similar to the Series C Warrants except that the warrants issued to AGI are exercisable on a cashless basis and include full ratchet anti-dilution protection.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Following below is a summary of the entire series C issuances:</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za8f8f4b7573b4b95bc4e3c5fc2899692" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year ended December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Six month period ended June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Thousands of U.S. $ (except units sold) (unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Number of units sold</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,828.9</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,174.9</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Gross amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,829</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,175</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Net of related cash expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,951</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,520</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Net amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,642</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Subject to certain ownership limitations described below, the Series C Preferred Stock are convertible at the option of the holder at any time and from time to time into shares of Common Stock at a conversion price of $4.50 per share (calculated by dividing the stated value per share of Preferred Stock, which is initially $1,000, by the conversion price per share).&#160; The conversion price of the Series C Preferred Stock is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect, as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders.&#160; In addition, the holders of Preferred Stock will be entitled to receive any securities or rights to acquire securities or property granted or issued by the Company pro rata to the holders of Common Stock to the same extent as if such holders had converted all of their shares of Series C Preferred Stock prior to such distribution.&#160; In the event of a fundamental transaction, such as a merger, consolidation, sale of substantially all assets and similar reorganizations or recapitalizations of the Company, the holders of Series C Preferred Stock will be entitled to receive, upon conversion of their shares of Series C Preferred Stock, any securities or other consideration received by the holders of the Common Stock pursuant to the fundamental transaction.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong>NOTE 3</strong>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS&#160;(cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Holders of Series C Preferred Stock are entitled to receive cumulative dividends at a rate of 5.5% per annum, based on the stated value per share of Series C Preferred Stock.&#160; Dividends on the Series C Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on June 30, 2016, and on each conversion date (with respect to the shares of Preferred Stock being converted).&#160; For so long as required under the terms of the certificate of designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, dividends will be payable only in shares of Common Stock.&#160; Thereafter, dividends on the Series C Preferred Stock will be payable, at the option of the Company, in cash and/or, if certain conditions are satisfied, shares of Common Stock or a combination of both.&#160; Shares of Common Stock issued as payment of dividends will be valued at the lower of (a) the then current conversion price of the Series C Preferred Stock or (b) the average of the volume weighted average price for the Common Stock on the principal trading market therefor for the 10 trading days immediately prior to the applicable dividend payment date.&#160; The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Subject to any limitations under the terms of the certificate of designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, the Company may become obligated to redeem the Series&#160;C Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Series C Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service.&#160; In addition, upon the occurrence of certain triggering events, each holder of Series C Preferred Stock will have the option to require the Company to redeem such holder&#8217;s shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder&#8217;s outstanding Series C Preferred Stock.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Subject to certain conditions contained in the Certificate of Designations, Preferences and Rights relating to the Series C Preferred Stock (the &#8220;Certificate of Designations&#8221;), the Company will have the option to force the conversion of the Series C Preferred Stock (in whole or in part) if (a) the volume weighted average price for the Common Stock on its principal trading market exceeds $7.00 for each of any 20 trading days during any 30&#160;consecutive trading day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $50,000 or (b) the Company receives approval to list the Common Stock on a national securities exchange.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Subject to certain exceptions contained in the Certificate of Designations, if the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Series C Preferred Stock (the &#8220;Conversion Shares&#8221;) and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a &#8220;Buy-In&#8221;), the Company will be required to:&#160; (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder&#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Series C Preferred Stock equal to the number of shares of Series C Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements.&#160; In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Series C Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the fifth trading day following the applicable conversion date and the Company will continue to pay such partial liquidated damages for each trading day after such eighth trading day until such certificates are delivered or the holder rescinds such conversion.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">As long as at least 35% of the originally issued shares of Series C Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Series C Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">17</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong>NOTE 3</strong>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS&#160;(cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Subject to the beneficial ownership limitation described below, holders of Series C Preferred Stock will vote together with the holders of Common Stock, Series A Preferred Stock and Series B Preferred Stock on an as&#8209;converted basis.&#160; Holders will not be permitted to convert their Series C Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding Common Stock (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the &#8220;Beneficial Ownership Limitation&#8221;).&#160; In addition, no holder may vote any shares of Series C Preferred Stock (on an as-converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Subject to certain limitations, so long as any purchaser holds any shares of Series C Preferred Stock, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series C Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser after taking into account all of the terms and conditions of the terms granted to the purchasers under the purchase agreement relating to the issuance and sale of the Series C Units and the terms granted in such subsequent issuance or sale, including all of the components of the Series C Units and of the securities or units involved in such subsequent issuance or sale, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The Series C Warrants have a five-year term commencing on their respective issuance dates.&#160; Until the end of the applicable term, each Series C Warrant will be exercisable at any time and from time to time at an exercise price of $4.50 per share (with respect to the Series C-1 Warrants) or $7.75 per share (with respect to the Series&#160;C-2 Warrants).&#160; The Series C Warrants contain adjustment provisions substantially similar to those to the adjustment provisions of the Series C Preferred Stock as described above, except that the Series C Warrants do not include dilution protection for issuances of securities at an effective price per share lower than the conversion price of such Series C Warrants.&#160; In addition, the Series C Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Series C Preferred Stock.&#160; No holder may exercise its Series C Warrants in excess of the Beneficial Ownership Limitation.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Based on the terms of the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, respectively, so long as any initial purchaser of Series A Units or Series B Units, as applicable, holds any shares of Series A Preferred Stock or Series B Preferred Stock, respectively, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series A or Series B Preferred Stock or Warrants reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Pursuant to the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, the Company was required to and did notify the holders of the Series A Preferred Stock and Series B Preferred Stock of the closing of the sale of the Series C Units, and following receipt thereof such holders of Series A Preferred Stock and Series B Preferred Stock will be entitled, pursuant to the &#8220;most favored nation&#8221; provisions contained in their respective purchase agreements (as described above), to elect to amend the terms of their purchase of Series A Units and Series B Units, respectively, to match the terms of the Series C Units.&#160; The Company is obligated to amend the terms of any of Series A Units or Series B Units who timely makes such election and tenders its Series A Units or Series B Units for exchange.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">18</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong>NOTE 3</strong>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS&#160;(cont.)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">As of June 30, 2017, none of the Series A or B Unit holders asked the company to amend the terms of their Units.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Upon their initial recognition, the Series C Preferred Stock issued together with detachable Series C Warrants (classified as equity) were measured based on the relative fair value basis and were presented net of the direct issuance expenses that were allocated to them.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The Company has determined that, due to the economic characteristics and risks of the Series C Preferred Stock, based on their stated or implied substantive terms and features, such Preferred Stock are considered as more akin to equity than debt.&#160; Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Series C Preferred Stock themselves (the &#8216;host contract&#8217;) are clearly and closely related.&#160; As a result, the embedded conversion feature was not required to be bifurcated.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Since at each of the issuances dates of the Series C Preferred Stock the exercise price of the conversion feature (based on the effective conversion rate of the Series C Preferred Stock into Common Stock) was higher than the estimated fair value of the Company&#8217;s Common Stock, it was determined that given the current market price, conversion at the conversion price was not a beneficial transaction.&#160; Also, due to the liquidation preference and certain redemption rights for the benefit of the holders of the Series C Preferred Stock, upon the occurrence of certain contingent events, which are not considered as solely within the Company&#8217;s control management determined that the Series C Preferred Stock were to be presented as temporary equity.&#160; On each balance sheet date, the Company&#8217;s management assesses the probability of redemption of the outstanding Preferred Stock.&#160; In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will reclassify the amount allocated to the preferred stock from temporary equity to liability. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and the aggregate redemption amount of the Preferred Stock will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 4</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;INVENTORIES</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z77e0ac1d71ad4d328b59935502edbb92" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Raw materials</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">705,810</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">735,201</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Work in process</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">794,582</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">633,132</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Finished products</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,920</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">51,271</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,508,312</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,419,604</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 5</font>&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;&#160;OTHER CURRENT LIABILITIES</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1a1e6963dae0441190723ce209223498" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31, </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Employees and related institutions</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">353,250</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">363,738</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Accrued expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">588,338</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">261,651</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Other current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,848</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">88,160</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">957,436</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">713,549</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">19</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 6</font>&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;FINANCING INCOME, NET</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc93f5981e2ff4d68818dc0c3e6e3f12c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Six month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Israeli CPI linkage difference on principal of loans from stockholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(639</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,393</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">825</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Exchange rate differences</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,194</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,211</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,720</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,296</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Change in fair value of Warrants with down-round protection</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(191,075</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64,212</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(106,976</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(20,702</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Interest expenses on credit from banks and other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,687</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,575</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,970</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,149</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(160,168</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(32,065</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(90,893</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,568</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 7</font>&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;&#160;LOSS PER SHARE</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">In periods of net loss, basic loss per share is computed by dividing net loss for the period after consideration of the effect of dividends on preferred stock by the weighted average number of shares outstanding during the period.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2017 and 2016 are as follows:</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7bc0d56fca264921af72a81b7571f419" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">US dollars</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Six month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Loss for the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,087,526</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,815,762</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,557,201</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,588,998</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,714</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(9,453</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,014</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,753</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(491,668</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(254,101</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(245,637</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(131,281</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(276,574</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(20,355</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(160,588</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(20,355</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Loss for the period attributable to common stockholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,862,482</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,099,671</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,965,440</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,745,387</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z05ebdd4316af445495e94b284b94a130" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 88%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number of shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number of shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Six month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three month period ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Number of shares:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="6">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="6">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Common shares used in computing basic income (loss) per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,116,366</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,716,566</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,205,104</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,742,468</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Common shares used in computing diluted income (loss) per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,116,366</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,716,566</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,203,104</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,742,468</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10.8pt">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,868,112</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,220,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,001,400</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,210,613</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z8f54093400a94ea6a3b078a6c358100c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(*)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">20</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (cont.)</div>
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOTE 8</font>&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#8211;</font>&#160;&#160;SUBSEQUENT EVENTS</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">On July 31, 2017, the Company, entered into a Securities Purchase Agreement with certain accredited investors pursuant to which, the Company issued to the Purchasers an aggregate of 1,000 Series C Units.&#160; The shares of Preferred Stock comprising the Units are convertible into an aggregate of 222,236 shares of Common Stock, and the Warrants comprising the Units are exercisable for an aggregate of 444,472 shares of Common Stock, in each case subject to certain adjustments.&#160; The Company received aggregate gross proceeds of $1,000,000 from the sale of the Units.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">The sale of the Units pursuant to the securities purchase agreement was the twelfth closing of an offering of Units by the Company.&#160; The first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth&#160; and eleventh closings, involving the sale by the Company of an aggregate of 1,133 Units, 1,351 Units, 890.5 Units, 1,050.65 Units, 540 Units, 357.75 Units, 506 Units, 403.9 Units, 2,560 Units, 1,551 Units and 660 Units, respectively (collectively, the &#8220;Prior Issuances&#8221;), were disclosed by the Company in Current Reports on Form 8-K filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on April 14, 2016, May 4, 2016, June 6, 2016, July 7, 2016, September 7, 2016, October 7, 2016, December 5, 2016, January 5, 2017, March 14, 2017, May 3, 2017 and June 23, 2017, respectively (collectively, the &#8220;Prior 8-Ks&#8221;), each of which is incorporated herein by reference.&#160; The terms of the Preferred Stock and the Warrants are the same as the terms of the Preferred Stock and Warrants issued in the Prior Issuances, as described in the Prior 8-Ks.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">Pursuant to the Placement Agent Agreement, at the closing of the sale of the Units the Company paid AGI, as a commission, an amount (payable in cash and Common Stock) equal to 10% of the aggregate sales price of the Units, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Units.&#160; In addition, pursuant to the AGI Agreement, the Company is required to issue to AGI: (a) 5 year warrants to purchase up to 44,445 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 22,223 shares of Common Stock at an exercise price of $7.75 per share.&#160; The terms of these warrants will be substantially similar to the Warrants except that the AGI warrants will also be exercisable on a cashless basis and will include full ratchet anti-dilution protection.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">21</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item2." name="Item2."><!--Anchor--></a>Item 2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Cautionary Note Regarding Forward-Looking Statements</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">This Quarterly Report on Form 10-Q contains forward-looking statements.&#160; These forward looking statements include statements about our expectations, beliefs or intentions regarding our product development efforts, business, financial condition, results of operations, strategies and prospects.&#160; All statements other than statements of historical fact included in this Quarterly Report on Form 10-Q, including statements regarding our future activities, events or developments, including such things as future revenues, capital raising and financing, product development, clinical trials, regulatory approval, market acceptance, responses from competitors, capital expenditures (including the amount and nature thereof), business strategy and measures to implement strategy, competitive strengths, goals, expansion and growth of our business and operations, plans, references to future success, projected performance and trends, and other such matters, are forward-looking statements.&#160; The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and other similar words and phrases, are intended to identify forward-looking statements.&#160; The forward-looking statements made in this Quarterly Report on Form 10-Q are based on certain historical trends, current conditions and expected future developments as well as other factors we believe are appropriate in the circumstances.&#160; These statements relate only to events as of the date on which the statements are made and we undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.&#160; All of the forward-looking statements made in this Quarterly Report on Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations.&#160; Whether actual results will conform to our expectations and predictions is subject to a number of risks and uncertainties that may cause actual results to differ materially.&#160; Risks and uncertainties, the occurrence of which could adversely affect our business, include the risks identified under the caption &#8220;Risk Factors&#8221; included in our Annual Report on Form 10-K for the year ended December 31, 2016.&#160; The following discussion should be read in conjunction with the condensed consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Operational Highlights</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Regulatory Progress</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z36948ce9dc5f4130bab44718476113c3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Approval for Glucotrack DF-F as a medical device in China is advancing. CFDA (the local regulatory body in China) approval is expected in 2017.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z507e13596bd54a9c8d6aadf32073f732" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval activities are moving forward, with the required clinical trial expected to start before the end of 2017. We are in discussions with U.S. clinical and regulatory advisors and trial centers. Study start date is dependent on funding.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zfe7a49c527044362a45732981e62188c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Further EU member state approvals are progressing and may broaden our market entry opportunities.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Commercial Progress</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="ze3cfbff6fcdf4a5197349f9f19ee399c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">U.S. pre-launch commercial leadership in place.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z8def8bddf0494cfeb6b28bcfa2f3945e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">New clinical data presented at the American Diabetes Association Congress on June 12, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z968b71a7f39045938a6ec2041b7bcc39" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">We plan to be present and present at the European Association for the Study of Diabetes Congress (EASD) in September 2017</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5b64ac4ea3bc48bd850dfeb03241f393" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Glucotrack DF-F European launch and commercial strategy re-defined.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25"><u>Strengthened Intellectual Property</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z7a29536b7c54440890ca5aeb499065cb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">rd</sup> U.S. patent issued on July 27<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>, 2017, following issuances in China, South Korea and Israel.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">22</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Lifecycle Management</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zf186152a5b764f18bf1dbcb32b553a8e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Future generations of Glucotrack devices defined and undergoing feasibility studies; including wireless ear-clip, consumer oriented devices, digital health applications, smartphone, tablet and cloud connectivity.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25"><u>Partnering</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zdfa2739ec1184f2fb0d103a6f572fce5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Partnering discussions underway with a number of potential strategic partners in Europe and Asia.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Management Appointments</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5180cced710b4b5d90f47c6adbcfefde" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">David Podwalski appointed Chief Commercial Officer.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Overview</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Integrity is a medical device company focused on the design, development and commercialization of non&#8209;invasive glucose monitoring devices for use by people with diabetes and pre-diabetics.&#160; Integrity Israel was founded in 2001 with a mission to develop, produce and market non-invasive glucose monitors for home use by diabetics.&#160; We have developed a non-invasive glucose monitor, the GlucoTrack&#174; model DF-F glucose monitoring device, which is designed to help people with diabetes and individuals with pre-diabetics obtain glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices.&#160; The GlucoTrack&#174; model DF-F utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one&#8217;s earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In June 2013, we received initial CE Mark (marking the Company&#8217;s declaration that the product meets the requirements of the applicable European Union directives) approval for the GlucoTrack&#174; model DF-F non-invasive glucose monitoring device from DEKRA Certification B.V., our European notified body (the &#8220;Notified Body&#8221;).&#160; This original approval required that the device be re-calibrated every 30 days, with each such re- calibration taking between 2.5 and 3 hours to complete.&#160; In March 2014, we received CE Mark approval for six months&#8217; calibration validity of the same device.&#160; This approval eliminates the need for monthly re-calibrations, and enables the calibration process to be conducted only when the sensor is replaced, once every 6 months.&#160; We believe that this is a significant feature of the GlucoTrack&#174; model DF-F.&#160; Receipt of the CE Mark allows us to market and sell the GlucoTrack&#174; model DF-F glucose monitoring device in European Union (&#8220;EU&#8221;) member countries that have adopted the European Medical Device Directive (the &#8220;MDD&#8221;) without being subject to additional national regulations with regard to demonstration of performance and safety.&#160; However, although the MDD is applicable throughout the EU, in practice it does not ensure uniform regulation throughout the EU.&#160; Accordingly, member countries may apply and enforce the MDD&#8217;s terms differently, and certain EU member countries may request or require performance and/or safety data in addition to the MDD&#8217;s requirements from time to time, on a case-by-case basis.&#160; The CE Mark also permits the sale in countries that have an MDD Mutual Recognition Agreement with the EU.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On August 31, 2015, we received approval from the Notified Body for improvements to the GlucoTrack&#174; model DF-F to simplify and shorten (from approximately 2.5 hours to approximately half an hour) the initial calibration process for the device.&#160; These improvements are intended to reduce the backlog created as purchasers of the device await calibration.&#160; In addition, we received approval from the Notified Body on the updated intended use for the device, which expands the intended user population to include not only Type 2 diabetics, but also people suffering from pre-diabetes conditions as well, which we believe represents a material expansion of the potential market for the device.&#160; In December 2015, we received approval from the Notified Body for further improvements to the GlucoTrack&#174; model DF-F that increase the accuracy and efficacy of the device.&#160; On February 19, 2016, we received an extension of our ISO 13485:2003 certificate and Annex II certification from the EU.&#160; The ISO 13485:2003 certification signifies that we have met the standards required for company-wide implementation of device quality management system(s).&#160; The scope of the certification is design, development, manufacture and service of non-invasive glucose monitoring systems for home use.&#160; Annex II also addresses quality control systems.&#160; The certification allows us to self-certify certain modifications and changes and simplifies some of the reporting to and review by the relevant Notified Body.&#160; This can shorten the CE-mark review process of future GlucoTrack&#174; model DF-F enhancements or revisions, including software updates and other improvements of the device that do not affect the intended use and/or safety performance.&#160; Without an Annex II certification, each new device enhancement or modified version would be subject to the full EU CE-mark review process.&#160; The ISO 13485:2003 and Annex II certifications enable us to potentially reduce the time to market for product sales on new, enhanced or modified GlucoTrack&#174; model DF-F devices.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">23</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The GlucoTrack&#174; model DF-F has not yet been approved for commercial sale in the United States.&#160; On August 10, 2015, we submitted pre-submission documents to the FDA in connection with our proposed future application for FDA approval of our U.S. clinical trial protocol.&#160; The pre&#8209;submission documentation was submitted to the FDA in order to obtain the FDA&#8217;s guidance regarding the U.S. regulatory pathway for the GlucoTrack&#174; model DF-F, the proper approach to refining the trial protocol and preparing the pre-marketing application.&#160; On October 19, 2015, we met with the FDA to discuss the pre-submission documents, including the approach to and details of the clinical trial protocol for the GlucoTrack&#174; model DF-F.&#160; On May 10, 2016, we submitted a pre-submission supplement (including clinical trial protocol) to the FDA which reflects the feedback received from the FDA at our October 2015 meeting.&#160; On July 18, 2016, we completed a teleconference with the FDA to further discuss our pre-submission supplement.&#160; At the end of this discussion, we received verbal confirmation from the FDA that clinical trials of the GlucoTrack&#174; model DF-F constitute non&#8209;significant risk device studies, which allows the trials to proceed without an Investigational Device Exemption (IDE) application.&#160; Such trials are assessed by the FDA and not considered to present a potential for serious risk to the health, safety or the welfare of subjects.&#160; We have identified and are currently negotiating agreements with two diabetes and endocrinology institutions in the United States, as well as prominent endocrinologists to conduct the clinical trials as primary investigators.&#160; Subject to finalizing these agreements and raising adequate financing to do so, we expect to begin clinical trials in the United States in the second half of 2017.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are continuing to work to improve certain features of the GlucoTrack&#174; model DF-F, such as further simplifying the calibration process and improving the accuracy of the device.&#160; Clinical trials conducted in Germany by Pfutzner Science &amp; Health Institute, GmbH, headed by Prof.&#160;Dr.&#160;Andreas Pfutzner, on subjects with Type 2 diabetes and pre-diabetics, as well as at Soroka University Medical Center, Beer-Sheva, Israel, demonstrated favorable results, which were presented on November 10, 2016 by the Company at the 16th annual Diabetes Technology Meeting (DTM), Bethesda, MD in an invited presentation.&#160; Most notably, the presentation included data validating that GlucoTrack&#8217;s accuracy has increased significantly.&#160; Results from the trials show 99.7% of the study data points within the clinically accepted A and B zones of the Consensus Error Grid (Type 2), 99.3% of the study data points were within the clinically accepted A and B zones of the Clarke Error Grid, 17.0% Mean Absolute Relative Difference, and 12.9% Median Absolute Relative Difference.&#160; In addition, the German trial concluded that the data confirms the performance of the GlucoTrack&#174; among its intended users, including pre-diabetic patients.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition, we are developing a wireless module (&#8220;WLM&#8221;) with embedded Bluetooth Low-Energy (BLE) and Wi-Fi technologies, which we expect will enable transmission of measurement data captured by the GlucoTrack&#174; model DF-F to a cloud based server.&#160; We expect this module and the related applications, if successfully developed, to facilitate sharing, viewing and analysis of GlucoTrack&#174; model DF-F glucose measurements and profile by clinicians and others.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Since receiving CE Mark approval for our GlucoTrack&#174; model DF-F glucose monitoring device, we have expanded our primary focus to include, in addition to research and development activities, preparation for anticipated future mass-production and distribution of the GlucoTrack&#174; model DF-F in EU member countries and other countries that have an MDD Mutual Recognition Agreement with the EU, as well as other countries which consider the CE Mark as a reference for their regulatory or registration requirements.&#160; We have entered into exclusive distribution agreements with more than 15 distributors, and we are continuing negotiations with distributors in additional territories.&#160; The effectiveness of these agreements, in many cases, is subject to the receipt of local regulatory approval or registration, if required, for the commencement of sales of the GlucoTrack&#174; model DF-F in the subject territory.&#160; We cannot provide any assurance that we will receive the required local regulatory approvals in any of the countries in which such approvals are required, and therefore we may never be permitted to commence commercial sales of our products in such territories.&#160; Additional discussions with other potential distributors are also in progress.&#160; Among other jurisdictions, we are in the process of seeking regulatory approval for the GlucoTrack&#174; model DF-F in China where we have a distribution agreement in place and are awaiting local regulatory approval.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">24</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On May 4, 2016 we received regulatory approval from the Korean Ministry of Food and Drug Safety (KMFDS, formerly KFDA) for the GlucoTrack&#174; model DF-F.&#160; In October 2016, we received the final approval from South Korea, which enables us to commence sales of the GlucoTrack&#174; model DF-F in South Korea.&#160; Following the official approval, our local distributor placed an initial order for 100 units of GlucoTrack&#174; model DF&#8209;F, which were fully paid for and delivered during the fourth quarter of 2016.&#160; In South Korea, the GlucoTrack&#174; device is sold with 2 personal ear-clips (&#8220;PECs&#8221;), so the consumer does not need to incur further expenses to use the device in the first year.&#160; This marketing model may be adopted by other distributors as well.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Based on input from our local distributors and regulatory consultants, we estimate that we could complete the local regulatory approval review process in China during 2017.&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The territories covered by our signed distribution agreements currently represent a potential market opportunity of up to approximately 141 million diagnosed diabetics (inclusive of both Type 1 and Type 2 diabetes patients).&#160; This represents approximately 34% of the potential worldwide market of approximately 414 million people, based on estimates included in the International Diabetes Federation&#8217;s (IDF) Diabetes Atlas, 7<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">th</font>&#160;edition, 2015.&#160; Of these territories, the territories in which the GlucoTrack&#174; model DF-F has been approved for sale currently represent a potential market opportunity of up to approximately 23 million diagnosed diabetics (inclusive of both Type 1 and Type 2 diabetes patients), or 5.6% of the potential worldwide market.&#160; While we do not have reliable statistics that bifurcate the market opportunity among Type 1 and Type 2 diabetics, we believe that on average approximately 87% of all people suffering from diabetes have Type 2 diabetes.&#160; Apart from the diagnosed patients, approximately 192 million people are estimated to suffer from diabetes that has not yet been diagnosed.&#160; Based on estimates included in the International Diabetes Federation&#8217;s (IDF) Diabetes Atlas, 7<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">th </font>edition, 2015, the market opportunity for undiagnosed diabetics is 71 million people in the territories covered by our signed distribution agreements, of which 11 million people are in the territories in which the GlucoTrack&#174; model DF-F has been approved for sale.&#160; Based on the IDF Diabetes Atlas, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>edition, 2015, the world prevalence of pre-diabetics was 6.4% of the worldwide population, while the prevalence of diagnosed people with diabetes was 7.7%.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We do not own commercial manufacturing facilities and do not intend to build commercial manufacturing facilities of our own in the foreseeable future.&#160; We currently utilize a third-party manufacturer in Israel to manufacture the GlucoTrack&#174; model DF-F.&#160; In July 2014, we entered into a manufacturing agreement with Wistron Corp. (&#8220;Wistron&#8221;), a Taiwanese entity and the manufacturing arm of Acer Inc.&#160; Pursuant to such agreement, Wistron has agreed to mass produce and service, on a non-exclusive basis, the GlucoTrack&#174; model DF-F and any future products, if any, introduced by us.&#160; Pursuant to such agreement, Wistron has also agreed to provide full turn-key manufacturing services for the GlucoTrack&#174; model DF- F, including components procurement, unit assembly, device integration, testing, packaging and delivery to customers (distributors).&#160; In November 2015, we sent a delegation to Wistron&#8217;s main production facility in Taiwan to, among other things, inspect the readiness of Wistron&#8217;s production line for the GlucoTrack&#174; model DF-F.&#160; Wistron has produced a small pilot batch and recently produced a second pilot batch of the GlucoTrack&#174; model DF-F device.&#160; A GMP (Good Manufacturing Practice) audit by the local regulatory authorities in Taiwan was conducted in September 2016 and successfully completed.&#160; The production line for the GlucoTrack&#174; model DF-F is now ready and we expect to receive an official clearance from the Taiwanese authorities shortly.&#160; We intend to utilize the services of both Wistron and the Israeli third-party manufacturer to produce the GlucoTrack&#174; model DF-F.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In support of the commercialization effort, we intend to conduct further post-market clinical trials, as well as publish scientific and clinical studies, case studies, and white papers.&#160; To that end, we have engaged with a leading clinic in Germany, Pfutzner Science &amp; Health Institute, GmbH, headed by Prof.&#160;Dr.&#160;Andreas Pfutzner, to conduct additional clinical trials on subjects with Type 2 diabetes and pre-diabetics.&#160; We are in negotiations with another site in Israel and anticipate adding additional sites in Europe.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Company is also seeking and is already engaged in discussions with potential strategic partners, to assist in expanding the Company&#8217;s presence and penetration in various markets throughout the world.&#160; In connection with the foregoing, we have approached certain leading companies in the field of diabetes and glucose monitoring, as well as other relevant companies that may have an interest in expanding their fields of interest.&#160; We cannot guarantee that such activities will conclude in positive results to the Company, if any.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">25</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition to the improvements to the GlucoTrack&#174; model DF-F described previously, we have also continued to work on additional incremental improvements to the device and the development of new devices and, subject to our raising sufficient funds to do so, intend to continue these efforts throughout 2017.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As part of our commercialization activities, in September 2016, we had a booth at the EASD (European Association for Study of Diabetes) 52nd annual conference in Munich.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In December 2016, we had a poster at the 9th Annual World Congress on Prevention of Diabetes and its Complications (WCPD, Atlanta, GA).&#160; This Congress provided the Company with an opportunity to showcase GlucoTrack&#174; model DF-F as a tool to fight diabetes and its complications, as well as using GlucoTrack&#174; model DF-F as a tool to assist pre-diabetics.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In February 2017, the Company presented at the 10th International Conference on Advanced Technologies &amp; Treatments for Diabetes (ATTD 2017) in Paris, France.&#160; The Company presented key findings including (1) the latest generation GlucoTrack&#174; algorithm, which compensates for the tissue-lagging effect relative to blood glucose changes post-meal intake, significantly improves GlucoTrack&#174; accuracy at different post-prandial (post- meal) states, and equalizes accuracy for pre- and post-meal glucose readings; (2) GlucoTrack&#174; clinical accuracy as measured by Consensus Error Grid (CEG) showed 100% of the pre-prandial readings in the A+B zones, and 98.2% of the post-prandial readings in the A+B zones; (3) GlucoTrack&#174; Model DF-F demonstrates consistent glucose measurement repeatability between different GlucoTrack&#174; devices and on each earlobe of the same subject; (4) the repeatability of different GlucoTrack&#174; devices is similar at all tested glucose ranges and post-prandial time periods; and (5) the GlucoTrack&#174; mean precision absolute relative difference (PARD) of 8.2% is equivalent or better than the independently reported PARD values of commercially available continuous glucose monitoring systems.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On June 12, 2017, we announced new data demonstrating the clinical performance of GlucoTrack&#174;, further supporting its suitability for people with type 2 diabetes across various medication regimes.&#160; The data was recently presented at the American Diabetes Association&#8217;s (ADA) 77<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> Scientific Sessions in San Diego, CA.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The study evaluated GlucoTrack&#8217;s accuracy in 172 adults with type 2 diabetes who were prescribed one or more medications for major medical conditions associated with diabetes.&#160; The experiment stratified participants into five medication groups, focusing on anti-cholesterolemia, anti-hypertension, anti-thrombotic, and anti-diabetic (prolonged duration and short and mixed duration) medications.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We were incorporated in Delaware in May 2010.&#160; On July 15, 2010, we completed a reverse triangular merger with Integrity Israel and Integrity Acquisition Corp. Ltd., an Israeli corporation and a wholly owned subsidiary of ours, pursuant to which Integrity Acquisition Corp. Ltd. merged with and into Integrity Israel and all of the stockholders and option holders of Integrity Israel became entitled to receive shares and options in us in exchange for their shares and options in Integrity Israel (the &#8220;Reorganization&#8221;).&#160; Following the Reorganization, the former equity holders of Integrity Israel were entitled to the same proportional ownership in us as they had in Integrity Israel prior to the Reorganization.&#160; As a result of the Reorganization, Integrity Israel became a wholly owned subsidiary of ours.&#160; We operate primarily through Integrity Israel.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our principal offices are located at 19 Ha&#8217;Yahalomim St., Ashdod, Israel 7760049 and our telephone number is 972-8-675-7878.&#160; Our website address is http://www.integrity-app.com; the reference to such website address does not constitute incorporation by reference of the information contained on the website and such information should not be considered part of this report.&#160; There is no relationship between us and Integrity Applications, Incorporated, the engineering and software services company based in Chantilly, Virginia.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have six members on our Board, four of whom are independent.&#160; The Board of Directors has an Audit Committee, Compensation Committee and a Nominating and Corporate Governance Committee, each consisting solely of independent directors, except that Angela Strand, Chairman of the Nominating and Corporate Governance Committee, is not independent as she is an interim executive officer of the Company until September 30, 2017.&#160; We are continuing to consider expansion of the Board of Directors and the establishment of additional appropriate Board of Directors committees to support the Company.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">26</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During 2016 we expanded our advisory board to include renowned key opinion leaders, in order to support the Company&#8217;s global clinical, regulatory and commercialization efforts.&#160; The advisory board now comprises seven experts:&#160; Prof.&#160;Dr.&#160;Lutz Heinemann (Chairman):&#160; CEO, Science &amp; Co, D&#252;sseldorf, Germany; Prof.&#160;Irl B. Hirsch:&#160; University of Washington, School of Medicine, WA, USA; Prof.&#160;Dr.&#160;Michael Heise:&#160; University of Applied Science of South-Westphalia, Iserlohn, Germany; Prof.&#160;Jan Bolinder:&#160; Professor of Clinical Diabetes Research at the Department of Medicine, Huddinge, Sweden; Prof.&#160;Katharine Barnard:&#160; Health Psychologist, Bournemouth University, Faculty of Health and Social Science, England; Dr.&#160;Barry H. Ginsberg:&#160; Diabetes Consultant, DMTC, NJ, USA; and Avner Gal, co-founder and former CEO of the Company.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have not yet generated any material revenues from our operations and, as of June 30, 2017, have incurred an accumulated deficit of $41,466,658, stockholders&#8217; deficit of $13,366,077 and negative operating cash flows.&#160; We currently have no material sources of recurring revenue and therefore are dependent upon external sources for financing our operations.&#160; There can be no assurance that we will succeed in obtaining the necessary financing to continue our operations.&#160; As a result, substantial doubt exists regarding our ability to continue as a going concern.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Recent Developments</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On April 7, 2017, the Board of Directors of the Company (the &#8220;Board&#8221;) approved an amendment to the 2010 Incentive Compensation Plan of the Company (the &#8220;Plan&#8221;) to increase the number of shares of the Company&#8217;s Common Stock reserved for issuance under the Plan from 1,000,000 shares to 5,625,000 shares.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Effective April 7, 2017 (the &#8220;Gal Effective Date&#8221;), the Company and Integrity Israel entered into a letter agreement with Avner Gal whereby Mr. Gal separated from his employment and directorship at the Company to act as a part time consultant to the Company (the &#8220;Gal Agreement&#8221;).&#160; Pursuant to the terms of the Gal Agreement, and as consideration for Mr. Gal&#8217;s separation from employment and services as a consultant, the Company agreed, among other things, to (a) pay Mr. Gal an amount equal to his Salary (as defined in the Gal Employment Agreement) and other financial benefits Mr. Gal was entitled to receive under the Employment Agreement entered into by and between Integrity Israel and Mr. Gal in October 2010 (the &#8220;Gal Employment Agreement&#8221;), that would have been paid to Mr. Gal during the Notice Period (as defined in the Gal Employment Agreement), in lieu of such prior notice; (b) modify the Adjustment Period, pursuant to section 19 of the Gal Employment Agreement, to 24 Salaries (as defined in the Gal Employment Agreement), including all the benefits mentioned in the Gal Employment Agreement, provided Mr. Gal does not work or provide services to a company in direct competition with the Company; (c) accelerate the vesting of 88,259 outstanding unvested options to purchase Common Stock, at an exercise price per share equal to $6.25, held by Mr. Gal as of the Gal Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date; such amount was measured as approximately $51,000);&#160; (d) extend the term of all outstanding options (vested and unvested) held by Mr. Gal to be exercisable for five years from the Gal Effective Date (with respect to all vested options, at the modification date the company recognized compensation cost in an amount equal to the excess amount of the fair value of the modified award as of the modification date over the fair value of the original award immediately); and (e) grant Mr. Gal an option to purchase up to 300,000 shares of Common Stock of the Company having an exercise price per share equal to $4.50 and an option to purchase up to an additional 50,000 shares of common stock of the Company having an exercise price per share equal to $7.75.&#160; These options vest monthly over a 24 months period following the date of grant.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Effective April 7, 2017, the Company entered into an amendment to the employment agreement (the &#8220;Graham Employment Amendment&#8221;) with John Graham, whom the Company appointed as Chief Executive Officer on March 20, 2017, to modify the base compensation provision and the equity compensation provision under that certain Employment Agreement, dated March 20, 2017 (the &#8220;Graham Effective Date&#8221;), by and between the Company and Mr. Graham.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to the terms of the Graham Employment Amendment, (a) Mr. Graham&#8217;s base compensation was modified such that he receives a base salary of $500,000 per year, as well as a one-time payment of $375,000 paid to Mr. Graham upon commencement of Mr. Graham&#8217;s employment with the Company which amount was recognized as an expense as of the employment commencement date, and (b) the vesting periods of Mr. Graham&#8217;s options to purchase Common Stock were modified whereby (1) 307,754 shares of Common Stock underlying Mr. Graham&#8217;s option to purchase Common Stock at an exercise price of $4.50 per share (the &#8220;$4.50 Options&#8221;) vested immediately, (2) 923,262 of the $4.50 Options vest on the six month anniversary of the Graham Effective Date, and (3) the remaining 442,980 of the $4.50 Options as well as Mr. Graham&#8217;s remaining unvested options granted pursuant to the Graham Employment Amendment vest on the two (2) year anniversary of the Graham Effective Date.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">27</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Effective April 7, 2017, Integrity Israel entered into an amended and restated personal employment agreement (the &#8220;Malka Employment Agreement&#8221;) with David Malka for his continued service as Vice President of Operations of the Company and Integrity Israel, effective as of March 20, 2017 (the &#8220;Malka Effective Date&#8221;).&#160; Pursuant to the terms of the Malka Employment Agreement, Mr. Malka (a) receives a base monthly salary of NIS 20,000 (approximately $5,508 based on an exchange rate of 3.63 NIS / 1 USD in effect on August 8, 2017), which may increase to NIS 35,000 per month (approximately $9,639 using the same exchange rate) in the event certain performance milestones are met (the &#8220;Malka Base Salary&#8221;); (b) is eligible to earn an annual performance bonus between 420-864% of the Malka Base Salary, subject to certain performance criteria to be established by the Board of Directors within the first ninety (90) days of each fiscal year; (c) is eligible to earn a retention bonus equal to 60% of the aggregate Malka Base Salary earned through the one-year anniversary of the Malka Effective Date, payable thirty days following the one-year anniversary of the Malka Effective Date and provided that Mr. Malka remains employed with Integrity Israel through and on the one-year anniversary of the Malka Effective Date; (d) received a modification to the terms of his option to purchase Common Stock at an exercise price per share equal to $6.25 whereby the unvested portion of such options will accelerate and will be immediately exercisable, effective as of the Malka Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date);&#160; and (e) received certain additional equity awards (pursuant to the Plan) under the terms and conditions as set forth in the Malka Employment Agreement.&#160; In addition, the Malka Employment Agreement provides for the payment of certain social benefits and the use of a company car.&#160; The Malka Employment Agreement is terminable by Integrity Israel and Mr. Malka on 90 days&#8217; prior written notice (the &#8220;Malka Notice Period&#8221;), without Cause, or immediately by Integrity Israel for Cause (as defined in the Malka Employment Agreement).&#160; Integrity Israel may terminate Mr. Malka&#8217;s employment without Cause prior to the expiration of the Malka Notice Period, but will be required to pay Mr. Malka a severance fee equal to the Malka Base Salary plus the financial value of all other benefits Mr. Malka would have been entitled to receive in respect of the portion of the Malka Notice Period which was forfeited.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On May 23, 2017, the Board approved the salary increase to NIS 35,000 per month pursuant to the Malka Employment Agreement, notwithstanding the foregoing performance goal requirement, as consideration for Mr. Malka&#8217;s continued service as Vice President of Operations of the Company and Integrity Israel.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On May 4, 2017, the Board of Directors unanimously voted to appoint Angela Strand, a member of the Board of Directors, as the interim Chief Strategy Officer of the Company, effective as of May 1, 2017 through September 30, 2017. On May 5, 2017, the Company entered into a letter agreement (the &#8220;Strand Employment Agreement&#8221;) with Ms. Angela Strand confirming her appointment as interim Chief Strategy Officer of the Company.&#160; Pursuant to the terms of the Strand Employment Agreement, Ms. Strand receives aggregate compensation of $150,000 for her service during the term of employment, paid monthly on the schedule mutually agreed upon by the parties.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On May 23, 2017, the Board approved the following compensation for all non-employee directors and interim officers serving on the Board:</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0e05d3b655a24b08ab74829b11e2d12f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an annual cash payment to each non-employee director and interim officer of the Company in the amount of $35,000, payable in four equal quarterly installments of $8,750 each on the last day of each calendar quarter commencing with the fourth quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5fb0f02ba1844f4a916bdf32c782d9aa" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an additional annual cash payment to each member of a Board committee who is not the Chairperson of that particular committee in the amount of $5,000, payable in four equal quarterly installments of $1,250 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">28</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z070edcdd85134a9e92ec006f480b1b54" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an additional annual cash payment to the chairperson of a Board committee in the amount of $12,500, payable in four equal quarterly installments of $3,125 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7d97b00d089446fea204bcbbca8181c3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the grant to each non-employee director and each interim officer of the Company of a one-time award of options to purchase up to an aggregate of 14,894 shares of Common Stock, at an exercise price of $4.50, under and pursuant to the Plan, which options vest in 12 equal monthly increments commencing as of June 1, 2017 (subject to their continued service as of each such date) and have a term of 10 years;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z875c7dd6956f44238e14d4e90112ea91" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the grant to each non-employee director and each interim officer of the Company of an award of Restricted Stock Units (&#8220;RSUs&#8221;), to be granted on June 1, 2017 and vesting on June 1, 2018, with a fair value of $45,000 based on the 30-day volume weighted average price of the Company&#8217;s Common Stock on June 1, 2017, subject to their continued service on and through such date; and</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1ce6a7991e334f31bf34587c1ce5b9ea" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an additional annual fair value payment to the vice chairperson of the Board in the amount of $20,000, payable in RSUs under the same vesting terms.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On May 23, 2017, the Board appointed Michael Hauck to serve as a director of the Company, effective on that date.&#160; The Board further appointed Mr. Hauck to serve as a member of the Nominating and Corporate Governance Committee of the Board as well as on the Compensation Committee of the Board.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There are no arrangements or understandings between Mr. Hauck and any other person pursuant to which Mr. Hauck was selected as a director.&#160; There are no relationships between Mr. Hauck and the Company that would require disclosure under Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On May 23, 2017, the Board established an Audit Committee of the Board and appointed each of Leslie Seff and Revan Schwartz to serve as members of the committee.&#160; Mr. Schwartz will serve as chairperson of the committee. The Board determined that each of the members of the Audit Committee designated above is independent pursuant to the required standards set forth in Rule 10A-3(b) of the Securities Exchange Act of 1934, as amended, based on an evaluation of the relationships between the Company and each of the members.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On June 7, 2017, the Board appointed David Podwalski as the Chief Commercial Officer of the Company, effective as of June 26, 2017 (the &#8220;Podwalski Effective Date&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On June 7, 2017, the Company entered into an employment agreement (the &#8220;CCO Employment Agreement&#8221;) with Mr. Podwalski to serve as Chief Commercial Officer of the Company.&#160; Under the CCO Employment Agreement, Mr. Podwalski (1) receives a base salary of $240,000 per year (&#8220;Base Salary&#8221;); (2) receives a sign-on bonus of $25,000, payable on the six month anniversary of the Podwalski Effective Date, subject to his continued employment through and on such payment date; (3) is eligible to receive an annual performance bonus, having a minimum bonus opportunity equal to 20% of his current Base Salary based upon 80% achievement of performance criteria (the &#8220;Minimum Performance Goal&#8221;), a target bonus opportunity equal to 25% of his current Base Salary based upon 100% achievement of performance criteria, and a maximum bonus opportunity equal to 37.5% of his current Base Salary based upon 150% achievement of performance criteria (the &#8220;Maximum Performance Goal&#8221;), provided, however, that such performance bonus will be determined using straight-line interpolation of the level of achievement between the Minimum Performance Goal and the Maximum Performance Goal; and (4)&#160; receive an initial stock option grant to purchase shares of Common Stock equal to 1% of the total fully diluted shares of Common Stock as of the Podwalski Effective Date, with an exercise price of $4.50 per share or the fair market value of a share of Common Stock on the grant date, whichever is greater, vesting monthly over a three year period commencing on the Podwalski Effective Date, subject to his continued employment through and on each such vesting date (the total fair value of the grant as of the Podwalski Effective Date is approximately $270,000).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">29</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The CCO Employment Agreement is terminable by the Company on 90 days written notice and by Mr. Podwalski on 30 days written notice.&#160; The CCO Employment Agreement is immediately terminable by the Company for Cause (as defined in the CCO Employment Agreement) without the payment of severance.&#160; The CCO Employment Agreement contains non-compete obligations applicable during the term of the agreement and for one year thereafter and confidentiality obligations that survive the termination of the agreement indefinitely.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the six-month period ended June 30, 2017 we raised funds in an aggregate amount of approximately $4.5 million (net of related cash expenses) from the issuance in four separate closings of 5,174.90 units (the &#8220;Series C Units&#8221;), each consisting of (a) one share of our newly designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series C Preferred Stock&#8221;), convertible into shares of our common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), at an initial conversion price of $4.50 per share, (b) a five year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-1 Warrant&#8221;) and (c) a five year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-2 Warrant&#8221; and, together with the Series C-1 Warrants, collectively, the &#8220;Series C Warrants&#8221;). During the period between April 2016 and June 2017, the Company raised funds in an aggregate amount of approximately $9.47 million (net of related cash expenses) through the issuance of 11,003.8 Series C Units in eleven separate closings.&#160; As of June 30, 2017, the shares of Series C Preferred Stock comprising the Series C Units are convertible into an aggregate of 2,445,317 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 4,890,634 shares of Common Stock, in each case subject to adjustments in certain circumstances.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with Andrew Garrett, Inc. (&#8220;AGI&#8221;), the placement agent for the offering of the Series C Units, at the initial closing of the sale of the Series C Units we paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units.&#160; At each of the second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth and eleventh closings of the sale of the Series C Units, we paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing.&#160; In addition, pursuant to the Placement Agent Agreement, we are required to issue to AGI :&#160; (a) 5 year warrants to purchase up to 489,064 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 244,531 shares of Common Stock at an exercise price of $7.75 per share.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the warrants issued by us to purchasers of units consisting of shares of its Series A 5% Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) and warrants to purchase shares of Common Stock (the &#8220;Series A Warrants&#8221;), on April 8, 2016, the exercise price per share of the Series A Warrants decreased from $5.80 per share to $4.50 per share and the number of shares of Common Stock issuable upon exercise of each of the Series A Warrants, in the aggregate, increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, will be equal to the aggregate exercise price prior to such adjustment.&#160; Also as a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the certificates of designations for our Series A Preferred Stock and Series B 5.5% Convertible Preferred Stock (the &#8220;Series B Preferred Stock&#8221;), on April 8, 2016, the conversion price per share of Series A Preferred Stock and Series B Preferred Stock decreased to $4.50 per share.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Significant Accounting Policies</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;).&#160; In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events, and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures.&#160; We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared.&#160; On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP.&#160; However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">30</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our significant accounting policies are described in Note 2, Summary of Significant Accounting Policies, of the Notes to the Consolidated Financial Statements appearing in our Annual Report on Form 10-K for the year ended December 31, 2016.&#160; Our management believes that, as for the financial statements for the interim periods included in this report, the estimates and assumptions relating to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series&#160;C Units, and (iii) the going concern assumption are considered critical accounting policies.&#160; However, due to the early stage of operations of the Company, there are no other accounting policies that are considered to be critical accounting policies by management.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Going Concern Uncertainty</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The development and commercialization of our product will require substantial expenditures.&#160; We have not yet generated material revenues and have incurred a substantial accumulated deficit and negative operating cash flows.&#160; We currently have no sources of recurring revenue and are therefore dependent upon external sources for financing our operations.&#160; There can be no assurance that we will succeed in obtaining the necessary financing to continue our operations.&#160; Management&#8217;s plans concerning these matters are described in Note 1B to our Annual Report on Form 10-K for the year ended December 31, 2016 (see also Note 1B to our interim financial statements for the period ended June 30, 2017). As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.&#160; The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Recently Issued Accounting Pronouncements</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting Standards Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606) (&#8220;ASU 2014-09&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance.&#160; ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">An entity should apply the amendments in ASU 2014-09 using one of the following two methods:&#160; 1.&#160;Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application.&#160; If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During 2016, the FASB issued several Accounting Standards Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, &#8220;Revenue from contracts with Customers &#8211; Deferral of the Effective Date&#8221;, for a public entity, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).&#160; Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Company intends to adopt ASU 2014-09 as of January 1, 2018.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">31</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Company is in the process of evaluating the impact of ASU 2014-09 on its revenue streams and selling contracts, if any, and on its financial reporting and disclosures.&#160; Management is expecting to complete the evaluation of the impact of the accounting and disclosure changes on the business processes, controls and systems during 2017.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Since the company did not report significant revenues, management believes that the adoption of ASU 2014-09 will not have a significant impact on its consolidated financial statements.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting Standards Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Effective January 1, 2017, the Group adopted ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) (&#8220;ASU 2015- 11&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value.&#160; Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance.&#160; Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The adoption of ASU 2015-11 did not have a significant effect on the consolidated financial statements.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting Standard Update (ASU) No. 2017-11, &#8220;Earnings Per Share&#8221;</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480);Derivatives and Hedging (Topic 815):&#160; (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings.&#160; Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification.&#160; Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company).&#160; Early adoption is permitted for all entities.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Company is evaluating the impact of ASU 2017-11 on its financial statements.&#160; Although this process has not been completed, managements believes that its provisions might impact the accounting of the financial instruments issued by the Company that include down-round protection.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Results of Operations</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following discussion of our operating results explains material changes in our results of operations for the six-month period ended June 30, 2017 compared with the same period ended June 30, 2016.&#160; The discussion should be read in conjunction with the financial statements and related notes included elsewhere in this report.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">32</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Six Months Ended June 30, 2017 Compared to Six Months Ended June 30, 2016</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Revenues</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the six-month period ended June 30, 2017, we had revenues of $104,981 from orders for our GlucoTrack&#174; model DF-F glucose monitoring device and personal ear-clip (&#8220;PEC&#8221;) that are replaced every six months, as compared with $470,878<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>for the prior-year period.&#160; The decrease in revenues is due primarily to the fact that during the six-month period ended June 30, 2016 we had revenues which resulted from the approval of the Notified Body in late 2015.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We recognize revenues from sales of the GlucoTrack&#174; model DF-F and PECs when delivery has occurred, persuasive evidence of an agreement exists, the fee is fixed and determinable, collectability is reasonably assured and no further obligations exist.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Research and development expenses</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Research and development expenses were $1,198,363 for the six-month period ended June 30, 2017, as compared to $1,531,396 for the prior-year period.&#160; The decrease is attributable primarily to the decrease in our cost of revenues, which is in line with the decrease in revenues.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Research and development expenses consist primarily of salaries and other personnel-related expenses, including materials, travel expenses, clinical trials and other expenses.&#160; Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect research and development expenses to increase during the remainder of 2017 and beyond, primarily due to hiring additional personnel and developing our product line, as well as improvement of the GlucoTrack&#174; model DF-F; however, we may adjust or allocate the level of our research and development expenses based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Selling and marketing expenses</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Selling and marketing expenses were $598,234 for the six-month period ended June 30, 2017, as compared to $614,121 for the prior-year period.&#160; The decrease is attributable to higher professional fees incurred during 2016 primarily due to the engagement during the second quarter of 2015 of the marketing firm Ogilvy CommonHealth (Paris).&#160; This engagement ended during the fourth quarter of 2016.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Selling and marketing expenses consist primarily of salaries, travel expenses and other related expenses.&#160; Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect selling and marketing expenses to increase during the remainder of 2017 and beyond as we continue our focus on marketing and sales of the GlucoTrack<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#174;</font> model DF-F; however, we may adjust or allocate the level of our marketing based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>General and administrative expenses</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">General and administrative expenses were $3,556,078 for the six-month period ended June 30, 2017, as compared to $1,173,188 for the prior-year period.&#160; The increase is primarily attributable to severance paid to our former Chairman and CEO of approximately $162,000 as well as stock-based compensation in the amount of $152,000.&#160; In addition, the increase is attributable to a one time signing bonus of $412,500 including employer payroll taxes and stock-based compensation in the amount of approximately $868,000 paid to our new Chairman and CEO, recruiting fees of $195,000 and the related professional fees associated with the changes in management.&#160; The company also incurred approximately $182,000 related to stock-based compensation and fees paid to our Board members.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;General and administrative expenses consist primarily of professional services, salaries, travel expenses and other related expenses for executive, finance and administrative personnel, including stock-based compensation expenses.&#160; Other general and administrative costs and expenses include facility-related costs not otherwise included in research and development costs and expenses, and professional fees for legal and accounting services.&#160; Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect selling, general and administrative expenses to increase during the remainder of 2017 and beyond.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">33</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Financing income, net</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Financing income, net was $160,168 for the six-month period ended June 30, 2017, as compared to $32,065 for the prior-year period.&#160; The change is primarily attributable to changes in fair market value adjustments relating to our Warrants with down-round protection.&#160; In accordance with U.S. GAAP, we mark the warrants to market on a quarterly basis based on the fair value estimate derived by using a binomial pricing model, with the changes in fair value recognized as finance expense or income, as applicable, in our consolidated statement of operations.&#160; The decrease in the estimated fair value of our Warrants with down-round protection during the six-month period ended June 30, 2017 and 2016 amounted to $191,075 and $64,212, respectively, resulting primarily from the decrease in the expected term of Warrants and the changes in the estimated expected volatility.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Net Loss</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net loss was $5,087,526 for the six-month period ended June 30, 2017, as compared to $2,815,762 for the prior-year period.&#160; The increase in net loss is attributable primarily to the increase in our general and administrative expenses, as described above.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Three Months Ended June 30, 2017 Compared to Three Months Ended June 30, 2016</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Revenues</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the three-month period ended June 30, 2017, we had revenues of $8,744 from orders for our GlucoTrack&#174; model DF-F glucose monitoring device and PECs that are replaced every six months, as compared with $381,731<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>for the prior-year period.&#160; The decrease in revenues is due primarily to the fact that during the three-month period ended June 30, 2016 we had revenues which resulted from the approval of the Notified Body in late 2015.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We recognize revenues from sales of the GlucoTrack&#174; model DF-F and PECs when delivery has occurred, persuasive evidence of an agreement exists, the fee is fixed and determinable, collectability is reasonably assured and no further obligations exist.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Research and development expenses</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Research and development expenses were $616,824 for the three-month period ended June 30, 2017, as compared to $880,696 for the prior-year period.&#160; The decrease is attributable to the decrease in our cost of revenues which is in line with the decrease in revenues.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Research and development expenses consist primarily of salaries and other personnel-related expenses, including materials, travel expenses, clinical trials and other expenses.&#160; Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect research and development expenses to increase during the remainder of 2017 and beyond, primarily due to hiring additional personnel and developing our product line, as well as improvement of the GlucoTrack&#174; model DF-F; however, we may adjust or allocate the level of our research and development expenses based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Selling and marketing expenses</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Selling and marketing expenses were $361,295 for the three-month period ended June 30, 2017, as compared to $349,804 for the prior-year period.&#160; The change is not material.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Selling and marketing expenses consist primarily of salaries, travel expenses and other related expenses.&#160; Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect selling and marketing expenses to increase during the remainder of 2017 and beyond as we continue our focus on marketing and sales of the GlucoTrack<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#174;</font> model DF-F; however, we may adjust or allocate the level of our marketing based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">34</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>General and administrative expenses</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">General and administrative expenses were $1,678,719 for the three-month period ended June 30, 2017, as compared to $734,661 for the prior-year period.&#160; The increase is primarily attributable to stock-based compensation paid to our current Chairman and CEO and our former Chairman and CEO of approximately $565,000 and $152,000, respectively.&#160; In addition, the company also incurred approximately $81,000 related to stock-based compensation and fees paid to our Board members.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;General and administrative expenses consist primarily of professional services, salaries, travel expenses and other related expenses for executive, finance and administrative personnel, including stock-based compensation expenses.&#160; Other general and administrative costs and expenses include facility-related costs not otherwise included in research and development costs and expenses, and professional fees for legal and accounting services.&#160; Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect selling, general and administrative expenses to increase during the remainder of 2017 and beyond.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Financing income.net</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Financing income, net was $90,893 for the three-month period ended June 30, 2017, as compared to a loss of $5,568 for the prior-year period.&#160; The change is primarily attributable to changes in fair market value adjustments relating to our Warrants with down-round protection.&#160; In accordance with U.S. GAAP, we mark the warrants to market on a quarterly basis based on the fair value estimate derived by using a binomial pricing model, with the changes in fair value recognized as finance expense or income, as applicable, in our consolidated statement of operations.&#160; The decrease in the estimated fair value of our Warrants with down-round protection during the three-month period ended June 30, 2017 and 2016 amounted to $106,976 and $20,70<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2</font>, respectively, resulting primarily from the decrease in the expected term of Warrants and the changes in the estimated expected volatility.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><u>Net Loss</u></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net loss was $2,557,201 for the three-month period ended June 30, 2017, as compared to $1,588,998 for the prior-year period.&#160; The increase in net loss is attributable primarily to the increase in our general and administrative expenses, as described above.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Liquidity and Capital Resources</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As of June 30, 2017, cash on hand was approximately $1,133,000.&#160; During the first six months of 2017 we received aggregate net proceeds of approximately $4.5 million (net of related cash expenses) from the issuance and sale of Series C Units.&#160; During the first six months of 2017, we did not collect a material amount in cash proceeds from the fulfillment of orders for our improved GlucoTrack&#174; model DF-F.&#160; While we expect to generate additional cash from sales, we do not anticipate that our income from operations will be sufficient to sustain our operations in the next 12 months.&#160; Based on our current cash burn rate, strategy and operating plan, we believe that our cash and cash equivalents will enable us to operate for a period of less than three months from the date of this report.&#160; In order to fund our anticipated liquidity needs beyond such period (or possibly earlier if our current cash burn rate, strategy or operating plan change in a way that accelerates or increases our liquidity needs), we will need to raise additional capital.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have a credit line with Bank HaPoalim of NIS 150,000 (approximately $42,906 based on the exchange rate of 3.496 NIS/dollar as of June 30, 2017).&#160; Borrowings under the line of credit are secured by our funds on deposit with the bank at the time of borrowing, which generally must be sufficient to cover the principal amount of the borrowings in full.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">35</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Messrs. Avner Gal and Zvi Cohen collectively loaned Integrity Israel NIS 176,000 ($50,343 based on the same exchange rate) on May 15, 2002 pursuant to Board approval. Messrs. Nir Tarlovsky, Yitzhak Fisher and Asher Kugler loaned Integrity Israel NIS 336,300 ($96,196 based on the same exchange rate) on March 16, 2004.&#160; These loans are not required to be repaid until the first year in which we realize profits in our annual statement of operations (accounting profit).&#160; At such time, the loans are to be repaid on a quarterly basis in an amount equal to 10% of our total sales in the relevant quarter, beginning on the quarter following the first year in which we realize profits in our annual statement of operations.&#160; The total amount to be repaid by us to each lender shall be an amount equal to the aggregate principal amount loaned by such lender to us, plus an amount equal to the product of the amount of each payment made by us in respect of such loan multiplied by the percentage difference between the Israeli Consumer Price Index on the date on which the loan was made and the Israeli Consumer Price Index on the date of such payment.&#160; However, notwithstanding the above-mentioned mechanism, we will not be required to repay the loans during any time when such repayment would cause a deficit in our working capital.&#160; Our Board is entitled to modify the repayment terms of these loans, so long as such modification does not discriminate against any particular lender, and provided that all payments must be allocated among the lenders on a pro-rata basis.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Integrity Israel is required to pay royalties to the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of the State of Israel at a rate ranging between 3-5% of the proceeds from the sale of the Company&#8217;s products arising from the development plan up to an amount equal to $93,300, plus interest at LIBOR from the date of grant.&#160; As of June 30, 2017, the contingent liability with respect to royalty payment on future sales equaled approximately $53,639, excluding interest.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net Cash Used in Operating Activities for the Six-Month Periods Ended June 30, 2017 and June 30, 2016</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net cash used in operating activities was $3,606,014 and $2,887,167 for the six-month periods ended June&#160;30, 2017 and 2016, respectively. Net cash used in operating activities primarily reflects the net loss for those periods of $5,087,526<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>and $2,815,762, respectively, increased by non-cash changes in fair value of Warrants with down&#8209;round protection of $191,075 and $64,212, respectively and partially offset by the decrease of $1,208,246 related to stock-based compensation as described above in general and administrative expenses. Net cash used in operating activities was also partially offset by changes in operating assets and liabilities in the aggregate amounts of $431,291 and $279,908, respectively.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net Cash Used in Investing Activities for the Six-Month Periods Ended June 30, 2017 and June 30, 2016</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net cash used in investing activities was $4,489 and $46,397 for the six-month periods ended June 30, 2017, and 2016, respectively, and was used to purchase equipment (such as computers, R&amp;D and office equipment).</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net Cash Provided by Financing Activities for the Six-Month Periods Ended June 30, 2017 and June 30, 2016</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net cash provided by financing activities was $4,520,229 and $3,745,726 for the six-month period ended June 30, 2017 and 2016, respectively.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Cash provided by financing activities for the six</font>-month period ended June 30, 2017 and 2016 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">reflected net capital raised from the issuance of Series C Units.</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Off-Balance Sheet Arrangements</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As of June 30, 2017, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item3" name="Item3"><!--Anchor--></a>Item 3.</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Quantitative and Qualitative Disclosures About Market Risk.</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Not required for smaller reporting companies.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">36</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item4" name="Item4"><!--Anchor--></a>Item 4.</font>&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Controls and Procedures.</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Evaluation of Disclosure Controls and Procedures</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2017.&#160; The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the &#8220;SEC&#8221;).&#160; Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.&#160; Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.&#160; Based on the evaluation of our disclosure controls and procedures as of June 30, 2017, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Changes in Internal Control over Financial Reporting</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There were no changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">37</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a id="PARTII-OTHERINFORMATION" name="PARTII-OTHERINFORMATION"><!--Anchor--></a>PART II - OTHER INFORMATION</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item6." name="Item6."><!--Anchor--></a>Item 6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Exhibits.</font></div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2f444990cfca4674b1006320152db301" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exhibit No.</div>
</td>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Description</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.1</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certificate of Incorporation of Integrity Applications, Inc. (1)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.2</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certificate of Amendment to Certificate of Incorporation of Integrity Applications, Inc. (1)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.3</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Bylaws of Integrity Applications, Inc. (1)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.4</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certificate of Designation of Preferences and Rights of Series A 5% Convertible Preferred Stock (2)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.5</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certificate of Designation of Preferences and Rights of Series B 5.5% Convertible Preferred Stock (3)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.6</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certificate of Designation of Preferences and Rights of Series C 5.5% Convertible Preferred Stock (4)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4.1</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Form of Securities Purchase Agreement (4)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4.2</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Form of Series C-1 Common Stock Purchase Warrant (4)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4.3</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Form of Series C-2 Common Stock Purchase Warrant (4)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4.4</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Form of Registration Rights Agreement (4)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10.1 *</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Letter Agreement, effective as of April 7, 2017, among Integrity Applications, Inc., A.D. Integrity Applications Ltd., and Avner Gal (6)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10.2 *</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">First Amendment to Employment Agreement, effective as of April 7, 2017, between Integrity Applications, Inc. and John Graham (6)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10.3 *</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Amended and Restated Personal Employment Agreement, effective as of April 7, 2017, between A.D. Integrity Applications Ltd. and David Malka (6)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10.4 *</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Amendment No. 2 to Integrity Applications, Inc. 2010 Incentive Compensation Plan (6) </div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10.5*</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Letter Agreement, effective as of April 7, 2017, among Integrity Applications, Inc. and Angela Strand</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10.6*</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Personal Employment Agreement between Integrity Applications, Inc. and David Podwalski</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">31.1</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">31.2</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">32.1</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">32.2</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.INS</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Instance Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.SCH</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Schema Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.CAL</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Calculation Linkbase Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.LAB</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Label Linkbase Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.PRE</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Presentation Linkbase Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.DEF</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Definition Linkbase Document (7)</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf10e085f477d4c5aa625548a1a272bab" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1, as filed with the SEC on August 22, 2011, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9bcea14f100c4c51915dc70ffc4fc612" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on March&#160;18, 2013, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z60114e7f40b145aa8e8187431b4466b1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(3)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on September 5, 2014, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5d1717f30ca0480891e98f5b10e8118c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(4)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on April 14, 2016, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5aa94d9ef9d2469daf281280cfdc004d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(5)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K, as filed with the SEC on March&#160;31, 2017, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdf23fc5a39dd4cc896637d0b249caebf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(6)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on April 13, 2017, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb16ca0a4e5a64325becf0e89863e6485" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(7)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Pursuant to Rule 406T of Regulation S-T, the interactive files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zcf6288c42bb54b278a9e17eb83334bbd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">*</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Compensation Plan or Arrangement or Management Contract.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">38</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SIGNATURES</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Dated:&#160; August 14, 2017</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb0abf9925ec342f7869d8cb9ceb41fef" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 49.67%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 50.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><font style="FONT-FAMILY: 'Times New Roman', Times, serif">By:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ John Graham</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Name:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">John Graham</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Title:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chairman of the Board and Chief Executive Officer </font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (Principal Executive Officer)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 49.67%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 50.33%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">By:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ John Graham</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Name:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">John Graham</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Title:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chairman of the Board and Chief Executive Officer<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> (Principal Executive Officer)</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-WEIGHT: normal; TEXT-ALIGN: left; CLEAR: both; MARGIN-TOP: 10pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">39</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT INDEX<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z4d129210206e4f449e47803b2354a58e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exhibit No.</div>
</td>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Description</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-1.htm">3.1</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-1.htm">Certificate of Incorporation of Integrity Applications, Inc. (1)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-2.htm">3.2</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-2.htm">Certificate of Amendment to Certificate of Incorporation of Integrity Applications, Inc. (1)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-3.htm">3.3</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-3.htm">Bylaws of Integrity Applications, Inc. (1)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891313000746/exhibit_3-1.htm">3.4</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891313000746/exhibit_3-1.htm">Certificate of Designation of Preferences and Rights of Series A 5% Convertible Preferred Stock (2)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891314002852/exhibit_3-1.htm">3.5</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891314002852/exhibit_3-1.htm">Certificate of Designation of Preferences and Rights of Series B 5.5% Convertible Preferred Stock (3)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_3-1.htm">3.6</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_3-1.htm">Certificate of Designation of Preferences and Rights of Series C 5.5% Convertible Preferred Stock (4)</a></div>
</td>
</tr>

<tr style="HEIGHT: 6px">
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-1.htm">4.1</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-1.htm">Form of Securities Purchase Agreement (4)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-2.htm">4.2</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-2.htm">Form of Series C-1 Common Stock Purchase Warrant (4)</a></div>
</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-3.htm">4.3</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-3.htm">Form of Series C-2 Common Stock Purchase Warrant (4)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-4.htm">4.4</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891316005077/exhibit_4-4.htm">Form of Registration Rights Agreement (4)</a></div>
</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-1.htm">10.1 *</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-1.htm">Letter Agreement, effective as of April 7, 2017, among Integrity Applications, Inc., A.D. Integrity Applications Ltd., and Avner Gal (6)</a></div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-2.htm">10.2 *</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-2.htm">First Amendment to Employment Agreement, effective as of April 7, 2017, between Integrity Applications, Inc. and John Graham (6)</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-3.htm">10.3 *</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-3.htm">Amended and Restated Personal Employment Agreement, effective as of April 7, 2017, between A.D. Integrity Applications Ltd. and David Malka (6)</a></div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-4.htm">10.4 *</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-4.htm">Amendment No. 2 to Integrity Applications, Inc. 2010 Incentive Compensation Plan (6) </a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="exhibit_10-5.htm">10.5*</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 87%">
<div><a href="exhibit_10-5.htm">Letter Agreement, effective as of April 7, 2017, among Integrity Applications, Inc. and Angela Strand</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 13.13%"><a href="exhibit_10-6.htm">10.6*</a></td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 87%">
<div id="DSPFPageHeader"><a href="exhibit_10-6.htm"></a></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_10-6.htm">Personal Employment Agreement between Integrity Applications, Inc. and David Podwalski</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="exhibit_31-1.htm">31.1</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_31-1.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="exhibit_31-2.htm">31.2</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_31-2.htm">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="exhibit_32-1.htm">32.1</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_32-1.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a href="exhibit_32-2.htm">32.2</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_32-2.htm">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.INS</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Instance Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.SCH</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Schema Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.CAL</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Calculation Linkbase Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.LAB</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Label Linkbase Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.PRE</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Presentation Linkbase Document (7)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 13.13%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.DEF</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 1%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Definition Linkbase Document (7)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6504e73f77f3431ca7d31413dd4ead0f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1, as filed with the SEC on August 22, 2011, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc4a9c966baea4700b67dcaa152cfdfc2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on March&#160;18, 2013, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zbdc6e1538c074f2a833757ae0bcfaed2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(3)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on September 5, 2014, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z64cf3294b7934ed18b056577ca708e6e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(4)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on April 14, 2016, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zabc484b096a54ff08ee5a2160faf1c11" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(5)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K, as filed with the SEC on March&#160;31, 2017, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0b5c2bbf295a4eb1a6fd61ab4548c300" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(6)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on April 13, 2017, which exhibit is incorporated herein by reference.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z739e85bd27a24e3badcd4de103416449" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(7)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Pursuant to Rule 406T of Regulation S-T, the interactive files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9ac5fdd5491f4c548071f63ea936056a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">*</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Compensation Plan or Arrangement or Management Contract.</div>
</td>
</tr>
</table>
</div>
</div>

<div id="DSPFPageNumberArea" style="FONT-WEIGHT: normal; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal"></font>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">40</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
</div>
</div>
</div>

<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal"></font>&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>2
<FILENAME>exhibit_10-5.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader" style="FONT-WEIGHT: bold">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 10.5</u></div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">May 1, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">John Graham </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chairman and CEO </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Integrity Applications </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">19 Ha&#8217;Yahalomim St. Ashdod</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ISRAEL</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Dear Angela:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">This letter confirms your appointment as Integrity Application&#8217;s interim Chief Strategy Officer, effective May 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup>, 2017 through September 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>, 2017. As we discussed, your primary responsibilities include leading the company&#8217;s Strategy and Innovation group, as well as identifying and managing external advisors and consultants to deliver a three-year strategy, plan, and financial model. In addition, you will work with me to support fundraising, partnering and investor relations efforts.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Your compensation for the period will be $150,000, paid monthly on the schedule that we have mutually agreed upon. Out of pocket travel expenses will be paid separately on a pre-approved basis.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">I look forward to continuing our work together. </div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Sincerely,</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">John Graham</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">CEO and Chairman </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Integrity Applications, Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 11pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">__________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Angela Strand</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>3
<FILENAME>exhibit_10-6.htm
<DESCRIPTION>EXHIBIT 10.6
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 10.6</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>EMPLOYMENT AGREEMENT</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">This Employment Agreement (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Agreement</font>&#8221;) is made and entered into on this 26<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> day of June, 2017 (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Effective Date</font>&#8221;) by and between Integrity Applications, Inc., a Delaware corporation (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Company</font>&#8221;), and David Podwalski (hereinafter, the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Executive</font>&#8221;).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>W I T N E S S E T </u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>H</u></font>:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">WHEREAS, the Company is in the business of development and commercialization of a noninvasive glucose monitoring device and related products; and</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">WHEREAS, the Company and Executive desire to enter into this Agreement to establish certain terms of Executive&#8217;s employment with the Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">NOW, THEREFORE, in consideration of the premises and mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are mutually acknowledged, the Company and the Executive hereby agree as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Definitions</font>.&#160; When used in this Agreement, the following terms shall have the following meanings:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Accrued Obligations</font>&#8221; means:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">all accrued but unpaid Base Salary through the end of the Term of Employment;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">any unpaid or unreimbursed expenses incurred in accordance with Company policy, including amounts due under Section 5(a) hereof, to the extent incurred during the Term of Employment;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">any accrued but unpaid benefits provided under the Company&#8217;s employee benefit plans, subject to and in accordance with the terms of those plans; and</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">rights to indemnification by virtue of the Executive&#8217;s position as an officer or director of the Company or its subsidiaries and the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">benefits under any directors&#8217; and officers&#8217; liability insurance policy maintained by the Company, in accordance with its terms </font>thereof.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Affiliate</font>&#8221; means any entity that controls, is controlled by, or is under common control with, the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Base Salary</font>&#8221; means the salary provided for in Section <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4(a)</font> hereof or any increased salary granted to Executive pursuant to Section <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4(a)</font> hereof.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Board</font>&#8221; means the Board of Directors of the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%2%%%-->
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Cause</font>&#8221; means the good faith and reasonable determination of the Board that the Executive has:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">been grossly negligent or engaged in willful misconduct, fraud, embezzlement, acts of dishonesty or a conflict of interest (to the extent such conflict of interest materially harms the Company), in each case, relating to the affairs of the Company; provided, that &#8220;Cause&#8221; shall not be deemed to exist under this clause (A) unless Executive has been given written notice specifying the act or omission constituting Cause and Executive has failed to cure such act or omission within thirty (30) days after receiving such notice; provided further, that such notice and cure right shall not be required to be given if the act or omission giving rise to the determination that Cause exists is not, in the reasonable determination of the Board, susceptible of cure;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">been convicted of or pleaded <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">nolo contendere</font> to any felony crime or been involved in the commission of any act (i) involving (A) misuse or misappropriation of money or other property of Company or (B) repeated use of illegal substances; or (ii) which disparages the business integrity of the Company, its directors, employees or customers, and materially and adversely affects the business reputation of Company; or</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">engaged in a willful violation of any federal or state securities laws.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Code</font>&#8221; means the Internal Revenue Code of 1986, as amended.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Disability</font>&#8221; has the meaning set forth in the Company&#8217;s long-term disability plan as in effect as of the date on which a &#8220;Disability&#8221; is claimed hereunder.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Good Reason</font>&#8221; means</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a material diminution in Executive&#8217;s title or responsibilities not otherwise agreed to in writing by Executive;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a material reduction in Executive&#8217;s Base Salary not otherwise agreed to in writing by Executive;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the Company&#8217;s failure to satisfy any payment obligation under this Agreement; or</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a material breach by the Company of this Agreement (other than a failure to satisfy any payment obligation).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">A termination for Good Reason hereunder shall not be effective until Executive has first given the Company written notice specifying such act or omission giving rise to the alleged Good Reason event and the Company has failed to cure such act or omission within thirty (30) days after receiving such notice. Executive shall provide the Company with such written notice detailing the specific circumstances alleged to constitute Good Reason within ninety (90) days after the first occurrence of such circumstances, otherwise, any claim of such circumstances as &#8220;Good Reason&#8221; shall be deemed irrevocably waived by Executive.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Severance Amount</font>&#8221; shall mean 50% of the Executive&#8217;s Base Salary.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Severance Term</font>&#8221; means the six month period following the date on which the Term of Employment ends.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Term of Employment</font>&#8221; means the period during which the Executive shall be employed by the Company pursuant to the terms of this Agreement.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Termination Date</font>&#8221; means the date on which the Term of Employment ends.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Employment.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Employment and Term</font>.&#160; The Company hereby agrees to employ the Executive and the Executive hereby agrees to serve the Company during the Term of Employment on the terms and conditions set forth herein.&#160; Executive&#8217;s services shall be performed from Executive&#8217;s home-based office until such time that the location of the Company's U.S. headquarters has been established.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Duties of Executive</font>.&#160; During the Term of Employment, the Executive shall be employed and serve as the Chief Commercial Officer of the Company, and shall have such duties typically associated with such title, including, without limitation creating, managing and implementing a successful commercial strategy for the Company on a global level. The Executive shall faithfully and diligently perform all services as may be assigned to him by the Chief Executive Officer (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">CEO</font>&#8221;) of the Company or the Board, and shall exercise such power and authority as may from time to time be delegated to him by the CEO or the Board.&#160; The Executive shall devote his full business time, attention and efforts to the performance of his duties under this Agreement, render such services to the best of his ability, and use his reasonable best efforts to promote the interests of the Company.&#160; The Executive shall not engage in any other business or occupation during the Term of Employment, including, without limitation, any activity that (i) conflicts with the interests of the Company or its subsidiaries, (ii) interferes with the proper and efficient performance of his duties for the Company, or (iii) interferes with the exercise of his judgment in the Company&#8217;s best interests.&#160; Notwithstanding the foregoing or any other provision of this Agreement, it shall not be a breach or violation of this Agreement for the Executive to (x) serve on corporate, civic or charitable boards or committees, (y) deliver lectures, fulfill speaking engagements or teach at educational institutions, or (z) manage personal investments, so long as such activities do not significantly interfere with or significantly detract from the performance of the Executive&#8217;s responsibilities to the Company in accordance with this Agreement.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Term</font>.&#160; The Term of Employment under this Agreement, and the employment of the Executive hereunder, shall commence on June 26, 2017 and shall continue until it is terminated pursuant to the terms set forth herein.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Compensation.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Base Salary</font>.&#160; The Executive shall receive a Base Salary at the annual rate of Two Hundred Forty Thousand Dollars ($240,000) during the Term of Employment, with such Base Salary payable in installments consistent with the Company&#8217;s normal payroll schedule, subject to applicable withholding and other taxes.&#160; The Base Salary shall be reviewed, at least annually, for merit increases and may, by action and in the discretion of the Compensation Committee of the Board, be increased at any time or from time to time.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Bonuses and Equity Awards</font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">During the Term of Employment, Executive shall be eligible to earn an annual performance bonus (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Performance Bonus</font>&#8221;), having a minimum bonus opportunity equal to 20% of his current Base Salary based upon 80% achievement of performance criteria (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Minimum Performance Goal</font>&#8221;), a target bonus opportunity equal to 25% of his current Base Salary based upon 100% achievement of performance criteria (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Target Performance Goal</font>&#8221;), and a maximum bonus opportunity equal to 37.5% of his current Base Salary based upon 150% achievement of performance criteria (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Maximum Performance Goal</font>&#8221;); provided, however, the Performance Bonus shall be determined using straight-line interpolation if the level of achievement is between the Minimum Performance Goal and the Target Performance Goal, or between the Target Performance Goal and the Maximum Performance Goal.&#160; The performance criteria shall be established by the Board or the Compensation Committee of the Board within the first ninety (90) days of each fiscal year that begins during the Term of Employment.&#160; Payment of any Performance Bonus shall be made based on the Board&#8217;s (or the Board&#8217;s Compensation Committee&#8217;s), as applicable, determination regarding Executive&#8217;s satisfaction of the criteria applicable to such Performance Bonus.&#160; If the level of achievement for any fiscal year is less than the Minimum Performance Goal, the Board (or the Board&#8217;s Compensation Committee) may elect to pay the Executive such other bonus amount in its sole discretion.&#160; Any payment in respect of a Performance Bonus shall be paid within thirty (30) days following the final determination of the amount of the Performance Bonus to be paid and during the immediately following calendar year to which the Performance Bonus related and provided that the Term of Employment continues through and on such payment date, except as otherwise required herein.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive is eligible for a Twenty-five Thousand Dollars ($25,000) signing bonus, minus applicable deductions and withholdings, payable on the six-month anniversary of the Effective Date, provided that the Term of Employment continues through and on such payment date.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Effective as of the Effective Date, the Company shall grant to Executive options to purchase up to One Percent (1%) of the fully diluted common stock, par value $0.001 per share, of the Company (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Common Stock</font>&#8221;) as of the Effective Date, with a per share exercise price equal to the greater of (A) $4.50 per share or (B) the fair market value of a share of Common Stock on the Effective Date, which shall vest in equal monthly installments over a three year period following the Effective Date, subject to the Term of Employment continuing through and on each such vesting date and subject to the terms and conditions set forth in the Stock Option Agreement attached as Exhibit A hereto and made a part hereof, and the provisions of the Company&#8217;s Incentive Compensation Plan.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; TEXT-ALIGN: center">4

<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Expense Reimbursement and Other Benefits.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Reimbursement of Expenses</font>. Upon the submission of proper substantiation by the Executive, and subject to such rules and guidelines as the Company may from time to time adopt with respect to the reimbursement of expenses of executive personnel, the Company shall reimburse the Executive for all reasonable expenses actually paid or incurred by the Executive during the Term of Employment in the course of and pursuant to the business of the Company.&#160; The Executive shall account to the Company in writing for all expenses for which reimbursement is sought and shall supply to the Company copies of all relevant invoices, receipts or other evidence reasonably requested by the Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Compensation/Benefit Programs</font>.&#160; During the Term of Employment, the Executive shall be entitled to participate in all medical, dental, hospitalization, accidental death and dismemberment, disability, travel and life insurance plans, and any and all other plans as are presently and hereinafter offered by the Company to its personnel, including savings, pension, profit-sharing and deferred compensation plans, subject to the general eligibility and participation provisions set forth in such plans.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> Until such time as the Company has obtained health insurance coverage, AD&amp;D, and executive level Short and Long Term Disability insurance for its U.S. employees generally, the Company shall reimburse Executive for his out-of-pocket costs to maintain such coverage up to Two Thousand Eighty-three Dollars ($2,083) per month, in accordance with Section 5(a) hereof, and provided that such reimbursement would not cause the Company to incur any penalties under any applicable law (including without limitation, pursuant to Section 2716 of the Public Health Service Act or the Patient Protection and Affordable Care Act).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Working Facilities</font>.&#160; During the Term of Employment, the Company shall furnish the Executive with an office, secretarial help and such other facilities and services suitable to his position and adequate for the performance of his duties hereunder.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><font style="FONT-WEIGHT: normal; FONT-STYLE: normal">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other Benefits</font>.&#160; The Executive shall be entitled to twenty-five (25) days of paid vacation each calendar year during the Term of Employment, to be taken at such times as the Executive and the Company shall mutually determine and provided that no vacation time shall significantly interfere with the duties required to be rendered by the Executive hereunder.&#160; Any vacation time not taken by Executive during any calendar year may not be carried forward into any succeeding calendar year, except as may be agreed to in writing by the Chief Executive Officer of the Company in his sole discretion.&#160; The Executive shall receive such additional benefits, if any, as the Board shall from time to time determine.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Termination</font>.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">General</font>.&#160; The Term of Employment shall terminate upon the earliest to occur of (i) the Executive&#8217;s death, (ii) a termination by the Company by reason of the Executive&#8217;s Disability, (iii) a termination by the Company with or without Cause, or (iv)&#160;a termination by Executive with or without Good Reason.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Upon any termination of Executive&#8217;s employment for any reason, except as may otherwise be requested by the Company in writing and agreed upon in writing by Executive, the Executive shall resign from any and all directorships, committee memberships or any other positions Executive holds with the Company or any of its subsidiaries.</font></font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Termination By Company for Cause</font>.&#160; The Company shall at all times have the right, upon written notice to the Executive, to terminate the Term of Employment, for Cause.&#160; In the event that the Term of Employment is terminated by the Company for Cause, Executive shall be entitled only to the Accrued Obligations, payable as and when those amounts would have been payable had the Term of Employment not ended.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Disability</font>.&#160; The Company shall have the option, in accordance with applicable law, to terminate the Term of Employment upon written notice to the Executive, at any time during which the Executive is suffering from a Disability.&#160; In the event that the Term of Employment is terminated due to the Executive&#8217;s Disability, the Executive shall be entitled only to the Accrued Obligations, payable as and when those amounts would have been payable had the Term of Employment not ended.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Death</font>.&#160; In the event that the Term of Employment is terminated due to the Executive&#8217;s death, the Executive shall be entitled only to the Accrued Obligations, payable as and when those amounts would have been payable had the Term of Employment not ended.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Termination Without Cause</font>.&#160; The Company may terminate the Term of Employment at any time without Cause, by written notice to the Executive not less than ninety (90) days prior to the effective date of such termination.&#160; In the event that the Term of Employment is terminated by the Company without Cause (other than due to the Executive&#8217;s death or Disability) the Executive shall be entitled to:</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Accrued Obligations, payable as and when those amounts would have been payable had the Term of Employment not ended;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;The Severance Amount, payable for the Severance Term.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Termination by Executive for Good Reason</font>.&#160; The Executive may terminate the Term of Employment for Good Reason and the Executive shall be entitled to the same payments and benefits as provided in Section 6(e) above for a termination without Cause.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Termination by Executive Without Good Reason</font>.&#160; The Executive may terminate his employment without Good Reason by providing the Company thirty (30) days&#8217; written notice of such termination.&#160; In the event of a termination of employment by the Executive under this Section 6(g), the Executive shall be entitled only to the Accrued Obligations.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In the event of termination of the Executive&#8217;s employment under this </font>Section 6(g)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">, the Company may, in its sole and absolute discretion, by written notice, accelerate such date of termination and still have it treated as a termination without Good Reason.</font></font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Release</font>.&#160; Any payments due to Executive under this Section 6 (other than the Accrued Obligations) shall be conditioned upon Executive&#8217;s execution of a general release of claims in the form attached hereto as Exhibit A (subject to such modifications as the Company reasonably may request) that becomes irrevocable within sixty (60) days of the Termination Date.&#160; Payment of any amounts subject to the Executive&#8217;s release shall be delayed until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup> day following the Termination Date (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Payment Commencement Date</font>&#8221;) and any payments that are so delayed shall be paid on the Payment Commencement Date.&#160; All payments and benefits provided under Section 6 (other than the Accrued Obligations) shall be forfeited if the Executive does not timely execute (or subsequently revokes) the release within the aforementioned sixty (60) day period.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Cooperation</font>.&#160; Following the Term of Employment, the Executive shall give his assistance and cooperation willingly, upon reasonable advance notice with due consideration for his other business or personal commitments, in any matter relating to his position with the Company, or his expertise or experience as the Company may reasonably request, including his attendance and truthful testimony where deemed appropriate by the Company, with respect to any investigation or the Company&#8217;s defense or prosecution of any existing or future claims or litigations or other proceedings relating to matters in which he was involved or potentially had knowledge by virtue of his employment with the Company.&#160; In no event shall his cooperation materially interfere with his services for a subsequent employer or other similar service recipient.&#160; To the extent permitted by law, the Company agrees that (i) it shall promptly reimburse the Executive for his reasonable and documented expenses in connection with his rendering assistance and/or cooperation under this Section 6(i) upon his presentation of documentation for such expenses and (ii) the Executive shall be reasonably compensated for any continued material services as required under this Section 6(i).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Return of Company Property</font>.&#160; Following the Termination Date, the Executive or his personal representative shall return all Company property in his possession, including but not limited to all computer equipment (hardware and software), telephones, facsimile machines, palm pilots and other communication devices, credit cards, office keys, security access cards, badges, identification cards and all copies (including drafts) of any documentation or information (however stored) relating to the business of the Company, its customers and clients or its prospective customers and clients (provided that the Executive may retain a copy the addresses contained in his rolodex, palm pilot, PDA or similar device).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Compliance with Section 409A</font>.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">General.</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160; </font>It is the intention of both the Company and the Executive that the benefits and rights to which the Executive could be entitled pursuant to this Agreement comply with Section 409A of the Code and the Treasury Regulations and other guidance promulgated or issued thereunder (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Section 409A</font>&#8221;), to the extent that the requirements of Section 409A are applicable thereto, and the provisions of this Agreement shall be construed in a manner consistent with that intention.&#160; If the Executive or the Company believes, at any time, that any such benefit or right that is subject to Section 409A does not so comply, it shall promptly advise the other and shall negotiate reasonably and in good faith to amend the terms of such benefits and rights such that they comply with Section 409A (with the most limited possible economic effect on the Executive and on the Company).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Distributions on Account of Separation from Service.</font>&#160; If and to the extent required to comply with Section 409A, no payment or benefit required to be paid under this Agreement on account of termination of the Executive&#8217;s employment shall be made unless and until the Executive incurs a &#8220;separation from service&#8221; within the meaning of Section 409A.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">6 Month Delay for Specified Employees.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">If the Executive is a &#8220;specified employee&#8221;, then no payment or benefit that is payable on account of the Executive&#8217;s &#8220;separation from service&#8221;, as that term is defined for purposes of Section 409A, shall be made before the date that is six months after the Executive&#8217;s &#8220;separation from service&#8221; (or, if earlier, the date of the Executive&#8217;s death) if and to the extent that such payment or benefit constitutes deferred compensation (or may be nonqualified deferred compensation) under Section 409A and such deferral is required to comply with the requirements of Section&#160;409A.&#160; Any payment or benefit delayed by reason of the prior sentence shall be paid out or provided in a single lump sum at the end of such required delay period in order to catch up to the original payment schedule.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">For purposes of this provision, the Executive shall be considered to be a &#8220;specified employee&#8221; if, at the time of his or her separation from service, the Executive is a &#8220;key employee&#8221;, within the meaning of Section 416(i) of the Code, of the Company (or any person or entity with whom the Company would be considered a single employer under Section 414(b) or Section 414(c) of the Code) any stock in which is publicly traded on an established securities market or otherwise.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">No Acceleration of Payments.</font>&#160; Neither the Company nor the Executive, individually or in combination, may accelerate any payment or benefit that is subject to Section 409A, except in compliance with Section 409A and the provisions of this Agreement, and no amount that is subject to Section 409A shall be paid prior to the earliest date on which it may be paid without violating Section 409A.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Treatment of Each Installment as a Separate Payment.</font> For purposes of applying the provisions of Section 409A to this Agreement, each separately identified amount to which the Executive is entitled under this Agreement shall be treated as a separate payment.&#160; In addition, to the extent permissible under Section 409A, any series of installment payments under this Agreement shall be treated as a right to a series of separate payments.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Taxable Reimbursements and In-Kind Benefits.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any reimbursements by the Company to the Executive of any eligible expenses under this Agreement that are not excludable from the Executive&#8217;s income for Federal income tax purposes (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Taxable Reimbursements</font>&#8221;) shall be made by no later than the last day of the taxable year of the Executive following the year in which the expense was incurred.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The amount of any Taxable Reimbursements, and the value of any in-kind benefits to be provided to the Executive, during any taxable year of the Executive shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year of the Executive.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The right to Taxable Reimbursements, or in-kind benefits, shall not be subject to liquidation or exchange for another benefit.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">No Guaranty of 409A Compliance</font>.&#160; Notwithstanding the foregoing, the Company does not make any representation to the Executive that the payments or benefits provided under this Agreement are exempt from, or satisfy, the requirements of Section 409A, and the Company shall have no liability or other obligation to indemnify or hold harmless the Executive or any beneficiary of the Executive for any tax, additional tax, interest or penalties that the Executive or any beneficiary of the Executive may incur in the event that any provision of this Agreement, or any amendment or modification thereof, or any other action taken with respect thereto, is deemed to violate any of the requirements of Section 409A.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Restrictive Covenants.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Noncompetition; Non-solicitation.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive acknowledges that the Company is engaged in a highly competitive business on a world-wide scale and that, by virtue of the position in which Executive is employed, his engaging in or working for or with any business which is directly competitive with the Company would cause the Company great and irreparable harm.&#160; Executive also acknowledges that, by virtue of his/her employment, he has gained or will gain knowledge of the identity, characteristics, and preferences of the Company&#8217;s customers, suppliers and other business partners, among other Confidential Information, and that Executive would inevitably have to draw on such Confidential Information if he were to solicit or service the Company&#8217;s customers, suppliers and other business partners on behalf of a competing business enterprise.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive agrees that &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Restricted Business</u></font>&#8221; at any date means the goods, products, and/or services of the type provided, marketed, sold, produced and/or developed by the Company during the twelve (12) month period ending on that date for or concerning the development and commercialization of glucose monitoring devices or any technology or software that measures or monitors glucose levels.&#160; The &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Territory</font>&#8221; for the purposes of this Section 7 shall be anywhere in (x) the World.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Accordingly, Executive agrees that during Executive&#8217;s employment with Company, whether or not under this Agreement, and thereafter for a period of twelve (12) months (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Noncompetition Period</font>&#8221;), he will not within the Territory:</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">directly or indirectly, engage or invest in, own, manage, operate, finance, control or participate in the ownership, management, operation, financing, or control of or be employed by, associated with or in any manner connected with any entity or organization engaged in Restricted Business;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">directly or indirectly approach, advise, solicit or deal with, in competition with the Company, any entity or organization engaged in Restricted Business;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">provide technical, commercial or professional advice to any business or concern engaged in Restricted Business; or</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(D)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">interfere or seek to interfere with the supply of any components, materials, goods or services to the Company (or with the terms of any such supply).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive agrees that during Executive&#8217;s employment with Company, whether or not under this Agreement, and thereafter for a period of twenty-four (24) months, he will not within the Territory, directly or indirectly, for the purpose of competing with the Company:</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">induce or procure or attempt to induce or procure any person who is on, or was during the twenty-four (24) months preceding, the date of the termination of Executive&#8217;s employment with the Company, an officer or key employee of, consultant for or other person under contract to provide services to the Company, to leave his/her/her employment or service with the Company (whether or not that person would commit any breach of his/her or her employment or appointment by reason of leaving the service of the Company); or</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 144pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">accept into employment or otherwise engage or use the services of any person who is on, or was during the twenty-four (24) months preceding, the date of the termination of Executive&#8217;s employment with the Company, an officer or key employee of, consultant for or other person under contract to provide services to the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive agrees that during Executive&#8217;s employment with Company and for all time thereafter, he will not disparage the Company, its directors, officers, employees, the Company brand or its products and services.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Intellectual Property.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive shall disclose promptly to the Company all ideas, inventions, discoveries, improvements, designs, formulae, processes, production methods and technological innovations (which, together with all intellectual property rights that might be available therein including, without limitation, patents, copyrights and trade secrets, shall hereinafter be referred to as &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Intellectual Property</font>&#8221;), whether or not patentable, which Executive may conceive or make, alone or with others, in connection with his/her employment with the Company from and after the date of this Agreement, whether or not during working hours, and which: (A) relate specifically to the business of the Company; (B) are based on or derived from Executive&#8217;s knowledge of the actual or planned business activities of the Company; or (C) are developed using existing Intellectual Property belonging to the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive shall assign, and does hereby assign, to the Company (and to bind his/her heirs, executors and administrators, to assign to the Company) all Intellectual Property covered by Section 7(b)(i) hereof (collectively, &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Company Intellectual Property</font>&#8221;).</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Without further compensation but at the Company&#8217;s expense, Executive agrees to give all testimony and execute all patent applications, rights of priority, assignments and other documents, and in general do all lawful things reasonably requested of Executive by the Company to enable the Company to obtain, maintain and enforce its rights to such Company Intellectual Property.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All of Executive&#8217;s work product during his/her employment hereunder and all parts thereof shall be &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>work made for hire</u></font>&#8221; for the Company within the meaning of the United States Copyright Act of 1976, as amended from time to time, and for all other purposes, and Executive hereby quitclaims and assigns to the Company any and all other rights he may have or acquire therein.&#160; Accordingly, all right, title and interest in any and all materials, or other property, including, without limitation, trademarks, service marks and related rights, whether or not copyrightable, created, developed, adapted, formulated or improved by Executive (whether alone or in conjunction with any other person or employee), constituting Company Intellectual Property shall be owned exclusively by the Company.&#160; Executive will not have or claim to have under this Agreement, or otherwise, any right title or interest of any kind or nature whatsoever in any Company Intellectual Property.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Confidential Relationship and Confidential Information.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Confidential Information</u></font>.&#160; Executive acknowledges that, during the course of his/her employment, he will have access to information relating to the Company&#8217;s business that provides the Company with a competitive advantage, that is not generally known by persons not employed by or providing services for the Company and that could not easily be determined or learned by someone outside the Company (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Confidential Information</font>&#8221;).&#160; Such Confidential Information includes both written information and information not reduced to writing and includes, without limitation:&#160; (i) the identity of the Company&#8217;s customers, suppliers and other business partners and prospective customers, suppliers and other business partners, including names, addresses and phone numbers, the characteristics, preferences and investment strategies of those parties, the types of services provided to and ordered by those third parties; (ii) the Company&#8217;s internal corporate policies related to those services, price lists, fee arrangements and terms of dealings with such third parties; (iii) the identity of the Company&#8217;s sources in the field and off-site consultants and the terms and conditions on which the Company transacts business with those sources and consultants; (iv) financial and sales information, including the Company&#8217;s financial condition and performance and the compensation paid to other employees of the Company; (v) information relating to inventions, discoveries and formulas, records, research and development data, trade secrets, processes, other methods of doing business, forecasts and business and marketing plans of the Company and (vi) all Company Intellectual Property (as hereinafter defined).&#160; Executive acknowledges that the Company has gathered such information at great cost and over time and that such information is not generally known and cannot easily be obtained from publicly available sources.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Notwithstanding the foregoing, the term &#8220;Confidential Information&#8221; shall not include, and Executive shall not have any obligations under this Section 7 with respect to, any information which (i) is or becomes publicly known through no unlawful or other wrongful act or omission by Executive or any other person or entity; (ii) becomes known to Executive from a third party having the legal right to make an unrestricted disclosure without a breach of any obligation of confidentiality to the Company by Executive or such third party; (iii) is&#160; voluntarily disclosed to the public or competitors of the Company by the Company (except where such public disclosure has been made by Executive or another without authorization); or (iv) has been independently developed and disclosed by others, or that otherwise enters the public domain through lawful means.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Restriction on Use and Disclosure of Confidential Information</u></font>.&#160; Executive shall, both during and after his/her employment by Company, hold all Confidential Information in a fiduciary capacity.&#160; Executive shall not directly or indirectly use or disclose such Confidential Information except as is (i) necessary for the good faith performance of his/her services for Company, (ii) reasonably necessary, in the opinion of counsel to the Company (or, in respect of claims by the Company against Executive, counsel to Executive), to respond to or defend any claim(s) against Executive or the Company or (iii) required to be disclosed by court order, governmental action, legal process or by applicable law; provided, however, that if disclosure is required under this clause (iii), Executive shall first give written notice thereof to the Company and shall fully cooperate (at the Company&#8217;s cost and expense) in the Company&#8217;s attempt to obtain a protective order or other waiver or exclusion from the court or other applicable governmental or other authority.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Ownership of Confidential Information</u></font>.&#160; Executive acknowledges that any documents received or created by him during the course of his/her employment with the Company that contains or pertains to Confidential Information are and will remain the sole property of the Company.&#160; Such documents include, without limitation, files, memoranda, correspondence, reports, client records, contact lists and compilations of information, however such information may be recorded and whether on hard copy or on a computer disk, magnetic disk,&#160; CD-ROM, flash drive, or other electronic storage device.&#160; Executive shall return all such documents (including all copies) promptly upon the termination of his/her employment and shall not, during and after his/her employment, disclose those documents to anyone outside the Company or use those documents for any purpose other than the advancement of the Company&#8217;s interests, or as reasonably necessary, in the opinion of counsel to the Company (or, in respect of claims by the Company against Executive, counsel to Executive), to respond to or defend any claim(s) against Executive or the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Release</font>.&#160; Executive acknowledges that the Company may use the image, likeness, voice, or other characteristics of Executive in the services, materials, computer programs, marketing and advertising and other deliverables created or used or distributed by or on behalf of the Company in the course of its business.&#160; Executive hereby consents to the use of such characteristics of Executive by the Company and releases the Company, its directors, officers, employees, agents, contractors, licensees and assigns from any claims which Executive has or may have for invasion of privacy, right of publicity, defamation, copyright infringement, or any other causes of action arising out of the use, adaptation, reproduction, distribution, broadcast, or exhibition of such characteristics.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Acknowledgment by Executive</font>. The Executive acknowledges and confirms that the restrictive covenants contained in this Section 7 are fair, reasonable, and necessary for the protection of the legitimate business interests of the Company and that the Company will suffer irreparable harm in the event of an actual or threatened breach of any such provision by Executive.&#160; Executive therefore consents to the entry of a restraining order, preliminary injunction, or other court order to enforce such provisions and expressly waives any security that might otherwise be required in connection with such relief.&#160; Executive also agrees that any request for such relief by the Company shall be in addition and without prejudice to any claim for monetary damages which the Company might elect to assert.&#160; Executive agrees that the terms of this Section 7 are in addition to, and not in limitation of, any other restrictive covenants agreed to by Executive with respect to the Company.&#160; For all purposes of this Section 7, the term &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Company</u></font>&#8221; means the Company and each of its now existing or hereafter created or acquired or affiliated companies, subsidiaries and parent companies, and their respective successors and assigns.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Reformation by Court</font>.&#160; In the event that a court of competent jurisdiction shall determine that any provision of this Section 7 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then only as to enforcement of this Section 7 within the jurisdiction of such court, such provision shall be interpreted or reformed and enforced as if it provided for the maximum restriction permitted under such governing law.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Extension of Time</font>.&#160; If the Executive shall be in violation of any provision of this Section 7, then each time limitation set forth in this Section 7 shall be extended for a period of time equal to the period of time during which such violation or violations occur.&#160; If the Company or any its Affiliates seeks injunctive relief from such violation in any court, then the covenants set forth in this Section 7 shall be extended for a period of time equal to the pendency of such proceeding including all appeals by the Executive.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Injunction</font>.&#160; It is recognized and hereby acknowledged by the parties hereto that a breach by the Executive of any of the covenants contained in Section 7 of this Agreement will cause irreparable harm and damage to the Company, and its Affiliates, the monetary amount of which may be virtually impossible to ascertain.&#160; As a result, the Executive recognizes and hereby acknowledges that the Company and its Affiliates shall be entitled to an injunction from any court of competent jurisdiction enjoining and restraining any violation of any or all of the covenants contained in Section 7 of this Agreement by the Executive or any of his affiliates, associates, partners or agents, either directly or indirectly, and that such right to injunction shall be cumulative and in addition to whatever other remedies the Company may possess.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Representations and Warranties of Executive</font>.&#160; The Executive represents and warrants to the Company that:</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Executive&#8217;s employment will not conflict with or result in his breach of any agreement to which he is a party or otherwise may be bound;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Executive has not violated, and in connection with his employment with the Company will not violate, any non-solicitation, non-competition or other similar covenant or agreement of a prior employer by which he is or may be bound; and</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In connection with Executive&#8217;s employment with the Company, he will not use any confidential or proprietary information that he may have obtained in connection with employment with any prior employer.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Taxes</font>.&#160; Anything in this Agreement to the contrary notwithstanding, all payments required to be made by the Company hereunder to the Executive or his estate or beneficiaries shall be subject to the withholding of such amounts relating to taxes as the Company may reasonably determine it should withhold pursuant to any applicable law or regulation.&#160; In lieu of withholding such amounts, in whole or in part, the Company may, in its sole discretion, accept other provisions for payment of taxes and withholding as required by law, provided it is satisfied that all requirements of law affecting its responsibilities to withhold have been satisfied.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Assignment</font>.&#160; The Company shall have the right to assign this Agreement and its rights and obligations hereunder in whole, but not in part, to any corporation or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer all or substantially all of its assets, if in any such case said corporation or other entity shall by operation of law or expressly in writing assume all obligations of the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise assign this Agreement or its rights and obligations hereunder.&#160; The Executive may not assign or transfer this Agreement or any rights or obligations hereunder.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Governing Law</font>.&#160; This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to principles of conflict of laws.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Jurisdiction and Venue</font>.&#160; Each of the parties irrevocably and unconditionally (i) agrees that any suit, action or legal proceeding arising out of or relating to this Agreement which is expressly permitted by the terms of this Agreement to be brought in a court of law, shall be brought in the courts of record of the State of New York in New York County or the federal courts sitting in New York, New York; (ii) consents to the jurisdiction of each such court in any such suit, action or proceeding; (iii) waives any objection which it or he may have to the laying of venue of any such suit, action or proceeding in any of such courts; and (iv) agrees that service of any court papers may be effected on such party by mail, as provided in this Agreement, or in such other manner as may be provided under applicable laws or court rules in such courts.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Entire Agreement</font>.&#160; This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and, upon its effectiveness, shall supersede all prior agreements, understandings and arrangements, both oral and written, between the Executive and the Company (or any of its affiliates) with respect to such subject matter.&#160; This Agreement may not be modified in any way unless by a written instrument signed by both the Company and the Executive.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Survival</font>.&#160; The respective rights and obligations of the parties hereunder shall survive any termination of the Executive&#8217;s employment hereunder, including without limitation, the Company&#8217;s obligations under Section 6 and the Executive&#8217;s obligations under Section 7 above, and the expiration of the Term of Employment, to the extent necessary to the intended preservation of such rights and obligations.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Notices</font>.&#160; All notices required or permitted to be given hereunder shall be in writing and shall be personally delivered by courier, sent by registered or certified mail, return receipt requested or sent by confirmed facsimile transmission addressed as set forth herein.&#160; Notices personally delivered, sent by facsimile or sent by overnight courier shall be deemed given on the date of delivery and notices mailed in accordance with the foregoing shall be deemed given upon the earlier of receipt by the addressee, as evidenced by the return receipt thereof, or three (3) days after deposit in the U.S. mail.&#160; Notice shall be sent (i)&#160;if to the Company, addressed to Integrity Applications, Inc., Chairman of the Board &#8211; John Graham, 19 Ha'Yahalomim Street, P.O. Box 12163, Ashdod, Israel, and (ii)&#160;if to the Executive, to his address as reflected on the payroll records of the Company, or to such other address as either party shall request by notice to the other in accordance with this provision.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Benefits; Binding Effect</font>.&#160; This Agreement shall be for the benefit of and binding upon the parties hereto and their respective heirs, personal representatives, legal representatives, successors and, where permitted and applicable, assigns, including, without limitation, any successor to the Company, whether by merger, consolidation, sale of stock, sale of assets or otherwise.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Right to Consult with Counsel; No Drafting Party</font>.&#160; The Executive acknowledges having read and considered all of the provisions of this Agreement carefully, and having had the opportunity to consult with counsel of his own choosing, and, given this, the Executive agrees that the obligations created hereby are not unreasonable.&#160; The Executive acknowledges that he has had an opportunity to negotiate any and all of these provisions and no rule of construction shall be used that would interpret any provision in favor of or against a party on the basis of who drafted the Agreement.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Severability</font>.&#160; The invalidity of any one or more of the words, phrases, sentences, clauses, provisions, sections or articles contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event that any one or more of the words, phrases, sentences, clauses, provisions, sections or articles contained in this Agreement shall be declared invalid, this Agreement shall be construed as if such invalid word or words, phrase or phrases, sentence or sentences, clause or clauses, provisions or provisions,&#160; section or sections or article or articles had not been inserted.&#160; If such invalidity is caused by length of time or size of area, or both, the otherwise invalid provision will be considered to be reduced to a period or area which would cure such invalidity.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Waivers</font>.&#160; The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Damages; Attorneys Fees</font>.&#160; Nothing contained herein shall be construed to prevent the Company or the Executive from seeking and recovering from the other damages sustained by either or both of them as a result of its or his breach of any term or provision of this Agreement. In the event that either party hereto seeks to collect any damages resulting from, or the injunction of any action constituting, a breach of any of the terms or provisions of this Agreement, then the party found to be at fault shall pay all reasonable costs and attorneys&#8217; fees of the other.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Waiver of Jury Trial</font>.&#160; THE EXECUTIVE HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHT THAT THE EXECUTIVE MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT AND ANY AGREEMENT, DOCUMENT OR INSTRUMENT CONTEMPLATED TO BE EXECUTED IN CONNECTION HEREWITH, OR ANY COURSE OF CONDUCT, COURSE OF DEALING STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY HERETO.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Section Headings</font>.&#160; The article, section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">23.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">No Third Party Beneficiary</font>.&#160; Nothing expressed or implied in this Agreement is intended, or shall be construed, to confer upon or give any person other than the Company, the parties hereto and their respective heirs, personal representatives, legal representatives, successors and permitted assigns, any rights or remedies under or by reason of this Agreement.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">24.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Counterparts</font>.&#160; This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument and agreement.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z7e4588dd9ea04a7eab0f6628ece754bd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%">
<div>
<div style="FONT-WEIGHT: bold">COMPANY:</div>

<div>&#160;</div>

<div></div>

<div></div>

<div></div>

<div>By:&#160;_______________________________&#160;&#160;&#160;&#160;&#160;&#160;</div>

<div>Name: _____________________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>

<div>Title:&#160;______________________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>

<div>&#160;</div>

<div></div>

<div></div>

<div style="FONT-WEIGHT: bold">EXECUTIVE:</div>

<div>&#160;</div>

<div>__________________________________</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 234pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">17</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT A<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> FORM OF RELEASE</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GENERAL RELEASE OF CLAIMS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">_______________ (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Executive</u></font>&#8221;), for himself and his family, heirs, executors, administrators, legal representatives and their respective successors and assigns, in exchange for the consideration received pursuant to Section 6 (other than the Accrued Obligations) of the Employment Agreement to which this release is attached as Exhibit A (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Employment Agreement</u></font>&#8221;), does hereby release and forever discharge _____________________ (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Company</u></font>&#8221;), its subsidiaries, affiliated companies, successors and assigns, and its current or former directors, officers, employees, shareholders or agents in such capacities (collectively with the Company, the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Released Parties</u></font>&#8221;) from any and all actions, causes of action, suits, controversies, claims and demands whatsoever, for or by reason of any matter, cause or thing whatsoever, whether known or unknown including, but not limited to, all claims under any applicable laws arising under or in connection with Executive&#8217;s employment or termination thereof, whether for tort, breach of express or implied employment contract, wrongful discharge, intentional infliction of emotional distress, or defamation or injuries incurred on the job or incurred as a result of loss of employment.&#160; Executive acknowledges that the Company encouraged him to consult with an attorney of his choosing, and through this General Release of Claims encourages him to consult with his attorney with respect to possible claims under the Age Discrimination in Employment Act (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>ADEA</u></font>&#8221;) and that he understands that the ADEA is a Federal statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefits and benefit plans.&#160; Without limiting the generality of the release provided above, Executive expressly waives any and all claims under ADEA that he may have as of the date hereof.&#160; Executive further understands that by signing this General Release of Claims he is in fact waiving, releasing and forever giving up any claim under the ADEA as well as all other laws within the scope of this paragraph 1 that may have existed on or prior to the date hereof.&#160; Notwithstanding anything in this paragraph 1 to the contrary, this General Release of Claims shall not apply to (i) any rights to receive any payments or benefits pursuant to Section 6 of the Employment Agreement, (ii) any rights or claims that may arise as a result of events occurring after the date this General Release of Claims is executed, (iii) any indemnification rights Executive may have as a former officer or director of the Company or its subsidiaries or affiliated companies, (iv) any claims for benefits under any directors&#8217; and officers&#8217; liability policy maintained by the Company or its subsidiaries or affiliated companies in accordance with the terms of such policy, and (v) any rights as a holder of equity securities of the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive represents that he has not filed against the Released Parties any complaints, charges, or lawsuits arising out of his employment, or any other matter arising on or prior to the date of this General Release of Claims, and covenants and agrees that he will never individually or with any person file, or commence the filing of, any charges, lawsuits, complaints or proceedings with any governmental agency, or against the Released Parties with respect to any of the matters released by Executive pursuant to paragraph 1 hereof (a &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Proceeding</u></font>&#8221;); <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>provided</u></font>, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>however</u></font>, Executive shall not have relinquished his right to commence a Proceeding to challenge whether Executive knowingly and voluntarily waived his rights under ADEA.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive hereby acknowledges that the Company has informed him that he has up to twenty-one (21) days to sign this General Release of Claims and he may knowingly and voluntarily waive that twenty-one (21) day period by signing this General Release of Claims earlier.&#160; Executive also understands that he shall have seven (7) days following the date on which he signs this General Release of Claims within which to revoke it by providing a written notice of his revocation to the Company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive acknowledges that this General Release of Claims will be governed by and construed and enforced in accordance with the internal laws of the State of Delaware applicable to contracts made and to be performed entirely within such State.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Executive acknowledges that he has read this General Release of Claims, that he has been advised that he should consult with an attorney before he executes this general release of claims, and that he understands all of its terms and executes it voluntarily and with full knowledge of its significance and the consequences thereof.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">This General Release of Claims shall take effect on the eighth day following Executive&#8217;s execution of this General Release of Claims unless Executive&#8217;s written revocation is delivered to the Company within seven (7) days after such execution.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="zaaa34b255b0649beb048a25eb1dafec7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="WIDTH: 50%">
<div>________________________________________</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>_______________, 20__</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 234pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">A- 2

<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31-1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br>
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 31.1</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>THE SECURITIES EXCHANGE ACT OF 1934,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>AS ADOPTED PURSUANT TO SECTION 302 OF<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, John Graham, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z10785e02c76d4334a232dd0ba15ff580" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2017 of Integrity Applications, Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0ebd2e7566694586abb933c91742a54f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5c1db6ba40664cddb8a57969fb5f83ff" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zfebfcf48805d479597a3aed803e41e65" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z839437bd1cdb4e0abde79fffa9aaf14e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z661584bf4e564f268f25e93bb3b3b332" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze8401566e1204ef3b261825d36edccd0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(c)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z64d338f6299d4770bae171087da39a79" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(d)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z281cea090ce24d27929c727b43b2c3a5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf3e7ad06a7814b828c9de2fbbea78c9c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb1627bae72954ace9d2baeab0c0fadba" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Dated:&#160; August 14, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z58ac9760c94e492da536e1cfad46c0c6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 45.54%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 54.46%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">By:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ John Graham</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Name:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">John Graham</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Title:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chairman of the Board and Chief Executive Officer</font></div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 31.2</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>THE SECURITIES EXCHANGE ACT OF 1934,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>AS ADOPTED PURSUANT TO SECTION 302 OF<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Sami Sassoun, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7a0e3ff774c740a7b577fde3af932fc0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2017 of Integrity Applications, Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z41be884e7a5945f3838fced986f0bc9d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc9639d21db4c4ca7abd8e830d30c2c13" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1ac851990e0748de96fbca2b9543511e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z951d613ad50244fb95b1411c36815bdf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9d01d4e0c3f047f483704b76851165e7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0c9d98f706bb4ffc93997d5800954a53" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(c)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zfed2a76355e3480f9a2ce3e6813bdecc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(d)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z629087a3eb0045adb293eaa29eeb1b88" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6504ae28cdd9492a8c3de3bb7a79e3bd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z4541dc5cd5c04de3982571e417882329" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Dated:&#160; August 14, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zf877c67cad744627ad340c9fa5222d6a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 45.57%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 54.43%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">By:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ Sami Sassoun</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Name:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Sami Sassoun</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Title:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chief Financial Officer</font></div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 32.1</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>18 U.S.C. SECTION 1350,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>AS ADOPTED PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Quarterly Report on Form 10-Q of Integrity Applications, Inc. (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Company</u></font>&#8221;) for the six&#8209;month period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Report</u></font>&#8221;), I, John Graham, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z4ecb8ddf4b064ce5833fef2fe4338430" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z940154e7640344e687ff6dffe025fda2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zb370af3f875a490b93c287ef7c44335c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 45.54%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 54.46%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">By:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ John Graham&#160;</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Name:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">John Graham</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Title:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chairman of the Board and Chief Executive Officer</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Dated:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">August 14, 2017</font></div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 32.2</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>18 U.S.C. SECTION 1350,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>AS ADOPTED PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Quarterly Report on Form 10-Q of Integrity Applications, Inc. (the &#8220;Company&#8221;) for the six&#8209;month period ended June 30, 2017, as filed with the Securities and Exchange Commission on <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>the</u></font> date hereof (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Report</u></font>&#8221;), I, Sami Sassoun, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd38221f6b8f04f1f96b25e09deef562c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf6a34de38250418a891cd3ebaa3b2e52" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z9cee909224294d5ba355ae4b478888a9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 45.57%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; WIDTH: 54.43%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">By:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal">&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ Sami Sassoun</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Name:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Sami Sassoun</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Title:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chief Financial Officer</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Dated:</font>&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">August 14, 2017</font></div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>igap-20170630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 0617 10Q.xfr; Date: 2017%2D08%2D09T22:10:59Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:igap="http://integrity-app.com/20170630">
    <link:schemaRef xlink:href="igap-20170630.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2017-08-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618154">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_InitialClosingMember_custom_AgreementWithPlacementAgentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="igap:SaleAgreementAxis">igap:InitialClosingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_SecondClosingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="igap:SaleAgreementAxis">igap:SecondClosingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_custom_SeriesC1WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesC1WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_custom_SeriesC2WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesC2WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_SeriesC1WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesC1WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_SeriesC2WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesC2WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-12-31_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-06to2017-06-07_custom_MrPodwalskiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-06</xbrli:startDate>
        <xbrli:endDate>2017-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_DeferredBonusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredBonusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-06</xbrli:startDate>
        <xbrli:endDate>2017-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-06</xbrli:startDate>
        <xbrli:endDate>2017-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-06</xbrli:startDate>
        <xbrli:endDate>2017-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MinimumMember_us-gaap_DeferredBonusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredBonusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-06</xbrli:startDate>
        <xbrli:endDate>2017-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MaximumMember_us-gaap_DeferredBonusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredBonusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-06</xbrli:startDate>
        <xbrli:endDate>2017-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-07_custom_MrPodwalskiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:MrPodwalskiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_NonEmployeeDirectorAndInterimOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:NonEmployeeDirectorAndInterimOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-04to2017-05-05_custom_ChiefStrategyOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:ChiefStrategyOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-04</xbrli:startDate>
        <xbrli:endDate>2017-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_AvnerGalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:AvnerGalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_AvnerGalMember_custom_OptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:AvnerGalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">igap:OptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_AvnerGalMember_custom_AdditionalOptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:AvnerGalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">igap:AdditionalOptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-06to2017-04-07_custom_JohnGrahamMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:JohnGrahamMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-06</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:JohnGrahamMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:JohnGrahamMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:JohnGrahamMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_DavidMalkaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-06to2017-04-07_custom_DavidMalkaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-06</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-06</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-06</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MaximumMember_currency_ILS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-06</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-06to2017-04-07_custom_DavidMalkaMember_currency_ILS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-06</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_SeriesB1WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesB1WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_custom_SeriesB1WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesB1WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-06-30_custom_SeriesBandCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">igap:SeriesBandCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-07-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-07-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-01-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-23_custom_DavidMalkaMember_us-gaap_MaximumMember_currency_ILS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:DavidMalkaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-07-31_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_EachBoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:EachBoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_EachNonemployeeDirectorAndEachInterimOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:EachNonemployeeDirectorAndEachInterimOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EachNonemployeeDirectorAndEachInterimOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">igap:EachNonemployeeDirectorAndEachInterimOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_VicePresidentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:VicePresidentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPerShare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="ils">
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unit>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2017-06-30_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">10000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2016-12-31_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">10000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2017-06-30_us-gaap_PreferredStockMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2016-12-31_us-gaap_PreferredStockMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2017-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">11004</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2016-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2016-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">5829</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">6381149</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">6026527</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">6381149</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">6026527</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-06-30" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C618154" unitRef="USD" decimals="0">608701</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">148836</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">1132622</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">1405534</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">92061</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">130296</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">1419604</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">1508312</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">356994</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">157868</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2017495</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">2929098</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">240452</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">235230</us-gaap:PropertyPlantAndEquipmentNet>
    <igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">167326</igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent>
    <igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">184031</igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent>
    <us-gaap:Assets contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2460946</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">3387593</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">1634642</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">1789026</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">713549</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">957436</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2348191</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">2746462</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToOfficersOrStockholdersNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">162034</us-gaap:DueToOfficersOrStockholdersNoncurrent>
    <us-gaap:DueToOfficersOrStockholdersNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">178186</us-gaap:DueToOfficersOrStockholdersNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">176719</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">184030</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">681970</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">764545</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">1020723</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">1126761</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">3368914</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">3873223</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2017-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">11004</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2016-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2016-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">5829</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">10041462</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">12880447</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">6026527</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">6381149</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">6028</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">6384</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">24586142</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">27967185</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">62576</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">127012</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-35604176</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">-41466658</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">6384</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-10949430</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">-13366077</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">6028</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">24586142</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">27967185</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">62576</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">127012</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-35604176</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-41466658</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2460946</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">3387593</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1588998</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-5087526</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-5087526</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">-2557201</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2815762</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">33024</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">27980</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">1208246</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">34297</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-191075</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-64212</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">28615</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">51053</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-49255</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-130203</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-222952</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-147697</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">26829</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-638908</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">171018</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">132153</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-3606014</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2887167</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">4849</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">46397</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-4849</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-46397</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">4520229</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">3745726</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">74420</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-15329</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">983786</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">796833</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="INF">.055</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="From2017-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="INF">0.550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <igap:PreferredStockConversionPrice contextRef="AsOf2016-04-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember" unitRef="USDPerShare" decimals="2">4.50</igap:PreferredStockConversionPrice>
    <igap:PreferredStockConversionPrice contextRef="AsOf2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember" unitRef="USDPerShare" decimals="INF">4.50</igap:PreferredStockConversionPrice>
    <igap:PreferredStockConversionPrice contextRef="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USDPerShare" decimals="INF">5.80</igap:PreferredStockConversionPrice>
    <igap:PreferredStockConversionPrice contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USDPerShare" decimals="INF">4.50</igap:PreferredStockConversionPrice>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2017-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2017-01-01to2017-06-30_custom_SeriesC1WarrantMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2017-01-01to2017-06-30_custom_SeriesC2WarrantMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2017-01-01to2017-06-30_custom_SeriesB1WarrantMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheOneMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheTwoMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember" unitRef="USDPerShare" decimals="INF">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-06-30_custom_SeriesC1WarrantMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-06-30_custom_SeriesC2WarrantMember" unitRef="USDPerShare" decimals="INF">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-06-30_custom_NonEmployeeDirectorAndInterimOfficerMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-06-30_custom_SeriesB1WarrantMember" unitRef="USDPerShare" decimals="INF">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheOneMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheTwoMember" unitRef="USDPerShare" decimals="INF">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">735201</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">705810</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">633132</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">794582</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">51271</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">7920</us-gaap:InventoryFinishedGoods>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">20702</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">191075</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">106976</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">64212</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-04-01to2016-06-30" unitRef="Shares" id="Foot-00-0" decimals="INF">12210613</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-01-01to2017-06-30" unitRef="Shares" id="Foot-00-1" decimals="INF">19868112</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-04-01to2017-06-30" unitRef="Shares" id="Foot-00-2" decimals="INF">21001400</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-01-01to2016-06-30" unitRef="Shares" id="Foot-00-3" decimals="INF">11220345</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">35673</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">39234</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">64436</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2017-01-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">64436</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">1208246</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-01-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">31424</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-01-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1208214</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStockCash contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">4753</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">6714</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">2014</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">9453</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2017-04-01to2017-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">4700</us-gaap:DividendsCommonStockCash>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="C618154" unitRef="USD" decimals="0">321695</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">681970</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">764545</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">833153</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <igap:ChangeInFairValueOfSeriesaWarrants contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">191075</igap:ChangeInFairValueOfSeriesaWarrants>
    <igap:ChangeInFairValueOfSeriesaWarrants contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">64212</igap:ChangeInFairValueOfSeriesaWarrants>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2017-01-01to2017-06-30_us-gaap_WarrantMember" unitRef="Pure" xsi:nil="true" />
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember" unitRef="Pure" xsi:nil="true" />
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-06-30_us-gaap_WarrantMember" unitRef="Pure" id="Foot-01-0" decimals="INF">0.5659</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember" unitRef="Pure" id="Foot-01-1" decimals="INF">.6216</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2017-01-01to2017-06-30_us-gaap_WarrantMember" unitRef="Pure" decimals="INF">0.0092</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.0072</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.0111</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2017-01-01to2017-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">P0Y8M12D</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2017-01-01to2017-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">P4Y11M23D</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">P1Y8M12D</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2017-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" unitRef="USDPerShare" decimals="INF">0.0450</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2017-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="USDPerShare" decimals="INF">0.0775</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" unitRef="USDPerShare" decimals="INF">0.0450</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="USDPerShare" decimals="INF">0.0775</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice contextRef="AsOf2016-06-30_us-gaap_WarrantMember" unitRef="USDPerShare" id="Foot-02-0" decimals="INF">2.38</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2017-06-30_us-gaap_WarrantMember" unitRef="USDPerShare" id="Foot-02-1" decimals="INF">2.38</us-gaap:SharePrice>
    <igap:ClassOfWarrantOrRightFairValue contextRef="AsOf2017-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" unitRef="USDPerShare" decimals="INF">0.0006</igap:ClassOfWarrantOrRightFairValue>
    <igap:ClassOfWarrantOrRightFairValue contextRef="AsOf2017-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="USDPerShare" decimals="INF">0.0076</igap:ClassOfWarrantOrRightFairValue>
    <igap:ClassOfWarrantOrRightFairValue contextRef="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="USDPerShare" decimals="INF">0.0061</igap:ClassOfWarrantOrRightFairValue>
    <igap:NumberOfUnitsSold contextRef="From2017-01-01to2017-06-30" unitRef="Shares" decimals="INF">5174.90</igap:NumberOfUnitsSold>
    <igap:NumberOfUnitsSold contextRef="From2017-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">11003.80</igap:NumberOfUnitsSold>
    <igap:NumberOfUnitsSold contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">11003.80</igap:NumberOfUnitsSold>
    <igap:NumberOfUnitsSold contextRef="From2016-01-01to2016-12-31" unitRef="Shares" decimals="INF">5828.90</igap:NumberOfUnitsSold>
    <igap:NumberOfUnitsSold contextRef="From2017-07-01to2017-07-31_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">1000</igap:NumberOfUnitsSold>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-04-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">1</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-04-14" unitRef="Shares" decimals="INF">1133</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-05-04" unitRef="Shares" decimals="INF">1351</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-06-06" unitRef="Shares" decimals="INF">890.5</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-07-07" unitRef="Shares" decimals="INF">1050.65</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-09-07" unitRef="Shares" decimals="INF">540</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-10-07" unitRef="Shares" decimals="INF">357.75</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2017-03-14" unitRef="Shares" decimals="INF">2560</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2017-05-03" unitRef="Shares" decimals="INF">1551</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2017-06-23" unitRef="Shares" decimals="INF">660</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-12-05" unitRef="Shares" decimals="INF">506</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2017-01-05" unitRef="Shares" decimals="INF">403.9</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember" unitRef="Shares" decimals="INF">489064</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember" unitRef="Shares" decimals="INF">244531</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">4890634</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">444472</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheOneMember" unitRef="Shares" decimals="INF">44445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_PlacementAgentWarrantsTrancheTwoMember" unitRef="Shares" decimals="INF">22223</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_InitialClosingMember_custom_AgreementWithPlacementAgentMember" unitRef="Pure" decimals="INF">0.06</igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_SecondClosingMember" unitRef="Pure" decimals="INF">.10</igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <igap:RegistrationPaymentArrangementCommissionPercentage contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_InitialClosingMember_custom_AgreementWithPlacementAgentMember" unitRef="Pure" decimals="INF">0.04</igap:RegistrationPaymentArrangementCommissionPercentage>
    <igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_InitialClosingMember_custom_AgreementWithPlacementAgentMember" unitRef="Pure" decimals="INF">0.03</igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-04-30_us-gaap_SubsequentEventMember_custom_AgreementWithPlacementAgentMember_custom_SecondClosingMember" unitRef="Pure" decimals="INF">0.03</igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2017-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">221152</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">6715844</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">5943451</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2016-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">221152</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">6715844</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2016-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3104466</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <dei:DocumentType contextRef="From2017-01-01to2017-06-30">10-Q</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2017-01-01to2017-06-30">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2017-01-01to2017-06-30">2017-06-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2017-01-01to2017-06-30">Integrity Applications, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2017-01-01to2017-06-30">0001506983</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="From2017-01-01to2017-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2017-01-01to2017-06-30">2017</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2017-01-01to2017-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityFilerCategory contextRef="From2017-01-01to2017-06-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <igap:StockIssuedDuringPeriodValueStockDividendSeriesC contextRef="From2017-01-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">117</igap:StockIssuedDuringPeriodValueStockDividendSeriesC>
    <igap:StockIssuedDuringPeriodValueStockDividendSeriesC contextRef="From2017-01-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">276457</igap:StockIssuedDuringPeriodValueStockDividendSeriesC>
    <igap:StockIssuedDuringPeriodValueStockDividendSeriesC contextRef="From2017-01-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-276574</igap:StockIssuedDuringPeriodValueStockDividendSeriesC>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2017-01-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">207</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2017-01-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">491461</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2017-01-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-491668</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2017-01-01to2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">491668</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2017-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">276574</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2017-04-01to2017-06-30_custom_SeriesBandCPreferredStockMember" unitRef="USD" decimals="0">406225</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:PreferredStockDividendsShares contextRef="From2017-01-01to2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">206844</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">6714</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2017-01-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">6714</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2017-01-01to2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">32</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <igap:ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">3022002</igap:ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses>
    <igap:ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">2508321</igap:ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses>
    <igap:ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">1495541</igap:ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses>
    <igap:ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1242158</igap:ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">273650</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">234008</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <igap:PreferredStockConvertibleStockPriceTrigger contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="INF">7.00</igap:PreferredStockConvertibleStockPriceTrigger>
    <igap:PreferredStockConvertibleTradingVolumeTrigger contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">50000</igap:PreferredStockConvertibleTradingVolumeTrigger>
    <us-gaap:PreferredStockLiquidationPreference contextRef="AsOf2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USDPerShare" decimals="INF">10</us-gaap:PreferredStockLiquidationPreference>
    <igap:PreferredStockPercentageOutstandingGoverningDistributions contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="INF">0.35</igap:PreferredStockPercentageOutstandingGoverningDistributions>
    <igap:PreferredStockMaximumBeneficialOwnership contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="INF">0.0499</igap:PreferredStockMaximumBeneficialOwnership>
    <igap:PreferredStockMaximumBeneficialOwnershipSubjectToTerms contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="INF">0.0999</igap:PreferredStockMaximumBeneficialOwnershipSubjectToTerms>
    <igap:AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">1404911</igap:AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet>
    <igap:AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet contextRef="From2017-01-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1404911</igap:AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">363738</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">353250</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">261651</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">588338</us-gaap:AccruedLiabilitiesCurrent>
    <igap:OtherLiabilitiesClassifiedAsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">88160</igap:OtherLiabilitiesClassifiedAsCurrent>
    <igap:OtherLiabilitiesClassifiedAsCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="0">15848</igap:OtherLiabilitiesClassifiedAsCurrent>
    <us-gaap:ProceedsFromSaleOfInterestInCorporateUnit contextRef="From2016-04-01to2016-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="-5">4900000</us-gaap:ProceedsFromSaleOfInterestInCorporateUnit>
    <us-gaap:ProceedsFromSaleOfInterestInCorporateUnit contextRef="From2016-01-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="-5">4500000</us-gaap:ProceedsFromSaleOfInterestInCorporateUnit>
    <us-gaap:ProceedsFromSaleOfInterestInCorporateUnit contextRef="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">1000000</us-gaap:ProceedsFromSaleOfInterestInCorporateUnit>
    <us-gaap:Revenues contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">381731</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">104981</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">8744</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">470878</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">880696</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">1198363</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">616824</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1531396</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">349804</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">598234</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">361295</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">614121</us-gaap:SellingAndMarketingExpense>
    <us-gaap:CostsAndExpenses contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">1965161</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">5352675</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">2656838</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">3318705</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1583430</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-5247694</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">-2648094</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2847827</us-gaap:OperatingIncomeLoss>
    <igap:FinancingIncomeExpensesNet contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">5568</igap:FinancingIncomeExpensesNet>
    <igap:FinancingIncomeExpensesNet contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-160168</igap:FinancingIncomeExpensesNet>
    <igap:FinancingIncomeExpensesNet contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">-90893</igap:FinancingIncomeExpensesNet>
    <igap:FinancingIncomeExpensesNet contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-32065</igap:FinancingIncomeExpensesNet>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-8063</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">64436</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">31697</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-30039</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1597061</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-5023090</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">-2525504</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2845801</us-gaap:ComprehensiveIncomeNetOfTax>
    <igap:ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion contextRef="From2016-07-01to2017-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">2445317</igap:ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion>
    <igap:ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion contextRef="From2017-07-01to2017-07-31_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">222236</igap:ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion>
    <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">4520</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="From2016-04-01to2016-04-30" unitRef="USD" decimals="0">9470</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
    <us-gaap:InterestExpenseDebt contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">6149</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">13687</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">7970</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">8575</us-gaap:InterestExpenseDebt>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">734661</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">3556078</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">1678719</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1173188</us-gaap:GeneralAndAdministrativeExpense>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">825</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">26</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">1393</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-639</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">5742468</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-06-30" unitRef="Shares" decimals="INF">6116366</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-04-01to2017-06-30" unitRef="Shares" decimals="INF">6205104</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">5716566</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">5742468</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-01-01to2017-06-30" unitRef="Shares" decimals="INF">6116366</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-04-01to2017-06-30" unitRef="Shares" decimals="INF">6205104</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">5716566</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <igap:StockDividendOnSeriesCPreferredStockShares contextRef="From2017-01-01to2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">116354</igap:StockDividendOnSeriesCPreferredStockShares>
    <us-gaap:OtherNoncashExpense contextRef="From2017-01-01to2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNoncashExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">211077</us-gaap:OtherNoncashExpense>
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2017-01-01to2017-06-30" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">341662</igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-10148</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <igap:FairValueOfWarrantsIssuedAsConsiderationForPlacementServices contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">273650</igap:FairValueOfWarrantsIssuedAsConsiderationForPlacementServices>
    <igap:AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">90633</igap:AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital>
    <igap:AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">183017</igap:AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity>
    <us-gaap:OfficersCompensation contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember" unitRef="USD" decimals="0">240000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_DeferredBonusMember" unitRef="USD" decimals="0">25000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-05-04to2017-05-05_custom_ChiefStrategyOfficerMember" unitRef="USD" decimals="0">150000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-04-06to2017-04-07_custom_JohnGrahamMember" unitRef="USD" decimals="0">500000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-04-06to2017-04-07_custom_DavidMalkaMember" unitRef="USD" decimals="0">5508</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MaximumMember" unitRef="USD" decimals="0">9639</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MaximumMember_currency_ILS" unitRef="ils" decimals="0">35000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-04-06to2017-04-07_custom_DavidMalkaMember_currency_ILS" unitRef="ils" decimals="0">20000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-05-01to2017-05-23_custom_DavidMalkaMember_us-gaap_MaximumMember_currency_ILS" unitRef="ils" decimals="0">35000</us-gaap:OfficersCompensation>
    <igap:AnnualPerformanceBonusPercentage contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.20</igap:AnnualPerformanceBonusPercentage>
    <igap:AnnualPerformanceBonusPercentage contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.80</igap:AnnualPerformanceBonusPercentage>
    <igap:AnnualPerformanceBonusPercentage contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MinimumMember_us-gaap_DeferredBonusMember" unitRef="Pure" decimals="INF">0.25</igap:AnnualPerformanceBonusPercentage>
    <igap:AnnualPerformanceBonusPercentage contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember_us-gaap_MaximumMember_us-gaap_DeferredBonusMember" unitRef="Pure" decimals="INF">0.375</igap:AnnualPerformanceBonusPercentage>
    <igap:AnnualPerformanceBonusPercentage contextRef="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">4.20</igap:AnnualPerformanceBonusPercentage>
    <igap:AnnualPerformanceBonusPercentage contextRef="From2017-04-06to2017-04-07_custom_DavidMalkaMember_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">8.64</igap:AnnualPerformanceBonusPercentage>
    <igap:PercentageOfFullyDilutedSharesOfCommonStock contextRef="AsOf2017-06-07_custom_MrPodwalskiMember" unitRef="Pure" decimals="INF">0.01</igap:PercentageOfFullyDilutedSharesOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-07_custom_MrPodwalskiMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_AvnerGalMember" unitRef="USDPerShare" decimals="INF">6.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_AvnerGalMember_custom_OptionsGrantedMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_AvnerGalMember_custom_AdditionalOptionsGrantedMember" unitRef="USDPerShare" decimals="INF">7.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-04-07_custom_DavidMalkaMember" unitRef="USDPerShare" decimals="INF">6.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2017-04-06to2017-04-07_custom_JohnGrahamMember">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <igap:NetGrantFairValue contextRef="From2017-06-06to2017-06-07_custom_MrPodwalskiMember" unitRef="USD" decimals="0">270000</igap:NetGrantFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2017-04-07" unitRef="Shares" decimals="INF">5625000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2017-04-07_custom_DavidMalkaMember" unitRef="Pure" decimals="INF">3.63</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-04-07_custom_AvnerGalMember" unitRef="Shares" decimals="INF">88259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-04-07_custom_AvnerGalMember_custom_OptionsGrantedMember" unitRef="Shares" decimals="INF">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-04-07_custom_AvnerGalMember_custom_AdditionalOptionsGrantedMember" unitRef="Shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Shares" decimals="INF">307754</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Shares" decimals="INF">923262</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-04-07_custom_JohnGrahamMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" unitRef="Shares" decimals="INF">442980</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <igap:OneTimePayment contextRef="From2017-04-06to2017-04-07_custom_JohnGrahamMember" unitRef="USD" decimals="0">375000</igap:OneTimePayment>
    <igap:PercentOfOneShare contextRef="AsOf2017-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="Pure" decimals="INF">0.055</igap:PercentOfOneShare>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-19296</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-17194</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">-6720</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-24211</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:DividendsCommonStockStock contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">131281</us-gaap:DividendsCommonStockStock>
    <us-gaap:DividendsCommonStockStock contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">491668</us-gaap:DividendsCommonStockStock>
    <us-gaap:DividendsCommonStockStock contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">245637</us-gaap:DividendsCommonStockStock>
    <us-gaap:DividendsCommonStockStock contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">254101</us-gaap:DividendsCommonStockStock>
    <igap:DividendsCommonStockPreferredC contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">20355</igap:DividendsCommonStockPreferredC>
    <igap:DividendsCommonStockPreferredC contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">276574</igap:DividendsCommonStockPreferredC>
    <igap:DividendsCommonStockPreferredC contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">160588</igap:DividendsCommonStockPreferredC>
    <igap:DividendsCommonStockPreferredC contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">20355</igap:DividendsCommonStockPreferredC>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1745387</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-5862482</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2017-04-01to2017-06-30" unitRef="USD" decimals="0">-2965440</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-3099671</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <igap:GrossAmountOfSeriescUnitsSold contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">5175</igap:GrossAmountOfSeriescUnitsSold>
    <igap:GrossAmountOfSeriescUnitsSold contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="0">5829</igap:GrossAmountOfSeriescUnitsSold>
    <igap:AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">4520</igap:AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses>
    <igap:AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="0">4951</igap:AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses>
    <igap:NetAmountOfSeriescUnits contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">4246</igap:NetAmountOfSeriescUnits>
    <igap:NetAmountOfSeriescUnits contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="0">4642</igap:NetAmountOfSeriescUnits>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.30</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-06-30" unitRef="USDPerShare" decimals="INF">-0.96</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-04-01to2017-06-30" unitRef="USDPerShare" decimals="INF">-0.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-01-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.54</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">5742468</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-01-01to2017-06-30" unitRef="Shares" decimals="INF">6116366</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-04-01to2017-06-30" unitRef="Shares" decimals="INF">6205104</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">5716566</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <igap:PreferredStockInterestRatePercentage contextRef="From2017-04-01to2017-06-30_custom_SeriesBandCPreferredStockMember" unitRef="Pure" decimals="INF">0.09</igap:PreferredStockInterestRatePercentage>
    <igap:PercentageOfAggregateSalesPriceOfUnits contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember" unitRef="Pure" decimals="INF">0.10</igap:PercentageOfAggregateSalesPriceOfUnits>
    <igap:PercentageOfNonAccountableExpenseAllowance contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember" unitRef="Pure" decimals="INF">0.03</igap:PercentageOfNonAccountableExpenseAllowance>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-08-15" unitRef="Shares" decimals="INF">6381149</dei:EntityCommonStockSharesOutstanding>
    <igap:AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService contextRef="AsOf2017-06-30_custom_NonEmployeeDirectorAndInterimOfficerMember" unitRef="USD" decimals="0">35000</igap:AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService>
    <igap:AmountToBePaidEachQuarterForAnnualCashPayment contextRef="AsOf2017-06-30_custom_NonEmployeeDirectorAndInterimOfficerMember" unitRef="USD" decimals="0">8750</igap:AmountToBePaidEachQuarterForAnnualCashPayment>
    <igap:AdditionalCashPaymentAsCompensationSubjectToContinuedService contextRef="AsOf2017-06-30_us-gaap_BoardOfDirectorsChairmanMember" unitRef="USD" decimals="0">12500</igap:AdditionalCashPaymentAsCompensationSubjectToContinuedService>
    <igap:AdditionalCashPaymentAsCompensationSubjectToContinuedService contextRef="AsOf2017-06-30_custom_EachBoardOfDirectorsMember" unitRef="USD" decimals="0">5000</igap:AdditionalCashPaymentAsCompensationSubjectToContinuedService>
    <igap:AdditionalCashPaymentAsCompensationSubjectToContinuedService contextRef="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_VicePresidentMember" unitRef="USD" decimals="0">20000</igap:AdditionalCashPaymentAsCompensationSubjectToContinuedService>
    <igap:AmountToBePaidEachQuarterForAdditionalAnnualCashPayment contextRef="AsOf2017-06-30_us-gaap_BoardOfDirectorsChairmanMember" unitRef="USD" decimals="0">3125</igap:AmountToBePaidEachQuarterForAdditionalAnnualCashPayment>
    <igap:AmountToBePaidEachQuarterForAdditionalAnnualCashPayment contextRef="AsOf2017-06-30_custom_EachBoardOfDirectorsMember" unitRef="USD" decimals="0">1250</igap:AmountToBePaidEachQuarterForAdditionalAnnualCashPayment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-01-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_EachNonemployeeDirectorAndEachInterimOfficerMember" unitRef="Shares" decimals="INF">14894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_EachNonemployeeDirectorAndEachInterimOfficerMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_EachNonemployeeDirectorAndEachInterimOfficerMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <igap:CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals contextRef="From2017-01-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EachNonemployeeDirectorAndEachInterimOfficerMember" unitRef="USD" decimals="0">45000</igap:CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;div id="DSPFPageHeader" style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 1&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;GENERAL&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z0eaaec54c48a4597b73f5b0db7d79687" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;A.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Integrity Applications, Inc. (the &amp;#8220;Company&amp;#8221;) was incorporated on May 18, 2010 under the laws of the State of Delaware.&amp;#160; On July 15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter:&amp;#160; &amp;#8220;Integrity Acquisition&amp;#8221;), a wholly owned Israeli subsidiary of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter:&amp;#160; &amp;#8220;Integrity Israel&amp;#8221;), an Israeli corporation that was previously held by the stockholders of the Company.&amp;#160; Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger.&amp;#160; Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.&amp;#160; As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.&amp;#160; Integrity Israel was incorporated in 2001 and commenced its operations in 2002.&amp;#160; Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetes.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z9d7cdae391124ace8c337b23dddd54d2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;B.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Going concern uncertainty&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.&amp;#160; The development and commercialization of Integrity Israel&amp;#8217;s product is expected to require substantial expenditures.&amp;#160; Integrity Israel and the Company (collectively, the &amp;#8220;Group&amp;#8221;) have not yet generated significant revenues from operations, and therefore they are dependent upon external sources for financing their operations.&amp;#160; As of June 30, 2017, the Group has incurred an accumulated deficit of $41,466,658, a stockholder&amp;#8217;s deficit of $13,366,077 and negative operating cash flows.&amp;#160; Management considered the significance of such conditions in relation to the Group&amp;#8217;s ability to meet its current and future obligations and determined that these conditions raise substantial doubt about the Group&amp;#8217;s ability to continue as a going concern.&amp;#160; The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&amp;#160; To fund its operations the Company has raised funds through the issuance of (a) Series A units (the &amp;#8220;Series A Units&amp;#8221;) consisting of shares of the Company&amp;#8217;s Series A Convertible Preferred Stock (the &amp;#8220;Series A Preferred Stock&amp;#8221;) and detachable warrants to purchase shares of the Company&amp;#8217;s Common Stock (the &amp;#8220;Series A Warrants&amp;#8221; or &amp;#8220;Warrants with down-round protection&amp;#8221;) and (b)&amp;#160;Series B units (the &amp;#8220;Series B Units&amp;#8221;), each consisting of (i) one share of the Company&amp;#8217;s designated Series B 5.5% Convertible Preferred Stock, par value $0.001 per share (the &amp;#8220;Series B Preferred Stock&amp;#8221;), convertible into Common Stock at an initial conversion price of $5.80 per share, (ii) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &amp;#8220;Series B-1 Warrant&amp;#8221;) and (iii) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &amp;#8220;Series B-2 Warrant&amp;#8221; and, together with the Series B-1 Warrants, collectively, the &amp;#8220;Series B Warrants&amp;#8221;).&amp;#160; Additionally, during the period between April 2016 and June 2017, the Company raised funds in an aggregate amount of approximately $9.47 million (of which amount of approximately $4.52 million was raised during the six-month period ended June 30, 2017) (net of related cash expenses) through the issuance of 11,003.80 units (the &amp;#8220;Series C Units&amp;#8221;).&amp;#160; Each of the Series&amp;#160;C Units consists of (a) one share of the Company&amp;#8217;s designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &amp;#8220;Series C Preferred Stock&amp;#8221;), convertible into Common Stock at an initial conversion price of $4.50 per share, (b) a five&amp;#8209;year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &amp;#8220;Series C-1 Warrant&amp;#8221;) and (c) a five-year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &amp;#8220;Series C-2 Warrant&amp;#8221; and, together with the Series C-1 Warrants, collectively, the &amp;#8220;Series C Warrants&amp;#8221;), as described in further detail in Note 3.&amp;#160; See also Note 8 regarding issuance of additional Series C Units subsequent to the balance sheet date.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long-term loans.&amp;#160; There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations as a going concern.&lt;/div&gt;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z8ce5980da1ac491eab6681a9e83fed99" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;C.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Risk factors&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;As described in Note 1A and Note 1B above, the Group has a limited operating history and faces a number of risks and uncertainties, including risks and uncertainties regarding continuation of the development process, demand and market acceptance of the Group&amp;#8217;s products, the effects of technological changes, competition and the development of products by competitors.&amp;#160; Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group&amp;#8217;s future results and the availability of necessary financing.&amp;#160; In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts.&amp;#160; The Group has not yet generated material revenues from its operations to fund its activities and therefore is dependent on the receipt of additional funding from its stockholders and/ or new investors in order to continue its operations.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z61039d533ff5421587bb93882f4a5489" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;D.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Use of estimates in the preparation of financial statements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (&amp;#8220;U.S. GAAP&amp;#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods.&amp;#160; Actual results could differ from those estimates.&amp;#160; As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series C Units, and (iii) the going concern assumptions.&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 2&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="ze3bed8565cbd4af196e0f9930c9f7510" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;A.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Basis of presentation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Accounting Principles&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.&amp;#160; The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) related to interim financial statements.&amp;#160; As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.&amp;#160; The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&amp;#8217;s financial position and operating results for the interim periods.&amp;#160; All such adjustments are of a normal recurring nature.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The results for the three and six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any other interim period or for any future period.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Principles of Consolidation&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The consolidated financial statements include the accounts of the Company and its subsidiary.&amp;#160; Significant intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z2989f80eb6924fd0be110b6a761018c3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;B.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The Company has determined its derivative warrant liability with respect to the remaining Series A Warrants and warrants issued to Andrew Garrett, Inc., (&amp;#8220;AGI&amp;#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value.&amp;#160; Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The changes in the fair value of the Level 3 liability are as follows (in US dollars):&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z1132eec3ceab41aaa949f8987297b2a5" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Warrants with down-round Protection&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Balance, Beginning of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;681,970&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;321,695&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Warrants issued as consideration for placement services&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;273,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;234,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Amount classified out of stockholders&amp;#8217; deficit and presented as Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;341,662&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Change in fair value Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(191,075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Balance, End of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;764,545&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;833,153&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 90pt"&gt;The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z2b2a3288de9344079dc77d44b79841c1" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Dividend yield (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Expected volatility (%) (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;56.59&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;62.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Risk free interest rate (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.92&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72-1.11&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Expected term of options (years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.70-4.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.70-5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Exercise price (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.50, 7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.50, 7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Share price (US dollars) (**)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Fair value (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.06-0.76&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.61&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 138px"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 62px"&gt;(*)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 137px"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 63px"&gt;(**)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Common Stock price, per share reflects the Company&amp;#8217;s management&amp;#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&amp;#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z8bbffd1de76d495fa0364f370875f35d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;C.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Recently issued accounting pronouncements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zec85f35dae2544c0b0224644e914d57d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;1.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting Standards Update 2014-09, &amp;#8220;Revenue from Contracts with Customers&amp;#8221;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;In May 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606) (&amp;#8220;ASU 2014-09&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance.&amp;#160; ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;An entity should apply the amendments in ASU 2014-09 using one of the following two methods:&amp;#160; 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application.&amp;#160; If an entity elects the latter transition method, it also should provide certain additional disclosures.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;During 2016, the FASB issued several Accounting Standards Updates (&amp;#8220;ASUs&amp;#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, &amp;#8220;Revenue from contracts with Customers &amp;#8211; Deferral of the Effective Date&amp;#8221;, for a public entity, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).&amp;#160; Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The Company intends to adopt ASU 2014-09 as of January 1, 2018.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The Company is in the process of evaluating the impact of ASU 2014-09 on its revenue streams and selling contracts, if any, and on its financial reporting and disclosures.&amp;#160; Management is expecting to complete the evaluation of the impact of the accounting and disclosure changes on the business processes, controls and systems during 2017.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;Since the company did not report significant revenues, management believes that the adoption of ASU 2014-09 will not have a significant impact on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z758d56036bd141459bf82772df83228d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;2.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting Standards Update 2015-11, &amp;#8220;Simplifying the Measurement of Inventory&amp;#8221;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;Effective January 1, 2017, the Group adopted ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) (&amp;#8220;ASU 2015- 11&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value.&amp;#160; Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance.&amp;#160; Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The adoption of ASU 2015-11 did not have a significant effect on the consolidated financial statements.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z8dd941e9a76d4c9093332bde8c50d2fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;3.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting Standard Update (ASU) No. 2017-11, &amp;#8220;Earnings Per Share&amp;#8221;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815):&amp;#160; (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&amp;#8220;ASU 2017-11&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings.&amp;#160; Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification.&amp;#160; Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company).&amp;#160; Early adoption is permitted for all entities.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The Company is evaluating the impact of ASU 2017-11 on its financial statements.&amp;#160; Although this process has not been completed, managements believes that its provisions might impact the accounting of the financial instruments issued by the Company that include down-round protection.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z7598ba7b9ca1490684b1de837f2bc02f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;D.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Reclassified Amounts&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Certain prior year amounts have been reclassified for consistency with the current year presentation.&amp;#160; These reclassifications did not have material effect on the reported results of operations, shareholder&amp;#8217;s deficit or cash flows.&lt;/div&gt;&#13;&#13;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 3&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;RECENT EVENTS&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z619088227ed94ab3bb44f84c79fc5a96" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;1.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On April 7, 2017, the Board of Directors of the Company (the &amp;#8220;Board&amp;#8221;) approved an amendment to the 2010 Incentive Compensation Plan of the Company (the &amp;#8220;Plan&amp;#8221;) to increase the number of shares of the Company&amp;#8217;s Common Stock reserved for issuance under the Plan from 1,000,000 shares to 5,625,000 shares.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zdad3c9f82a474bd6b4faf6b20bf4ac65" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;2.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Effective April 7, 2017 (the &amp;#8220;Gal Effective Date&amp;#8221;), the Company and Integrity Israel entered into a letter agreement with Avner Gal whereby Mr.&amp;#160;Gal separated from his employment and directorship at the Company to act as a part time consultant to the Company (the &amp;#8220;Gal Agreement&amp;#8221;).&amp;#160; Pursuant to the terms of the Gal Agreement, and as consideration for Mr.&amp;#160;Gal&amp;#8217;s separation from employment and services as a consultant, the Company agreed, among other things, to (a) pay Mr.&amp;#160;Gal an amount equal to his Salary (as defined in the Gal Employment Agreement) and other financial benefits Mr.&amp;#160;Gal was entitled to receive under the Employment Agreement entered into by and between Integrity Israel and Mr.&amp;#160;Gal in October 2010 (the &amp;#8220;Gal Employment Agreement&amp;#8221;), that would have been paid to Mr.&amp;#160;Gal during the Notice Period (as defined in the Gal Employment Agreement), in lieu of such prior notice; (b) modify the Adjustment Period, pursuant to section 19 of the Gal Employment Agreement, to 24 Salaries (as defined in the Gal Employment Agreement), including all the benefits mentioned in the Gal Employment Agreement, provided Mr.&amp;#160;Gal does not work or provide services to a company in direct competition with the Company; (c) accelerate the vesting of 88,259 outstanding unvested options to purchase Common Stock, at an exercise price per share equal to $6.25, held by Mr.&amp;#160;Gal as of the Gal Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date&lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;; s&lt;/font&gt;uch amount was measured as approximately $51,000);&amp;#160; (d) extend the term of all outstanding options (vested and unvested) held by Mr.&amp;#160;Gal to be exercisable for five years from the Gal Effective Date (with respect to all vested options, at the modification date the company recognized compensation cost in an amount equal to the excess amount of the fair value of the modified award as of the modification date over the fair value of the original award immediately); and (e) grant Mr.&amp;#160;Gal an option to purchase up to 300,000 shares of Common Stock of the Company having an exercise price per share equal to $4.50 and an option to purchase up to an additional 50,000 shares of common stock of the Company having an exercise price per share equal to $7.75.&amp;#160; These options vest monthly over a 24 months period following the date of grant.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z31c31810474845138f161eaa694e3bff" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;3.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Effective April 7, 2017, the Company entered into an amendment to the employment agreement (the &amp;#8220;Graham Employment Amendment&amp;#8221;) with John Graham, whom the Company appointed as Chief Executive Officer on March 20, 2017, to modify the base compensation provision and the equity compensation provision under that certain Employment Agreement, dated March 20, 2017 (the &amp;#8220;Graham Effective Date&amp;#8221;), by and between the Company and Mr.&amp;#160;Graham.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z84a49bf20de1467f9d45d964c0caa136" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;4.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Pursuant to the terms of the Graham Employment Amendment, (a) Mr.&amp;#160;Graham&amp;#8217;s base compensation was modified such that he receives a base salary of $500,000 per year, as well as a one-time payment of $375,000 paid to Mr.&amp;#160;Graham upon commencement of Mr.&amp;#160;Graham&amp;#8217;s employment with the Company which amount was recognized as an expense as of the employment commencement date, and (b) the vesting periods of Mr.&amp;#160;Graham&amp;#8217;s options to purchase Common Stock were modified whereby (1) 307,754 shares of Common Stock underlying Mr.&amp;#160;Graham&amp;#8217;s option to purchase Common Stock at an exercise price of $4.50 per share (the &amp;#8220;$4.50 Options&amp;#8221;) vested immediately, (2) 923,262 of the $4.50 Options vest on the six month anniversary of the Graham Effective Date, and (3) the remaining 442,980 of the $4.50 Options as well as Mr.&amp;#160;Graham&amp;#8217;s remaining unvested options granted pursuant to the Graham Employment Amendment vest on the two (2) year anniversary of the Graham Effective Date.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z87b18fe9f20b4aee869df74827371a13" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;5.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Effective April 7, 2017, Integrity Israel entered into an amended and restated personal employment agreement (the &amp;#8220;Malka Employment Agreement&amp;#8221;) with David Malka for his continued service as Vice President of Operations of the Company and Integrity Israel, effective as of March 20, 2017 (the &amp;#8220;Malka Effective Date&amp;#8221;).&amp;#160; Pursuant to the terms of the Malka Employment Agreement, Mr.&amp;#160;Malka (a) receives a base monthly salary of NIS 20,000 (approximately $5,508 based on an exchange rate of 3.63 NIS / 1 USD in effect on August 8, 2017), which may increase to NIS 35,000 per month (approximately $9.639 using the same exchange rate) in the event certain performance milestones are met (the &amp;#8220;Malka Base Salary&amp;#8221;); (b)&amp;#160;is eligible to earn an annual performance bonus between 420-864% of the Malka Base Salary, subject to certain performance criteria to be established by the Board within the first ninety (90) days of each fiscal year; (c) is eligible to earn a retention bonus equal to 60% of the aggregate Malka Base Salary earned through the one-year anniversary of the Malka Effective Date, payable thirty days following the one-year anniversary of the Malka Effective Date and provided that Mr.&amp;#160;Malka remains employed with Integrity Israel through and on the one-year anniversary of the Malka Effective Date; (d)&amp;#160;received a modification to the terms of his option to purchase Common Stock at an exercise price per share equal to $6.25 whereby the unvested portion of such options will accelerate and will be immediately exercisable, effective as of the Malka Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date);&amp;#160; and (e) received certain additional equity awards (pursuant to the Plan) under the terms and conditions as set forth in the Malka Employment Agreement.&amp;#160; In addition, the Malka Employment Agreement provides for the payment of certain social benefits and the use of a company car.&amp;#160; The Malka Employment Agreement is terminable by Integrity Israel and Mr.&amp;#160;Malka on 90 days&amp;#8217; prior written notice (the &amp;#8220;Malka Notice Period&amp;#8221;), without Cause, or immediately by Integrity Israel for Cause (as defined in the Malka Employment Agreement).&amp;#160; Integrity Israel may terminate Mr.&amp;#160;Malka&amp;#8217;s employment without Cause prior to the expiration of the Malka Notice Period, but will be required to pay Mr.&amp;#160;Malka a severance fee equal to the Malka Base Salary plus the financial value of all other benefits Mr.&amp;#160;Malka would have been entitled to receive in respect of the portion of the Malka Notice Period which was forfeited.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;On May 23, 2017, the Board approved the salary increase to NIS 35,000 per month pursuant to the Malka Employment Agreement, notwithstanding the foregoing performance goal requirement, as consideration for Mr.&amp;#160;Malka&amp;#8217;s continued service as Vice President of Operations of the Company and Integrity Israel.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z5f7b68a68bcf46f9bcff4face6b7ebcb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;6.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On May 4, 2017, the Board unanimously voted to appoint Angela Strand, a member of the Board, as the interim Chief Strategy Officer of the Company, effective as of May 1, 2017 through September 30, 2017. On May 5, 2017, the Company entered into a letter agreement (the &amp;#8220;Strand Employment Agreement&amp;#8221;) with Ms.&amp;#160;Angela Strand confirming her appointment as interim Chief Strategy Officer of the Company.&amp;#160; Pursuant to the terms of the Strand Employment Agreement, Ms.&amp;#160;Strand receives aggregate compensation of $150,000 for her service during the term of employment, paid monthly on the schedule mutually agreed upon by the parties.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z9156810b192944449d02317c2f91730a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;7.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On May 23, 2017, the Board approved the following compensation for all non-employee directors and interim officers serving on the Board:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z482b475b085d45fdb8d988adf113e7fc" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 54pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;a.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;an annual cash payment to each non-employee director and interim officer of the Company in the amount of $35,000, payable in four equal quarterly installments of $8,750 each on the last day of each calendar quarter commencing with the fourth quarter of 2017, subject to their continued service as of each such date;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zcb358595b2994e52812eab1b474b580b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 54pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;b.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;an additional annual cash payment to each member of a Board committee who is not the Chairperson of that particular committee in the amount of $5,000, payable in four equal quarterly installments of $1,250 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zc176fe69347b41a3a81634526d119f27" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 54pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;c.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;an additional annual cash payment to the chairperson of a Board committee in the amount of $12,500, payable in four equal quarterly installments of $3,125 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z81a45bf2aa3049ecb6a3e5db605cd75b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 54pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;d.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;the grant to each non-employee director and each interim officer of the Company of a one-time award of options to purchase up to an aggregate of 14,894 shares of Common Stock, at an exercise price of $4.50, under and pursuant to the Plan, which options vest in 12 equal monthly increments commencing as of June 1, 2017 (subject to their continued service as of each such date) and have a term of 10 years;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zfcd1c1296795424e95305a241828a6d2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 54pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;e.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;the grant to each non-employee director and each interim officer of the Company of an award of Restricted Stock Units (&amp;#8220;RSUs&amp;#8221;), to be granted on June 1, 2017 and vesting on June 1, 2018, with a fair value of $45,000 based on the 30-day volume weighted average price of the Company&amp;#8217;s Common Stock on June 1, 2017, subject to their continued service on and through such date; and&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z5a37ef11c08e4b82b9d034ab9f8c3cff" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 54pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;f.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;an additional annual fair value payment to the vice chairperson of the Board in the amount of $20,000, payable in RSUs under the same vesting terms.&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="zb9f1fe0447824a18a10218d586431d39" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;8.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: left; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On May 23, 2017, the Board appointed Michael Hauck to serve as a director of the Company, effective on that date.&amp;#160; The Board further appointed Mr.&amp;#160;Hauck to serve as a member of the Nominating and Corporate Governance Committee of the Board as well as on the Compensation Committee of the Board.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt"&gt;There are no arrangements or understandings between Mr.&amp;#160;Hauck and any other person pursuant to which Mr.&amp;#160;Hauck was selected as a director.&amp;#160; There are no relationships between Mr.&amp;#160;Hauck and the Company that would require disclosure under Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z98fa32447c9a4f2a8f6ecf47de59785c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;9.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On May 23, 2017, the Board established an Audit Committee of the Board and appointed each of Leslie Seff and Revan Schwartz to serve as members of the committee.&amp;#160; Mr. Schwartz will serve as chairperson of the committee. The Board determined that each of the members of the Audit Committee designated above is independent pursuant to the required standards set forth in Rule 10A-3(b) of the Securities Exchange Act of 1934, as amended, based on an evaluation of the relationships between the Company and each of the members.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z1b32e95ea1774520bf8316873c9c6e85" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;10.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On June 7, 2017, the Board appointed David Podwalski as the Chief Commercial Officer of the Company, effective as of June 26, 2017 (the &amp;#8220;Podwalski Effective Date&amp;#8221;).&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;On June 7, 2017, the Company entered into an employment agreement (the &amp;#8220;CCO Employment Agreement&amp;#8221;) with Mr.&amp;#160;Podwalski to serve as Chief Commercial Officer of the Company.&amp;#160; Under the CCO Employment Agreement, Mr.&amp;#160;Podwalski (1) receives a base salary of $240,000 per year (&amp;#8220;Base Salary&amp;#8221;); (2) receives a sign-on bonus of $25,000, payable on the six month anniversary of the Podwalski Effective Date, subject to his continued employment through and on such payment date; (3) is eligible to receive an annual performance bonus, having a minimum bonus opportunity equal to 20% of his current Base Salary based upon 80% achievement of performance criteria (the &amp;#8220;Minimum Performance Goal&amp;#8221;), a target bonus opportunity equal to 25% of his current Base Salary based upon 100% achievement of performance criteria, and a maximum bonus opportunity equal to 37.5% of his current Base Salary based upon 150% achievement of performance criteria (the &amp;#8220;Maximum Performance Goal&amp;#8221;), provided, however, that such performance bonus will be determined using straight-line interpolation of the level of achievement between the Minimum Performance Goal and the Maximum Performance Goal; and (4) &lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;receive an initial stock option grant to purchase shares of Common Stock equal to 1% of the total fully diluted shares of Common Stock as of the &lt;/font&gt;Podwalski &lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;Effective Date, with an exercise price of $4.50 per share or the fair market value of a share of Common Stock on the grant date, whichever is greater, vesting monthly over a three year period commencing on the &lt;/font&gt;Podwalski &lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;Effective Date, subject to his continued employment through and on each such vesting date (the total fair value of the grant as of the &lt;/font&gt;Podwalski &lt;font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff"&gt;Effective Date is approximately $270,000).&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The CCO Employment Agreement is terminable by the Company on 90 days written notice and by Mr.&amp;#160;Podwalski on 30 days written notice.&amp;#160; The CCO Employment Agreement is immediately terminable by the Company for Cause (as defined in the CCO Employment Agreement) without the payment of severance.&amp;#160; The CCO Employment Agreement contains non-compete obligations applicable during the term of the agreement and for one year thereafter and confidentiality obligations that survive the termination of the agreement indefinitely.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Between April 2016 and December 31, 2016, and during the first six months of 2017, the Company received aggregate net proceeds of approximately $4.9 million and $4.5 million, respectively (net of related cash expenses), from the issuance and sale in a private placement transaction, at a price of $1,000 per unit, of 11,003.80 Series C Units.&amp;#160; As of June 30, 2017, the shares of Series C Preferred Stock comprising the Series C Units are convertible into an aggregate of 2,445,317 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 4,890,634 shares of Common Stock, in each case subject to adjustment in certain circumstances.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Pursuant to a placement agent agreement (the &amp;#8220;Placement Agent Agreement&amp;#8221;) with AGI, at the initial closing of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units.&amp;#160; At the end of the second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth and eleventh closings of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing.&amp;#160; In addition, pursuant to the Placement Agent Agreement, the Company is required to issue to AGI: (a) 5-year warrants to purchase up to 489,064 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 244,531 shares of Common Stock at an exercise price of $7.75 per share.&amp;#160; The terms of such warrants are substantially similar to the Series C Warrants except that the warrants issued to AGI are exercisable on a cashless basis and include full ratchet anti-dilution protection.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Following below is a summary of the entire series C issuances:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="za8f8f4b7573b4b95bc4e3c5fc2899692" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended December 31, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Thousands of U.S. $ (except units sold) (unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Number of units sold&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,828.9&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,174.9&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Gross amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,829&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,175&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Net of related cash expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,951&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,520&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Net amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,642&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,246&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Subject to certain ownership limitations described below, the Series C Preferred Stock are convertible at the option of the holder at any time and from time to time into shares of Common Stock at a conversion price of $4.50 per share (calculated by dividing the stated value per share of Preferred Stock, which is initially $1,000, by the conversion price per share).&amp;#160; The conversion price of the Series C Preferred Stock is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect, as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders.&amp;#160; In addition, the holders of Preferred Stock will be entitled to receive any securities or rights to acquire securities or property granted or issued by the Company pro rata to the holders of Common Stock to the same extent as if such holders had converted all of their shares of Series C Preferred Stock prior to such distribution.&amp;#160; In the event of a fundamental transaction, such as a merger, consolidation, sale of substantially all assets and similar reorganizations or recapitalizations of the Company, the holders of Series C Preferred Stock will be entitled to receive, upon conversion of their shares of Series C Preferred Stock, any securities or other consideration received by the holders of the Common Stock pursuant to the fundamental transaction.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Holders of Series C Preferred Stock are entitled to receive cumulative dividends at a rate of 5.5% per annum, based on the stated value per share of Series C Preferred Stock.&amp;#160; Dividends on the Series C Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on June 30, 2016, and on each conversion date (with respect to the shares of Preferred Stock being converted).&amp;#160; For so long as required under the terms of the certificate of designations for the Company&amp;#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, dividends will be payable only in shares of Common Stock.&amp;#160; Thereafter, dividends on the Series C Preferred Stock will be payable, at the option of the Company, in cash and/or, if certain conditions are satisfied, shares of Common Stock or a combination of both.&amp;#160; Shares of Common Stock issued as payment of dividends will be valued at the lower of (a) the then current conversion price of the Series C Preferred Stock or (b) the average of the volume weighted average price for the Common Stock on the principal trading market therefor for the 10 trading days immediately prior to the applicable dividend payment date.&amp;#160; The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Subject to any limitations under the terms of the certificate of designations for the Company&amp;#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, the Company may become obligated to redeem the Series&amp;#160;C Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Series C Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service.&amp;#160; In addition, upon the occurrence of certain triggering events, each holder of Series C Preferred Stock will have the option to require the Company to redeem such holder&amp;#8217;s shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder&amp;#8217;s outstanding Series C Preferred Stock.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Subject to certain conditions contained in the Certificate of Designations, Preferences and Rights relating to the Series C Preferred Stock (the &amp;#8220;Certificate of Designations&amp;#8221;), the Company will have the option to force the conversion of the Series C Preferred Stock (in whole or in part) if (a) the volume weighted average price for the Common Stock on its principal trading market exceeds $7.00 for each of any 20 trading days during any 30&amp;#160;consecutive trading day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $50,000 or (b) the Company receives approval to list the Common Stock on a national securities exchange.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Subject to certain exceptions contained in the Certificate of Designations, if the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Series C Preferred Stock (the &amp;#8220;Conversion Shares&amp;#8221;) and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a &amp;#8220;Buy-In&amp;#8221;), the Company will be required to:&amp;#160; (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder&amp;#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Series C Preferred Stock equal to the number of shares of Series C Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements.&amp;#160; In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Series C Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the fifth trading day following the applicable conversion date and the Company will continue to pay such partial liquidated damages for each trading day after such eighth trading day until such certificates are delivered or the holder rescinds such conversion.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;As long as at least 35% of the originally issued shares of Series C Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Series C Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Subject to the beneficial ownership limitation described below, holders of Series C Preferred Stock will vote together with the holders of Common Stock, Series A Preferred Stock and Series B Preferred Stock on an as&amp;#8209;converted basis.&amp;#160; Holders will not be permitted to convert their Series C Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding Common Stock (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the &amp;#8220;Beneficial Ownership Limitation&amp;#8221;).&amp;#160; In addition, no holder may vote any shares of Series C Preferred Stock (on an as-converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Subject to certain limitations, so long as any purchaser holds any shares of Series C Preferred Stock, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series C Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser after taking into account all of the terms and conditions of the terms granted to the purchasers under the purchase agreement relating to the issuance and sale of the Series C Units and the terms granted in such subsequent issuance or sale, including all of the components of the Series C Units and of the securities or units involved in such subsequent issuance or sale, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The Series C Warrants have a five-year term commencing on their respective issuance dates.&amp;#160; Until the end of the applicable term, each Series C Warrant will be exercisable at any time and from time to time at an exercise price of $4.50 per share (with respect to the Series C-1 Warrants) or $7.75 per share (with respect to the Series&amp;#160;C-2 Warrants).&amp;#160; The Series C Warrants contain adjustment provisions substantially similar to those to the adjustment provisions of the Series C Preferred Stock as described above, except that the Series C Warrants do not include dilution protection for issuances of securities at an effective price per share lower than the conversion price of such Series C Warrants.&amp;#160; In addition, the Series C Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Series C Preferred Stock.&amp;#160; No holder may exercise its Series C Warrants in excess of the Beneficial Ownership Limitation.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Based on the terms of the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, respectively, so long as any initial purchaser of Series A Units or Series B Units, as applicable, holds any shares of Series A Preferred Stock or Series B Preferred Stock, respectively, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series A or Series B Preferred Stock or Warrants reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Pursuant to the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, the Company was required to and did notify the holders of the Series A Preferred Stock and Series B Preferred Stock of the closing of the sale of the Series C Units, and following receipt thereof such holders of Series A Preferred Stock and Series B Preferred Stock will be entitled, pursuant to the &amp;#8220;most favored nation&amp;#8221; provisions contained in their respective purchase agreements (as described above), to elect to amend the terms of their purchase of Series A Units and Series B Units, respectively, to match the terms of the Series C Units.&amp;#160; The Company is obligated to amend the terms of any of Series A Units or Series B Units who timely makes such election and tenders its Series A Units or Series B Units for exchange.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;As of June 30, 2017, none of the Series A or B Unit holders asked the company to amend the terms of their Units.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Upon their initial recognition, the Series C Preferred Stock issued together with detachable Series C Warrants (classified as equity) were measured based on the relative fair value basis and were presented net of the direct issuance expenses that were allocated to them.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The Company has determined that, due to the economic characteristics and risks of the Series C Preferred Stock, based on their stated or implied substantive terms and features, such Preferred Stock are considered as more akin to equity than debt.&amp;#160; Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Series C Preferred Stock themselves (the &amp;#8216;host contract&amp;#8217;) are clearly and closely related.&amp;#160; As a result, the embedded conversion feature was not required to be bifurcated.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Since at each of the issuances dates of the Series C Preferred Stock the exercise price of the conversion feature (based on the effective conversion rate of the Series C Preferred Stock into Common Stock) was higher than the estimated fair value of the Company&amp;#8217;s Common Stock, it was determined that given the current market price, conversion at the conversion price was not a beneficial transaction.&amp;#160; Also, due to the liquidation preference and certain redemption rights for the benefit of the holders of the Series C Preferred Stock, upon the occurrence of certain contingent events, which are not considered as solely within the Company&amp;#8217;s control management determined that the Series C Preferred Stock were to be presented as temporary equity.&amp;#160; On each balance sheet date, the Company&amp;#8217;s management assesses the probability of redemption of the outstanding Preferred Stock.&amp;#160; In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will reclassify the amount allocated to the preferred stock from temporary equity to liability. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and the aggregate redemption amount of the Preferred Stock will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 4&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;INVENTORIES&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z77e0ac1d71ad4d328b59935502edbb92" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;December 31, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Raw materials&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;705,810&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;735,201&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Work in process&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;794,582&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;633,132&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Finished products&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,920&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;51,271&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,508,312&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,419,604&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 5&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;OTHER CURRENT LIABILITIES&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z1a1e6963dae0441190723ce209223498" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;December 31, &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Employees and related institutions&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;353,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;363,738&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Accrued expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;588,338&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;261,651&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Other current liabilities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;15,848&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;88,160&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;957,436&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;713,549&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <igap:FinancingExpensesNetDisclosureTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 6&lt;/font&gt;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;FINANCING INCOME, NET&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="zc93f5981e2ff4d68818dc0c3e6e3f12c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Three month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Israeli CPI linkage difference on principal of loans from stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;26&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(639&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,393&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Exchange rate differences&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17,194&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;24,211&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,720&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;19,296&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Change in fair value of Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(191,075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(106,976&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(20,702&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Interest expenses on credit from banks and other&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,687&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8,575&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,970&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,149&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(160,168&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(32,065&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(90,893&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,568&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</igap:FinancingExpensesNetDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 7&lt;/font&gt;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;LOSS PER SHARE&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt"&gt;In periods of net loss, basic loss per share is computed by dividing net loss for the period after consideration of the effect of dividends on preferred stock by the weighted average number of shares outstanding during the period.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt"&gt;The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2017 and 2016 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z7bc0d56fca264921af72a81b7571f419" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Three month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Loss for the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(5,087,526&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,815,762&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,557,201&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,588,998&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Cash dividend on Series A Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(6,714&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(9,453&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,014&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(4,753&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Stock dividend on Series B Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(491,668&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(254,101&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(245,637&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(131,281&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Stock dividend on Series C Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(276,574&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(160,588&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Loss for the period attributable to common stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(5,862,482&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(3,099,671&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,965,440&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,745,387&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z05ebdd4316af445495e94b284b94a130" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Three month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Number of shares:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Common shares used in computing basic income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,116,366&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,205,104&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Common shares used in computing diluted income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,116,366&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,203,104&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;19,868,112&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,220,345&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;21,001,400&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,210,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z8f54093400a94ea6a3b078a6c358100c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;(*)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: left; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;NOTE 8&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#8211;&lt;/font&gt;&amp;#160;&amp;#160;SUBSEQUENT EVENTS&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt"&gt;On July 31, 2017, the Company, entered into a Securities Purchase Agreement with certain accredited investors pursuant to which, the Company issued to the Purchasers an aggregate of 1,000 Series C Units.&amp;#160; The shares of Preferred Stock comprising the Units are convertible into an aggregate of 222,236 shares of Common Stock, and the Warrants comprising the Units are exercisable for an aggregate of 444,472 shares of Common Stock, in each case subject to certain adjustments.&amp;#160; The Company received aggregate gross proceeds of $1,000,000 from the sale of the Units.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt"&gt;The sale of the Units pursuant to the securities purchase agreement was the twelfth closing of an offering of Units by the Company.&amp;#160; The first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth&amp;#160; and eleventh closings, involving the sale by the Company of an aggregate of 1,133 Units, 1,351 Units, 890.5 Units, 1,050.65 Units, 540 Units, 357.75 Units, 506 Units, 403.9 Units, 2,560 Units, 1,551 Units and 660 Units, respectively (collectively, the &amp;#8220;Prior Issuances&amp;#8221;), were disclosed by the Company in Current Reports on Form 8-K filed by the Company with the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) on April 14, 2016, May 4, 2016, June 6, 2016, July 7, 2016, September 7, 2016, October 7, 2016, December 5, 2016, January 5, 2017, March 14, 2017, May 3, 2017 and June 23, 2017, respectively (collectively, the &amp;#8220;Prior 8-Ks&amp;#8221;), each of which is incorporated herein by reference.&amp;#160; The terms of the Preferred Stock and the Warrants are the same as the terms of the Preferred Stock and Warrants issued in the Prior Issuances, as described in the Prior 8-Ks.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt"&gt;Pursuant to the Placement Agent Agreement, at the closing of the sale of the Units the Company paid AGI, as a commission, an amount (payable in cash and Common Stock) equal to 10% of the aggregate sales price of the Units, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Units.&amp;#160; In addition, pursuant to the AGI Agreement, the Company is required to issue to AGI: (a) 5 year warrants to purchase up to 44,445 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 22,223 shares of Common Stock at an exercise price of $7.75 per share.&amp;#160; The terms of these warrants will be substantially similar to the Warrants except that the AGI warrants will also be exercisable on a cashless basis and will include full ratchet anti-dilution protection.&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;table id="ze3bed8565cbd4af196e0f9930c9f7510" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;A.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Basis of presentation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Accounting Principles&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.&amp;#160; The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) related to interim financial statements.&amp;#160; As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.&amp;#160; The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&amp;#8217;s financial position and operating results for the interim periods.&amp;#160; All such adjustments are of a normal recurring nature.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The results for the three and six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any other interim period or for any future period.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Principles of Consolidation&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The consolidated financial statements include the accounts of the Company and its subsidiary.&amp;#160; Significant intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;table id="z2989f80eb6924fd0be110b6a761018c3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;B.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The Company has determined its derivative warrant liability with respect to the remaining Series A Warrants and warrants issued to Andrew Garrett, Inc., (&amp;#8220;AGI&amp;#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value.&amp;#160; Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The changes in the fair value of the Level 3 liability are as follows (in US dollars):&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z1132eec3ceab41aaa949f8987297b2a5" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Warrants with down-round Protection&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Balance, Beginning of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;681,970&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;321,695&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Warrants issued as consideration for placement services&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;273,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;234,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Amount classified out of stockholders&amp;#8217; deficit and presented as Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;341,662&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Change in fair value Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(191,075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Balance, End of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;764,545&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;833,153&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 90pt"&gt;The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z2b2a3288de9344079dc77d44b79841c1" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Dividend yield (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Expected volatility (%) (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;56.59&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;62.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Risk free interest rate (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.92&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72-1.11&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Expected term of options (years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.70-4.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.70-5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Exercise price (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.50, 7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.50, 7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Share price (US dollars) (**)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Fair value (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.06-0.76&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.61&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 138px"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 62px"&gt;(*)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 137px"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 63px"&gt;(**)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Common Stock price, per share reflects the Company&amp;#8217;s management&amp;#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&amp;#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;table id="z8bbffd1de76d495fa0364f370875f35d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;C.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Recently issued accounting pronouncements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zec85f35dae2544c0b0224644e914d57d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;1.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting Standards Update 2014-09, &amp;#8220;Revenue from Contracts with Customers&amp;#8221;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;In May 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606) (&amp;#8220;ASU 2014-09&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance.&amp;#160; ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;An entity should apply the amendments in ASU 2014-09 using one of the following two methods:&amp;#160; 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application.&amp;#160; If an entity elects the latter transition method, it also should provide certain additional disclosures.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;During 2016, the FASB issued several Accounting Standards Updates (&amp;#8220;ASUs&amp;#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, &amp;#8220;Revenue from contracts with Customers &amp;#8211; Deferral of the Effective Date&amp;#8221;, for a public entity, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).&amp;#160; Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The Company intends to adopt ASU 2014-09 as of January 1, 2018.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The Company is in the process of evaluating the impact of ASU 2014-09 on its revenue streams and selling contracts, if any, and on its financial reporting and disclosures.&amp;#160; Management is expecting to complete the evaluation of the impact of the accounting and disclosure changes on the business processes, controls and systems during 2017.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;Since the company did not report significant revenues, management believes that the adoption of ASU 2014-09 will not have a significant impact on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z758d56036bd141459bf82772df83228d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;2.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting Standards Update 2015-11, &amp;#8220;Simplifying the Measurement of Inventory&amp;#8221;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;Effective January 1, 2017, the Group adopted ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) (&amp;#8220;ASU 2015- 11&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value.&amp;#160; Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance.&amp;#160; Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The adoption of ASU 2015-11 did not have a significant effect on the consolidated financial statements.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z8dd941e9a76d4c9093332bde8c50d2fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;3.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting Standard Update (ASU) No. 2017-11, &amp;#8220;Earnings Per Share&amp;#8221;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815):&amp;#160; (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&amp;#8220;ASU 2017-11&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings.&amp;#160; Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification.&amp;#160; Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company).&amp;#160; Early adoption is permitted for all entities.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt"&gt;The Company is evaluating the impact of ASU 2017-11 on its financial statements.&amp;#160; Although this process has not been completed, managements believes that its provisions might impact the accounting of the financial instruments issued by the Company that include down-round protection.&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&lt;table id="z7598ba7b9ca1490684b1de837f2bc02f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;D.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Reclassified Amounts&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;Certain prior year amounts have been reclassified for consistency with the current year presentation.&amp;#160; These reclassifications did not have material effect on the reported results of operations, shareholder&amp;#8217;s deficit or cash flows.&lt;/div&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt"&gt;The changes in the fair value of the Level 3 liability are as follows (in US dollars):&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z1132eec3ceab41aaa949f8987297b2a5" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Warrants with down-round Protection&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Balance, Beginning of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;681,970&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;321,695&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Warrants issued as consideration for placement services&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;273,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;234,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Amount classified out of stockholders&amp;#8217; deficit and presented as Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;341,662&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Change in fair value Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(191,075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Balance, End of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;764,545&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;833,153&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div&gt;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 90pt"&gt;The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z2b2a3288de9344079dc77d44b79841c1" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Dividend yield (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Expected volatility (%) (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;56.59&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;62.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Risk free interest rate (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.92&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72-1.11&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Expected term of options (years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.70-4.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.70-5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Exercise price (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.50, 7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.50, 7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Share price (US dollars) (**)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Fair value (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.06-0.76&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.61&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 138px"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 62px"&gt;(*)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 137px"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 63px"&gt;(**)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Common Stock price, per share reflects the Company&amp;#8217;s management&amp;#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&amp;#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock>
    <igap:SummaryOfSeriescIssuancesTableTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Following below is a summary of the entire series C issuances:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="za8f8f4b7573b4b95bc4e3c5fc2899692" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended December 31, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Thousands of U.S. $ (except units sold) (unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Number of units sold&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,828.9&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,174.9&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Gross amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,829&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,175&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Net of related cash expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,951&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,520&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Net amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,642&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,246&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</igap:SummaryOfSeriescIssuancesTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z77e0ac1d71ad4d328b59935502edbb92" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;December 31, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Raw materials&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;705,810&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;735,201&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Work in process&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;794,582&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;633,132&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Finished products&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,920&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;51,271&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,508,312&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,419,604&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z1a1e6963dae0441190723ce209223498" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;December 31, &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Employees and related institutions&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;353,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;363,738&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Accrued expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;588,338&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;261,651&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Other current liabilities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;15,848&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;88,160&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;957,436&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;713,549&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="zc93f5981e2ff4d68818dc0c3e6e3f12c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Three month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Israeli CPI linkage difference on principal of loans from stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;26&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(639&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,393&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Exchange rate differences&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17,194&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;24,211&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,720&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;19,296&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Change in fair value of Warrants with down-round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(191,075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(106,976&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(20,702&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Interest expenses on credit from banks and other&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,687&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8,575&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,970&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,149&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(160,168&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(32,065&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(90,893&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,568&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2017-01-01to2017-06-30">&lt;div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt"&gt;The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2017 and 2016 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z7bc0d56fca264921af72a81b7571f419" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Three month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Loss for the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(5,087,526&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,815,762&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,557,201&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,588,998&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Cash dividend on Series A Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(6,714&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(9,453&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,014&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(4,753&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Stock dividend on Series B Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(491,668&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(254,101&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(245,637&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(131,281&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Stock dividend on Series C Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(276,574&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(160,588&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Loss for the period attributable to common stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(5,862,482&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(3,099,671&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,965,440&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,745,387&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z05ebdd4316af445495e94b284b94a130" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Six month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Three month period ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Number of shares:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Common shares used in computing basic income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,116,366&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,205,104&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Common shares used in computing diluted income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,116,366&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,203,104&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt"&gt;Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;19,868,112&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,220,345&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;21,001,400&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,210,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: normal; text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z8f54093400a94ea6a3b078a6c358100c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt"&gt;(*)&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: left; width: auto"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <igap:PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock contextRef="From2017-01-01to2017-06-30" unitRef="USD" decimals="0">-2686</igap:PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock>
    <igap:PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">4753</igap:PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-02" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">The Common Stock price, per share reflects the Company's management's estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series B Units and the Series C Units (See Note 3). </link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>igap-20170630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 0617 10Q.xfr; Date: 2017%2D08%2D09T22:10:59Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /a4po7xRiXgen8uNbH1cSaaCibPtypVxGYkxu2JxfemK/yUlK2rH+S9IgUD2kZ8K -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:igap="http://integrity-app.com/20170630" elementFormDefault="qualified" targetNamespace="http://integrity-app.com/20170630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://integrity-app.com/role/igap-daei1" id="igap-daei1">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" id="Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" id="Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT">
	  <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" id="Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" id="CondensedConsolidatedStatementsOfCashFlowsParenthetical">
	  <link:definition>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-g" id="igap-g">
	  <link:definition>00000008 - Disclosure - GENERAL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-sosap" id="igap-sosap">
	  <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" id="Disclosure-EVENTSDURINGTHEREPORTEDPERIOD">
	  <link:definition>00000010 - Disclosure - RECENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-i" id="igap-i">
	  <link:definition>00000011 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
	  <link:definition>00000012 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" id="Disclosure-FINANCINGINCOMEEXPENSESNET">
	  <link:definition>00000013 - Disclosure - FINANCING INCOME, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" id="Disclosure-LOSSPERSHARE">
	  <link:definition>00000014 - Disclosure - LOSS PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000015 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-sosapp" id="igap-sosapp">
	  <link:definition>00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-sosapt" id="igap-sosapt">
	  <link:definition>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/RecentEventsTables" id="RecentEventsTables">
	  <link:definition>00000018 - Disclosure - RECENT EVENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-it1" id="igap-it1">
	  <link:definition>00000019 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
	  <link:definition>00000020 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" id="Disclosure-FINANCINGINCOMEEXPENSESNETTables">
	  <link:definition>00000021 - Disclosure - FINANCING INCOME, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" id="Disclosure-LOSSPERSHARETables">
	  <link:definition>00000022 - Disclosure - LOSS PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/GeneralDetails" id="GeneralDetails">
	  <link:definition>00000023 - Disclosure - GENERAL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" id="SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails">
	  <link:definition>00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" id="CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails">
	  <link:definition>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" id="EventsDuringReportedPeriodDetails">
	  <link:definition>00000026 - Disclosure - RECENT EVENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" id="RecentEventsSummaryOfEntireSeriesCIssuancesDetails">
	  <link:definition>00000027 - Disclosure - RECENT EVENTS (Summary of Entire Series C Issuances) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-id" id="igap-id">
	  <link:definition>00000028 - Disclosure - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" id="OtherCurrentLiabilitiesDetails">
	  <link:definition>00000029 - Disclosure - OTHER CURRENT LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" id="Disclosure-FINANCINGINCOMEEXPENSESNETDetails">
	  <link:definition>00000030 - Disclosure - FINANCING INCOME, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" id="Disclosure-LOSSPERSHAREDetails">
	  <link:definition>00000031 - Disclosure - LOSS PER SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
	  <link:definition>00000032 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20170630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20170630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20170630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20170630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
    <element id="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" name="FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockConversionPrice" name="PreferredStockConversionPrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ClassOfWarrantOrRightTerm" name="ClassOfWarrantOrRightTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ChangeInFairValueOfSeriesaWarrants" name="ChangeInFairValueOfSeriesaWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ClassOfWarrantOrRightFairValue" name="ClassOfWarrantOrRightFairValue" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfUnitsSold" name="NumberOfUnitsSold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" name="NumberOfConvertiblePreferredSharesOfferedPerUnit" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" name="RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_RegistrationPaymentArrangementCommissionPercentage" name="RegistrationPaymentArrangementCommissionPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" name="NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_StockIssuedDuringPeriodValueStockDividendSeriesC" name="StockIssuedDuringPeriodValueStockDividendSeriesC" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" name="ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" name="ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockConvertibleStockPriceTrigger" name="PreferredStockConvertibleStockPriceTrigger" nillable="true" xbrli:periodType="duration" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockConvertibleTradingVolumeTrigger" name="PreferredStockConvertibleTradingVolumeTrigger" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockPercentageOutstandingGoverningDistributions" name="PreferredStockPercentageOutstandingGoverningDistributions" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockMaximumBeneficialOwnership" name="PreferredStockMaximumBeneficialOwnership" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" name="PreferredStockMaximumBeneficialOwnershipSubjectToTerms" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" name="AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_OtherLiabilitiesClassifiedAsCurrent" name="OtherLiabilitiesClassifiedAsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_FinancingIncomeExpensesNet" name="FinancingIncomeExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" name="ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" name="LinkageDifferenceOnPrincipalOfLoansFromStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_StockDividendOnSeriesCPreferredStockShares" name="StockDividendOnSeriesCPreferredStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" name="AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" name="FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" name="AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" name="AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AnnualPerformanceBonusPercentage" name="AnnualPerformanceBonusPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PercentageOfFullyDilutedSharesOfCommonStock" name="PercentageOfFullyDilutedSharesOfCommonStock" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NetGrantFairValue" name="NetGrantFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_OneTimePayment" name="OneTimePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PercentOfOneShare" name="PercentOfOneShare" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_DividendsCommonStockPreferredC" name="DividendsCommonStockPreferredC" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_GrossAmountOfSeriescUnitsSold" name="GrossAmountOfSeriescUnitsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" name="AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NetAmountOfSeriescUnits" name="NetAmountOfSeriescUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockInterestRatePercentage" name="PreferredStockInterestRatePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PercentageOfAggregateSalesPriceOfUnits" name="PercentageOfAggregateSalesPriceOfUnits" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PercentageOfNonAccountableExpenseAllowance" name="PercentageOfNonAccountableExpenseAllowance" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" name="AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountToBePaidEachQuarterForAnnualCashPayment" name="AmountToBePaidEachQuarterForAnnualCashPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" name="AdditionalCashPaymentAsCompensationSubjectToContinuedService" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" name="AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" name="CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_FinancingExpensesNetDisclosureTextBlock" name="FinancingExpensesNetDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SummaryOfSeriescIssuancesTableTextBlock" name="SummaryOfSeriescIssuancesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" name="PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ExchangeOneMember" name="ExchangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesB1WarrantMember" name="SeriesB1WarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesB2WarrantMember" name="SeriesB2WarrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesAWarrantMember" name="SeriesAWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ArbitrationProceedingsWithShareholderMember" name="ArbitrationProceedingsWithShareholderMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ExchangeTwoMember" name="ExchangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AprilTwoThousandSixteenOfferingMember" name="AprilTwoThousandSixteenOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesConeWarrantMember" name="SeriesConeWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesCtwoWarrantMember" name="SeriesCtwoWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AgreementWithPlacementAgentMember" name="AgreementWithPlacementAgentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PlacementAgentWarrantsTrancheTwoMember" name="PlacementAgentWarrantsTrancheTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PlacementAgentWarrantsTrancheOneMember" name="PlacementAgentWarrantsTrancheOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_InitialClosingMember" name="InitialClosingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SecondClosingMember" name="SecondClosingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesC1WarrantMember" name="SeriesC1WarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesC2WarrantMember" name="SeriesC2WarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesCWarrantMember" name="SeriesCWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesBandCPreferredStockMember" name="SeriesBandCPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_MrPodwalskiMember" name="MrPodwalskiMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NonEmployeeDirectorAndInterimOfficerMember" name="NonEmployeeDirectorAndInterimOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_DavidMalkaMember" name="DavidMalkaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SalaryIncreaseMember" name="SalaryIncreaseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ChiefStrategyOfficerMember" name="ChiefStrategyOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PurchasersMember" name="PurchasersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AvnerGalMember" name="AvnerGalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_OptionsGrantedMember" name="OptionsGrantedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdditionalOptionsGrantedMember" name="AdditionalOptionsGrantedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_JohnGrahamMember" name="JohnGrahamMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_EachBoardOfDirectorsMember" name="EachBoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_EachNonemployeeDirectorAndEachInterimOfficerMember" name="EachNonemployeeDirectorAndEachInterimOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfWarrantsExchanged" name="NumberOfWarrantsExchanged" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_EventsDuringReportingPeriodAbstract" name="EventsDuringReportingPeriodAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" name="ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SaleAgreementAxis" name="SaleAgreementAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="igap_SaleAgreementDomain" name="SaleAgreementDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_StockUnitIssuedToPurchaseCommonStock" name="StockUnitIssuedToPurchaseCommonStock" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" name="NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" name="AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" name="AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>igap-20170630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 0617 10Q.xfr; Date: 2017%2D08%2D09T22:10:59Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://integrity-app.com/role/igap-daei1" xlink:href="igap-20170630.xsd#igap-daei1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" xlink:href="igap-20170630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="igap-20170630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="igap-20170630.xsd#CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-g" xlink:href="igap-20170630.xsd#igap-g" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosap" xlink:href="igap-20170630.xsd#igap-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:href="igap-20170630.xsd#Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-i" xlink:href="igap-20170630.xsd#igap-i" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilities" xlink:href="igap-20170630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHARE" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SubsequentEvents" xlink:href="igap-20170630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapp" xlink:href="igap-20170630.xsd#igap-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapt" xlink:href="igap-20170630.xsd#igap-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/RecentEventsTables" xlink:href="igap-20170630.xsd#RecentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-it1" xlink:href="igap-20170630.xsd#igap-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" xlink:href="igap-20170630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHARETables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/GeneralDetails" xlink:href="igap-20170630.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:href="igap-20170630.xsd#SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:href="igap-20170630.xsd#CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:href="igap-20170630.xsd#EventsDuringReportedPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:href="igap-20170630.xsd#RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-id" xlink:href="igap-20170630.xsd#igap-id" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" xlink:href="igap-20170630.xsd#OtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHAREDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SubsequentEventsDetails" xlink:href="igap-20170630.xsd#SubsequentEventsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-daei1" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_igapFinancingIncomeExpensesNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:label="loc_igapPaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_igapPaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:label="loc_igapProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_igapProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:label="loc_igapProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_igapProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-g" xlink:title="00000008 - Disclosure - GENERAL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosap" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:title="00000010 - Disclosure - RECENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-i" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:title="00000013 - Disclosure - FINANCING INCOME, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:title="00000014 - Disclosure - LOSS PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SubsequentEvents" xlink:title="00000015 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapp" xlink:title="00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapt" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/RecentEventsTables" xlink:title="00000018 - Disclosure - RECENT EVENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-it1" xlink:title="00000019 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000020 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:title="00000021 - Disclosure - FINANCING INCOME, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:title="00000022 - Disclosure - LOSS PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/GeneralDetails" xlink:title="00000023 - Disclosure - GENERAL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:title="00000026 - Disclosure - RECENT EVENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:title="00000027 - Disclosure - RECENT EVENTS (Summary of Entire Series C Issuances) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-id" xlink:title="00000028 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" xlink:title="00000029 - Disclosure - OTHER CURRENT LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OtherLiabilitiesClassifiedAsCurrent" xlink:label="loc_igapOtherLiabilitiesClassifiedAsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_igapOtherLiabilitiesClassifiedAsCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:title="00000030 - Disclosure - FINANCING INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:title="00000031 - Disclosure - LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaapDividendsCommonStockCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapDividendsCommonStockCash" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockStock" xlink:label="loc_us-gaapDividendsCommonStockStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapDividendsCommonStockStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DividendsCommonStockPreferredC" xlink:label="loc_igapDividendsCommonStockPreferredC" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_igapDividendsCommonStockPreferredC" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SubsequentEventsDetails" xlink:title="00000032 - Disclosure - SUBSEQUENT EVENTS (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>igap-20170630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 0617 10Q.xfr; Date: 2017%2D08%2D09T22:10:59Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://integrity-app.com/role/igap-daei1" xlink:href="igap-20170630.xsd#igap-daei1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" xlink:href="igap-20170630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="igap-20170630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="igap-20170630.xsd#CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-g" xlink:href="igap-20170630.xsd#igap-g" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosap" xlink:href="igap-20170630.xsd#igap-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:href="igap-20170630.xsd#Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-i" xlink:href="igap-20170630.xsd#igap-i" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilities" xlink:href="igap-20170630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHARE" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SubsequentEvents" xlink:href="igap-20170630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapp" xlink:href="igap-20170630.xsd#igap-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapt" xlink:href="igap-20170630.xsd#igap-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/RecentEventsTables" xlink:href="igap-20170630.xsd#RecentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-it1" xlink:href="igap-20170630.xsd#igap-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" xlink:href="igap-20170630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHARETables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/GeneralDetails" xlink:href="igap-20170630.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:href="igap-20170630.xsd#SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:href="igap-20170630.xsd#CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:href="igap-20170630.xsd#EventsDuringReportedPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:href="igap-20170630.xsd#RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-id" xlink:href="igap-20170630.xsd#igap-id" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" xlink:href="igap-20170630.xsd#OtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHAREDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SubsequentEventsDetails" xlink:href="igap-20170630.xsd#SubsequentEventsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-daei1" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsCurrentAbstract_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapInventoryNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapOtherAssetsCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAssetsCurrent_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssets_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccountsPayableCurrent_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrent_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapDueToOfficersOrStockholdersNoncurrent_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrent_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilities_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityAbstract_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityAbstract_90" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquityAbstract_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommonStockValue_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapCommonStockSharesAuthorized_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapCommonStockSharesIssued_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapCommonStockSharesOutstanding_110" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" xlink:label="loc_igapAmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockIssuedDuringPeriodValueStockDividendSeriesC" xlink:label="loc_igapStockIssuedDuringPeriodValueStockDividendSeriesC_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockIssuedDuringPeriodValueStockDividendSeriesC_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockDividendOnSeriesCPreferredStockShares" xlink:label="loc_igapStockDividendOnSeriesCPreferredStockShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockDividendOnSeriesCPreferredStockShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="loc_us-gaapPreferredStockDividendsShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsShares_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesBandCPreferredStockMember" xlink:label="loc_igapSeriesBandCPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_igapSeriesBandCPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaapDividendsCommonStockCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCommonStockCash_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockInterestRatePercentage" xlink:label="loc_igapPreferredStockInterestRatePercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapPreferredStockInterestRatePercentage_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfWarrantsExchanged" xlink:label="loc_igapNumberOfWarrantsExchanged_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapNumberOfWarrantsExchanged_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-g" xlink:title="00000008 - Disclosure - GENERAL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosap" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:title="00000010 - Disclosure - RECENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-i" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:title="00000013 - Disclosure - FINANCING INCOME, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:title="00000014 - Disclosure - LOSS PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SubsequentEvents" xlink:title="00000015 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapp" xlink:title="00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapt" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/RecentEventsTables" xlink:title="00000018 - Disclosure - RECENT EVENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-it1" xlink:title="00000019 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000020 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:title="00000021 - Disclosure - FINANCING INCOME, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:title="00000022 - Disclosure - LOSS PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/GeneralDetails" xlink:title="00000023 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC2WarrantMember" xlink:label="loc_igapSeriesC2WarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC2WarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC1WarrantMember" xlink:label="loc_igapSeriesC1WarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC1WarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesB1WarrantMember" xlink:label="loc_igapSeriesB1WarrantMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesB1WarrantMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:label="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConversionPrice_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentOfOneShare" xlink:label="loc_igapPercentOfOneShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPercentOfOneShare_130" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightFairValue" xlink:label="loc_igapClassOfWarrantOrRightFairValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_igapClassOfWarrantOrRightFairValue_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:title="00000026 - Disclosure - RECENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AvnerGalMember" xlink:label="loc_igapAvnerGalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapAvnerGalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_JohnGrahamMember" xlink:label="loc_igapJohnGrahamMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapJohnGrahamMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DavidMalkaMember" xlink:label="loc_igapDavidMalkaMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapDavidMalkaMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ChiefStrategyOfficerMember" xlink:label="loc_igapChiefStrategyOfficerMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapChiefStrategyOfficerMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NonEmployeeDirectorAndInterimOfficerMember" xlink:label="loc_igapNonEmployeeDirectorAndInterimOfficerMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapNonEmployeeDirectorAndInterimOfficerMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EachBoardOfDirectorsMember" xlink:label="loc_igapEachBoardOfDirectorsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapEachBoardOfDirectorsMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaapBoardOfDirectorsChairmanMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapBoardOfDirectorsChairmanMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EachNonemployeeDirectorAndEachInterimOfficerMember" xlink:label="loc_igapEachNonemployeeDirectorAndEachInterimOfficerMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapEachNonemployeeDirectorAndEachInterimOfficerMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="loc_us-gaapVicePresidentMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapVicePresidentMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_MrPodwalskiMember" xlink:label="loc_igapMrPodwalskiMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapMrPodwalskiMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OptionsGrantedMember" xlink:label="loc_igapOptionsGrantedMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_igapOptionsGrantedMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalOptionsGrantedMember" xlink:label="loc_igapAdditionalOptionsGrantedMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_igapAdditionalOptionsGrantedMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusMember" xlink:label="loc_us-gaapDeferredBonusMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapDeferredBonusMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_ILS" xlink:label="loc_currencyILS_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyILS_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusMember" xlink:label="loc_us-gaapDeferredBonusMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="loc_us-gaapDeferredBonusMember_270" xlink:type="arc" order="273" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AgreementWithPlacementAgentMember" xlink:label="loc_igapAgreementWithPlacementAgentMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAgreementWithPlacementAgentMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="loc_igapAprilTwoThousandSixteenOfferingMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAprilTwoThousandSixteenOfferingMember_410" xlink:type="arc" order="411" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SaleAgreementAxis" xlink:label="loc_igapSaleAgreementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_igapSaleAgreementAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SaleAgreementDomain" xlink:label="loc_igapSaleAgreementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_igapSaleAgreementAxis" xlink:to="loc_igapSaleAgreementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SaleAgreementDomain" xlink:label="loc_igapSaleAgreementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_igapSaleAgreementAxis" xlink:to="loc_igapSaleAgreementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_InitialClosingMember" xlink:label="loc_igapInitialClosingMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapInitialClosingMember_350" xlink:type="arc" order="352" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SecondClosingMember" xlink:label="loc_igapSecondClosingMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapSecondClosingMember_370" xlink:type="arc" order="372" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheTwoMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheTwoMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheOneMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheOneMember_380" xlink:type="arc" order="382" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC1WarrantMember" xlink:label="loc_igapSeriesC1WarrantMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC1WarrantMember_430" xlink:type="arc" order="431" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC2WarrantMember" xlink:label="loc_igapSeriesC2WarrantMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC2WarrantMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapOfficersCompensation_460" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AnnualPerformanceBonusPercentage" xlink:label="loc_igapAnnualPerformanceBonusPercentage_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAnnualPerformanceBonusPercentage_460" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfFullyDilutedSharesOfCommonStock" xlink:label="loc_igapPercentageOfFullyDilutedSharesOfCommonStock_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPercentageOfFullyDilutedSharesOfCommonStock_460" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_460" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_460" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NetGrantFairValue" xlink:label="loc_igapNetGrantFairValue_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNetGrantFairValue_460" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSalariesAndWages_460" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" xlink:label="loc_igapAnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService_460" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountToBePaidEachQuarterForAnnualCashPayment" xlink:label="loc_igapAmountToBePaidEachQuarterForAnnualCashPayment_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountToBePaidEachQuarterForAnnualCashPayment_460" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" xlink:label="loc_igapAdditionalCashPaymentAsCompensationSubjectToContinuedService_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAdditionalCashPaymentAsCompensationSubjectToContinuedService_460" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" xlink:label="loc_igapAmountToBePaidEachQuarterForAdditionalAnnualCashPayment_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountToBePaidEachQuarterForAdditionalAnnualCashPayment_460" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_460" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_460" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_460" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_460" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" xlink:label="loc_igapCashValueOfRestrictedStockUnitsGrantedToVariousIndividuals_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapCashValueOfRestrictedStockUnitsGrantedToVariousIndividuals_460" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1_460" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockUnitIssuedToPurchaseCommonStock" xlink:label="loc_igapStockUnitIssuedToPurchaseCommonStock_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapStockUnitIssuedToPurchaseCommonStock_460" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_460" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_460" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OneTimePayment" xlink:label="loc_igapOneTimePayment_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapOneTimePayment_460" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_460" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold_460" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit_460" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_460" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_460" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConversionPrice_460" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_460" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm_460" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_460" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_460" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_460" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_RegistrationPaymentArrangementCommissionPercentage" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentage_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentage_460" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_460" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_460" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_460" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:label="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_460" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConvertibleStockPriceTrigger" xlink:label="loc_igapPreferredStockConvertibleStockPriceTrigger_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConvertibleStockPriceTrigger_460" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConvertibleTradingVolumeTrigger" xlink:label="loc_igapPreferredStockConvertibleTradingVolumeTrigger_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConvertibleTradingVolumeTrigger_460" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="loc_us-gaapPreferredStockLiquidationPreference_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreference_460" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockPercentageOutstandingGoverningDistributions" xlink:label="loc_igapPreferredStockPercentageOutstandingGoverningDistributions_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockPercentageOutstandingGoverningDistributions_460" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockMaximumBeneficialOwnership" xlink:label="loc_igapPreferredStockMaximumBeneficialOwnership_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockMaximumBeneficialOwnership_460" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" xlink:label="loc_igapPreferredStockMaximumBeneficialOwnershipSubjectToTerms_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockMaximumBeneficialOwnershipSubjectToTerms_460" xlink:type="arc" order="42" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:title="00000027 - Disclosure - RECENT EVENTS (Summary of Entire Series C Issuances) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-id" xlink:title="00000028 - Disclosure - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" xlink:title="00000029 - Disclosure - OTHER CURRENT LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:title="00000030 - Disclosure - FINANCING INCOME, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:title="00000031 - Disclosure - LOSS PER SHARE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SubsequentEventsDetails" xlink:title="00000032 - Disclosure - SUBSEQUENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheTwoMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheTwoMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheOneMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapNumberOfUnitsSold_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapPercentageOfAggregateSalesPriceOfUnits_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapPercentageOfAggregateSalesPriceOfUnits_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfNonAccountableExpenseAllowance" xlink:label="loc_igapPercentageOfNonAccountableExpenseAllowance_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapPercentageOfNonAccountableExpenseAllowance_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapPreferredStockConversionPrice_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm_190" xlink:type="arc" order="10" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>igap-20170630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 0617 10Q.xfr; Date: 2017%2D08%2D09T22:10:59Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US">Liability Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="us-gaap_RegistrationPaymentArrangementByArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:to="us-gaap_RegistrationPaymentArrangementByArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegistrationPaymentArrangementByArrangementAxis_lbl" xml:lang="en-US">Registration Payment Arrangement by Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="igap_AprilTwoThousandSixteenOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AprilTwoThousandSixteenOfferingMember" xlink:to="igap_AprilTwoThousandSixteenOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AprilTwoThousandSixteenOfferingMember_lbl" xml:lang="en-US">April 2016 Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AgreementWithPlacementAgentMember" xlink:label="igap_AgreementWithPlacementAgentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AgreementWithPlacementAgentMember" xlink:to="igap_AgreementWithPlacementAgentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AgreementWithPlacementAgentMember_lbl" xml:lang="en-US">Advisory Agreement with Andrew Garrett, Inc.[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class Of Warrant Or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="igap_PlacementAgentWarrantsTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheTwoMember" xlink:to="igap_PlacementAgentWarrantsTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PlacementAgentWarrantsTrancheTwoMember_lbl" xml:lang="en-US">Placement Agent Warrants Tranche Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="igap_PlacementAgentWarrantsTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheOneMember" xlink:to="igap_PlacementAgentWarrantsTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PlacementAgentWarrantsTrancheOneMember_lbl" xml:lang="en-US">Placement Agent Warrants Tranche One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SaleAgreementAxis" xlink:label="igap_SaleAgreementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SaleAgreementAxis" xlink:to="igap_SaleAgreementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SaleAgreementAxis_lbl" xml:lang="en-US">Sale Agreement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_InitialClosingMember" xlink:label="igap_InitialClosingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_InitialClosingMember" xlink:to="igap_InitialClosingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_InitialClosingMember_lbl" xml:lang="en-US">Initial Closing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SecondClosingMember" xlink:label="igap_SecondClosingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SecondClosingMember" xlink:to="igap_SecondClosingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SecondClosingMember_lbl" xml:lang="en-US">Second Closing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid in capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated other comprehensive income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC1WarrantMember" xlink:label="igap_SeriesC1WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesC1WarrantMember" xlink:to="igap_SeriesC1WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesC1WarrantMember_lbl" xml:lang="en-US">Series C-1 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC2WarrantMember" xlink:label="igap_SeriesC2WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesC2WarrantMember" xlink:to="igap_SeriesC2WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesC2WarrantMember_lbl" xml:lang="en-US">Series C-2 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_MrPodwalskiMember" xlink:label="igap_MrPodwalskiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_MrPodwalskiMember" xlink:to="igap_MrPodwalskiMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_MrPodwalskiMember_lbl" xml:lang="en-US">Mr. Podwalski [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusMember" xlink:label="us-gaap_DeferredBonusMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredBonusMember" xlink:to="us-gaap_DeferredBonusMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredBonusMember_lbl" xml:lang="en-US">Bonus [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_lbl" xml:lang="en-US">Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NonEmployeeDirectorAndInterimOfficerMember" xlink:label="igap_NonEmployeeDirectorAndInterimOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NonEmployeeDirectorAndInterimOfficerMember" xlink:to="igap_NonEmployeeDirectorAndInterimOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NonEmployeeDirectorAndInterimOfficerMember_lbl" xml:lang="en-US">Non-employee Director and Interim Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ChiefStrategyOfficerMember" xlink:label="igap_ChiefStrategyOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChiefStrategyOfficerMember" xlink:to="igap_ChiefStrategyOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ChiefStrategyOfficerMember_lbl" xml:lang="en-US">Chief Strategy Officer, Ms. Angela Strand [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AvnerGalMember" xlink:label="igap_AvnerGalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AvnerGalMember" xlink:to="igap_AvnerGalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AvnerGalMember_lbl" xml:lang="en-US">Avner Gal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OptionsGrantedMember" xlink:label="igap_OptionsGrantedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OptionsGrantedMember" xlink:to="igap_OptionsGrantedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_OptionsGrantedMember_lbl" xml:lang="en-US">Options Granted [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalOptionsGrantedMember" xlink:label="igap_AdditionalOptionsGrantedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalOptionsGrantedMember" xlink:to="igap_AdditionalOptionsGrantedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdditionalOptionsGrantedMember_lbl" xml:lang="en-US">Additional Options Granted [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_JohnGrahamMember" xlink:label="igap_JohnGrahamMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_JohnGrahamMember" xlink:to="igap_JohnGrahamMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_JohnGrahamMember_lbl" xml:lang="en-US">John Graham [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Vesting immediately [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Vesting on the six month anniversary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xml:lang="en-US">Vesting in two years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DavidMalkaMember" xlink:label="igap_DavidMalkaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DavidMalkaMember" xlink:to="igap_DavidMalkaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_DavidMalkaMember_lbl" xml:lang="en-US">David Malka [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="us-gaap_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrencyAxis" xlink:to="us-gaap_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_ILS" xlink:label="currency_ILS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_ILS" xlink:to="currency_ILS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_ILS_lbl" xml:lang="en-US">NIS [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesB1WarrantMember" xlink:label="igap_SeriesB1WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB1WarrantMember" xlink:to="igap_SeriesB1WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesB1WarrantMember_lbl" xml:lang="en-US">Series B-1 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesBandCPreferredStockMember" xlink:label="igap_SeriesBandCPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesBandCPreferredStockMember" xlink:to="igap_SeriesBandCPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesBandCPreferredStockMember_lbl" xml:lang="en-US">Series B and C Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_ILS" xlink:to="currency_ILS_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="currency_ILS_2_lbl" xml:lang="en-US">ILS [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="us-gaap_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BoardOfDirectorsChairmanMember" xlink:to="us-gaap_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors - Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EachBoardOfDirectorsMember" xlink:label="igap_EachBoardOfDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_EachBoardOfDirectorsMember" xlink:to="igap_EachBoardOfDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_EachBoardOfDirectorsMember_lbl" xml:lang="en-US">Each Member of Board Committee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EachNonemployeeDirectorAndEachInterimOfficerMember" xlink:label="igap_EachNonemployeeDirectorAndEachInterimOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_EachNonemployeeDirectorAndEachInterimOfficerMember" xlink:to="igap_EachNonemployeeDirectorAndEachInterimOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_EachNonemployeeDirectorAndEachInterimOfficerMember_lbl" xml:lang="en-US">Each Non-employee Director and Each Interim Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="us-gaap_VicePresidentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VicePresidentMember" xlink:to="us-gaap_VicePresidentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VicePresidentMember_lbl" xml:lang="en-US">Vice President [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DocumentAndEntityInformationAbstract" xlink:label="igap_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DocumentAndEntityInformationAbstract" xlink:to="igap_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">A S S E T S</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xml:lang="en-US">Long-Term Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:to="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_lbl" xml:lang="en-US">Funds in Respect of Employee Rights Upon Retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="us-gaap_DueToOfficersOrStockholdersNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:to="us-gaap_DueToOfficersOrStockholdersNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOfficersOrStockholdersNoncurrent_lbl" xml:lang="en-US">Long-Term Loans from Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="us-gaap_PostemploymentBenefitsLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:to="us-gaap_PostemploymentBenefitsLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitsLiabilityNoncurrent_lbl" xml:lang="en-US">Liability for Employee Rights Upon Retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_lbl" xml:lang="en-US">Convertible Preferred Stock of $ 0.001 par value ("Preferred Stock")</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Total Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock of $ 0.001 par value ("Common Stock"): 40,000,000 shares authorized as of June 30, 2017 and December 31, 2016; 6,381,149 and 6,026,527 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, temporary equity and stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Convertible Preferred Stock, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Convertible Preferred Stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Convertible Preferred Stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Convertible Preferred Stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="igap_FinancingIncomeExpensesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_FinancingIncomeExpensesNet_lbl" xml:lang="en-US">Financing income (expenses), net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive (income) loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation loss (income)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per share (Basic and Diluted)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Common shares used in computing loss per share (Basic and Diluted)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Loss for the period of six months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" xlink:label="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" xlink:to="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet_lbl" xml:lang="en-US">Amounts allocated to Series C-1 and Series C-2 Warrants, net</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockIssuedDuringPeriodValueStockDividendSeriesC" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendSeriesC" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockIssuedDuringPeriodValueStockDividendSeriesC" xlink:to="igap_StockIssuedDuringPeriodValueStockDividendSeriesC_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendSeriesC_lbl" xml:lang="en-US">Stock dividend on Series C Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockDividendOnSeriesCPreferredStockShares" xlink:label="igap_StockDividendOnSeriesCPreferredStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockDividendOnSeriesCPreferredStockShares" xlink:to="igap_StockDividendOnSeriesCPreferredStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_StockDividendOnSeriesCPreferredStockShares_lbl" xml:lang="en-US">Stock dividend on Series C Preferred Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xml:lang="en-US">Stock dividend on Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="us-gaap_PreferredStockDividendsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xml:lang="en-US">Stock dividend on Series B Preferred Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xml:lang="en-US">Cash dividend on Series A Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile loss for the period to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="us-gaap_OtherNoncashExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Remeasurement adjustment of warrants issued to placement agent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in the fair value of Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_lbl" xml:lang="en-US">Linkage difference on principal of loans from stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">(Increase) in accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Decrease in inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Decrease in other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">(Decrease) increase in accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Increase in other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Decrease in liability for employee rights upon retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:label="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:to="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Cash dividend on Series A Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:label="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:to="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses_lbl" xml:lang="en-US">Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:label="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:to="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses_lbl" xml:lang="en-US">Proceeds allocated to Series C Warrants, net of cash issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents at end of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xml:lang="en-US">Stock dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="us-gaap_DividendsCommonStockCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US">Cash dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockInterestRatePercentage" xlink:label="igap_PreferredStockInterestRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockInterestRatePercentage" xlink:to="igap_PreferredStockInterestRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockInterestRatePercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfWarrantsExchanged" xlink:label="igap_NumberOfWarrantsExchanged" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfWarrantsExchanged" xlink:to="igap_NumberOfWarrantsExchanged_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfWarrantsExchanged_lbl" xml:lang="en-US">Number of warrants exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:to="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_lbl" xml:lang="en-US">Warrants issued as consideration for placement agent services</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_lbl" xml:lang="en-US">Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_lbl" xml:lang="en-US">Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="igap_EventsDuringReportingPeriodAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_EventsDuringReportingPeriodAbstract" xlink:to="igap_EventsDuringReportingPeriodAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_EventsDuringReportingPeriodAbstract_lbl" xml:lang="en-US">EVENTS DURING THE REPORTED PERIOD [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl" xml:lang="en-US">RECENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingExpensesNetDisclosureTextBlock" xlink:label="igap_FinancingExpensesNetDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingExpensesNetDisclosureTextBlock" xlink:to="igap_FinancingExpensesNetDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FinancingExpensesNetDisclosureTextBlock_lbl" xml:lang="en-US">FINANCING INCOME, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently issued accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassified amounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Fair Value of Level 3 Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock_lbl" xml:lang="en-US">Schedule of Warrant Inputs</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SummaryOfSeriescIssuancesTableTextBlock" xlink:label="igap_SummaryOfSeriescIssuancesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SummaryOfSeriescIssuancesTableTextBlock" xlink:to="igap_SummaryOfSeriescIssuancesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SummaryOfSeriescIssuancesTableTextBlock_lbl" xml:lang="en-US">Summary of Entire Series C Issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Financing Income, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Loss and Weighted Average Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventTypeAxis_2_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_2_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:label="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:to="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_lbl" xml:lang="en-US">Proceeds from issuance of Common Stock, net of issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:to="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl" xml:lang="en-US">Proceeds from convertible preferred stock and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Dividend rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="igap_PreferredStockConversionPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConversionPrice" xlink:to="igap_PreferredStockConversionPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockConversionPrice_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="igap_ClassOfWarrantOrRightTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightTerm" xlink:to="igap_ClassOfWarrantOrRightTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ClassOfWarrantOrRightTerm_lbl" xml:lang="en-US">Warrants term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:to="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_lbl" xml:lang="en-US">Number of common shares that will be issued from conversion of units</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Number of shares covered by warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:to="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit_lbl" xml:lang="en-US">Proceeds from issuance of Series C Units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="igap_NumberOfUnitsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfUnitsSold" xlink:to="igap_NumberOfUnitsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfUnitsSold_lbl" xml:lang="en-US">Number of units sold</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentOfOneShare" xlink:label="igap_PercentOfOneShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentOfOneShare" xlink:to="igap_PercentOfOneShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PercentOfOneShare_lbl" xml:lang="en-US">Percent of one share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance, Beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US">Warrants issued as consideration for placement services</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_lbl" xml:lang="en-US">Amount classified out of stockholders' deficit and presented as Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ChangeInFairValueOfSeriesaWarrants" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChangeInFairValueOfSeriesaWarrants" xlink:to="igap_ChangeInFairValueOfSeriesaWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants_lbl" xml:lang="en-US">Change in fair value Warrants with down-round protection</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Balance, End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xml:lang="en-US">Expected term of options (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="us-gaap_FairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExercisePrice" xlink:to="us-gaap_FairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price (US dollars)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price (US dollars)</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightFairValue" xlink:label="igap_ClassOfWarrantOrRightFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightFairValue" xlink:to="igap_ClassOfWarrantOrRightFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ClassOfWarrantOrRightFairValue_lbl" xml:lang="en-US">Fair value (US dollars)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SaleAgreementAxis" xlink:to="igap_SaleAgreementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_SaleAgreementAxis_2_lbl" xml:lang="en-US">SaleAgreementAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="us-gaap_OfficersCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficersCompensation_lbl" xml:lang="en-US">Base salary per year</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AnnualPerformanceBonusPercentage" xlink:label="igap_AnnualPerformanceBonusPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AnnualPerformanceBonusPercentage" xlink:to="igap_AnnualPerformanceBonusPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AnnualPerformanceBonusPercentage_lbl" xml:lang="en-US">Annual performane bonus percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfFullyDilutedSharesOfCommonStock" xlink:label="igap_PercentageOfFullyDilutedSharesOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentageOfFullyDilutedSharesOfCommonStock" xlink:to="igap_PercentageOfFullyDilutedSharesOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PercentageOfFullyDilutedSharesOfCommonStock_lbl" xml:lang="en-US">Percentage of fully diluted shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Stock options vesting in three years</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NetGrantFairValue" xlink:label="igap_NetGrantFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NetGrantFairValue" xlink:to="igap_NetGrantFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NetGrantFairValue_lbl" xml:lang="en-US">Net grant fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_lbl" xml:lang="en-US">Cash payment as compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" xlink:label="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" xlink:to="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService_lbl" xml:lang="en-US">Annual cash payment payable in four equal quarterly installments, subject to employee's continued service</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountToBePaidEachQuarterForAnnualCashPayment" xlink:label="igap_AmountToBePaidEachQuarterForAnnualCashPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountToBePaidEachQuarterForAnnualCashPayment" xlink:to="igap_AmountToBePaidEachQuarterForAnnualCashPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountToBePaidEachQuarterForAnnualCashPayment_lbl" xml:lang="en-US">Amount to be paid each quarter for annual cash payment</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" xlink:label="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" xlink:to="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService_lbl" xml:lang="en-US">Amount of additional annual cash payment payable in four equal quarterly installments, subject to employee's continued service</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" xlink:label="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" xlink:to="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment_lbl" xml:lang="en-US">Amount to be paid each quarter for additional annual cash payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of shares reserved for issuance under Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">One-time award of options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">One-time award of options granted, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Stock options, expiration period</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" xlink:label="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" xlink:to="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals_lbl" xml:lang="en-US">Cash value of Restricted Stock Units granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xml:lang="en-US">Exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockUnitIssuedToPurchaseCommonStock" xlink:label="igap_StockUnitIssuedToPurchaseCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockUnitIssuedToPurchaseCommonStock" xlink:to="igap_StockUnitIssuedToPurchaseCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_StockUnitIssuedToPurchaseCommonStock_lbl" xml:lang="en-US">Stock unit issued to purchase common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OneTimePayment" xlink:label="igap_OneTimePayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OneTimePayment" xlink:to="igap_OneTimePayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_OneTimePayment_lbl" xml:lang="en-US">One-time payment</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:to="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_lbl" xml:lang="en-US">Number of convertible preferred shares offered per unit sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Number of common stock shares callable by warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xml:lang="en-US">Commission fee to agent expressed as percentage of aggregate sales price of the Units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_RegistrationPaymentArrangementCommissionPercentage" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentage" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentage_lbl" xml:lang="en-US">Managment fee percentage commission to agent</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xml:lang="en-US">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. from the company's common stock offering completed in 2010, that were subsequently extended</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. in connection with the Series B Unit offering, that were subsequently extended</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:label="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:to="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_lbl" xml:lang="en-US">Amount company expects it will classify as the fair market value at the time the warrants are issued</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConvertibleStockPriceTrigger" xlink:label="igap_PreferredStockConvertibleStockPriceTrigger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConvertibleStockPriceTrigger" xlink:to="igap_PreferredStockConvertibleStockPriceTrigger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockConvertibleStockPriceTrigger_lbl" xml:lang="en-US">Volume weighted average trading price for forced conversion of Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConvertibleTradingVolumeTrigger" xlink:label="igap_PreferredStockConvertibleTradingVolumeTrigger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConvertibleTradingVolumeTrigger" xlink:to="igap_PreferredStockConvertibleTradingVolumeTrigger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockConvertibleTradingVolumeTrigger_lbl" xml:lang="en-US">Average daily dollar trading value for forced conversion of Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="us-gaap_PreferredStockLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xml:lang="en-US">Preferred stock, liquidating damages</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockPercentageOutstandingGoverningDistributions" xlink:label="igap_PreferredStockPercentageOutstandingGoverningDistributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockPercentageOutstandingGoverningDistributions" xlink:to="igap_PreferredStockPercentageOutstandingGoverningDistributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockPercentageOutstandingGoverningDistributions_lbl" xml:lang="en-US">Convertible preferred stock, percentage outstanding which requires written consent of shareholders for Company to enter into certain transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockMaximumBeneficialOwnership" xlink:label="igap_PreferredStockMaximumBeneficialOwnership" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockMaximumBeneficialOwnership" xlink:to="igap_PreferredStockMaximumBeneficialOwnership_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockMaximumBeneficialOwnership_lbl" xml:lang="en-US">Convertible preferred stock, maximum beneficial ownership of Common Stock permitted to owners</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" xlink:label="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" xlink:to="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms_lbl" xml:lang="en-US">Convertible preferred stock, maximum beneficial ownership of Common Stock permitted to owners, after notice given to Company</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_GrossAmountOfSeriescUnitsSold" xlink:label="igap_GrossAmountOfSeriescUnitsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_GrossAmountOfSeriescUnitsSold" xlink:to="igap_GrossAmountOfSeriescUnitsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_GrossAmountOfSeriescUnitsSold_lbl" xml:lang="en-US">Gross amount of Series C units sold</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" xlink:label="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" xlink:to="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses_lbl" xml:lang="en-US">Net of related cash expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NetAmountOfSeriescUnits" xlink:label="igap_NetAmountOfSeriescUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NetAmountOfSeriescUnits" xlink:to="igap_NetAmountOfSeriescUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NetAmountOfSeriescUnits_lbl" xml:lang="en-US">Net amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in process</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished products</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and related institutions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OtherLiabilitiesClassifiedAsCurrent" xlink:label="igap_OtherLiabilitiesClassifiedAsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OtherLiabilitiesClassifiedAsCurrent" xlink:to="igap_OtherLiabilitiesClassifiedAsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_OtherLiabilitiesClassifiedAsCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_2_lbl" xml:lang="en-US">Israeli CPI linkage difference on principal of loans from stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Exchange rate differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Change in fair value of Warrants with down round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expenses on credit from banks and other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="igap_FinancingIncomeExpensesNet_2_lbl" xml:lang="en-US">Financing income, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCommonStockCash_2_lbl" xml:lang="en-US">Cash dividend on Series A Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockStock" xlink:label="us-gaap_DividendsCommonStockStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockStock" xlink:to="us-gaap_DividendsCommonStockStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCommonStockStock_lbl" xml:lang="en-US">Stock dividend on Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DividendsCommonStockPreferredC" xlink:label="igap_DividendsCommonStockPreferredC" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DividendsCommonStockPreferredC" xlink:to="igap_DividendsCommonStockPreferredC_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_DividendsCommonStockPreferredC_lbl" xml:lang="en-US">Stock dividend on Series C Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Loss for the period attributable to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xml:lang="en-US">Number of shares:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Common shares used in computing basic income (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Common shares used in computing diluted income (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Number of preferred stock convertible into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfAggregateSalesPriceOfUnits" xlink:label="igap_PercentageOfAggregateSalesPriceOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_PercentageOfAggregateSalesPriceOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PercentageOfAggregateSalesPriceOfUnits_lbl" xml:lang="en-US">Percentage of aggregate sales price of units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfNonAccountableExpenseAllowance" xlink:label="igap_PercentageOfNonAccountableExpenseAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentageOfNonAccountableExpenseAllowance" xlink:to="igap_PercentageOfNonAccountableExpenseAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PercentageOfNonAccountableExpenseAllowance_lbl" xml:lang="en-US">Percentage of non accountable expense allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. in connection with the Series B Unit offering, that were subsequently extended</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AgreementWithPlacementAgentMember" xlink:to="igap_AgreementWithPlacementAgentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AgreementWithPlacementAgentMember_doc" xml:lang="en-US">Agreement with Placement Agent [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:to="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_doc" xml:lang="en-US">Amount company expects it will classify as the fair market value at the time the warrants are issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AprilTwoThousandSixteenOfferingMember" xlink:to="igap_AprilTwoThousandSixteenOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AprilTwoThousandSixteenOfferingMember_doc" xml:lang="en-US">April 2016 Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ArbitrationProceedingsWithShareholderMember" xlink:label="igap_ArbitrationProceedingsWithShareholderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ArbitrationProceedingsWithShareholderMember" xlink:to="igap_ArbitrationProceedingsWithShareholderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ArbitrationProceedingsWithShareholderMember_doc" xml:lang="en-US">Arbitration Proceedings with Shareholder [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChangeInFairValueOfSeriesaWarrants" xlink:to="igap_ChangeInFairValueOfSeriesaWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants_doc" xml:lang="en-US">Change in fair value of Series A Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightFairValue" xlink:to="igap_ClassOfWarrantOrRightFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ClassOfWarrantOrRightFairValue_doc" xml:lang="en-US">Class Of Warrant Or Right, Fair Value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightTerm" xlink:to="igap_ClassOfWarrantOrRightTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ClassOfWarrantOrRightTerm_doc" xml:lang="en-US">Class Of Warrant Or Right, Term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:to="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_doc" xml:lang="en-US">Number of common shares that will be issued from conversion of units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DocumentAndEntityInformationAbstract" xlink:to="igap_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document and Entity Information [Abstract].</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ExchangeOneMember" xlink:label="igap_ExchangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeOneMember" xlink:to="igap_ExchangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ExchangeOneMember_doc" xml:lang="en-US">Exchange One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ExchangeTwoMember" xlink:label="igap_ExchangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeTwoMember" xlink:to="igap_ExchangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ExchangeTwoMember_doc" xml:lang="en-US">Exchange Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingExpensesNetDisclosureTextBlock" xlink:to="igap_FinancingExpensesNetDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FinancingExpensesNetDisclosureTextBlock_doc" xml:lang="en-US">The entire disclosure relating to financing expenses, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FinancingIncomeExpensesNet_doc" xml:lang="en-US">Financing income (expenses), net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:to="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_doc" xml:lang="en-US">Funds In Respect Of Employee Rights Upon Retirement, Noncurrent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_InitialClosingMember" xlink:to="igap_InitialClosingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_InitialClosingMember_doc" xml:lang="en-US">Initial Closing [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_doc" xml:lang="en-US">Linkage difference on principal of loans from stockholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xml:lang="en-US">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:to="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_doc" xml:lang="en-US">Number of convertible preferred shares offered per unit sold.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. from the company's common stock offering completed in 2010, that were subsequently extended.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfUnitsSold" xlink:to="igap_NumberOfUnitsSold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfUnitsSold_doc" xml:lang="en-US">Number of Series C units sold.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheOneMember" xlink:to="igap_PlacementAgentWarrantsTrancheOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PlacementAgentWarrantsTrancheOneMember_doc" xml:lang="en-US">Placement Agent Warrants Tranche One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheTwoMember" xlink:to="igap_PlacementAgentWarrantsTrancheTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PlacementAgentWarrantsTrancheTwoMember_doc" xml:lang="en-US">Placement Agent Warrants Tranche Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConversionPrice" xlink:to="igap_PreferredStockConversionPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockConversionPrice_doc" xml:lang="en-US">Preferred Stock, Conversion Price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:to="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_doc" xml:lang="en-US">The cash inflow from the additional capital contribution to the entity, net of issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xml:lang="en-US">Commission fee to agent expressed as percentage of aggregate sales price of the Units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentage" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentage_doc" xml:lang="en-US">Managment fee percentage commission to agent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SaleAgreementAxis" xlink:to="igap_SaleAgreementAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SaleAgreementAxis_doc" xml:lang="en-US">Sale Agreement [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SecondClosingMember" xlink:to="igap_SecondClosingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SecondClosingMember_doc" xml:lang="en-US">Second Closing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesAWarrantMember" xlink:label="igap_SeriesAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesAWarrantMember" xlink:to="igap_SeriesAWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesAWarrantMember_doc" xml:lang="en-US">Represents information pertaining to Series A warrant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB1WarrantMember" xlink:to="igap_SeriesB1WarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesB1WarrantMember_doc" xml:lang="en-US">Represents information pertaining to series B warrant.</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesB2WarrantMember" xlink:label="igap_SeriesB2WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB2WarrantMember" xlink:to="igap_SeriesB2WarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesB2WarrantMember_doc" xml:lang="en-US">Series B2 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesConeWarrantMember" xlink:label="igap_SeriesConeWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesConeWarrantMember" xlink:to="igap_SeriesConeWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesConeWarrantMember_doc" xml:lang="en-US">Series C-1 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesCtwoWarrantMember" xlink:label="igap_SeriesCtwoWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesCtwoWarrantMember" xlink:to="igap_SeriesCtwoWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesCtwoWarrantMember_doc" xml:lang="en-US">Series C-2 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockIssuedDuringPeriodValueStockDividendSeriesC" xlink:to="igap_StockIssuedDuringPeriodValueStockDividendSeriesC_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendSeriesC_doc" xml:lang="en-US">Value of stock issued to shareholders as a dividend during the period on Series C preferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockDividendOnSeriesCPreferredStockShares" xlink:to="igap_StockDividendOnSeriesCPreferredStockShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_StockDividendOnSeriesCPreferredStockShares_doc" xml:lang="en-US">Number of shares issued as a stock dividend to holders of Series C Preferred Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:to="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses_doc" xml:lang="en-US">Proceeds allocated to Series C preferred stock net of cash issuance expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:to="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses_doc" xml:lang="en-US">Proceeds allocated to Series C Warrants, net of cash issuance expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesC1WarrantMember" xlink:to="igap_SeriesC1WarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesC1WarrantMember_doc" xml:lang="en-US">Series C1 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesC2WarrantMember" xlink:to="igap_SeriesC2WarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesC2WarrantMember_doc" xml:lang="en-US">Series C2 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConvertibleStockPriceTrigger" xlink:to="igap_PreferredStockConvertibleStockPriceTrigger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockConvertibleStockPriceTrigger_doc" xml:lang="en-US">The volume weighted average price for the Common Stock on the principal trading market, above which the Company has the option to force the conversion of Preferred Stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConvertibleTradingVolumeTrigger" xlink:to="igap_PreferredStockConvertibleTradingVolumeTrigger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockConvertibleTradingVolumeTrigger_doc" xml:lang="en-US">The average daily dollar trading value for Common Stock on the Company's principal rading market, above which the Company has the option to force the conversion of Preferred Stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockPercentageOutstandingGoverningDistributions" xlink:to="igap_PreferredStockPercentageOutstandingGoverningDistributions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockPercentageOutstandingGoverningDistributions_doc" xml:lang="en-US">The percentage of originally issued shares of preferred stock outstanding which requires the Company to obtain written consent of the holders of a majority of the outstanding stock before incurring indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockMaximumBeneficialOwnership" xlink:to="igap_PreferredStockMaximumBeneficialOwnership_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockMaximumBeneficialOwnership_doc" xml:lang="en-US">The maximum beneficial ownership of the percentage of outstanding Common Stock which holders of Preferred Stock are permitted to convert their shares into.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" xlink:to="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms_doc" xml:lang="en-US">The maximum beneficial ownership of the percentage of outstanding Common Stock which holders of Preferred Stock are permitted to convert their shares into, if written notice is provided to the Company at least 61 days prior.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OneTimePayment" xlink:to="igap_OneTimePayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_OneTimePayment_doc" xml:lang="en-US">One-time payment given to employee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AnnualPerformanceBonusPercentage" xlink:to="igap_AnnualPerformanceBonusPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AnnualPerformanceBonusPercentage_doc" xml:lang="en-US">Annual performance bonus as a percentage of base salary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DividendsCommonStockPreferredC" xlink:to="igap_DividendsCommonStockPreferredC_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_DividendsCommonStockPreferredC_doc" xml:lang="en-US">Stock ividends on series C preferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" xlink:to="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet_doc" xml:lang="en-US">Amounts allocated to series C-1 and series C-2 warrants, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OtherLiabilitiesClassifiedAsCurrent" xlink:to="igap_OtherLiabilitiesClassifiedAsCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_OtherLiabilitiesClassifiedAsCurrent_doc" xml:lang="en-US">Other liabilities classified as current.</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesCWarrantMember" xlink:label="igap_SeriesCWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesCWarrantMember" xlink:to="igap_SeriesCWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesCWarrantMember_doc" xml:lang="en-US">Series c warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_doc" xml:lang="en-US">Adjustments to additional paid in capital reclassification out of stockholders equity to liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockInterestRatePercentage" xlink:to="igap_PreferredStockInterestRatePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockInterestRatePercentage_doc" xml:lang="en-US">The interest rate used to calculate dividend payments on preferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesBandCPreferredStockMember" xlink:to="igap_SeriesBandCPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesBandCPreferredStockMember_doc" xml:lang="en-US">Series B and C preferred stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfWarrantsExchanged" xlink:to="igap_NumberOfWarrantsExchanged_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfWarrantsExchanged_doc" xml:lang="en-US">Number of warrants exchanged.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:to="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_doc" xml:lang="en-US">Warrants issued as consideration for placement agent services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_doc" xml:lang="en-US">Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_doc" xml:lang="en-US">Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_MrPodwalskiMember" xlink:to="igap_MrPodwalskiMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_MrPodwalskiMember_doc" xml:lang="en-US">Mr Podwalski [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentageOfFullyDilutedSharesOfCommonStock" xlink:to="igap_PercentageOfFullyDilutedSharesOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PercentageOfFullyDilutedSharesOfCommonStock_doc" xml:lang="en-US">Percentage of fully diluted shares of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NetGrantFairValue" xlink:to="igap_NetGrantFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NetGrantFairValue_doc" xml:lang="en-US">Net grant fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NonEmployeeDirectorAndInterimOfficerMember" xlink:to="igap_NonEmployeeDirectorAndInterimOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NonEmployeeDirectorAndInterimOfficerMember_doc" xml:lang="en-US">Non employee director and interim officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DavidMalkaMember" xlink:to="igap_DavidMalkaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_DavidMalkaMember_doc" xml:lang="en-US">David Malka [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SalaryIncreaseMember" xlink:label="igap_SalaryIncreaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SalaryIncreaseMember" xlink:to="igap_SalaryIncreaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SalaryIncreaseMember_doc" xml:lang="en-US">Salary increase [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChiefStrategyOfficerMember" xlink:to="igap_ChiefStrategyOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ChiefStrategyOfficerMember_doc" xml:lang="en-US">Chief strategy officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockUnitIssuedToPurchaseCommonStock" xlink:to="igap_StockUnitIssuedToPurchaseCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_StockUnitIssuedToPurchaseCommonStock_doc" xml:lang="en-US">Stock unit issued to purchase common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_WarrantOneMember" xlink:label="igap_WarrantOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_WarrantOneMember" xlink:to="igap_WarrantOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_WarrantOneMember_doc" xml:lang="en-US">Warrant one [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AvnerGalMember" xlink:to="igap_AvnerGalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AvnerGalMember_doc" xml:lang="en-US">Avner Gal [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OptionsGrantedMember" xlink:to="igap_OptionsGrantedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_OptionsGrantedMember_doc" xml:lang="en-US">Options Granted [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalOptionsGrantedMember" xlink:to="igap_AdditionalOptionsGrantedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdditionalOptionsGrantedMember_doc" xml:lang="en-US">Additional options granted [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_JohnGrahamMember" xlink:to="igap_JohnGrahamMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_JohnGrahamMember_doc" xml:lang="en-US">John Graham [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PurchasersMember" xlink:label="igap_PurchasersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PurchasersMember" xlink:to="igap_PurchasersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PurchasersMember_doc" xml:lang="en-US">Purchasers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentOfOneShare" xlink:to="igap_PercentOfOneShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PercentOfOneShare_doc" xml:lang="en-US">Percent of one share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SummaryOfSeriescIssuancesTableTextBlock" xlink:to="igap_SummaryOfSeriescIssuancesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SummaryOfSeriescIssuancesTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of all Series C issuances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_GrossAmountOfSeriescUnitsSold" xlink:to="igap_GrossAmountOfSeriescUnitsSold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_GrossAmountOfSeriescUnitsSold_doc" xml:lang="en-US">Gross amount of Series C units sold.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" xlink:to="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses_doc" xml:lang="en-US">Amount of Series C units sold, net of related cash expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NetAmountOfSeriescUnits" xlink:to="igap_NetAmountOfSeriescUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NetAmountOfSeriescUnits_doc" xml:lang="en-US">Net amount of Series C units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_PercentageOfAggregateSalesPriceOfUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PercentageOfAggregateSalesPriceOfUnits_doc" xml:lang="en-US">Percentage of aggregate sales price of units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PercentageOfNonAccountableExpenseAllowance" xlink:to="igap_PercentageOfNonAccountableExpenseAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PercentageOfNonAccountableExpenseAllowance_doc" xml:lang="en-US">Percentage of non accountable expense allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" xlink:to="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService_doc" xml:lang="en-US">Annual cash payment payable in four equal quarterly installments, subject to employee's continued service.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountToBePaidEachQuarterForAnnualCashPayment" xlink:to="igap_AmountToBePaidEachQuarterForAnnualCashPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountToBePaidEachQuarterForAnnualCashPayment_doc" xml:lang="en-US">Amount to be paid each quarter for annual cash payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" xlink:to="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment_doc" xml:lang="en-US">Amount to be paid each quarter for additional annual cash payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" xlink:to="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService_doc" xml:lang="en-US">Amount of additional annual cash payment payable in four equal quarterly installments, subject to employee's continued service.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_EachBoardOfDirectorsMember" xlink:to="igap_EachBoardOfDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_EachBoardOfDirectorsMember_doc" xml:lang="en-US">Each Board of Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_EachNonemployeeDirectorAndEachInterimOfficerMember" xlink:to="igap_EachNonemployeeDirectorAndEachInterimOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_EachNonemployeeDirectorAndEachInterimOfficerMember_doc" xml:lang="en-US">Each Non-employee Director and Each Interim Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" xlink:to="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals_doc" xml:lang="en-US">Cash value of Restricted Stock Units granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:to="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock_doc" xml:lang="en-US">Amount of cash inflow (outflow) in the form of ordinary dividends to preferred shareholders of the parent entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_3_lbl" xml:lang="en-US">Inventory, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_5_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FinancingIncomeExpensesNet_4_lbl" xml:lang="en-US">Financing Income Expenses Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStockCash_2_lbl" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:to="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock_3_lbl" xml:lang="en-US">PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_2_lbl" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChangeInFairValueOfSeriesaWarrants" xlink:to="igap_ChangeInFairValueOfSeriesaWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants_3_lbl" xml:lang="en-US">EVENTS DURING THE REPORTED PERIOD [Abstract] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_OtherLiabilitiesClassifiedAsCurrent" xlink:to="igap_OtherLiabilitiesClassifiedAsCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_OtherLiabilitiesClassifiedAsCurrent_3_lbl" xml:lang="en-US">OtherLiabilitiesClassifiedAsCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockStock" xlink:to="us-gaap_DividendsCommonStockStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCommonStockStock_2_lbl" xml:lang="en-US">Dividends, Common Stock, Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DividendsCommonStockPreferredC" xlink:to="igap_DividendsCommonStockPreferredC_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_DividendsCommonStockPreferredC_3_lbl" xml:lang="en-US">DividendsCommonStockPreferredC</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>igap-20170630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 0617 10Q.xfr; Date: 2017%2D08%2D09T22:10:59Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://integrity-app.com/role/igap-daei1" xlink:href="igap-20170630.xsd#igap-daei1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" xlink:href="igap-20170630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="igap-20170630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:href="igap-20170630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="igap-20170630.xsd#CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-g" xlink:href="igap-20170630.xsd#igap-g" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosap" xlink:href="igap-20170630.xsd#igap-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:href="igap-20170630.xsd#Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-i" xlink:href="igap-20170630.xsd#igap-i" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilities" xlink:href="igap-20170630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHARE" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SubsequentEvents" xlink:href="igap-20170630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapp" xlink:href="igap-20170630.xsd#igap-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapt" xlink:href="igap-20170630.xsd#igap-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/RecentEventsTables" xlink:href="igap-20170630.xsd#RecentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-it1" xlink:href="igap-20170630.xsd#igap-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" xlink:href="igap-20170630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHARETables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/GeneralDetails" xlink:href="igap-20170630.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:href="igap-20170630.xsd#SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:href="igap-20170630.xsd#CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:href="igap-20170630.xsd#EventsDuringReportedPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:href="igap-20170630.xsd#RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-id" xlink:href="igap-20170630.xsd#igap-id" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" xlink:href="igap-20170630.xsd#OtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:href="igap-20170630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:href="igap-20170630.xsd#Disclosure-LOSSPERSHAREDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SubsequentEventsDetails" xlink:href="igap-20170630.xsd#SubsequentEventsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-daei1" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DocumentAndEntityInformationAbstract" xlink:label="loc_igapDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_igapFinancingIncomeExpensesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" xlink:label="loc_igapAmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockIssuedDuringPeriodValueStockDividendSeriesC" xlink:label="loc_igapStockIssuedDuringPeriodValueStockDividendSeriesC" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockIssuedDuringPeriodValueStockDividendSeriesC" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockDividendOnSeriesCPreferredStockShares" xlink:label="loc_igapStockDividendOnSeriesCPreferredStockShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockDividendOnSeriesCPreferredStockShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="loc_us-gaapPreferredStockDividendsShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:label="loc_igapPaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_igapPaymentsIncomeOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:label="loc_igapProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_igapProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:label="loc_igapProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_igapProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesBandCPreferredStockMember" xlink:label="loc_igapSeriesBandCPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_igapSeriesBandCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaapDividendsCommonStockCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCommonStockCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockInterestRatePercentage" xlink:label="loc_igapPreferredStockInterestRatePercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapPreferredStockInterestRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfWarrantsExchanged" xlink:label="loc_igapNumberOfWarrantsExchanged" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapNumberOfWarrantsExchanged" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-g" xlink:title="00000008 - Disclosure - GENERAL">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosap" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:title="00000010 - Disclosure - RECENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="loc_igapEventsDuringReportingPeriodAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaapAdditionalFinancialInformationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_us-gaapAdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-i" xlink:title="00000011 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:title="00000013 - Disclosure - FINANCING INCOME, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingExpensesNetDisclosureTextBlock" xlink:label="loc_igapFinancingExpensesNetDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapFinancingExpensesNetDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:title="00000014 - Disclosure - LOSS PER SHARE">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SubsequentEvents" xlink:title="00000015 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapp" xlink:title="00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapt" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:label="loc_us-gaapFairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/RecentEventsTables" xlink:title="00000018 - Disclosure - RECENT EVENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="loc_igapEventsDuringReportingPeriodAbstract" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SummaryOfSeriescIssuancesTableTextBlock" xlink:label="loc_igapSummaryOfSeriescIssuancesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_igapSummaryOfSeriescIssuancesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-it1" xlink:title="00000019 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000020 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaapOtherCurrentLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:title="00000021 - Disclosure - FINANCING INCOME, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:title="00000022 - Disclosure - LOSS PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/GeneralDetails" xlink:title="00000023 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC2WarrantMember" xlink:label="loc_igapSeriesC2WarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC2WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC1WarrantMember" xlink:label="loc_igapSeriesC1WarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC1WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesB1WarrantMember" xlink:label="loc_igapSeriesB1WarrantMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesB1WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:label="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConversionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentOfOneShare" xlink:label="loc_igapPercentOfOneShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPercentOfOneShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ChangeInFairValueOfSeriesaWarrants" xlink:label="loc_igapChangeInFairValueOfSeriesaWarrants" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapChangeInFairValueOfSeriesaWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightFairValue" xlink:label="loc_igapClassOfWarrantOrRightFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_igapClassOfWarrantOrRightFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:title="00000026 - Disclosure - RECENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="loc_igapEventsDuringReportingPeriodAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AvnerGalMember" xlink:label="loc_igapAvnerGalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapAvnerGalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_JohnGrahamMember" xlink:label="loc_igapJohnGrahamMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapJohnGrahamMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DavidMalkaMember" xlink:label="loc_igapDavidMalkaMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapDavidMalkaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ChiefStrategyOfficerMember" xlink:label="loc_igapChiefStrategyOfficerMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapChiefStrategyOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NonEmployeeDirectorAndInterimOfficerMember" xlink:label="loc_igapNonEmployeeDirectorAndInterimOfficerMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapNonEmployeeDirectorAndInterimOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EachBoardOfDirectorsMember" xlink:label="loc_igapEachBoardOfDirectorsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapEachBoardOfDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaapBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EachNonemployeeDirectorAndEachInterimOfficerMember" xlink:label="loc_igapEachNonemployeeDirectorAndEachInterimOfficerMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapEachNonemployeeDirectorAndEachInterimOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="loc_us-gaapVicePresidentMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapVicePresidentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_MrPodwalskiMember" xlink:label="loc_igapMrPodwalskiMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_igapMrPodwalskiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OptionsGrantedMember" xlink:label="loc_igapOptionsGrantedMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_igapOptionsGrantedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalOptionsGrantedMember" xlink:label="loc_igapAdditionalOptionsGrantedMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_igapAdditionalOptionsGrantedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusMember" xlink:label="loc_us-gaapDeferredBonusMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapDeferredBonusMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapCurrencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_ILS" xlink:label="loc_currencyILS" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyILS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredBonusMember" xlink:label="loc_us-gaapDeferredBonusMember_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="loc_us-gaapDeferredBonusMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AgreementWithPlacementAgentMember" xlink:label="loc_igapAgreementWithPlacementAgentMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAgreementWithPlacementAgentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="loc_igapAprilTwoThousandSixteenOfferingMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAprilTwoThousandSixteenOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SaleAgreementAxis" xlink:label="loc_igapSaleAgreementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_igapSaleAgreementAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SaleAgreementDomain" xlink:label="loc_igapSaleAgreementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapSaleAgreementAxis" xlink:to="loc_igapSaleAgreementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_InitialClosingMember" xlink:label="loc_igapInitialClosingMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapInitialClosingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SecondClosingMember" xlink:label="loc_igapSecondClosingMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapSecondClosingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheTwoMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheOneMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC1WarrantMember" xlink:label="loc_igapSeriesC1WarrantMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC1WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_SeriesC2WarrantMember" xlink:label="loc_igapSeriesC2WarrantMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesC2WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AnnualPerformanceBonusPercentage" xlink:label="loc_igapAnnualPerformanceBonusPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAnnualPerformanceBonusPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfFullyDilutedSharesOfCommonStock" xlink:label="loc_igapPercentageOfFullyDilutedSharesOfCommonStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPercentageOfFullyDilutedSharesOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NetGrantFairValue" xlink:label="loc_igapNetGrantFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNetGrantFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" xlink:label="loc_igapAnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountToBePaidEachQuarterForAnnualCashPayment" xlink:label="loc_igapAmountToBePaidEachQuarterForAnnualCashPayment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountToBePaidEachQuarterForAnnualCashPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService" xlink:label="loc_igapAdditionalCashPaymentAsCompensationSubjectToContinuedService" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAdditionalCashPaymentAsCompensationSubjectToContinuedService" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment" xlink:label="loc_igapAmountToBePaidEachQuarterForAdditionalAnnualCashPayment" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountToBePaidEachQuarterForAdditionalAnnualCashPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" xlink:label="loc_igapCashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapCashValueOfRestrictedStockUnitsGrantedToVariousIndividuals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_StockUnitIssuedToPurchaseCommonStock" xlink:label="loc_igapStockUnitIssuedToPurchaseCommonStock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapStockUnitIssuedToPurchaseCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OneTimePayment" xlink:label="loc_igapOneTimePayment" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapOneTimePayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConversionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_RegistrationPaymentArrangementCommissionPercentage" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentage" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:label="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConvertibleStockPriceTrigger" xlink:label="loc_igapPreferredStockConvertibleStockPriceTrigger" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConvertibleStockPriceTrigger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConvertibleTradingVolumeTrigger" xlink:label="loc_igapPreferredStockConvertibleTradingVolumeTrigger" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConvertibleTradingVolumeTrigger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="loc_us-gaapPreferredStockLiquidationPreference" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockPercentageOutstandingGoverningDistributions" xlink:label="loc_igapPreferredStockPercentageOutstandingGoverningDistributions" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockPercentageOutstandingGoverningDistributions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockMaximumBeneficialOwnership" xlink:label="loc_igapPreferredStockMaximumBeneficialOwnership" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockMaximumBeneficialOwnership" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms" xlink:label="loc_igapPreferredStockMaximumBeneficialOwnershipSubjectToTerms" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockMaximumBeneficialOwnershipSubjectToTerms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails" xlink:title="00000027 - Disclosure - RECENT EVENTS (Summary of Entire Series C Issuances) (Details)">
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="loc_igapEventsDuringReportingPeriodAbstract" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_igapNumberOfUnitsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_GrossAmountOfSeriescUnitsSold" xlink:label="loc_igapGrossAmountOfSeriescUnitsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_igapGrossAmountOfSeriescUnitsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" xlink:label="loc_igapAmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_igapAmountOfSeriescUnitsSoldNetOfRelatedCashExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NetAmountOfSeriescUnits" xlink:label="loc_igapNetAmountOfSeriescUnits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_igapNetAmountOfSeriescUnits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-id" xlink:title="00000028 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/OtherCurrentLiabilitiesDetails" xlink:title="00000029 - Disclosure - OTHER CURRENT LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_OtherLiabilitiesClassifiedAsCurrent" xlink:label="loc_igapOtherLiabilitiesClassifiedAsCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_igapOtherLiabilitiesClassifiedAsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:title="00000030 - Disclosure - FINANCING INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapFinancingIncomeExpensesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:title="00000031 - Disclosure - LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaapDividendsCommonStockCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapDividendsCommonStockCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockStock" xlink:label="loc_us-gaapDividendsCommonStockStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapDividendsCommonStockStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_DividendsCommonStockPreferredC" xlink:label="loc_igapDividendsCommonStockPreferredC" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_igapDividendsCommonStockPreferredC" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SubsequentEventsDetails" xlink:title="00000032 - Disclosure - SUBSEQUENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheTwoMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapNumberOfUnitsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapPercentageOfAggregateSalesPriceOfUnits" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapPercentageOfAggregateSalesPriceOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PercentageOfNonAccountableExpenseAllowance" xlink:label="loc_igapPercentageOfNonAccountableExpenseAllowance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapPercentageOfNonAccountableExpenseAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapPreferredStockConversionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20170630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806584032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Aug. 15, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Integrity Applications, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001506983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,381,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807386912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,132,622<span></span>
</td>
<td class="nump">$ 148,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">130,296<span></span>
</td>
<td class="nump">92,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,508,312<span></span>
</td>
<td class="nump">1,419,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">157,868<span></span>
</td>
<td class="nump">356,994<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,929,098<span></span>
</td>
<td class="nump">2,017,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net</a></td>
<td class="nump">235,230<span></span>
</td>
<td class="nump">240,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Long-Term Restricted Cash</a></td>
<td class="nump">39,234<span></span>
</td>
<td class="nump">35,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent', window );">Funds in Respect of Employee Rights Upon Retirement</a></td>
<td class="nump">184,031<span></span>
</td>
<td class="nump">167,326<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,387,593<span></span>
</td>
<td class="nump">2,460,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,789,026<span></span>
</td>
<td class="nump">1,634,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">957,436<span></span>
</td>
<td class="nump">713,549<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,746,462<span></span>
</td>
<td class="nump">2,348,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOfficersOrStockholdersNoncurrent', window );">Long-Term Loans from Stockholders</a></td>
<td class="nump">178,186<span></span>
</td>
<td class="nump">162,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent', window );">Liability for Employee Rights Upon Retirement</a></td>
<td class="nump">184,030<span></span>
</td>
<td class="nump">176,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants with down-round protection</a></td>
<td class="nump">764,545<span></span>
</td>
<td class="nump">681,970<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,126,761<span></span>
</td>
<td class="nump">1,020,723<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,873,223<span></span>
</td>
<td class="nump">3,368,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total Temporary Equity</a></td>
<td class="nump">12,880,447<span></span>
</td>
<td class="nump">10,041,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock of $ 0.001 par value ("Common Stock"): 40,000,000 shares authorized as of June 30, 2017 and December 31, 2016; 6,381,149 and 6,026,527 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively</a></td>
<td class="nump">6,384<span></span>
</td>
<td class="nump">6,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="nump">27,967,185<span></span>
</td>
<td class="nump">24,586,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">127,012<span></span>
</td>
<td class="nump">62,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(41,466,658)<span></span>
</td>
<td class="num">(35,604,176)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(13,366,077)<span></span>
</td>
<td class="num">(10,949,430)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity and stockholders' deficit</a></td>
<td class="nump">3,387,593<span></span>
</td>
<td class="nump">2,460,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount', window );">Convertible Preferred Stock of $ 0.001 par value ("Preferred Stock")</a></td>
<td class="nump">221,152<span></span>
</td>
<td class="nump">221,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount', window );">Convertible Preferred Stock of $ 0.001 par value ("Preferred Stock")</a></td>
<td class="nump">6,715,844<span></span>
</td>
<td class="nump">6,715,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount', window );">Convertible Preferred Stock of $ 0.001 par value ("Preferred Stock")</a></td>
<td class="nump">$ 5,943,451<span></span>
</td>
<td class="nump">$ 3,104,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds In Respect Of Employee Rights Upon Retirement, Noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOfficersOrStockholdersNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOfficersOrStockholdersNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6410138&amp;loc=d3e79691-111665<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807173456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">6,381,149<span></span>
</td>
<td class="nump">6,026,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">6,381,149<span></span>
</td>
<td class="nump">6,026,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible Preferred Stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, shares issued</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, shares outstanding</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, shares issued</a></td>
<td class="nump">15,031<span></span>
</td>
<td class="nump">15,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, shares outstanding</a></td>
<td class="nump">15,031<span></span>
</td>
<td class="nump">15,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, shares issued</a></td>
<td class="nump">11,004<span></span>
</td>
<td class="nump">5,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, shares outstanding</a></td>
<td class="nump">11,004<span></span>
</td>
<td class="nump">5,829<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6808203632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 8,744<span></span>
</td>
<td class="nump">$ 381,731<span></span>
</td>
<td class="nump">$ 104,981<span></span>
</td>
<td class="nump">$ 470,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">616,824<span></span>
</td>
<td class="nump">880,696<span></span>
</td>
<td class="nump">1,198,363<span></span>
</td>
<td class="nump">1,531,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">361,295<span></span>
</td>
<td class="nump">349,804<span></span>
</td>
<td class="nump">598,234<span></span>
</td>
<td class="nump">614,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">1,678,719<span></span>
</td>
<td class="nump">734,661<span></span>
</td>
<td class="nump">3,556,078<span></span>
</td>
<td class="nump">1,173,188<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,656,838<span></span>
</td>
<td class="nump">1,965,161<span></span>
</td>
<td class="nump">5,352,675<span></span>
</td>
<td class="nump">3,318,705<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">2,648,094<span></span>
</td>
<td class="nump">1,583,430<span></span>
</td>
<td class="nump">5,247,694<span></span>
</td>
<td class="nump">2,847,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FinancingIncomeExpensesNet', window );">Financing income (expenses), net</a></td>
<td class="nump">90,893<span></span>
</td>
<td class="num">(5,568)<span></span>
</td>
<td class="nump">160,168<span></span>
</td>
<td class="nump">32,065<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period</a></td>
<td class="nump">2,557,201<span></span>
</td>
<td class="nump">1,588,998<span></span>
</td>
<td class="nump">5,087,526<span></span>
</td>
<td class="nump">2,815,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (income) loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation loss (income)</a></td>
<td class="num">(31,697)<span></span>
</td>
<td class="nump">8,063<span></span>
</td>
<td class="num">(64,436)<span></span>
</td>
<td class="nump">30,039<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss for the period</a></td>
<td class="nump">$ 2,525,504<span></span>
</td>
<td class="nump">$ 1,597,061<span></span>
</td>
<td class="nump">$ 5,023,090<span></span>
</td>
<td class="nump">$ 2,845,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per share (Basic and Diluted)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (0.96)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Common shares used in computing loss per share (Basic and Diluted)</a></td>
<td class="nump">6,205,104<span></span>
</td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">6,116,366<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FinancingIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing income (expenses), net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FinancingIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e557-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806851376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - 6 months ended Jun. 30, 2017 - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated other comprehensive income [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2016</a></td>
<td class="nump">$ 6,028<span></span>
</td>
<td class="nump">$ 24,586,142<span></span>
</td>
<td class="nump">$ 62,576<span></span>
</td>
<td class="num">$ (35,604,176)<span></span>
</td>
<td class="num">$ (10,949,430)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2016</a></td>
<td class="nump">6,026,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,026,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period of six months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,087,526)<span></span>
</td>
<td class="num">$ (5,087,526)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet', window );">Amounts allocated to Series C-1 and Series C-2 Warrants, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,404,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,404,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_StockIssuedDuringPeriodValueStockDividendSeriesC', window );">Stock dividend on Series C Preferred Stock</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">276,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(276,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_StockDividendOnSeriesCPreferredStockShares', window );">Stock dividend on Series C Preferred Stock, shares</a></td>
<td class="nump">116,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend on Series B Preferred Stock</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">491,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(491,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Stock dividend on Series B Preferred Stock, shares</a></td>
<td class="nump">206,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividend on Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,714)<span></span>
</td>
<td class="num">(6,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation, shares</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 31,424<span></span>
</td>
<td class="nump">1,208,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,208,246<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2017</a></td>
<td class="nump">$ 6,384<span></span>
</td>
<td class="nump">$ 27,967,185<span></span>
</td>
<td class="nump">$ 127,012<span></span>
</td>
<td class="num">$ (41,466,658)<span></span>
</td>
<td class="num">$ (13,366,077)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2017</a></td>
<td class="nump">6,381,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,381,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts allocated to series C-1 and series C-2 warrants, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountsAllocatedToSeriesC1AndSeriesC2WarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_StockDividendOnSeriesCPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued as a stock dividend to holders of Series C Preferred Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_StockDividendOnSeriesCPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_StockIssuedDuringPeriodValueStockDividendSeriesC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period on Series C preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_StockIssuedDuringPeriodValueStockDividendSeriesC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=96864182&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=96864182&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796055472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period</a></td>
<td class="num">$ (5,087,526)<span></span>
</td>
<td class="num">$ (2,815,762)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile loss for the period to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">33,024<span></span>
</td>
<td class="nump">27,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,208,246<span></span>
</td>
<td class="nump">34,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Remeasurement adjustment of warrants issued to placement agent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">211,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in the fair value of Warrants with down-round protection</a></td>
<td class="num">(191,075)<span></span>
</td>
<td class="num">(64,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders', window );">Linkage difference on principal of loans from stockholders</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(639)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) in accounts receivable</a></td>
<td class="num">(28,615)<span></span>
</td>
<td class="num">(51,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease in inventory</a></td>
<td class="nump">49,255<span></span>
</td>
<td class="nump">130,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease in other current assets</a></td>
<td class="nump">222,952<span></span>
</td>
<td class="nump">147,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">(Decrease) increase in accounts payable</a></td>
<td class="nump">26,829<span></span>
</td>
<td class="num">(638,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Increase in other current liabilities</a></td>
<td class="nump">171,018<span></span>
</td>
<td class="nump">132,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Decrease in liability for employee rights upon retirement</a></td>
<td class="num">(10,148)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="num">(3,606,014)<span></span>
</td>
<td class="num">(2,887,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(4,849)<span></span>
</td>
<td class="num">(46,397)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(4,849)<span></span>
</td>
<td class="num">(46,397)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock', window );">Cash dividend on Series A Preferred Stock</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="num">(4,753)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses', window );">Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses</a></td>
<td class="nump">3,022,002<span></span>
</td>
<td class="nump">2,508,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses', window );">Proceeds allocated to Series C Warrants, net of cash issuance expenses</a></td>
<td class="nump">1,495,541<span></span>
</td>
<td class="nump">1,242,158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by financing activities</a></td>
<td class="nump">4,520,229<span></span>
</td>
<td class="nump">3,745,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">74,420<span></span>
</td>
<td class="num">(15,329)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">983,786<span></span>
</td>
<td class="nump">796,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of the period</a></td>
<td class="nump">148,836<span></span>
</td>
<td class="nump">608,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of the period</a></td>
<td class="nump">$ 1,132,622<span></span>
</td>
<td class="nump">$ 1,405,534<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Linkage difference on principal of loans from stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PaymentsIncomeOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds allocated to Series C preferred stock net of cash issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ProceedsAllocatedToSeriesCPreferredStockNetOfCashIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds allocated to Series C Warrants, net of cash issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ProceedsAllocatedToSeriesCWarrantsNetOfCashIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6939902&amp;loc=d3e20148-110875<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807287712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividend</a></td>
<td class="nump">$ 2,014<span></span>
</td>
<td class="nump">$ 6,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices', window );">Warrants issued as consideration for placement agent services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital', window );">Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity', window );">Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividend</a></td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=igap_SeriesBandCPreferredStockMember', window );">Series B and C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend</a></td>
<td class="nump">$ 406,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockInterestRatePercentage', window );">Interest rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued as consideration for placement agent services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockInterestRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockInterestRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=igap_SeriesBandCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=igap_SeriesBandCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798049488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><div><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"><div id="DSPFPageHeader" style="font-weight: normal; text-align: left; line-height: 1.25"><div style="line-height: 1.25"></div>
</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 1</font>&#160;&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;GENERAL</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z0eaaec54c48a4597b73f5b0db7d79687" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">A.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Integrity Applications, Inc. (the &#8220;Company&#8221;) was incorporated on May 18, 2010 under the laws of the State of Delaware.&#160; On July 15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter:&#160; &#8220;Integrity Acquisition&#8221;), a wholly owned Israeli subsidiary of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter:&#160; &#8220;Integrity Israel&#8221;), an Israeli corporation that was previously held by the stockholders of the Company.&#160; Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger.&#160; Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.&#160; As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.&#160; Integrity Israel was incorporated in 2001 and commenced its operations in 2002.&#160; Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetes.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z9d7cdae391124ace8c337b23dddd54d2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">B.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Going concern uncertainty</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.&#160; The development and commercialization of Integrity Israel&#8217;s product is expected to require substantial expenditures.&#160; Integrity Israel and the Company (collectively, the &#8220;Group&#8221;) have not yet generated significant revenues from operations, and therefore they are dependent upon external sources for financing their operations.&#160; As of June 30, 2017, the Group has incurred an accumulated deficit of $41,466,658, a stockholder&#8217;s deficit of $13,366,077 and negative operating cash flows.&#160; Management considered the significance of such conditions in relation to the Group&#8217;s ability to meet its current and future obligations and determined that these conditions raise substantial doubt about the Group&#8217;s ability to continue as a going concern.&#160; The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&#160; To fund its operations the Company has raised funds through the issuance of (a) Series A units (the &#8220;Series A Units&#8221;) consisting of shares of the Company&#8217;s Series A Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) and detachable warrants to purchase shares of the Company&#8217;s Common Stock (the &#8220;Series A Warrants&#8221; or &#8220;Warrants with down-round protection&#8221;) and (b)&#160;Series B units (the &#8220;Series B Units&#8221;), each consisting of (i) one share of the Company&#8217;s designated Series B 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series B Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $5.80 per share, (ii) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-1 Warrant&#8221;) and (iii) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-2 Warrant&#8221; and, together with the Series B-1 Warrants, collectively, the &#8220;Series B Warrants&#8221;).&#160; Additionally, during the period between April 2016 and June 2017, the Company raised funds in an aggregate amount of approximately $9.47 million (of which amount of approximately $4.52 million was raised during the six-month period ended June 30, 2017) (net of related cash expenses) through the issuance of 11,003.80 units (the &#8220;Series C Units&#8221;).&#160; Each of the Series&#160;C Units consists of (a) one share of the Company&#8217;s designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series C Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $4.50 per share, (b) a five&#8209;year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-1 Warrant&#8221;) and (c) a five-year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-2 Warrant&#8221; and, together with the Series C-1 Warrants, collectively, the &#8220;Series C Warrants&#8221;), as described in further detail in Note 3.&#160; See also Note 8 regarding issuance of additional Series C Units subsequent to the balance sheet date.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long-term loans.&#160; There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations as a going concern.</div>


<div style="line-height: 1.25">&#160;</div>
</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z8ce5980da1ac491eab6681a9e83fed99" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">C.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Risk factors</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">As described in Note 1A and Note 1B above, the Group has a limited operating history and faces a number of risks and uncertainties, including risks and uncertainties regarding continuation of the development process, demand and market acceptance of the Group&#8217;s products, the effects of technological changes, competition and the development of products by competitors.&#160; Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group&#8217;s future results and the availability of necessary financing.&#160; In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts.&#160; The Group has not yet generated material revenues from its operations to fund its activities and therefore is dependent on the receipt of additional funding from its stockholders and/ or new investors in order to continue its operations.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z61039d533ff5421587bb93882f4a5489" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">D.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Use of estimates in the preparation of financial statements</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods.&#160; Actual results could differ from those estimates.&#160; As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series C Units, and (iii) the going concern assumptions.</div></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789888208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: justify; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 2</font>&#160;&#160;&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="ze3bed8565cbd4af196e0f9930c9f7510" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">A.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Basis of presentation</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Accounting Principles</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.&#160; The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) related to interim financial statements.&#160; As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.&#160; The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&#8217;s financial position and operating results for the interim periods.&#160; All such adjustments are of a normal recurring nature.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The results for the three and six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any other interim period or for any future period.</div>



<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Principles of Consolidation</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The consolidated financial statements include the accounts of the Company and its subsidiary.&#160; Significant intercompany balances and transactions have been eliminated in consolidation.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z2989f80eb6924fd0be110b6a761018c3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">B.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Warrants with down-round protection</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The Company has determined its derivative warrant liability with respect to the remaining Series A Warrants and warrants issued to Andrew Garrett, Inc., (&#8220;AGI&#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value.&#160; Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z1132eec3ceab41aaa949f8987297b2a5" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Warrants with down-round Protection<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Balance, Beginning of the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">681,970</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">321,695</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Warrants issued as consideration for placement services</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">273,650</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">234,008</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Amount classified out of stockholders&#8217; deficit and presented as Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">341,662</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Change in fair value Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(191,075</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Balance, End of period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">764,545</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">833,153</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 90pt">The key inputs used in the fair value calculations were as follows:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z2b2a3288de9344079dc77d44b79841c1" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Dividend yield (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Expected volatility (%) (*)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">56.59</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">62.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Risk free interest rate (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.92</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72-1.11</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Expected term of options (years)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.70-4.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.70-5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Exercise price (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.50, 7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.50, 7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Share price (US dollars) (**)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Fair value (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.06-0.76</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.61</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 138px"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 62px">(*)</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 137px"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 63px">(**)</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z8bbffd1de76d495fa0364f370875f35d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">C.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Recently issued accounting pronouncements</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="zec85f35dae2544c0b0224644e914d57d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 90pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">1.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting Standards Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606) (&#8220;ASU 2014-09&#8221;).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance.&#160; ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">An entity should apply the amendments in ASU 2014-09 using one of the following two methods:&#160; 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application.&#160; If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">During 2016, the FASB issued several Accounting Standards Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, &#8220;Revenue from contracts with Customers &#8211; Deferral of the Effective Date&#8221;, for a public entity, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).&#160; Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The Company intends to adopt ASU 2014-09 as of January 1, 2018.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The Company is in the process of evaluating the impact of ASU 2014-09 on its revenue streams and selling contracts, if any, and on its financial reporting and disclosures.&#160; Management is expecting to complete the evaluation of the impact of the accounting and disclosure changes on the business processes, controls and systems during 2017.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">Since the company did not report significant revenues, management believes that the adoption of ASU 2014-09 will not have a significant impact on its consolidated financial statements.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z758d56036bd141459bf82772df83228d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 90pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">2.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting Standards Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">Effective January 1, 2017, the Group adopted ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) (&#8220;ASU 2015- 11&#8221;).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value.&#160; Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance.&#160; Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The adoption of ASU 2015-11 did not have a significant effect on the consolidated financial statements.</div>



<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z8dd941e9a76d4c9093332bde8c50d2fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 90pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">3.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting Standard Update (ASU) No. 2017-11, &#8220;Earnings Per Share&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815):&#160; (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings.&#160; Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification.&#160; Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company).&#160; Early adoption is permitted for all entities.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The Company is evaluating the impact of ASU 2017-11 on its financial statements.&#160; Although this process has not been completed, managements believes that its provisions might impact the accounting of the financial instruments issued by the Company that include down-round protection.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z7598ba7b9ca1490684b1de837f2bc02f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">D.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Reclassified Amounts</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Certain prior year amounts have been reclassified for consistency with the current year presentation.&#160; These reclassifications did not have material effect on the reported results of operations, shareholder&#8217;s deficit or cash flows.</div>

</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798050032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_EventsDuringReportingPeriodAbstract', window );"><strong>EVENTS DURING THE REPORTED PERIOD [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">RECENT EVENTS</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: justify; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 3</font>&#160;&#160;&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;&#160;RECENT EVENTS</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z619088227ed94ab3bb44f84c79fc5a96" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">1.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">On April 7, 2017, the Board of Directors of the Company (the &#8220;Board&#8221;) approved an amendment to the 2010 Incentive Compensation Plan of the Company (the &#8220;Plan&#8221;) to increase the number of shares of the Company&#8217;s Common Stock reserved for issuance under the Plan from 1,000,000 shares to 5,625,000 shares.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="zdad3c9f82a474bd6b4faf6b20bf4ac65" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">2.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Effective April 7, 2017 (the &#8220;Gal Effective Date&#8221;), the Company and Integrity Israel entered into a letter agreement with Avner Gal whereby Mr.&#160;Gal separated from his employment and directorship at the Company to act as a part time consultant to the Company (the &#8220;Gal Agreement&#8221;).&#160; Pursuant to the terms of the Gal Agreement, and as consideration for Mr.&#160;Gal&#8217;s separation from employment and services as a consultant, the Company agreed, among other things, to (a) pay Mr.&#160;Gal an amount equal to his Salary (as defined in the Gal Employment Agreement) and other financial benefits Mr.&#160;Gal was entitled to receive under the Employment Agreement entered into by and between Integrity Israel and Mr.&#160;Gal in October 2010 (the &#8220;Gal Employment Agreement&#8221;), that would have been paid to Mr.&#160;Gal during the Notice Period (as defined in the Gal Employment Agreement), in lieu of such prior notice; (b) modify the Adjustment Period, pursuant to section 19 of the Gal Employment Agreement, to 24 Salaries (as defined in the Gal Employment Agreement), including all the benefits mentioned in the Gal Employment Agreement, provided Mr.&#160;Gal does not work or provide services to a company in direct competition with the Company; (c) accelerate the vesting of 88,259 outstanding unvested options to purchase Common Stock, at an exercise price per share equal to $6.25, held by Mr.&#160;Gal as of the Gal Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date<font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">; s</font>uch amount was measured as approximately $51,000);&#160; (d) extend the term of all outstanding options (vested and unvested) held by Mr.&#160;Gal to be exercisable for five years from the Gal Effective Date (with respect to all vested options, at the modification date the company recognized compensation cost in an amount equal to the excess amount of the fair value of the modified award as of the modification date over the fair value of the original award immediately); and (e) grant Mr.&#160;Gal an option to purchase up to 300,000 shares of Common Stock of the Company having an exercise price per share equal to $4.50 and an option to purchase up to an additional 50,000 shares of common stock of the Company having an exercise price per share equal to $7.75.&#160; These options vest monthly over a 24 months period following the date of grant.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z31c31810474845138f161eaa694e3bff" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">3.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Effective April 7, 2017, the Company entered into an amendment to the employment agreement (the &#8220;Graham Employment Amendment&#8221;) with John Graham, whom the Company appointed as Chief Executive Officer on March 20, 2017, to modify the base compensation provision and the equity compensation provision under that certain Employment Agreement, dated March 20, 2017 (the &#8220;Graham Effective Date&#8221;), by and between the Company and Mr.&#160;Graham.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z84a49bf20de1467f9d45d964c0caa136" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">4.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Pursuant to the terms of the Graham Employment Amendment, (a) Mr.&#160;Graham&#8217;s base compensation was modified such that he receives a base salary of $500,000 per year, as well as a one-time payment of $375,000 paid to Mr.&#160;Graham upon commencement of Mr.&#160;Graham&#8217;s employment with the Company which amount was recognized as an expense as of the employment commencement date, and (b) the vesting periods of Mr.&#160;Graham&#8217;s options to purchase Common Stock were modified whereby (1) 307,754 shares of Common Stock underlying Mr.&#160;Graham&#8217;s option to purchase Common Stock at an exercise price of $4.50 per share (the &#8220;$4.50 Options&#8221;) vested immediately, (2) 923,262 of the $4.50 Options vest on the six month anniversary of the Graham Effective Date, and (3) the remaining 442,980 of the $4.50 Options as well as Mr.&#160;Graham&#8217;s remaining unvested options granted pursuant to the Graham Employment Amendment vest on the two (2) year anniversary of the Graham Effective Date.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z87b18fe9f20b4aee869df74827371a13" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">5.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Effective April 7, 2017, Integrity Israel entered into an amended and restated personal employment agreement (the &#8220;Malka Employment Agreement&#8221;) with David Malka for his continued service as Vice President of Operations of the Company and Integrity Israel, effective as of March 20, 2017 (the &#8220;Malka Effective Date&#8221;).&#160; Pursuant to the terms of the Malka Employment Agreement, Mr.&#160;Malka (a) receives a base monthly salary of NIS 20,000 (approximately $5,508 based on an exchange rate of 3.63 NIS / 1 USD in effect on August 8, 2017), which may increase to NIS 35,000 per month (approximately $9.639 using the same exchange rate) in the event certain performance milestones are met (the &#8220;Malka Base Salary&#8221;); (b)&#160;is eligible to earn an annual performance bonus between 420-864% of the Malka Base Salary, subject to certain performance criteria to be established by the Board within the first ninety (90) days of each fiscal year; (c) is eligible to earn a retention bonus equal to 60% of the aggregate Malka Base Salary earned through the one-year anniversary of the Malka Effective Date, payable thirty days following the one-year anniversary of the Malka Effective Date and provided that Mr.&#160;Malka remains employed with Integrity Israel through and on the one-year anniversary of the Malka Effective Date; (d)&#160;received a modification to the terms of his option to purchase Common Stock at an exercise price per share equal to $6.25 whereby the unvested portion of such options will accelerate and will be immediately exercisable, effective as of the Malka Effective Date (since the original performance conditions were not expected to be satisfied as of the date of the modification of the terms, the fair value of such grant was measured based on the fair value of the modified award at the modification date);&#160; and (e) received certain additional equity awards (pursuant to the Plan) under the terms and conditions as set forth in the Malka Employment Agreement.&#160; In addition, the Malka Employment Agreement provides for the payment of certain social benefits and the use of a company car.&#160; The Malka Employment Agreement is terminable by Integrity Israel and Mr.&#160;Malka on 90 days&#8217; prior written notice (the &#8220;Malka Notice Period&#8221;), without Cause, or immediately by Integrity Israel for Cause (as defined in the Malka Employment Agreement).&#160; Integrity Israel may terminate Mr.&#160;Malka&#8217;s employment without Cause prior to the expiration of the Malka Notice Period, but will be required to pay Mr.&#160;Malka a severance fee equal to the Malka Base Salary plus the financial value of all other benefits Mr.&#160;Malka would have been entitled to receive in respect of the portion of the Malka Notice Period which was forfeited.</div>
</td>
</tr>
</table>
</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>
</div>


<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">On May 23, 2017, the Board approved the salary increase to NIS 35,000 per month pursuant to the Malka Employment Agreement, notwithstanding the foregoing performance goal requirement, as consideration for Mr.&#160;Malka&#8217;s continued service as Vice President of Operations of the Company and Integrity Israel.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z5f7b68a68bcf46f9bcff4face6b7ebcb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">6.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">On May 4, 2017, the Board unanimously voted to appoint Angela Strand, a member of the Board, as the interim Chief Strategy Officer of the Company, effective as of May 1, 2017 through September 30, 2017. On May 5, 2017, the Company entered into a letter agreement (the &#8220;Strand Employment Agreement&#8221;) with Ms.&#160;Angela Strand confirming her appointment as interim Chief Strategy Officer of the Company.&#160; Pursuant to the terms of the Strand Employment Agreement, Ms.&#160;Strand receives aggregate compensation of $150,000 for her service during the term of employment, paid monthly on the schedule mutually agreed upon by the parties.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z9156810b192944449d02317c2f91730a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">7.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">On May 23, 2017, the Board approved the following compensation for all non-employee directors and interim officers serving on the Board:</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z482b475b085d45fdb8d988adf113e7fc" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 54pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">a.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">an annual cash payment to each non-employee director and interim officer of the Company in the amount of $35,000, payable in four equal quarterly installments of $8,750 each on the last day of each calendar quarter commencing with the fourth quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="zcb358595b2994e52812eab1b474b580b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 54pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">b.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">an additional annual cash payment to each member of a Board committee who is not the Chairperson of that particular committee in the amount of $5,000, payable in four equal quarterly installments of $1,250 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="zc176fe69347b41a3a81634526d119f27" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 54pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">c.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif"><font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">an additional annual cash payment to the chairperson of a Board committee in the amount of $12,500, payable in four equal quarterly installments of $3,125 each on the last day of each calendar quarter commencing with the second quarter of 2017, subject to their continued service as of each such date;</font></div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z81a45bf2aa3049ecb6a3e5db605cd75b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 54pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">d.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">the grant to each non-employee director and each interim officer of the Company of a one-time award of options to purchase up to an aggregate of 14,894 shares of Common Stock, at an exercise price of $4.50, under and pursuant to the Plan, which options vest in 12 equal monthly increments commencing as of June 1, 2017 (subject to their continued service as of each such date) and have a term of 10 years;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="zfcd1c1296795424e95305a241828a6d2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 54pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">e.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">the grant to each non-employee director and each interim officer of the Company of an award of Restricted Stock Units (&#8220;RSUs&#8221;), to be granted on June 1, 2017 and vesting on June 1, 2018, with a fair value of $45,000 based on the 30-day volume weighted average price of the Company&#8217;s Common Stock on June 1, 2017, subject to their continued service on and through such date; and</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z5a37ef11c08e4b82b9d034ab9f8c3cff" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 54pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">f.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif"><font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">an additional annual fair value payment to the vice chairperson of the Board in the amount of $20,000, payable in RSUs under the same vesting terms.</font></div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="zb9f1fe0447824a18a10218d586431d39" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">8.</td>
<td style="vertical-align: top; text-align: left; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">On May 23, 2017, the Board appointed Michael Hauck to serve as a director of the Company, effective on that date.&#160; The Board further appointed Mr.&#160;Hauck to serve as a member of the Nominating and Corporate Governance Committee of the Board as well as on the Compensation Committee of the Board.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt">There are no arrangements or understandings between Mr.&#160;Hauck and any other person pursuant to which Mr.&#160;Hauck was selected as a director.&#160; There are no relationships between Mr.&#160;Hauck and the Company that would require disclosure under Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z98fa32447c9a4f2a8f6ecf47de59785c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">9.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">On May 23, 2017, the Board established an Audit Committee of the Board and appointed each of Leslie Seff and Revan Schwartz to serve as members of the committee.&#160; Mr. Schwartz will serve as chairperson of the committee. The Board determined that each of the members of the Audit Committee designated above is independent pursuant to the required standards set forth in Rule 10A-3(b) of the Securities Exchange Act of 1934, as amended, based on an evaluation of the relationships between the Company and each of the members.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z1b32e95ea1774520bf8316873c9c6e85" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">10.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">On June 7, 2017, the Board appointed David Podwalski as the Chief Commercial Officer of the Company, effective as of June 26, 2017 (the &#8220;Podwalski Effective Date&#8221;).</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">On June 7, 2017, the Company entered into an employment agreement (the &#8220;CCO Employment Agreement&#8221;) with Mr.&#160;Podwalski to serve as Chief Commercial Officer of the Company.&#160; Under the CCO Employment Agreement, Mr.&#160;Podwalski (1) receives a base salary of $240,000 per year (&#8220;Base Salary&#8221;); (2) receives a sign-on bonus of $25,000, payable on the six month anniversary of the Podwalski Effective Date, subject to his continued employment through and on such payment date; (3) is eligible to receive an annual performance bonus, having a minimum bonus opportunity equal to 20% of his current Base Salary based upon 80% achievement of performance criteria (the &#8220;Minimum Performance Goal&#8221;), a target bonus opportunity equal to 25% of his current Base Salary based upon 100% achievement of performance criteria, and a maximum bonus opportunity equal to 37.5% of his current Base Salary based upon 150% achievement of performance criteria (the &#8220;Maximum Performance Goal&#8221;), provided, however, that such performance bonus will be determined using straight-line interpolation of the level of achievement between the Minimum Performance Goal and the Maximum Performance Goal; and (4) <font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">receive an initial stock option grant to purchase shares of Common Stock equal to 1% of the total fully diluted shares of Common Stock as of the </font>Podwalski <font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">Effective Date, with an exercise price of $4.50 per share or the fair market value of a share of Common Stock on the grant date, whichever is greater, vesting monthly over a three year period commencing on the </font>Podwalski <font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">Effective Date, subject to his continued employment through and on each such vesting date (the total fair value of the grant as of the </font>Podwalski <font style="font: 10pt Times New Roman, Times, serif; background-color: #ffffff">Effective Date is approximately $270,000).</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The CCO Employment Agreement is terminable by the Company on 90 days written notice and by Mr.&#160;Podwalski on 30 days written notice.&#160; The CCO Employment Agreement is immediately terminable by the Company for Cause (as defined in the CCO Employment Agreement) without the payment of severance.&#160; The CCO Employment Agreement contains non-compete obligations applicable during the term of the agreement and for one year thereafter and confidentiality obligations that survive the termination of the agreement indefinitely.</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Between April 2016 and December 31, 2016, and during the first six months of 2017, the Company received aggregate net proceeds of approximately $4.9 million and $4.5 million, respectively (net of related cash expenses), from the issuance and sale in a private placement transaction, at a price of $1,000 per unit, of 11,003.80 Series C Units.&#160; As of June 30, 2017, the shares of Series C Preferred Stock comprising the Series C Units are convertible into an aggregate of 2,445,317 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 4,890,634 shares of Common Stock, in each case subject to adjustment in certain circumstances.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Pursuant to a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with AGI, at the initial closing of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units.&#160; At the end of the second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth and eleventh closings of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing.&#160; In addition, pursuant to the Placement Agent Agreement, the Company is required to issue to AGI: (a) 5-year warrants to purchase up to 489,064 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 244,531 shares of Common Stock at an exercise price of $7.75 per share.&#160; The terms of such warrants are substantially similar to the Series C Warrants except that the warrants issued to AGI are exercisable on a cashless basis and include full ratchet anti-dilution protection.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Following below is a summary of the entire series C issuances:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="za8f8f4b7573b4b95bc4e3c5fc2899692" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended December 31, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Thousands of U.S. $ (except units sold) (unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Number of units sold</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,828.9</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,174.9</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Gross amount</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,829</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,175</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Net of related cash expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,951</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,520</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Net amount</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,642</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,246</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Subject to certain ownership limitations described below, the Series C Preferred Stock are convertible at the option of the holder at any time and from time to time into shares of Common Stock at a conversion price of $4.50 per share (calculated by dividing the stated value per share of Preferred Stock, which is initially $1,000, by the conversion price per share).&#160; The conversion price of the Series C Preferred Stock is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect, as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders.&#160; In addition, the holders of Preferred Stock will be entitled to receive any securities or rights to acquire securities or property granted or issued by the Company pro rata to the holders of Common Stock to the same extent as if such holders had converted all of their shares of Series C Preferred Stock prior to such distribution.&#160; In the event of a fundamental transaction, such as a merger, consolidation, sale of substantially all assets and similar reorganizations or recapitalizations of the Company, the holders of Series C Preferred Stock will be entitled to receive, upon conversion of their shares of Series C Preferred Stock, any securities or other consideration received by the holders of the Common Stock pursuant to the fundamental transaction.</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Holders of Series C Preferred Stock are entitled to receive cumulative dividends at a rate of 5.5% per annum, based on the stated value per share of Series C Preferred Stock.&#160; Dividends on the Series C Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on June 30, 2016, and on each conversion date (with respect to the shares of Preferred Stock being converted).&#160; For so long as required under the terms of the certificate of designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, dividends will be payable only in shares of Common Stock.&#160; Thereafter, dividends on the Series C Preferred Stock will be payable, at the option of the Company, in cash and/or, if certain conditions are satisfied, shares of Common Stock or a combination of both.&#160; Shares of Common Stock issued as payment of dividends will be valued at the lower of (a) the then current conversion price of the Series C Preferred Stock or (b) the average of the volume weighted average price for the Common Stock on the principal trading market therefor for the 10 trading days immediately prior to the applicable dividend payment date.&#160; The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Subject to any limitations under the terms of the certificate of designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, the Company may become obligated to redeem the Series&#160;C Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Series C Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service.&#160; In addition, upon the occurrence of certain triggering events, each holder of Series C Preferred Stock will have the option to require the Company to redeem such holder&#8217;s shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder&#8217;s outstanding Series C Preferred Stock.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Subject to certain conditions contained in the Certificate of Designations, Preferences and Rights relating to the Series C Preferred Stock (the &#8220;Certificate of Designations&#8221;), the Company will have the option to force the conversion of the Series C Preferred Stock (in whole or in part) if (a) the volume weighted average price for the Common Stock on its principal trading market exceeds $7.00 for each of any 20 trading days during any 30&#160;consecutive trading day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $50,000 or (b) the Company receives approval to list the Common Stock on a national securities exchange.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Subject to certain exceptions contained in the Certificate of Designations, if the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Series C Preferred Stock (the &#8220;Conversion Shares&#8221;) and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a &#8220;Buy-In&#8221;), the Company will be required to:&#160; (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder&#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Series C Preferred Stock equal to the number of shares of Series C Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements.&#160; In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Series C Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the fifth trading day following the applicable conversion date and the Company will continue to pay such partial liquidated damages for each trading day after such eighth trading day until such certificates are delivered or the holder rescinds such conversion.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">As long as at least 35% of the originally issued shares of Series C Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Series C Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Subject to the beneficial ownership limitation described below, holders of Series C Preferred Stock will vote together with the holders of Common Stock, Series A Preferred Stock and Series B Preferred Stock on an as&#8209;converted basis.&#160; Holders will not be permitted to convert their Series C Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding Common Stock (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the &#8220;Beneficial Ownership Limitation&#8221;).&#160; In addition, no holder may vote any shares of Series C Preferred Stock (on an as-converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Subject to certain limitations, so long as any purchaser holds any shares of Series C Preferred Stock, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series C Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser after taking into account all of the terms and conditions of the terms granted to the purchasers under the purchase agreement relating to the issuance and sale of the Series C Units and the terms granted in such subsequent issuance or sale, including all of the components of the Series C Units and of the securities or units involved in such subsequent issuance or sale, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The Series C Warrants have a five-year term commencing on their respective issuance dates.&#160; Until the end of the applicable term, each Series C Warrant will be exercisable at any time and from time to time at an exercise price of $4.50 per share (with respect to the Series C-1 Warrants) or $7.75 per share (with respect to the Series&#160;C-2 Warrants).&#160; The Series C Warrants contain adjustment provisions substantially similar to those to the adjustment provisions of the Series C Preferred Stock as described above, except that the Series C Warrants do not include dilution protection for issuances of securities at an effective price per share lower than the conversion price of such Series C Warrants.&#160; In addition, the Series C Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Series C Preferred Stock.&#160; No holder may exercise its Series C Warrants in excess of the Beneficial Ownership Limitation.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Based on the terms of the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, respectively, so long as any initial purchaser of Series A Units or Series B Units, as applicable, holds any shares of Series A Preferred Stock or Series B Preferred Stock, respectively, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series A or Series B Preferred Stock or Warrants reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Pursuant to the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, the Company was required to and did notify the holders of the Series A Preferred Stock and Series B Preferred Stock of the closing of the sale of the Series C Units, and following receipt thereof such holders of Series A Preferred Stock and Series B Preferred Stock will be entitled, pursuant to the &#8220;most favored nation&#8221; provisions contained in their respective purchase agreements (as described above), to elect to amend the terms of their purchase of Series A Units and Series B Units, respectively, to match the terms of the Series C Units.&#160; The Company is obligated to amend the terms of any of Series A Units or Series B Units who timely makes such election and tenders its Series A Units or Series B Units for exchange.</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>



<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">As of June 30, 2017, none of the Series A or B Unit holders asked the company to amend the terms of their Units.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Upon their initial recognition, the Series C Preferred Stock issued together with detachable Series C Warrants (classified as equity) were measured based on the relative fair value basis and were presented net of the direct issuance expenses that were allocated to them.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The Company has determined that, due to the economic characteristics and risks of the Series C Preferred Stock, based on their stated or implied substantive terms and features, such Preferred Stock are considered as more akin to equity than debt.&#160; Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Series C Preferred Stock themselves (the &#8216;host contract&#8217;) are clearly and closely related.&#160; As a result, the embedded conversion feature was not required to be bifurcated.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Since at each of the issuances dates of the Series C Preferred Stock the exercise price of the conversion feature (based on the effective conversion rate of the Series C Preferred Stock into Common Stock) was higher than the estimated fair value of the Company&#8217;s Common Stock, it was determined that given the current market price, conversion at the conversion price was not a beneficial transaction.&#160; Also, due to the liquidation preference and certain redemption rights for the benefit of the holders of the Series C Preferred Stock, upon the occurrence of certain contingent events, which are not considered as solely within the Company&#8217;s control management determined that the Series C Preferred Stock were to be presented as temporary equity.&#160; On each balance sheet date, the Company&#8217;s management assesses the probability of redemption of the outstanding Preferred Stock.&#160; In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will reclassify the amount allocated to the preferred stock from temporary equity to liability. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and the aggregate redemption amount of the Preferred Stock will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_EventsDuringReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_EventsDuringReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6621740464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 4</font>&#160;&#160;&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;&#160;INVENTORIES</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z77e0ac1d71ad4d328b59935502edbb92" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">December 31, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Raw materials</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">705,810</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">735,201</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Work in process</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">794,582</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">633,132</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Finished products</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,920</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">51,271</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,508,312</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,419,604</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798081392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 5</font>&#160;&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;&#160;OTHER CURRENT LIABILITIES</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z1a1e6963dae0441190723ce209223498" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">December 31, </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Employees and related institutions</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">353,250</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">363,738</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Accrued expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">588,338</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">261,651</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Other current liabilities</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">15,848</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">88,160</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">957,436</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">713,549</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798051552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING INCOME, NET<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FinancingExpensesNetDisclosureTextBlock', window );">FINANCING INCOME, NET</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 6</font>&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;FINANCING INCOME, NET</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="zc93f5981e2ff4d68818dc0c3e6e3f12c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Three month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Israeli CPI linkage difference on principal of loans from stockholders</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">26</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(639</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,393</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">825</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Exchange rate differences</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17,194</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">24,211</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,720</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">19,296</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Change in fair value of Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(191,075</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(106,976</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(20,702</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Interest expenses on credit from banks and other</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,687</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8,575</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,970</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,149</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(160,168</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(32,065</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(90,893</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,568</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FinancingExpensesNetDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure relating to financing expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FinancingExpensesNetDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798082480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">LOSS PER SHARE</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 7</font>&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;&#160;LOSS PER SHARE</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt">In periods of net loss, basic loss per share is computed by dividing net loss for the period after consideration of the effect of dividends on preferred stock by the weighted average number of shares outstanding during the period.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt">The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2017 and 2016 are as follows:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z7bc0d56fca264921af72a81b7571f419" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Three month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Loss for the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(5,087,526</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,815,762</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,557,201</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,588,998</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(6,714</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(9,453</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,014</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(4,753</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(491,668</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(254,101</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(245,637</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(131,281</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(276,574</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(160,588</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Loss for the period attributable to common stockholders</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(5,862,482</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(3,099,671</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,965,440</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,745,387</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z05ebdd4316af445495e94b284b94a130" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Three month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Number of shares:</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Common shares used in computing basic income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,116,366</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,205,104</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Common shares used in computing diluted income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,116,366</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,203,104</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">19,868,112</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,220,345</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">21,001,400</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,210,613</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z8f54093400a94ea6a3b078a6c358100c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 36pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">(*)</td>
<td style="vertical-align: top; text-align: left; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive.</div></td></tr></table></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798123024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; line-height: 1.25"><font style="font: bold 10pt Times New Roman, Times, serif">NOTE 8</font>&#160;&#160;&#160;<font style="font: bold 10pt Times New Roman, Times, serif"><font style="font: bold 10pt Times New Roman, Times, serif">&#8211;</font>&#160;&#160;SUBSEQUENT EVENTS</font></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt">On July 31, 2017, the Company, entered into a Securities Purchase Agreement with certain accredited investors pursuant to which, the Company issued to the Purchasers an aggregate of 1,000 Series C Units.&#160; The shares of Preferred Stock comprising the Units are convertible into an aggregate of 222,236 shares of Common Stock, and the Warrants comprising the Units are exercisable for an aggregate of 444,472 shares of Common Stock, in each case subject to certain adjustments.&#160; The Company received aggregate gross proceeds of $1,000,000 from the sale of the Units.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt">The sale of the Units pursuant to the securities purchase agreement was the twelfth closing of an offering of Units by the Company.&#160; The first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth&#160; and eleventh closings, involving the sale by the Company of an aggregate of 1,133 Units, 1,351 Units, 890.5 Units, 1,050.65 Units, 540 Units, 357.75 Units, 506 Units, 403.9 Units, 2,560 Units, 1,551 Units and 660 Units, respectively (collectively, the &#8220;Prior Issuances&#8221;), were disclosed by the Company in Current Reports on Form 8-K filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on April 14, 2016, May 4, 2016, June 6, 2016, July 7, 2016, September 7, 2016, October 7, 2016, December 5, 2016, January 5, 2017, March 14, 2017, May 3, 2017 and June 23, 2017, respectively (collectively, the &#8220;Prior 8-Ks&#8221;), each of which is incorporated herein by reference.&#160; The terms of the Preferred Stock and the Warrants are the same as the terms of the Preferred Stock and Warrants issued in the Prior Issuances, as described in the Prior 8-Ks.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt">Pursuant to the Placement Agent Agreement, at the closing of the sale of the Units the Company paid AGI, as a commission, an amount (payable in cash and Common Stock) equal to 10% of the aggregate sales price of the Units, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Units.&#160; In addition, pursuant to the AGI Agreement, the Company is required to issue to AGI: (a) 5 year warrants to purchase up to 44,445 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 22,223 shares of Common Stock at an exercise price of $7.75 per share.&#160; The terms of these warrants will be substantially similar to the Warrants except that the AGI warrants will also be exercisable on a cashless basis and will include full ratchet anti-dilution protection.</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798069600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: justify; line-height: 1.25"><table id="ze3bed8565cbd4af196e0f9930c9f7510" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">A.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Basis of presentation</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Accounting Principles</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.&#160; The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) related to interim financial statements.&#160; As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.&#160; The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&#8217;s financial position and operating results for the interim periods.&#160; All such adjustments are of a normal recurring nature.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The results for the three and six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any other interim period or for any future period.</div>



<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Principles of Consolidation</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The consolidated financial statements include the accounts of the Company and its subsidiary.&#160; Significant intercompany balances and transactions have been eliminated in consolidation.</div></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants with down-round protection</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: justify; line-height: 1.25"><table id="z2989f80eb6924fd0be110b6a761018c3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">B.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Warrants with down-round protection</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The Company has determined its derivative warrant liability with respect to the remaining Series A Warrants and warrants issued to Andrew Garrett, Inc., (&#8220;AGI&#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value.&#160; Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z1132eec3ceab41aaa949f8987297b2a5" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Warrants with down-round Protection<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Balance, Beginning of the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">681,970</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">321,695</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Warrants issued as consideration for placement services</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">273,650</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">234,008</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Amount classified out of stockholders&#8217; deficit and presented as Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">341,662</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Change in fair value Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(191,075</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Balance, End of period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">764,545</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">833,153</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 90pt">The key inputs used in the fair value calculations were as follows:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z2b2a3288de9344079dc77d44b79841c1" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Dividend yield (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Expected volatility (%) (*)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">56.59</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">62.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Risk free interest rate (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.92</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72-1.11</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Expected term of options (years)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.70-4.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.70-5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Exercise price (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.50, 7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.50, 7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Share price (US dollars) (**)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Fair value (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.06-0.76</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.61</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 138px"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 62px">(*)</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 137px"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 63px">(**)</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).</div></td></tr></table></div></div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued accounting pronouncements</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: justify; line-height: 1.25"><table id="z8bbffd1de76d495fa0364f370875f35d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">C.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Recently issued accounting pronouncements</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="zec85f35dae2544c0b0224644e914d57d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 90pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">1.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting Standards Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606) (&#8220;ASU 2014-09&#8221;).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance.&#160; ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">An entity should apply the amendments in ASU 2014-09 using one of the following two methods:&#160; 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application.&#160; If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">During 2016, the FASB issued several Accounting Standards Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, &#8220;Revenue from contracts with Customers &#8211; Deferral of the Effective Date&#8221;, for a public entity, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).&#160; Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The Company intends to adopt ASU 2014-09 as of January 1, 2018.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The Company is in the process of evaluating the impact of ASU 2014-09 on its revenue streams and selling contracts, if any, and on its financial reporting and disclosures.&#160; Management is expecting to complete the evaluation of the impact of the accounting and disclosure changes on the business processes, controls and systems during 2017.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">Since the company did not report significant revenues, management believes that the adoption of ASU 2014-09 will not have a significant impact on its consolidated financial statements.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z758d56036bd141459bf82772df83228d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 90pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">2.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting Standards Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">Effective January 1, 2017, the Group adopted ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) (&#8220;ASU 2015- 11&#8221;).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value.&#160; Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance.&#160; Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The adoption of ASU 2015-11 did not have a significant effect on the consolidated financial statements.</div>



<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z8dd941e9a76d4c9093332bde8c50d2fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 90pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">3.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting Standard Update (ASU) No. 2017-11, &#8220;Earnings Per Share&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815):&#160; (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;).</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings.&#160; Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification.&#160; Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company).&#160; Early adoption is permitted for all entities.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 108pt">The Company is evaluating the impact of ASU 2017-11 on its financial statements.&#160; Although this process has not been completed, managements believes that its provisions might impact the accounting of the financial instruments issued by the Company that include down-round protection.</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassified amounts</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: justify; line-height: 1.25"><table id="z7598ba7b9ca1490684b1de837f2bc02f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 72pt"></td>
<td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">D.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Reclassified Amounts</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">Certain prior year amounts have been reclassified for consistency with the current year presentation.&#160; These reclassifications did not have material effect on the reported results of operations, shareholder&#8217;s deficit or cash flows.</div></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41620-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5579240-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5579245-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41675-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41638-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807406336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Fair Value of Level 3 Liability</a></td>
<td class="text"><div><div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 90pt">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z1132eec3ceab41aaa949f8987297b2a5" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Warrants with down-round Protection<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Balance, Beginning of the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">681,970</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">321,695</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Warrants issued as consideration for placement services</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">273,650</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">234,008</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Amount classified out of stockholders&#8217; deficit and presented as Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">341,662</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Change in fair value Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(191,075</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Balance, End of period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">764,545</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">833,153</div>
</td>
</tr></table></div></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock', window );">Schedule of Warrant Inputs</a></td>
<td class="text"><div><div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"></div>

<div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 90pt">The key inputs used in the fair value calculations were as follows:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z2b2a3288de9344079dc77d44b79841c1" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Dividend yield (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Expected volatility (%) (*)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">56.59</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">62.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Risk free interest rate (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.92</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72-1.11</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Expected term of options (years)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.70-4.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.70-5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Exercise price (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.50, 7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.50, 7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Share price (US dollars) (**)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Fair value (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.06-0.76</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.61</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z7cd50abfef0d42a88b20c0f8756df29d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 138px"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 62px">(*)</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: justify; line-height: 1.25">
<table id="z5a486164a79240db906cd66324a49ed0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 137px"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 63px">(**)</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016.&#160; In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units (See Note 3).</div></td></tr></table></div></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quantitative information about the inputs used in the fair value measurement of liabilities. This disclosure may include, but is not limited to, the fair value of the liability, valuation technique used to measure fair value, the inputs used to measure fair value, the ranges of the inputs, and the weighted averages of the inputs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6607562352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT EVENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_EventsDuringReportingPeriodAbstract', window );"><strong>EVENTS DURING THE REPORTED PERIOD [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_SummaryOfSeriescIssuancesTableTextBlock', window );">Summary of Entire Series C Issuances</a></td>
<td class="text"><div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Following below is a summary of the entire series C issuances:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="za8f8f4b7573b4b95bc4e3c5fc2899692" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended December 31, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Thousands of U.S. $ (except units sold) (unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Number of units sold</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,828.9</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,174.9</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Gross amount</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,829</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,175</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Net of related cash expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,951</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,520</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Net amount</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,642</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,246</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_EventsDuringReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_EventsDuringReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_SummaryOfSeriescIssuancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all Series C issuances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_SummaryOfSeriescIssuancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789937280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; line-height: 1.25"></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z77e0ac1d71ad4d328b59935502edbb92" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">December 31, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Raw materials</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">705,810</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">735,201</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Work in process</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">794,582</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">633,132</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Finished products</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,920</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">51,271</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,508,312</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,419,604</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789756672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; line-height: 1.25"></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z1a1e6963dae0441190723ce209223498" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">December 31, </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Employees and related institutions</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">353,250</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">363,738</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Accrued expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">588,338</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">261,651</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Other current liabilities</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">15,848</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">88,160</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">957,436</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">713,549</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6616673968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING INCOME, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Financing Income, Net</a></td>
<td class="text"><div style="font-weight: normal; text-align: left; line-height: 1.25"></div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="zc93f5981e2ff4d68818dc0c3e6e3f12c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Three month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Israeli CPI linkage difference on principal of loans from stockholders</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">26</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(639</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,393</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">825</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Exchange rate differences</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17,194</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">24,211</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,720</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">19,296</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Change in fair value of Warrants with down-round protection</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(191,075</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(106,976</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(20,702</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Interest expenses on credit from banks and other</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,687</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8,575</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,970</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,149</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(160,168</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(32,065</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(90,893</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,568</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6621634032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Loss and Weighted Average Number of Shares</a></td>
<td class="text"><div style="font: normal 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 45pt">The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2017 and 2016 are as follows:</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">&#160;</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z7bc0d56fca264921af72a81b7571f419" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Three month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Loss for the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(5,087,526</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,815,762</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,557,201</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,588,998</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(6,714</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(9,453</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,014</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(4,753</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(491,668</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(254,101</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(245,637</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(131,281</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(276,574</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(160,588</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Loss for the period attributable to common stockholders</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(5,862,482</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(3,099,671</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,965,440</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,745,387</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z05ebdd4316af445495e94b284b94a130" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 88%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Six month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Three month period ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Number of shares:</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Common shares used in computing basic income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,116,366</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,205,104</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Common shares used in computing diluted income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,116,366</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,203,104</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 10.8pt; text-indent: -10.8pt">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">19,868,112</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,220,345</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">21,001,400</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,210,613</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="font-weight: normal; text-align: left; clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font-weight: normal; text-align: left; line-height: 1.25">
<table id="z8f54093400a94ea6a3b078a6c358100c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 36pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; vertical-align: top; width: 18pt">(*)</td>
<td style="vertical-align: top; text-align: left; width: auto">
<div style="font: 10pt Times New Roman, Times, serif">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was determined to be anti-dilutive.</div></td></tr></table></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6808363840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,466,658<span></span>
</td>
<td class="nump">$ 35,604,176<span></span>
</td>
<td class="nump">$ 41,466,658<span></span>
</td>
<td class="nump">$ 35,604,176<span></span>
</td>
<td class="nump">$ 41,466,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,366,077<span></span>
</td>
<td class="nump">10,949,430<span></span>
</td>
<td class="nump">$ 13,366,077<span></span>
</td>
<td class="nump">$ 10,949,430<span></span>
</td>
<td class="nump">$ 13,366,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock', window );">Proceeds from convertible preferred stock and warrants</a></td>
<td class="nump">$ 9,470<span></span>
</td>
<td class="nump">$ 4,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,174.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,828.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC2WarrantMember', window );">Series C-2 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC1WarrantMember', window );">Series C-1 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB1WarrantMember', window );">Series B-1 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion', window );">Number of common shares that will be issued from conversion of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,445,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares covered by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit', window );">Proceeds from issuance of Series C Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,003.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,003.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PercentOfOneShare', window );">Percent of one share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares that will be issued from conversion of units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Series C units sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PercentOfOneShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of one share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PercentOfOneShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Conversion Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflows (outflows) from issuing and redeeming redeemable preferred stock; includes convertible and nonconvertible redeemable preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow resulting from the sale of an interest in a corporate unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInterestInCorporateUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC2WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC2WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC1WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC1WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB1WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB1WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787336080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of the period</a></td>
<td class="nump">$ 681,970<span></span>
</td>
<td class="nump">$ 321,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants issued as consideration for placement services</a></td>
<td class="nump">273,650<span></span>
</td>
<td class="nump">234,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities', window );">Amount classified out of stockholders' deficit and presented as Warrants with down-round protection</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">341,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ChangeInFairValueOfSeriesaWarrants', window );">Change in fair value Warrants with down-round protection</a></td>
<td class="num">(191,075)<span></span>
</td>
<td class="num">(64,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of period</a></td>
<td class="nump">$ 764,545<span></span>
</td>
<td class="nump">$ 833,153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital reclassification out of stockholders equity to liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ChangeInFairValueOfSeriesaWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Series A Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ChangeInFairValueOfSeriesaWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787437728">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details) - Warrant [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Dividend yield (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56.59%<span></span>
</td>
<td class="nump">62.16%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="nump">$ 2.38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.72%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected term of options (years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">8 months 12 days<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Exercise price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0450<span></span>
</td>
<td class="nump">$ 0.0450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightFairValue', window );">Fair value (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected term of options (years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Exercise price (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0775<span></span>
</td>
<td class="nump">$ 0.0775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightFairValue', window );">Fair value (US dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0076<span></span>
</td>
<td class="nump">$ 0.0061<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The Common Stock price, per share reflects the Company's management's estimation of the fair value per share of Common Stock as of June 30, 2017 and 2016. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series B Units and the Series C Units (See Note 3).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6919479280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT EVENTS (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 07, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 05, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 07, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 07, 2017 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 23, 2017 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Apr. 30, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 23, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 03, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 05, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 05, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 07, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 07, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 07, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 06, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 04, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 14, 2016 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved for issuance under Plan | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,174.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,828.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit', window );">Number of convertible preferred shares offered per unit sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,560<span></span>
</td>
<td class="nump">403.9<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">357.75<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="nump">1,050.65<span></span>
</td>
<td class="nump">890.5<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC1WarrantMember', window );">Series C-1 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC2WarrantMember', window );">Series C-2 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Placement Agent Warrants Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock shares callable by warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Placement Agent Warrants Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock shares callable by warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Commission fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_RegistrationPaymentArrangementCommissionPercentage', window );">Managment fee percentage commission to agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Second Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Commission fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit', window );">Proceeds from issuance of Series C Units | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,003.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,003.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion', window );">Number of common shares that will be issued from conversion of units | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,445,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock shares callable by warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConvertibleStockPriceTrigger', window );">Volume weighted average trading price for forced conversion of Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConvertibleTradingVolumeTrigger', window );">Average daily dollar trading value for forced conversion of Preferred Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidating damages | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockPercentageOutstandingGoverningDistributions', window );">Convertible preferred stock, percentage outstanding which requires written consent of shareholders for Company to enter into certain transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockMaximumBeneficialOwnership', window );">Convertible preferred stock, maximum beneficial ownership of Common Stock permitted to owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms', window );">Convertible preferred stock, maximum beneficial ownership of Common Stock permitted to owners, after notice given to Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member] | April 2016 Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit', window );">Number of convertible preferred shares offered per unit sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_AvnerGalMember', window );">Avner Gal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_AvnerGalMember', window );">Avner Gal [Member] | Options Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_AvnerGalMember', window );">Avner Gal [Member] | Additional Options Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_JohnGrahamMember', window );">John Graham [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_OneTimePayment', window );">One-time payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_JohnGrahamMember', window );">John Graham [Member] | Vesting immediately [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_JohnGrahamMember', window );">John Graham [Member] | Vesting on the six month anniversary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_JohnGrahamMember', window );">John Graham [Member] | Vesting in two years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember', window );">David Malka [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember', window );">David Malka [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualPerformanceBonusPercentage', window );">Annual performane bonus percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">864.00%<span></span>
</td>
<td class="nump">864.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember', window );">David Malka [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualPerformanceBonusPercentage', window );">Annual performane bonus percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420.00%<span></span>
</td>
<td class="nump">420.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember', window );">David Malka [Member] | NIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember', window );">David Malka [Member] | NIS [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 35,000<span></span>
</td>
<td class="nump">&#8362; 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_ChiefStrategyOfficerMember', window );">Chief Strategy Officer, Ms. Angela Strand [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_NonEmployeeDirectorAndInterimOfficerMember', window );">Non-employee Director and Interim Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService', window );">Annual cash payment payable in four equal quarterly installments, subject to employee's continued service | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountToBePaidEachQuarterForAnnualCashPayment', window );">Amount to be paid each quarter for annual cash payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_EachBoardOfDirectorsMember', window );">Each Member of Board Committee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService', window );">Amount of additional annual cash payment payable in four equal quarterly installments, subject to employee's continued service | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment', window );">Amount to be paid each quarter for additional annual cash payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember', window );">Board of Directors - Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService', window );">Amount of additional annual cash payment payable in four equal quarterly installments, subject to employee's continued service | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment', window );">Amount to be paid each quarter for additional annual cash payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_EachNonemployeeDirectorAndEachInterimOfficerMember', window );">Each Non-employee Director and Each Interim Officer [Member] | Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">One-time award of options granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">One-time award of options granted, exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock options, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_EachNonemployeeDirectorAndEachInterimOfficerMember', window );">Each Non-employee Director and Each Interim Officer [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals', window );">Cash value of Restricted Stock Units granted | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_VicePresidentMember', window );">Vice President [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService', window );">Amount of additional annual cash payment payable in four equal quarterly installments, subject to employee's continued service | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember', window );">Mr. Podwalski [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | $</a></td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PercentageOfFullyDilutedSharesOfCommonStock', window );">Percentage of fully diluted shares of common stock</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NetGrantFairValue', window );">Net grant fair value | $</a></td>
<td class="nump">$ 270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember', window );">Mr. Podwalski [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualPerformanceBonusPercentage', window );">Annual performane bonus percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember', window );">Mr. Podwalski [Member] | Maximum [Member] | Bonus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualPerformanceBonusPercentage', window );">Annual performane bonus percentage</a></td>
<td class="nump">37.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember', window );">Mr. Podwalski [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualPerformanceBonusPercentage', window );">Annual performane bonus percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember', window );">Mr. Podwalski [Member] | Minimum [Member] | Bonus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AnnualPerformanceBonusPercentage', window );">Annual performane bonus percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember', window );">Mr. Podwalski [Member] | Bonus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Base salary per year | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional annual cash payment payable in four equal quarterly installments, subject to employee's continued service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdditionalCashPaymentAsCompensationSubjectToContinuedService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid each quarter for additional annual cash payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountToBePaidEachQuarterForAdditionalAnnualCashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountToBePaidEachQuarterForAnnualCashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid each quarter for annual cash payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountToBePaidEachQuarterForAnnualCashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual cash payment payable in four equal quarterly installments, subject to employee's continued service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AnnualCashPaymentApprovedByBoardOfDirectorsAsCompensationToBePaidQuarterlySubjectToEmployeesContinuedService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AnnualPerformanceBonusPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual performance bonus as a percentage of base salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AnnualPerformanceBonusPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash value of Restricted Stock Units granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_CashValueOfRestrictedStockUnitsGrantedToVariousIndividuals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares that will be issued from conversion of units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NetGrantFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net grant fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NetGrantFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of convertible preferred shares offered per unit sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfConvertiblePreferredSharesOfferedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Series C units sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_OneTimePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>One-time payment given to employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_OneTimePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PercentageOfFullyDilutedSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fully diluted shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PercentageOfFullyDilutedSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Conversion Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockConvertibleStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The volume weighted average price for the Common Stock on the principal trading market, above which the Company has the option to force the conversion of Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockConvertibleStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockConvertibleTradingVolumeTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average daily dollar trading value for Common Stock on the Company's principal rading market, above which the Company has the option to force the conversion of Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockConvertibleTradingVolumeTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockMaximumBeneficialOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum beneficial ownership of the percentage of outstanding Common Stock which holders of Preferred Stock are permitted to convert their shares into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockMaximumBeneficialOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum beneficial ownership of the percentage of outstanding Common Stock which holders of Preferred Stock are permitted to convert their shares into, if written notice is provided to the Company at least 61 days prior.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockMaximumBeneficialOwnershipSubjectToTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockPercentageOutstandingGoverningDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of originally issued shares of preferred stock outstanding which requires the Company to obtain written consent of the holders of a majority of the outstanding stock before incurring indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockPercentageOutstandingGoverningDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission fee to agent expressed as percentage of aggregate sales price of the Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_RegistrationPaymentArrangementCommissionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Managment fee percentage commission to agent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_RegistrationPaymentArrangementCommissionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(d)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow resulting from the sale of an interest in a corporate unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInterestInCorporateUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC1WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC1WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC2WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesC2WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_SaleAgreementAxis=igap_InitialClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_SaleAgreementAxis=igap_InitialClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_SaleAgreementAxis=igap_SecondClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_SaleAgreementAxis=igap_SecondClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_AvnerGalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_AvnerGalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=igap_OptionsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=igap_OptionsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=igap_AdditionalOptionsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=igap_AdditionalOptionsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_JohnGrahamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_JohnGrahamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_DavidMalkaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_ChiefStrategyOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_ChiefStrategyOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_NonEmployeeDirectorAndInterimOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_NonEmployeeDirectorAndInterimOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_EachBoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_EachBoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_EachNonemployeeDirectorAndEachInterimOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_EachNonemployeeDirectorAndEachInterimOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_VicePresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_VicePresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=igap_MrPodwalskiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredBonusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredBonusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_DeferredBonusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_DeferredBonusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789916672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT EVENTS (Summary of Entire Series C Issuances) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_EventsDuringReportingPeriodAbstract', window );"><strong>EVENTS DURING THE REPORTED PERIOD [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="nump">5,174.90<span></span>
</td>
<td class="nump">5,828.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_GrossAmountOfSeriescUnitsSold', window );">Gross amount of Series C units sold</a></td>
<td class="nump">$ 5,175<span></span>
</td>
<td class="nump">$ 5,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses', window );">Net of related cash expenses</a></td>
<td class="nump">4,520<span></span>
</td>
<td class="nump">4,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NetAmountOfSeriescUnits', window );">Net amount</a></td>
<td class="nump">$ 4,246<span></span>
</td>
<td class="nump">$ 4,642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Series C units sold, net of related cash expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountOfSeriescUnitsSoldNetOfRelatedCashExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_EventsDuringReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_EventsDuringReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_GrossAmountOfSeriescUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of Series C units sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_GrossAmountOfSeriescUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NetAmountOfSeriescUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net amount of Series C units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NetAmountOfSeriescUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Series C units sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789512672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 705,810<span></span>
</td>
<td class="nump">$ 735,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">794,582<span></span>
</td>
<td class="nump">633,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td>
<td class="nump">7,920<span></span>
</td>
<td class="nump">51,271<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 1,508,312<span></span>
</td>
<td class="nump">$ 1,419,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6621077344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and related institutions</a></td>
<td class="nump">$ 353,250<span></span>
</td>
<td class="nump">$ 363,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">588,338<span></span>
</td>
<td class="nump">261,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_OtherLiabilitiesClassifiedAsCurrent', window );">Other current liabilities</a></td>
<td class="nump">15,848<span></span>
</td>
<td class="nump">88,160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 957,436<span></span>
</td>
<td class="nump">$ 713,549<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_OtherLiabilitiesClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other liabilities classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_OtherLiabilitiesClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796388864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING INCOME, NET (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders', window );">Israeli CPI linkage difference on principal of loans from stockholders</a></td>
<td class="nump">$ 1,393<span></span>
</td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="num">$ (639)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Exchange rate differences</a></td>
<td class="nump">6,720<span></span>
</td>
<td class="nump">19,296<span></span>
</td>
<td class="nump">17,194<span></span>
</td>
<td class="nump">24,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of Warrants with down round protection</a></td>
<td class="num">(106,976)<span></span>
</td>
<td class="num">(20,702)<span></span>
</td>
<td class="num">(191,075)<span></span>
</td>
<td class="num">(64,212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expenses on credit from banks and other</a></td>
<td class="nump">7,970<span></span>
</td>
<td class="nump">6,149<span></span>
</td>
<td class="nump">13,687<span></span>
</td>
<td class="nump">8,575<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FinancingIncomeExpensesNet', window );">Financing income, net</a></td>
<td class="num">$ (90,893)<span></span>
</td>
<td class="nump">$ 5,568<span></span>
</td>
<td class="num">$ (160,168)<span></span>
</td>
<td class="num">$ (32,065)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FinancingIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing income (expenses), net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FinancingIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Linkage difference on principal of loans from stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797302448">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,557,201)<span></span>
</td>
<td class="num">$ (1,588,998)<span></span>
</td>
<td class="num">$ (5,087,526)<span></span>
</td>
<td class="num">$ (2,815,762)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividend on Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,014)<span></span>
</td>
<td class="num">(4,753)<span></span>
</td>
<td class="num">(6,714)<span></span>
</td>
<td class="num">(9,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockStock', window );">Stock dividend on Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(245,637)<span></span>
</td>
<td class="num">(131,281)<span></span>
</td>
<td class="num">(491,668)<span></span>
</td>
<td class="num">(254,101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_DividendsCommonStockPreferredC', window );">Stock dividend on Series C Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(160,588)<span></span>
</td>
<td class="num">(20,355)<span></span>
</td>
<td class="num">(276,574)<span></span>
</td>
<td class="num">(20,355)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Loss for the period attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,965,440)<span></span>
</td>
<td class="num">$ (1,745,387)<span></span>
</td>
<td class="num">$ (5,862,482)<span></span>
</td>
<td class="num">$ (3,099,671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Number of shares:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Common shares used in computing basic income (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,205,104<span></span>
</td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">6,116,366<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Common shares used in computing diluted income (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,205,104<span></span>
</td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">6,116,366<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21,001,400<span></span>
</td>
<td class="nump">12,210,613<span></span>
</td>
<td class="nump">19,868,112<span></span>
</td>
<td class="nump">11,220,345<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_DividendsCommonStockPreferredC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock ividends on series C preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_DividendsCommonStockPreferredC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823663440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 23, 2017</div></th>
<th class="th"><div>May 03, 2017</div></th>
<th class="th"><div>Mar. 14, 2017</div></th>
<th class="th"><div>Jan. 05, 2017</div></th>
<th class="th"><div>Dec. 05, 2016</div></th>
<th class="th"><div>Oct. 07, 2016</div></th>
<th class="th"><div>Sep. 07, 2016</div></th>
<th class="th"><div>Jul. 07, 2016</div></th>
<th class="th"><div>Jun. 06, 2016</div></th>
<th class="th"><div>May 04, 2016</div></th>
<th class="th"><div>Apr. 14, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,174.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,828.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit', window );">Number of convertible preferred shares offered per unit sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
<td class="nump">2,560<span></span>
</td>
<td class="nump">403.9<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">357.75<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="nump">1,050.65<span></span>
</td>
<td class="nump">890.5<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,003.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,003.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion', window );">Number of common shares that will be issued from conversion of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,445,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares covered by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,890,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit', window );">Proceeds from issuance of Series C Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion', window );">Number of common shares that will be issued from conversion of units</a></td>
<td class="nump">222,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares covered by warrants</a></td>
<td class="nump">444,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit', window );">Proceeds from issuance of Series C Units</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PercentageOfAggregateSalesPriceOfUnits', window );">Percentage of aggregate sales price of units</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PercentageOfNonAccountableExpenseAllowance', window );">Percentage of non accountable expense allowance</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Placement Agent Warrants Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares covered by warrants</a></td>
<td class="nump">22,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Placement Agent Warrants Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares covered by warrants</a></td>
<td class="nump">44,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares that will be issued from conversion of units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of convertible preferred shares offered per unit sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfConvertiblePreferredSharesOfferedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Series C units sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PercentageOfAggregateSalesPriceOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate sales price of units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PercentageOfAggregateSalesPriceOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PercentageOfNonAccountableExpenseAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of non accountable expense allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PercentageOfNonAccountableExpenseAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Conversion Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow resulting from the sale of an interest in a corporate unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInterestInCorporateUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>46
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MN?[PNPJ[SMB]_<?&%T'9P*^[D%]02P,$%     @ *$H.2YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MZY4W(5D[15%+:>G;V-:=:8?Q2T0FF]N )P.>#3C[KX%,!C(;4&22'U=F4OU
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M>=# 1>KN1O7Y6$'&@63]5!V#N407?P!02P,$%     @ *$H.2^<"DNUS!
M114  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX;6R-F-UNXS80A5_%\/VN
MR1G^!HZ!1D71 BT0;+'MM1(SL;&RY4I*O'W[4K)C.#/#;6YL23Y#GAF2GV@N
MCVWWK=^D-,R^[YI]?SO?#,/A9K'H'S=I5_>?VT/:YU^>VFY7#_FV>U[TAR[5
MZREHURQ *;?8U=O]?+6<GMUWJV7[,C3;?;KO9OW+;E=W_]ZEICW>SO7\[<&7
M[?-F&!\L5LM#_9S^3,/7PWV7[Q:75M;;7=KWVW8_Z]+3[?PG?5-A' ,FQ5_;
M=.ROKF=C*@]M^VV\^6U].U>CH]2DQV%LHLY?KZE*33.VE'W\<VYT?NES#+R^
M?FO]ERGYG,Q#W:>J;?[>KH?-[3S,9^OT5+\TPY?V^&LZ)V3GLW/VOZ?7U&3Y
MZ"3W\=@V_?0Y>WSIAW9W;B5;V=7?3]_;_?1]/+?_%B8'P#D +@':_#  SP%(
M A8G9U.J/]=#O5IV[7'6G4;K4(^30M]@+N;C^'"JW?1;SK;/3U]7 ,O%Z]C.
M67)WDL"UY+VB$A1XD2QR_Q<3()J *1ZOXXT<CV(\3O'F.MZ2)$X2/TGVDT1K
M!$>3K02="0&=;,>(=@RWXXB=D\1>=X,*(I%57!9!.2V;L:(9R\UX8L9R,U8%
MU+0V@L[HZ%1AK)SHQW$_@?AQ@A\?')%57(;6Q5APXT4WGKN)Q(UGW4"$J"*U
M(^B4]B9:V4\0_03F!Q7Q$W@_:('**D%FE+$@NXFBF\C=:.(F\D&(@(:8$536
M^0(CM)))I;@;ABK%ITXPBKJN)%WV X5EK@OLU-P14D>:IX[!VXC4$A>"<2J:
MDB<9I9JS% LK0LLPU9RF2&EZUKRKGP]14<Y5DM"A<:8P#[5,5,V1BA2I6H"E
M]8;J*D'G-5H3"XYDK&K.5:1<U1R8X'/NCKT_!2&:H&.!]%I&JW9\[$.A!1F'
MFO,0*0\U!UT>>QU8G06= U6<C3(0-2>BH434G'73JJ=(E'3>>5T:>1F*FE/1
M4"IJ#CSOC#66.N(ZEX?=*]D1R&0$3D9#R0@"\30X[R@:):$"Y8L[.IF-P-EH
M*!M!8&/(% ;*1DF(+D1=F$M0V&9R-II2"S(;@;.1CND=",B#$)0QGJ8E*)4R
M^AH0[UW)= 3#\RJ\-4"F&7":4;=WP"'E,- WO:124* 0R!P#OD<T=(\(?/<'
M/N;%'.@:DY3&!J=+[R"0V0B<C8:R$03F@5=L)RWH'%A?&C09C<#1:"D:@2/O
MTSC!G+-T_RI)\RXMS\>B+QF0P %I*2"!@^^3SFO:*<]6B23-^Z)HL(!)E#&)
M').68A(Y_>3MFB#\X78-94PBQZ0M@!9EJ.''H8:%?\\<:M;0NG!4 6A-ZU?]
MO^Z](QEHR+=[MO W"F6@H?UX560((8<0KPI'2R:0#892\0/"]YYD!"%'D"W-
M-YD9&#Y>%WEUH["Z65TB.T6Q>;D:BH%*$*+.;TI'LUI<G6>-!XQ_U-WS=M_/
M'MIA:'?3 =93VPXI-ZH^YS)O4KV^W#3I:1@O?;[N3@=[IYNA/9P/+1>7D]/5
M?U!+ P04    "  H2@Y+M0C(I<L"   (#   &    'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;(U6[8[:,!!\E2@/<+&=3Q @%:JJE5H)7=7VMP$#T25QZABX
MOGUM)Q<E]@+A!XF=F?6LUQ[MXL;%6W-F3'KO95$U2_\L93T/@F9_9B5M7GC-
M*O7ER$5)I1J*4]#4@M&#(95%0!!*@I+FE;]:F+FM6"WX119YQ;;":RYE2<6_
M-2OX;>EC_V/B-3^=I9X(5HN:GMA/)G_56Z%&01_ED)>L:G)>>8(=E_XG/-\0
MH@D&\3MGMV;P[NE4=IR_Z<&WP])'6A$KV%[J$%0]KFS#BD)'4CK^=D']?DU-
M'+Y_1/]BDE?)[&C#-KSXDQ_D>>EGOG=@1WHIY"N_?65=0K'O==E_9U=6*+A6
MHM;8\Z(Q_][^TDA>=E&4E)*^M\^\,L];^R5).QI,(!V!] 0</22$'2&T"$&K
MS*3ZF4JZ6@A^\T1;K9KJ0X'GH=K,O9XT>V>^J6P;-7M=Q>DBN.HX'63=0L@
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M+2()13J6-D2YB"1PBL)V>*,B1,E9V=2$"4DX8'+M(('$/.:,N// G'E@=AX
MY:%#Q#@/4E!4M?5];J2'._5P6P_*Y(I;ZTP$B4)!<8JXG2(,CA0)IR)A*V*H
MML*.G'.&Y=RC1EJD4XNTM:"7="FM58 3'@.JZOH^-](3.O6$MA[4$1:A500
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MJ8>1&O.N&783R9J^T3O#WT;Z#U!+ P04    "  H2@Y+OO_XTJX!  #2 P
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M-VX;H1TY&X\O&_M?&^,!I6RN<(1:_&"S(:'VX7B+9SN.V6AXTTT_B,W?N/@
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MR\;^U\9X0"F[*QRA%C_88DBH?3A^PK.=QFPRO.GG'\26;US\!E!+ P04
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M4V%OVR 0_2N('U <)VVSR+;4=)HVJ96B3ML^$_MLHP+G 8[;?S_ CN=MUKX
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M]S#7\XJ2N?B/< 6%X5$)YJBL\FDEU>"#U3,+2M'B>=JE2?LXW? W,VP;P&<
M7P!W*0^;$B7E;T409>[L2-S4^U[$)\Z.''M316=J1;I#\1Z]US*[S7)VC41S
MS&F*X>N8)8(A^Y*";Z4X\;_@?!N^WU2X3_#];PK_07#8)#@D@L-_2]R*V?^1
MA*UZJL&U:9H\J>Q@TB2OO,O WO/T)K_"IVG_)%PKC2<7&_!E4_\;:P.@E-T-
MCE"''VPQ%#0A'E_CV4UC-AG!]O,/8LLW+G\"4$L#!!0    ( "A*#DO1#JF0
MXP$    %   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;&U4VVZ<,!#]
M%>0/B('ELET!4C91U$JMM$K5]MD+PT6Q,;7-DOY];4,H9?V"/>,SY\P8SV03
M%V^R!5#>.Z.]S%&KU'#"6)8M,"(?^ "]/JFY8$1I4S18#@)(98,8Q:'O)YB1
MKD=%9GT7461\5+3KX2(\.3)&Q)\S4#[E*$ ?CM>N:95QX"(;2 /?0?T8+D);
M>&6I.@:]['CO":AS]!B<SJG!6\#/#B:YV7NFDBOG;\;X4N7(-PD!A5(9!J*7
M&SP!I89(I_%[X42KI G<[C_87VSMNI8KD?#$Z:^N4FV.CLBKH"8C5:]\^@Q+
M/3'REN*_P@VHAIM,M$;)J;1?KQREXFQAT:DP\CZO76_7:3Z)HR7,'1 N >$:
M<+0Z>!:RF3\318I,\,D3\]T/Q/SBX!3JNRF-TUZ%/=/)2^V]%4$29?AFB!;,
M><:$6\R*P)I]E0A=$N?P+CQTAQ^<&1YL^&&K'D5N@LA)$%F"Z+\2XUV)+DSB
M%HF=(O$=013L-.XA09*Z-1*G1N(@..Y$7)A/;I'4*9+>$Z3^3L2%V3\)O'F!
M#$1C>T]Z)1][V_<;[]K>CZ%]P?_@\VSX1D33]=*[<J7[P+[6FG,%.A7_0=]J
MJ\?1:E"HE=FF>B_FIIP-Q8=EWN!UZ!5_ 5!+ P04    "  H2@Y+TX:!U\4!
M   W!   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6QU5-MNW" 0_17$
M!X1=UDZBE6TIFRA*I59:)6K[S-KCB\+% ;Q._SZ '<?=TA?##&?.F6$89Z/2
MKZ8%L.A=<&ERW%K;[PDQ90N"F2O5@W0GM=*"66?JAIA> ZM"D."$;C;71+!.
MXB(+OJ,N,C58WDDX:F0&(9C^<P"NQAQO\:?CN6M:ZQVDR'K6P O8G_U1.XLL
M+%4G0)I.2:2ASO'==G](/3X ?G4PFM4>^4I.2KUZXUN5XXU/"#B4UC,PMYSA
M'CCW1"Z-MYD3+Y(^<+W_9'\,M;M:3LS O>*_N\JV.;[%J(*:#=P^J_$)YGI2
MC.;BO\,9N(/[3)Q&J;@)7U0.QBHQL[A4!'N?UDZ&=9Q.TG0.BP?0.8 N ;=!
MATQ"(?,'9EF1:34B/=U]SWR+MWOJ[J;TSG 5X<PE;YSW7&QO:$;.GFC&'"8,
M76,6!''LBP2-21SH/^$T'KZ+9K@+X;NU>I+$"9(H01((DK]*W%V4&,/\1R2-
MBJ01@O1")(:YOA AJ\8)T$UXL@:5:I!A7%;>92KN:&C\%WP:J1],-YTTZ*2L
M>SZAR;52%EPJFRN72^NF>#$XU-9O;]Q>3V]Y,JSJYS$ER[^B^ !02P,$%
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MW>\S=@U"$^8T8I(E9D8PKSZ'2-9"G)+_Z,DZ?;>:X2[2=\OHZ7Y=(%T52*-
M^D^)AP\EKF'N/@1ABYXJ,$V<)DM*['6<Y(5W'MC[)+[)7_@X[8_<-$);<D'G
M7S;VOT9TX%/9W/@1:OT'FPT)M0O'O3^;<<Q&PV$W_2 V?^/B#5!+ P04
M"  H2@Y+&G* B[4!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6QM4V%OW" ,_2N('U"2W+4[G9)(O4Y3*VW2J=.VSUSB)*B 4R"7[M\/2)IE
M7;X -G[/S\;D(YH7VP$X\J:DM@7MG.N/C-FJ \7M#?:@_4V#1G'G3=,RVQO@
M=00IR;(DN6.*"TW+//K.ILQQ<%)H.!MB!Z6X^7T"B6-!4_KN>!9MYX*#E7G/
M6_@.[D=_-MYB"TLM%&@K4!,#34'OT^-I'^)CP$\!HUV=2:CD@O@2C*>ZH$D0
M!!(J%QBXWZ[P %(&(B_C=>:D2\H 7)_?V;_$VGTM%V[A >4O4;NNH =*:FCX
M(-TSCH\PUW-+R5S\5[B"].%!B<]1H;1Q)=5@':J9Q4M1_&W:A8[[.-WLLAFV
M#<AF0+8 #C$/FQ)%Y9^YXV5N<"1FZGW/PQ.GQ\SWI@K.V(IXY\5;[[V6Z2')
MV340S3&G*29;QRP1S+,O*;*M%*?L/WBV#=]M*MQ%^&Z=_3;9)MAO$NPCP?Z?
M$M,/)6[%?%3)5CU58-HX3994..@XR2OO,K#W\1'9W_!IVK]QTPIMR06=?]G8
M_P;1@9>2W/@1ZOP'6PP)C0O'3_YLIC&;#(?]_(/8\HW+/U!+ P04    "  H
M2@Y+,,E::K8!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6QM
M4]MNG# 0_17+'Q#O MNN5H"4312U4BNM4K5]]L( 5GRAMEG2O^_8$$I37FS/
M^)PS%X_ST=@7UP%X\JJD=@7MO.]/C+FJ \7=G>E!XTUCK.(>3=LRUUO@=20I
MR9+=[@-37&A:YM%WL65N!B^%AHLE;E"*V]]GD&8LZ)Z^.9Y%V_G@8&7>\Q:^
M@?_>7RQ:;%&IA0+MA-'$0E/0^_WIG 5\!/P0,+K5F81*KL:\!.-S7=!=2 @D
M5#XH<-QN\ !2!B%,X]>L29>0@;@^OZD_Q=JQEBMW\&#D3U'[KJ!'2FIH^"#]
MLQD_P5S/@9*Y^"]P XGPD G&J(QT<275X+Q1LPJFHOCKM L=]W&Z28\S;9N0
MS(1D(1QC'#8%BID_<L_+W)J1V*GW/0]/O#\EV)LJ.&,KXATF[]![*_?'-&>W
M(#1CSA,F66,6!$/U)42R%>*<_$=/MNGI9H9II*?KZ(=T6R#;%,BB0/9/B=F[
M$K<PAW=!V*JG"FP;I\F1R@PZ3O+*NPSL?1+?Y"]\FO:OW+9".W(U'E\V]K\Q
MQ@.FLKO#$>KP@RV&A,:'XT<\VVG,)L.;?OY!;/G&Y1]02P,$%     @ *$H.
M2RL^&5^W 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL;5/;
M;N,@$/T5Q >4A*1)%-F6FE;5KK25HE:[^TSL\44%Q@LX;O^^@%VOM^L78(9S
MSEP8DA[-JZT!''E34MN4ULZU1\9L7H,2]@9;T/ZF1*.$\Z:IF&T-B"*2E&1\
MM=HQ)1I-LR3ZSB9+L'.RT7 VQ'9*"?-^ HE]2M?TT_'<5+4+#I8EK:C@!=S/
M]FR\Q2:5HE&@;8.:&"A3>K<^GK8!'P&_&NCM[$Q")1?$UV!\+U*Z"@F!A-P%
M!>&W*]R#E$'(I_%GU*13R$"<GS_5'V/MOI:+L'"/\G=3N#JE!TH**$4GW3/V
MWV"LYY:2L?@?< 7IX2$3'R-':>-*\LXZ5*.*3T6)MV%O=-S[X6:S'VG+!#X2
M^$0XQ#AL"!0S?Q!.9(G!GIBA]ZT(3[P^<M^;/#AC*^*=3]YZ[S5;'W8)NP:A
M$7,:,'R.F1#,JT\A^%*($_^/SI?IF\4,-Y&^F4>_W2T+;!<%ME%@^T^)^R\E
M+F$.7X*P64\5F"I.DR4Y=CI.\LP[#>P=CV_R%SY,^Y,P5:,MN:#S+QO[7R(Z
M\*FL;OP(U?Z#38:$TH7CWI_-,&:#X; =?Q";OG'V 5!+ P04    "  H2@Y+
M-6_\)[<!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6QM4^UN
MFS 4?17+#U 3DG1)!$A-IVJ3-BGJM.ZW Q>PZ@]FF]"]_:X-9:CCC^U[?<ZY
M'[[.!F-?70O@R9N2VN6T];X[,>;*%A1W=Z8#C3>UL8I[-&W#7&>!5Y&D)$N3
MY)XI+C0MLNB[V"(SO9="P\42URO%[9\S2#/D=$/?'<^B:7UPL"+K> ,_P/_L
M+A8M-JM40H%VPFABH<[IP^9TW@5\!+P(&-SB3$(E5V->@_&URFD2$@()I0\*
M'+<;/(*400C3^#UITCED("[/[^I/L7:LY<H=/!KY2U2^S>F!D@IJWDO_;(8O
M,-6SIV0J_AO<0"(\9((Q2B-=7$G9.V_4I(*I*/XV[D+'?1AO]ON)MDY()T(Z
M$PXQ#AL#Q<P_<\^+S)J!V+'W'0]/O#FEV)LR.&,KXATF[]![*S:'8\9N06C"
MG$=,NL3,"(;J<XAT+<0Y_8^>KM.WJQEN(WV[C+X_K@OL5@5V46"W%#@F'TI<
MPWPLDBUZJL V<9H<*4VOXR0OO// /J3Q3?[!QVG_SFTCM"-7X_%E8_]K8SQ@
M*LD=CE"+'VPV)-0^'#_AV8YC-AK>=-,/8O,W+OX"4$L#!!0    ( "A*#DM^
MCHCV/P0  (85   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;)68Z8ZC
M.!#'7P7Q  %?'*TD4G<.9J19J36CW?U,)\ZA 9P%IS/S]LOA26.["'1_Z(#Y
M5;E<9?\-GM]$^;,Z<2Z=7WE65 OW).7ER?.JW8GG:343%U[43PZBS%-9WY9'
MK[J4/-VW1GGF8=\/O#P]%^YRWK:]ELNYN,KL7/#7TJFN>9Z6OU]X)FX+%[E_
M&KZ?CR?9-'C+^24]\A]<_GUY+>L[[^YE?\YY49U%X93\L'"?T5-":&/0$O^<
M^:WJ73O-4-Z$^-G<?-TO7+^)B&=\)QL7:?WSSE<\RQI/=1S_*:?NO<_&L'_]
MQ_NV'7P]F+>TXBN1_7O>R]/"C5QGSP_I-9/?Q>T+5P-BKJ-&_XV_\ZS&FTCJ
M/G8BJ]K_SNY:29$K+W4H>?JK^ST7[>^M>Q+$R@PVP,H WPWJOA\9$&5 IAI0
M94"G&C!EP#X,@H<&@3((/@SH0X-0&81&#UZ7W;9<ZU2FRWDI;D[9S;A+VDQL
M]!36$V+7-+;U;Y_5%:OJUO<EBO'<>V\<*>:E8[#&$)U9 8Q.K"$O5&<V$,-T
M)H&8X,YX]6CO0\;0D%\PX" TAF,S1E+6 &'D9#/J9#ON)'GD1!LL >M+6G.B
M#3:"'5#0 6T=T)X#YAO)ZI"P18H6H8@&0< B(V<V2%C@4Q0&1N:F>MQ.]9A,
M\*@E@X')8%8R4!P;V>@8UNL)$1($?FC,L34 ^C&-*3'RNV%6[+#'+0""'I,)
M'K5L!& V BL;]19H:$=@]133T)Q -D09]N%00C"4$ C%$*!5QR"_UPU#(9T9
M!=Q"7(2C'J<%%($!14!  PLW!AW$TQ=N$RHD[3X0@Z7;$$0'^AG80A#@@IG]
M=%#<2VHX"PUJ,XE*QB@]:' 3>$88"'I@&T&PM*)/:"N"Q179Z@J4"(*&2@3K
M%K*%"R@1L])*9U:%F+TZ+"H9H_28875!D+P,Z!."50&%GZ@0O(X1M)"M"D'0
M4(7@Y8[B*16* 8$W"Q0#VXI9GH>,_@H%:PNV98,-O83!JH'1]-I@> UC: T;
M;P@K$!J0<@PO=$QL%V9.5PJ*>CGU9[ZY"6T4AM!C+AGG],AA?<& ="!S7U30
MXW4_!4I&(#UB6*DPI%3F>@.A@?6&877!@+H@; XZL-8)II01-"!#&)8A#+R=
M(&M,H=47C6(_(.8WTE0PF0#JT<,*B %Q0T9?:P5IKW"QW_R900$@TT$]*%@N
M,227UL2.[5T((=\GL\C,Z012_]B"99$ LC@P_PDLB^03LDA@622 XEERI: Q
MN9J&):.8'O? IRHDLV9-%=27&&:5<PJ4C$!ZQ+"\$DA>S4T;A,P/WBE0,@)U
M$7N]DY^<E\?VH*]R=N):R.8<H==Z/TQ\QLW)D=&^04_;[DCPPTUW0OE76A[/
M1>6\"2E%WIX>'820O([1G]5R<^+I_GZ3\8-L+L/ZNNQ.!KL;*2[JU-.['[TN
M_P=02P,$%     @ *$H.2X/@F*U+ @  H@8  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL?97=CILP$(5?!7'?!=O\)2)(2ZJJE5IIM57;:R>9!+0&
M4]L)V[>O;0C+@MN;8 ]GSGSCP)#W7+S("D!YKPUKY<ZOE.JV02"/%314/O .
M6GWGS$5#E=Z*2R [ ?1DDQH6X#!,@H;6K5_D-O8DBIQ?%:M;>!*>O#8-%7]*
M8+S?^<B_!Y[K2Z5,("CRCE[@.Z@?W9/0NV!R.=4-M++FK2?@O/,?T7:?&;T5
M_*RAE[.U9SHY</YB-E]..S\T0,#@J(P#U9<;[($Q8Z0Q?H^>_E32),[7=_=/
MMG?=RX%*V'/VJSZI:N=GOG>",[TR]<S[SS#V$_O>V/Q7N '3<D.B:QPYD_;7
M.UZEXLWHHE$:^CI<Z]9>^]'_GN9.P&,"GA)T[?\ED#&!O"5$MOF!S+;ZD2I:
MY(+WGAC^K(Z:9P)MB3[,HPG:L[/W=+=21V\%1FD>W(S1J"D'#9YIT*0(M/M4
M KM*E'B5CM\7V*\5R<9=@3B;(#:?S &CR&T0.0TB:Q"].X5L<0J#)K6:=H#,
MT"8-%[VL902C9!.[<6(G3NS V2QP!DT\JX-3DL1+'(>,1&&8N7$2)TZRQL&+
M.N5:@\(%\CY9L9 ()0EVLZ1.EM3!@A8LZ:K.![1!81HO>!RZ),+H'SR9DR=S
M\"P>[S);/1)I$L71$F<MRPA!,5G@!+-7NP%QL5-0>D=^;95YB6;1:= ^8C,:
M%O%2#^!A7K[9#-/[&Q67NI7>@2L]>.QX.'.N0%.&#_J\*OW!F#8,SLHL4[T6
MP]@<-HIWXQ<AF#Y+Q5]02P,$%     @ *$H.2Z0[O$<' P  NPP  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&ULE5=A;YLP$/TKB!\0;&,@1$FD)M&T
M29M4=5KWV4V<!!4PLYVD^_<SAM)@CB;KAX+M=W?O[//+,;\(^:J.G&OOK<A+
MM?"/6E>S(%#;(R^8FHB*EV9E+V3!M!G*0Z JR=G.&A5Y0!"*@X)EI;^<V[E'
MN9R+D\ZSDC]*3YV*@LF_*YZ+R\+'_OO$4W8XZGHB6,XK=N _N?Y5/4HS"CHO
MNZS@I<I$Z4F^7_@/>+8AI#:PB.>,7]35NU>G\B+$:SWXMEOXJ&;$<[[5M0MF
M'F>^YGE>>S(\_K1._2YF;7C]_N[]BTW>)//"%%^+_'>VT\>%/_6]'=^S4ZZ?
MQ.4K;Q.*?*_-_CL_\]S :R8FQE;DRO[WMB>E1=%Z,50*]M8\L](^+ZW_=S/8
M@+0&Y%Z#L#4(.P,2?VI 6P/Z84#M;C6IV+W9,,V6<RDNGFR.MV)U%>$9-;N_
MK2?M9MLULSW*S)Z7A(3SX%P[:C'K!D.N,+A#!,9[%X) (=9D8$[Z 39#1)S"
M$4(PB=#:A[TD*.R @@ZH=4![#B)G%X88C%(GD<\Q/2(12"0"B,3]("L(DSAD
M(<S4(0MA1LC&(-EXZ"!$#A$(,U(]"1@D 1PX];.",&X1-YC48LH&,PG=+;D!
MZM&=@G2G )614DQ!!^G]M8P1?*71[7/9@*!H),Z(=&# 1>QJ!P1*7#(0:&3;
M,2@R#Y@ +E*73 /"Y.J T031R.5S$]>G!*L2#H>4J'L_6I ;"J$H[?^-A(;U
M# ."1D>N'8:5"$?_48BP/N [!&(#@2@9B0-+!(;N_Z 0 1 -73( "(TE#0L
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MMG]R8_MA-7\XV_X]D='3'S4Y_S]02P,$%     @ *$H.2\6I#Y\H @  %P8
M !D   !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL?97;CILP$(9?!?$  <PI
MB0C2)E752JT4;=7MM0.3@-;&U';"]NWK \L2XO8&V^-_9KXQ>"@&QE]% R"]
M-THZL?,;*?MM$(BJ 8K%BO70J9TSXQ1+M>270/0<<&V<* E0&&8!Q6WGEX6Q
M'7E9L*LD;0='[HDKI9C_V0-AP\Z/_'?#<WMII#8$9='C"_P ^;,_<K4*IBAU
M2Z$3+>L\#N>=_Q1M#[G6&\%+"X.8S3U=R8FQ5[WX6N_\4 ,!@4KJ"%@--S@
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MNBWN@Y(_<7V)&(\NX(C\AM@*0%C?$5O$Y_Y%"(PMD?CCQ+^ +8LL&(,+MD)
MA#&\P"%>X% K,#?,VP@W$-EW?8Q;B"VZ/D:6E_BR[F#,+2R HY@2/*9$CXF
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M)+:[J(N].F7VCD?=L_\!4$L#!!0    ( "E*#DO(N$49XU,  &=4 0 4
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MD9>#O13$*RS;Q@-M%W2@"@ ((AA?\EU  4\4/8^/9^()\BQ ^Z%R#Y]05[V
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M-TNUS17ZW/!V@&?C"QQQJ(A6*9G/ME.0:8],^B-X$GNMI(\ZF2(8!7/\M;*
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MC!-44'5KME@Z ]B./QAP;]JLFC<2 6S''W%,"E9>2ISV8AO^!%!+ P04
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M[(<052X)+]NL_2"BW$UEQCID^]5B.7&HJ;>J->^\94WVG&N'U%>9>5"+)>W
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M$(Y[$ X^0@%!,2I'42I'<2I'D2I'L2I'T2I'\2I'$2M',:M ,:M ,:M ,:M
M,:M ,:M ,:M ,:M ,:M ,:M ,6N&8M8,Q:S9!<W:M6DCE?Z+Y,.8Y:$^ZWYO
MSKX 4$L! A0#%     @ *$H.2Q\CSP/     $P(   L              ( !
M     %]R96QS+RYR96QS4$L! A0#%     @ *$H.2V;S"V""    L0   !
M             ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  H
M2@Y+:K4GH>\    K @  $0              @ &9 0  9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    "  H2@Y+F5R<(Q &  "<)P  $P
M@ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "A*#DM(YV$-
M5@(  *X'   8              "  ?@(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    "  H2@Y+YP*2[7,$  !%%0  &
M@ &$"P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ *$H.
M2[4(R*7+ @  " P  !@              ( !+1   'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( "A*#DM^<-8>W ,  'P/   8
M      "  2X3  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M"  H2@Y+-Y9R"$\#  #9#   &               @ % %P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ *$H.2WW_AMTE!   _Q$  !@
M             ( !Q1H  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( "A*#DM5\1+U?0(  'D(   8              "  2 ?  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  H2@Y+OO_XTJX!  #2
M P  &               @ '3(0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ *$H.2WE;>A&T 0  T@,  !@              ( !MR,
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( "A*#DO_9N.+
MM0$  -(#   9              "  :$E  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ *$H.2SMBGT^T 0  T@,  !D
M ( !C2<  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  H
M2@Y+A=0_3[0!  #2 P  &0              @ %X*0  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( "A*#DL^FID-M0$  -(#   9
M          "  6,K  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#
M%     @ *$H.2X?WC>>U 0  T@,  !D              ( !3RT  'AL+W=O
M<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    "  H2@Y+DHW3F+0!  #2
M P  &0              @ $[+P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM
M;%!+ 0(4 Q0    ( "A*#DO1#JF0XP$    %   9              "  28Q
M  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ *$H.2].&
M@=?% 0  -P0  !D              ( !0#,  'AL+W=O<FMS:&5E=',O<VAE
M970Q-RYX;6Q02P$"% ,4    "  H2@Y+@GT7YK<!  #2 P  &0
M    @ $\-0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M "A*#DL:<H"+M0$  -(#   9              "  2HW  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ *$H.2S#)6FJV 0  T@,  !D
M             ( !%CD  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    "  H2@Y+*SX97[<!  #2 P  &0              @ $#.P  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( "A*#DLU;_PGMP$
M -(#   9              "  ?$\  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ *$H.2WZ.B/8_!   AA4  !D              ( !
MWSX  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  H2@Y+
M@^"8K4L"  "B!@  &0              @ %50P  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( "A*#DND.[Q'!P,  +L,   9
M      "  ==%  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ *$H.2P8TL>D:"@  X$0  !D              ( !%4D  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  H2@Y+Q:D/GR@"   7!@
M&0              @ %F4P  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( "A*#DML\N$( P(  ($%   9              "  <55  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ *$H.2YIBGS $
M @  ?P4  !D              ( !_U<  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    "  H2@Y+!CBPJ*T"  #V"   &0
M@ $Z6@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( "E*
M#DNU>1GU9 ,  "4-   9              "  1Y=  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ *4H.2S!FB6B,!   ]A8  !D
M         ( !N6   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M    "  I2@Y+R+A%&>-3  !G5 $ %               @ %\90  >&PO<VAA
M<F5D4W1R:6YG<RYX;6Q02P$"% ,4    "  I2@Y+/(A0TG\"  #E#@  #0
M            @ &1N0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "E*#DL;
MEN&KP0(  /T4   /              "  3N\  !X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    "  I2@Y+#^Q,2W@!  !%%   &@              @ $IOP
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  I2@Y+Z/4N
M&I !  #F%   $P              @ '9P   6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     *0 I !$+  ":P@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>112</ContextCount>
  <ElementCount>178</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>42</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-daei1</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-g</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-sosap</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - RECENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD</Role>
      <ShortName>RECENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-i</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - FINANCING INCOME, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET</Role>
      <ShortName>FINANCING INCOME, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-LOSSPERSHARE</Role>
      <ShortName>LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-sosapp</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-sosapt</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-sosap</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - RECENT EVENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/RecentEventsTables</Role>
      <ShortName>RECENT EVENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-it1</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-i</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - FINANCING INCOME, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables</Role>
      <ShortName>FINANCING INCOME, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-LOSSPERSHARETables</Role>
      <ShortName>LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-LOSSPERSHARE</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/GeneralDetails</Role>
      <ShortName>GENERAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-g</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-sosapt</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-sosapt</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - RECENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/EventsDuringReportedPeriodDetails</Role>
      <ShortName>RECENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/RecentEventsTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - RECENT EVENTS (Summary of Entire Series C Issuances) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/RecentEventsSummaryOfEntireSeriesCIssuancesDetails</Role>
      <ShortName>RECENT EVENTS (Summary of Entire Series C Issuances) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/RecentEventsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-id</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-it1</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - OTHER CURRENT LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - FINANCING INCOME, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails</Role>
      <ShortName>FINANCING INCOME, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails</Role>
      <ShortName>LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-LOSSPERSHARETables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="igap-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/SubsequentEventsDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/SubsequentEvents</ParentRole>
      <Position>32</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>igap-20170630.xml</File>
    <File>igap-20170630.xsd</File>
    <File>igap-20170630_cal.xml</File>
    <File>igap-20170630_def.xml</File>
    <File>igap-20170630_lab.xml</File>
    <File>igap-20170630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>52
<FILENAME>0001178913-17-002404-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-17-002404-xbrl.zip
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MT=!8#)S1ZRE5UE]\%0 POV91Z(<"5BT(X4FN!8C%O/E(PI2)LG?W?X1D'$8
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M_#RHN(7ERZ^7+_YQ=>.MMTZKQ:A](/Y-'1_/F@B8W&]?]7/=_26QZ9(GR'+
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M#_8<5$5SZMAWP/%,K^^];<_6Z"&CLPV=K(OV&HO@V79Y.(YH"0]O3H[IJ#2
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M4-J2MDD?DY2&US&W_/U[3.'-B(^^/N!C[*^(N?S+3C#+.D*MS;E .U>TW^T
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MT>A,"; 1=I8Y_N DY_Q BIT!]1<K9A1K1E4,GX<IQ>F$,_(BB?C]/,5M0K^
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MYJX7[>C;Q>=C9F:A4.02D)N,TKAO\J1^99XL$2REWOPKN!JHZ '5>?GR83A
M_T] P-'=#9:Q%W_AF]B+->;=5T$A*#J)XWL#Z3/S:<@T1ABO"8L,#Y,H2=+6
M)R+4U(BD)%#9)F$N2.)%DOWW9BV*'0.IGS4H4=*]& N%;D,E:E]PW'M$1Q",
M;(.."$9T^"-]9%F6.0ZHYSMZ8$[H09U:HDY93T^=DMK4$1R?8RFDAW6]Z@-)
MT:^3:5^!);)DS(,&U8/#]#_FT;VB-*F^<D5EXKNQN 52.3)=_?BM]A[.(GP_
M#S,6??='2-@-#5X:,F?IAW_.68U5_H[ML7< ZEMVZ\+M_7^GP36^+![R#.=8
MO3HZ^DK V+TX5KVUZ%0\%W[X\F;](L[R=,X]IDP OD_N8D 9MG3]2-D5(B!-
MC <#?E/$IO!B7,1,K(9 FX4+%R?[C'2+<<F NF\TH'3*F%?SW!C'*(#[DL3"
ML_M!7J;BDN77+</"6\(CPJ3WA2@3F$FQSN\*/OSR*9=##3HJ;M^+5U'+F$Z\
M3&';KLAL1!$(:683\+!Q6K^SEW<]I8P.ZS2&;8,UWC9X4M#8W4WHWZ _C?!;
MNXQYMF-V <A.Q F@\&=%^)<#:T<P,[JP@X 6@XI;*'$'B /CQ'?(2TF B%"I
M6 8*T&H]E4J<?1%$/YGC^ (N^ "H'D^\JMB>B_$4[!0JO \J(]Z@%>HZ]QK^
MPL$0A4EZ36)0*7EI,6X@(+-9$Z>H>_/ !)A]@(L 7,+V)@@,+"P$K"M!Q=.J
M:<<<F !X2E4\XP8GH(VG;'NX3O<BSXER'D3PAYI-P8(_4GJ-M,;NNQ=V!^B=
MPH:@+Y<97O"G"*2NX)LYQ0,@R@ '14,01\IX@@C2RFR>SI*,WZ(&%,O2A>QB
M)Q)BY1ZW3! J4PB9>EV_:#^O)H+(:W,J15D9<'[TX>O5,=[?$^X!Y2<)P09"
M0J("MOWU2NTF5EQGE?$"[!I,Q4.>AM?7&%6N'86G]'0@/F4),)7S*%Y.:<0,
M@0Z< 3D*@Q$>*,[_F/H$0X[$<(O;P^U=OD(>X"-"&!I6(H"7ICN'Z:4?"H8U
M,"M2=EVAQ>0VO"8B] (X"$B).%.='4RE:O0BGB=!0;/%QN.U6LR.AE ] JEZ
MD%L21DPE@&=F3&U2CN9+W);O_$J-B]1*N 5NF(+1\AAD#??E0BDK[J**4#?\
M4KG#SOC56NO%.$;$51]?=1WM:4?B!?ACM/)Z_+[T-E1NQMFE/QQH"?A+I07E
MPG75]2H[R@N7I*K310F*C&!OY]<8)A86-Y7:#<F8@V=,@:'+V]% O7/+:I=N
M.)="KE-$J82LIF]*4=*H%@G[3#@@Y:*%NQ6#&SC?/^%\'V;,>5#0?I)%_[=Q
M(V],AN.13PQ[I+N>/38"ZEG#B3GV=7.R_^ZC1TP(>K_G[J-O5*IZZ*!@ <#/
M-_=G&PRS<$V>%\&R>$_!0K1X0'7&7=:,K:4JNB?<1 +K*J>Q7XF<Y18A&T2$
MZBXHXL"?,ZH,Z LCL.(GGQ(4K1BX6W&1\Q@'  '&GD?<J<)3NG&( 5?@;X",
M:%I)-44=R@^Y;5>$?R_A@O+3O[R>9R?7A,S>7)5N^U*%^YI$&/2>?0=LOXO
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M$]Q+\0KS-L==8T"WW, BPFLQSRP5A7^RLDA%O><A#R$L\ICJ79)9:!^  33
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M-V9W#H+AY4G%AX+UD.)K[F*9IZR*WQ@>B[&4"Q 0,)>8=[8O1R@=54O4L+=
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M*HQY")^,DU95X8P[.[OL<H,WLN;2DKMP5.&5I7-,>53F)BSGY'&-+(_9!M\
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MVKUXPX%;Y<!8JAPX 3P*H]U.XV"Z-)W@$S5=X[?M##ER-X5=PSS7K.3(&M!
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MIW0?1+$39_$)SL)M/UWQ><E%%*O[ZE-09DM?O <N(QZQNS%86K'\KOG"Q?D
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M1""DA4U0YY+SU9A]&^M9R.AX%<>PE[!2]Q*..AR[G<;!%/UIK([:%<*SG8H
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M'8*L052A$ KU>C70?K9\.Z0-F_-6E"VRT(_.+Z_>8/R>U1[0FI)PV8!(B%3
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M?CN.HG$#VW%?LI(E2GTS!\PU!JMEUUQ)N]2 8,G0RWG"\+DR4[*J+$J6XKG
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M&O"ZM08< R+;9Q[]_:</ #>\^'6LZ?#_,JO_=HZQ_$J5QO5#7Z_>_P0'$\3
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M?5YKWP^'TG%O#?W2N#5&KUKML>!P9?2@C(?(8/2@?.MV?QG(;,+L=4>9.%(
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MM2_?TW]N1E=7'QJ7'][<_!]G)X$1A/ZFD\N7R]5_<?7?'-O]_H'^\VCX2"-
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MDNM?B+9^^ZSF;'+W*]0))18+($QRW1!%$*HW.$5QD>N,2%"[M4,+K5'[U11
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M33.<APZ]B!RG_<#SA8=F]'[6$^J017^.[K'O=U'0FXR,%^;)49&&:H5P"=9
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M$;AQ*((JQV\D+,R\(\V]HF,Y9C=[E( &])9F-2<[X,)-'BK,:A4,+^$0Y3,
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MWXR&?:R?:7;L#-54/A$*8G['.1*(RCJBI?FLO)QU:XCT$3N#2Z_"%4:TE#B
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MI]$UDF*M")KJMV@@(JDD1<+PVL'3 V%(*&J%8^4+4 _'O$&IDNKFR-2*?':
MV.NHM*R(]S1;P!QK2,!!>O' CG%@V^FFEU-3X,DIUZ.?-%&[E!8)Y!RFK=]L
MV J29N?)%I(<>8:*:&I2ITGI#<JV<M KZ&:?N!;**0J54I)Y$53G@(04<-(\
MEL]3'.^\Z(:FO#@-&XFS)-YEVF0[ECSN?) LU:]]B7H89H?+$"TEWQ[.!I 1
M?)3< Q_\H& \;F !^\!J\WX71?LBU;:(?6QE;5,U=Q"[ZV"$(8WJABG8\.)
MW'"%-:$-D!:=W9(W((,$0D@9BM<(:05!.';",D4\#9HK\P).6 ]\[S[;UR0W
MWIYOYR]>&O _?J197L6RZ])H3/L)Y_>GB3M'NH%-)'_VB73$1G4G6T&$RFUI
M=+-7PA(";:+!(@XJJUP"/UKM\BSWXH U5X3*3=WK@S__*B;@R$Z=9'(._/;K
MG[CC&JQ.<E+:EY^+*1[&)'^$EP]N;SY6&##-/X!)P6C941"Y"P/6*5B' 7<I
M9H>542TI#)CFY(&G7:K]GY&LZW 1#2EX OW$3G?:Y$H2F=-U4J-D:SWKT,P.
MD![%)!=Y+WLD3V+9$:%2]2)U5/, ?+A<[IZ>TN09\G&<);#P;2["E"UU29HM
M6I:-=7)&(83EKSLOS6D:[>]V]W]CA.OD<OL4)7M*&7G,%K@=NV.(L"[]1=C5
M]QV;+=QV:\<$XN;CLT^QN5JL,<WXS2G,_@N>R3SFA366T-^ Y+?R6^SG[-@0
M184?9"8^3?*$T.+C?^#ADN+S97#DL18"'C96]L>EYS\6??(^2:7N58[!, 'N
MIN*8AM5S:0@WDLDP0F5-$"&#XCUE, X#0IF<$KH\:M>3 7^TL-TR9K(YPUOS
MN)JV5GO.0?(<AM\>WNQ&B.UX84A@?7@+-"A/-L2KA*MP_?M9R*MF'KZDFT3A
M6-S[&VNWS.OE()D9!RD_9NDWSA8DE]JQIIYV6L_%+G],TO"_:3=OVA&_\RK,
MCWW=-(F=4?>1V>?=L5O6F_02,C:DSY @ELW'*JG@+@X8U0UC?>63L+"W<L-:
MMHS%6\F1C+K=C[R*Z6?LH"EM_.TOO/Z)9VI6=]:M8GJ:AUM*/.!L^H9S0RY]
M+>]RV:#.*(N@%S70;;S,G6J :GY.W[6#)N]TGW\],WOR-@^>]B<X*V= I]SW
M+XGWW7Z[_/P4BG1L_?OL-/*=3^$INT6:H%,(QS7])FR1\0T<)E+)-9&KBR[,
M@5U0BW15MS3+V:S-BWH./'WS!S&QU\F/'E-BQU:/ "*ZV=56G7/L &GNPB,.
M;G(=.C%:U.RXGD9_Y4NM"+E@VT,M4U0:%@G=<1T2WR<IVPGC\UV:TMC?7W[V
M>3XV",E=,SVSB$]"G8.C-;?38,)A36J%%-JQSH[><?K*X86"?)(ZK)H%MII-
MHA#..KDIRAOWN(;;\3E;-(<THXYILF":'4I#-55OW%#"H$SFFR>DK&']>W+[
M+JX1KMQ27[G_J1-'T]^O1ZFMZVA!#KE\2_K?W30[AN%IJJ^_TBDYN<%IFD__
M'J?O"$-3R4(\P3.Q64ES4EO%=!UNJ>'=OTOA[/2E5JTZ9[5_/3N(]#II+8K'
M=90J'Q65M2N+.+\-U,J[H:FB[MQ(&<XKA0UMGE1(S%8 #H2-U-I4=;02!*G_
MA:0ZA)/+XF'I_+#?5Z[LB!LAPMJ::))53-V@_B*U_/Y7UMQDXKA'W(1%-S6+
MVBU]"+.\L"P7.W"]/\.]E5U'A=59A"=??H9Z%FR_7F3-H.>J;B_D[<B*BNG<
M4*>:="Z^ZFSA=->%U5)[_$_B6)R=M5.R0%>BR892L,4P.7$.#RI"/@00/;5"
M]KWR&Y!ZA$UBD6.JJ(MVS!JD@SM)Z;8]1@K>*2:[: \7\4JG@.XZ]-&+O0?N
M;PV(;F#7K[%>XOQ8)^@D]GP?'&!A=X,HWSBCBRA*7L"_[EB;C8NONCNE.^O"
M^EQ_]$_BF&G.VBD=!I/XM/%EV&3@T\0KOXU_#RJ/Q*RU25J>@F_2!/*V!SQB
M)-M%.?OAY>><QNQGG\"7=A$\AUF2[JL\;Z8+VL&BG=^D)^H,Z8)]H%PDLVW2
MQNCO5T\@O[I%0>4S_@683HLX2.D+^<!^1_/\A"QC_VM11QZF"X2'>_&>QQ8U
MKFC\!@^))>#W$07[8A@3-B/>G# V+R<O[((/04H9_6W'%(SV;,**%AP]@.^(
ML_ ('YDAU.]8,W/R+^"8H\=JUG2SE4T]-OJQJ&4HRAS"W!4U$\D9W_.J*3O;
M!.4Q7^=B/1&Y;;)E_E,81>>BC.A^D4%^DX]>^BO-18;K_(+MXI7A*5L6,2C*
M49I2O./8PDD[I1-O.(EL)!-Q\@;IZMJ*3_ CJ ^%I=ET85\IZ]WNX<@)$XPG
MV=GRKQ6.>FQBP2_X.PS\I9K#D&];N+0<*WMF9:Z'#;IAQ^?_YN?O=1H^/$@^
M)H.YW>7.'-RD.G6F-2L.: _65\KEET0[AKF7[FMOGGH!S_''[T 0R,?^WV<$
MXH&&VSO8CE-]7SB7NL;H6F@I&C$&IFH!\R/5U+!^L*JXD>/5H+*TV!80#;P0
MLKSRC/(57L5RZ@JOT[@IM3OE*OQM%P;"8LE_0>63RR!.E^Y! YK2?/FT8)L=
MO\-UE9(4U^_9P'I"HI*9 3?PMI!]S<D*VK"WU3Y"'Q(V3V+VEPNPF(?W.^Y$
MU#^)!PF;:64=T6#-*CM TNR(G41]^6U/Z: A -VTI];RR<MCZ#^2E-T80WB@
M?TG#G%T986G.J,AQPY_N'Y.(77LSOGH7IW6>IP:*KD'IM83X[,L>Y"2%N */
M7UO=S)B/WN=PN]N>T9AN0C_THM5+S%1]#)_Z^]S$.]-\Z&^.!OYZ1HQH[]5V
M$+BW0AJYK\21I)0'&!9A"D64%9L)6T Y-[X(LIF!6B6@@GIS%NNZO21T(%8W
M=3"DVV)>%\"5NCN%^PGQ-K!PQTD.5\B'\)GR)_)B93_2;/B0)EDFS#'@8@:&
M3)\_W=VQS475H3T,SK!MI7@%82,U#J3:J-@%).<A7I7ZKK!$GW-OSZS7W?-@
M*[.LZ#7-(2XW\ABV(;"V>-A6KI_#93BV%P]O7L<H;"\ !P9':JU*C\[0F H&
MD5"N<#,X8DY\E?+*MV =J<O\^"9EFUGR570XL&)63@4)L4[AL"$MV4[.;DCI
M_M9[^<A0FH9R>H@>6I=V(J.Z3<N0DG!VP-AH)U41]U[8F:J@00::GY+TUV5\
MDR8^S7I1TR&>!39*A96X:5'B XY*/2D4C]' 6_V3H$*&G?=A'&:/-/B0)$$O
M=CK$LV!'J; 2.RU*?-A1J2?5WRUH #S!SC>[,+KH?;9Q&ON<_=YQ(%.>Y%YT
M9=/A3=VZ'5T2A8<?":>9H&61B.*8>Q5Z]V$DXJUXII:NH]H /I?3UKH9333U
M,J&9S+::2FESRA(@Q(N#ZF8"N=[#?#>)77P:%"Y\/]T-0)^!WB7J>M5NHDU+
MC 9E?1I*3^R"_MB7W%7^2-.F4L)/*H28 #5,[-G<Y06P;T2=+*"?!TLL[T!]
MI>P"P$E\04.B6L1,YQ"I)?IIK2'%=CKI4Q/KB'!@7;%_>P_T(MP4KA,K=A<*
M8S]\\J+5YBKQXNP]H^:/#,7SL#291LC $RI_< ND<VB6>C0*R?G-DD1"+@DJ
MP01RF9:BP:89@7 1MI$UQ.,X/'0R"Z[K5_\/7AA?)5EV1C>,9NU]UDR.01)F
MS ]ITS1#CD@3NQND?R^0'O/XN<"T7@U7W9@RL@%N)*C]%*?4BZ!@1MF@57Q!
MT_#9R\-G;0737BZ7Z+1L0A.1/2S84&BGKO1@+G 'I;:J.KFPBI9A B*&)DA>
M8I(FNYA;77(17H,#FTOPI:)97CQX7=![W45,2>G67J=5M6TXDLC07+OTNLG6
M(T%9W;A@H_93&H2YV)SOO?A7<==/X/PVQUGM?1A[[. 0/RQC/]F6(=Y9QZ#7
M0XKE]&RKIL*>*EC8(@ \)R2FQB? (\Z0"T@$3N,@:R3(A==LU331T;H:#_N5
MN5=39;[SH."">5-XC2QP>ONKVJ?*0&U![W(Y[E6[#VT.,TT?!K;^1-,*L)TY
M"H52*5Q]^5RUR/5Q.#.4V:E>[2%F<BQ LE?5&DKG.-<MMBN*;1(.RXMG+XP@
MW0I$KU=M+HP'9UX6^IH)-UB*RS5N9!.;*]] $3@.0X<IWP4V,/,8#@AD%H5S
MB)>+P!*>H0<".1I)05"9G#J9DMNE,!LQ,Q=AM&-D%V'F1TFV2^DRI]ML<0_)
MQGS=G6HJX2[GQ+0=TIPJTTA&<]F;M#E]-59_>%VSQ;0C#)2!$?O:W6"0@%>'
M9-,F4$2'%"EY=YE(] 0),G8\W/4>>(L[-/F2383L*Y[6F3.@!G<Q?Z7>&-:9
M>BD( -[71 N(ZT1@!WF/WD-A'@AQN(&^B/.0*QH^TSHK]^5G/]H%-("7QW/>
M(![EOMI<>CQ8&+(V\FX27O,ZSY-I9#OU_9FR.UI^0E,(1C.!IFQ-=UJMX:8B
M)Z6)I;SO9<%YX?X&L8>-L/-F+8'.E?JD*IL+)O4JVQ(MM&_D,?0B?R<JV$']
M@;X)3;[\/U_AF-1W58JV2W!,7</-2S.2:E*G584,RK9* "GHT$P(@W*2[:<B
M)9R6_,RI_PLE=*["6-Q1[-K=()\10I+2!AA5M%BAU%6P'T[ 03@+$DPI"\1P
M:SM?PD7)QT]/27Q>Y6O2],TH22Z1>$!36]5@AHM!@]_QNIN2F[82%+1V=Y$<
M9L(RG[I<&Z/3Z*-+A3\RG?UK2DE_4%KY&[O4\+LCIH5OZG^=Q M]>OV^UO=Q
MSX(ZNR8ID6=FQ8<^*WW-"(S9TF8L<S"'2]!KS T>)+XS<+!O[>"C_/ZH LFQ
MFO<:<X0?#:1EW_S$E+^)/)__8P'50#[2;E5H.PYD(+)45XKR*OG$L%:<A+.2
MGP6S\0)QM#%[)?G-<>%@\H;-D>?\ZUGPQI;%:/V2K!^37>;%P5W(%BP:KXIU
M3;=.V' AP\@ E:71!UXHUO(=*>FM%HE#TG*E]V%9O@VR7U P[&:PSMW5&4/;
MH]-J[1!V=\FXAC>JAIP]+S+@#59<@E\M@31$B,VK(636C4M$B"QC6&?Y"EMF
MD_+*)58:TGX67"-IK:]M]$SEKUWRS[(%*(L55VV41\U(CFS$;'251@N8V$)?
MC@I9I80SGA!@)9P7STA!GE.[00+*5S ^#34'# UPS3,H.I-O97EK^Q$)&_!.
M:P:?3"BRH9ZN1?U5T<7KN+B2P_G\OCQCB_?M=FD,;LF<!3H71:<MXN RSL-\
MOXPW2;KE?:AR(+5FPC7T S3N#FW)RKT5!#-I<).?2_[_,@[@ 0?Q,N9Z%5/]
M<5M!Y.Q0K56P0HQ$@0L>.O6TT>^,\-C7K_);[,+8/^H-(N>C+BDHC7I%@7/4
MN^II1YT1SGK!J0)@&]&RM2_[FG[.SZ).5. 0/ERC,TQIR8OMD4+QDC"%)!4E
MDW!6 ]-)GI!-%4U<QGWS>.)9=N%IPKMQ#I].S[[H;O)E.2Y?S3@PNSC(EO$M
MS<#:NMI4*0/AQ)^!%\4M!9!!5UPS69J<8^/$(!O00]H@#38(8\<H4HB#"U4I
M4%RG,@(B22WSA-129\'"DAW20R\Z9VN)WBRM(L(UC@8-Y<P8G)04M+/N?5?A
M/-G*4(W=^ 9(@:+AV/1DL\P]-O4]O1,'1(*PRS68MTN_#4;"1B"#)(DCO:V.
M_TE<V'+67LEVDL2G1N\:LJ$\<-GC3^.T_"R\=#[9>8K!<^>GV6PLI55):7\2
MP4Y\$@:L&T%+&8H#!2 #UCCM328V9>DL87%+A"P>%@)F-5ZX:-9AG]HMZW?I
MC(75!:L.1A)^%W_(6K[.E?<5_WU$17@2O-._Z?7'FA64^O)F$@5.H'35TP^Y
MHI#9+%W?]@XK,0XY./U'@^G4C@W7( W26?*][?C"50D>"WYKX^LL ZFWAMJQ
MO:*![+.;]@[DW/;4]BM@_<C'#ZWR^)FHD0V;A:KZ"NE%E&[-1CC?/(NF<#;B
MU]K201*.DE52)%Y.L/S->9*IXF:&R\ VG&,;H#*+\Q**8;QAMZOZ>.-5SO#L
M]T\AA("SH:DJDL/Y*"],ZOF>VV-A:PV+3S+:;*;+U2U]@,KIPKG-V_.U"I:9
M![[R',4R</Q/XH*?L_:J,GP(T:_=!#"X"^7M9[B(5XXBW4;UT8N]!WZL % T
MAM^OX5)"99;!!GA7-]+%YU!>020*7$.E4T^*?6=TI(YD^1E(9SG(W5%&$9A?
M9A0TR'I=JZ#4[YQRT+/, 8XHXOZ\*$[O>E\4-9TS=Q23F@T0R$384*#54*IJ
M2V$;I'"C"AL.:6Q%S+TP+MP<*@?OPN8USXK(E3A[:S,X'2J,HZ-6<=3P9&4L
MI\WP'#R)S]Y9SF*)T/$TUBC:A<H[_%!1JB@OZ (%[RJO<B=K.KOA4TM *$@=
M0T*K; <4$AU&6.B4U #C_/2M8V3D+XDM,F12U\C0*=M%1I<.)3(T2FJ1,6S-
M.-I(@!E*!$Q<[.!![(8G'^>!2OQW99[^HI7R$ T4@&SLQFG?'=0?R[ \\;A8
M!(S ,:$.L<S Z.'5Q0L"_KUFPO=F.8-.YJ9Y3G_-#EC%11>HDE.I46'%BA /
M0_3N2SI>8H&/?=8N7\'P44*C^=S9,.AS$;/:[\&1R(=$H>M$V1G<@@W5A$HK
M=NDPK+7FCY:("RE3-4=^SA%RN1N57Z9HU:T+I4%?O V45OW2 1L9<LIWQ"DP
MTROKM:#%MB$#<5**/4&(D*+E5E:%<_Q6!;6*NG/?L O!D8? ZK9^CO^VKE91
M-P0X3MZJMW[N&UF4P@I]ND[#AP>51XHU*Z[!&JRWZAG\.8G85^1$Y^+%L*RA
M5!09$ 7#X&'ID3:\Y//4X]G.19ZE$^+=)\],Y&/H/Y;</%G38Y&4220^Y]%G
M">N4PK&P&0G>\<*8:>?5=.]:-/='WG.#0:7B?B6X,JBN@E8)I< +HST)DBCR
MT@HK(O4*X$N%K?/*S;1&V?\'(&NX"=1%!#ZP=O+"!1?P<%QXHJ@.=R,E80;?
M\&:H@-CVC4@8<,.8G?/VY6VR\IF7[@/-6@X":BG];1>*G!8UYJ#JPST\9Y"7
M-,QSRA-6PIM'Z7+1N)AZ#,%_8SKD^_*7S8^(S][S\O,0 ;I+4Q$+&M![MCS'
M-&-"4A*%[+Q)XB2'MFWADP'9@2NX4 OFZR:$8RQ\XX)FX4,L"DC\B37@R=N?
MP'_8V+')0D\(^T%UC>9EG]D7>(WGES"C3-U?>?1PW=7@VYT6$8O0(M8#=1>V
MIW,AB&15>0[RMUT,SN>%*Y6NXN2?P,F*,8J\VN*Q"!:/./-\H01/NN5M-F$4
MLH9F96\68_(G^'9#!"CIM;--EDTH-($N?TA8;R-8"#YZG\/M;GM&8\K&,?2B
MU4O,\/,8/O7,>STCYFG>J[5J5F\%$YLL)1=)2K82#)V9WYAH+9B*J=V8I!TP
M\MR0]4SCF=[YK@@?"=/*.,6 AAH\=[O[OS'$KQ/(T=2WA=B*>9W 4K;A]<#L
MA(2;:K-A^P <UL-V($]S@_)R$E$OR\EW;]EQ;)^) *!9L+J*Z3K<TL+W3<)@
M^]>XL*74K8L91G3*D\L^"3+R$#Y3?@ZE163_/.EEXWCG1>P\Q5TP&.U9$N\R
M@Z-E'P.NH;'45DKHR=E@SI5\Y!X8Q0-#>UK?L[,2N--ZZ7Z>'&63%B]'-7I6
MNJJKES>/K1FFYSZ1J%IAHGZ[J-X_WS7,U?($'"@ UY".U%Z=[KMCEB_'^?0M
MST97_?-=%=$Z7ZJ<%5QWKD+OGEU+X+I3Y#T/(0K@7),7QX('U^#:*RSMCOPV
M&-6L9<;V4+SJVF2V.=RMQ]:G9V:''JOG!/RO"0,>$_QR!L];^B'XVR[+H6G9
M.JGKH]QX8;",ST5<V"TM@>N+\J*[?+5I9IRY_&T7YOMUTI@F\A)_I _A@L&1
M6REM&?7G> !,'=+WQ+[(J\D4H7UIYZ-P<ZO<CLIK&N4?!DF-50O!+7\)MBV:
MY;=L5S0<XVV8<,%E@,:J^WI8,) 4S)^\'C9<I(LBNK3V%RKN9YG(^#3_@;'P
ME&8GFH[/B]GY6T>/:U#ME-4YA/-CGNRM,^<>42;@*(^P9794?281B1+7"/6I
MJ7?-:]:N%BSS)*FLBT$T:PGQ,VD29VS2BZC+]TE:I61@ 'L.?<7.?(@P7.,Z
M04NZ0U]EL*B],?VF*/ZL^U2EO1#1REDA<\;+^&IS$;(]/^_XA#7NJ&7+%MDM
M#7:^J!NO.;)H+NS3?@07EH[80DV=+U[O'CXF.=NI/?4*DX <%I#QGS-)21J4
M#L1IJ1Q_Q=2>$U$C5K34[U1R:/;[FFZ?DM1+]^((/1JV@[_T.K$[MID3 5A^
M$S+#-B^5*2XJLX#U8WJ3!"]>E/T::@ZK$@4N<.C4DY(NI*0BG-?=L9%0Y/TN
MBO878;3+ZTR2#4.Z?"6TY\4U2L,5-Q<TWH ,-CVYD(8+2S.UX3SI"6G^ 38M
M?>TOB0+72.G4DRX1-"</W-Y7UV.;*[-RF7A=;!!)NH@#;GP(MZO-AIU<=?40
M[5F1C=%0O149BZLW[6*38^=^V*]"(032@H*465?*"^\Y##YZT:^>9ORZ!+A&
M2:.=5)X)R BG.WIH-'\"7\9^2KW,4(I)3>?N#<6@9C,#D42$:_P-&BKR$,$Y
M,"QH9RY"&M+-'>2YH@][\_JI)\4U$KUZRL5&&0/)"@X4BR$_&T'^-V$"6B<W
MA1.PZ;QHPX1KJ 9HK/8JX2G3Z[CSTE7:_F1XP/I:UN TE;F3:9RMJSKU*KAT
M"7!!0Z.=QL1)DIF3+"^>8YI^\")=+>[6KW'UM%(WR4H"1(11S=K+*QXKE/$K
M"PTT?:TBPM7C!@TE/QQ!2@K:F=TM2LNKU3B8R7&-B)6NL@-#98E.BF%Z0#!,
M_Y8\QDS]1V^K&9@N :ZAT&C7[7P@(X+NV!>I\E"29OJ-7J9QMM'KU*OMB!T"
M7..MT4ZR"%9D&.RYJPT[F'!SILYJ6U,@ZVZ->AH++(^386<K;G2=Q]UFM]VR
MZ_)J4SSXE"]"V1K*;^FKR%KRX1J=84I+;E7>_0YBMQLE9.'!-(KJ5ZOR<6N>
MY_T/:9)EY0-?T41]:1\C-:YQLU&U.UJ<AWC5\R.6PC^Z9O!4/;=0DI@&D+%'
MF[YHJ !<0SE2>_VSLF)<J_1$J9 GTA3-FIV(-4_5<M6#EHH.UQB:E50];NFF
MX3P.Q.,*?;S&8AT'%=QHOQ)K:VG@&,CK)%[H"Y8:!]/,BG= K?0V#VJ<Q,18
M;77&(%W8!<K2($\0T4V#L_U9XJ5!Z;V4I!EX;VY!9]YCZ^2,@E?=7W=>FM,T
MVE?A[>43+SA[YF&\HT'AW"EOKPX_C@M;,[1<$XC,]^LR<)S]EV,S!(?:70H.
M7HSDM_);[.=9SO#*@QA.H+CFWXIL)N6C/*_267R^]+^=\>A7]M:EYS\6/?8>
M? XZG:\Y]UER(T/6"-4U)SXVKO=4N*92)J?$ ?>U]F3TX!OGRJIYX(CKY;RB
ML>]MQ!@4U'9C-("H5&JNKJTUM%HR^S>H X0A@\;A+='?"\TP^!WM*C"ENONS
MQE2M)\4%C%X]N\,.#(1S\$QO)<^LMFS0B1W1J>Q<"+^Q\JD<+@+?.([27SF^
M3-)IY6AYT72TY+\NQ)$5 @<C6,^*:+-;"BD#_;P(H> 7[N+Y<YW\Z*5ALLN6
M,0_'92N0;'88+PH7%@YNA^17!LOY<UDCHY99!(QPJ>6+\3SFB2*R>AG[R9;"
M4E8DZ>D$U<2!^ %EXC2A"F,EX8+ H<W0;_;-*L9?)KL<_O(5[.U%1LNMR'@:
MA#&XAM9)/L&IK8ZF;I95*5/:>9"'I:AT[!I%N^STP6/]MHR?F0))NN_D1U+]
M_I=O?XGN(V=CWM*Z&&NC6MTQK(A."".;J8,7649S55XB)<$O[]!TL5HO:9YP
MJA-2T,W:R?K>1=>M/?TY4S<V\TWI 2M3(>I>@W+=KFZ0SHW?ABKL).I;]7U-
MB+/[%?H91Z"FGW\0>KH>9X?;=/-,72NGF5+UL$SURS^@Z6B#<LH AX+T#T00
MDT4NLKMSRQ [&]YX.* .N2*M1J>/!^>D,*MJF"GB\L_)9QJD\R3+07^5MXZ.
M!M$@:%63+MM *+J[()VIPU=//+M._" ND5=)INQS!1FB;C=I)X<H%+1$$),O
M@?RK65)+L>MS[%=JETA09>W5D_[RQ]F'P5;#[E!4+.50E$PS7EUY)EEX,4GI
M(],E?*8UIMXG*0T?8G%L]O?KNFP(F_+\7Q&WU=2I(KD7WMK[K)Q21_D2IEEY
MW :J<P"WOM>>XB>D^"HI/TL:W^6+<>/+I/XT-Z6 !8M]?K9]4>I&$[8,Y(@
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MSF:&*I%S,_*%1->L&IKJ/M5N P>38S-\?D:A,!$X C+=I]IM@ ))PA#0Q!7
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M\S"QW*WV\EO'5+L]T_OZVU/_2NDQ8/'5 PK=97WD"Z\RF%9V-EV=%D9!@HB
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MN>C">?RG>P?Z4MGC%5*[^A9/0;.S_(K?T#_NG!B1G_P/4$L! A0#%     @
M*4H.2SE@\N9GHP  @R4( !$              ( !     &EG87 M,C Q-S V
M,S N>&UL4$L! A0#%     @ *4H.2]E$"HOD#P  2(\  !$
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L &EG87 M,C Q-S V,S!?<')E+GAM;%!+!08     !@ & (H!  "N8@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
